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Abstract
Current strain development has been hindered by the vast biochemical space in nature. The
concept of modular cell design has been invented to enable rapid and predictable construction of
multiple optimal production strains for efficient production of a large variety of biochemicals with
minimal experimental effort. While modular cell design principles have been successfully
validated in some cases, its development is still limited by the small library of the production
modules demonstrated.
The goals of this thesis are i) to establish a framework for rapid design, construction,
and validation of production modules to explore a large space of molecules (e.g., a library of
esters), and ii) to demonstrate the modular cell design principles as a rapid strain
development platform for production of molecules of interest. This dissertation consists of five
chapters. Part I presents a framework for rapid design and construction of biosynthetic pathways
for combinatorial biosynthesis of C4-derived esters including butyl acetate, ethyl butyrate, and
butyl butyrate. Part II presents the de novo biosynthesis of lactate esters as green solvents as well
as identification and alleviation of the most limiting enzymatic steps in lactate esters biosynthesis.
Part III presents the development of a computer-guided rational protein engineering protocol for
improved production of designer esters. Part IV presents the establishment of a 96-well platebased high throughput ester synthesis screening platform. Part V presents the evaluation of growth
selection of an efficient butyl acetate production module in a modular (chassis) cell.
Using knowledge gained from ester biosynthesis, the work presented will facilitate future
strain development efforts for production of a large space of biofuels and biochemicals in a more
systematic and efficient fashion.
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Esters are ubiquitous in nature and often responsible for the characteristic fragrances of
fruits and flowers [1]. Esters comprise of carboxylic acid and alcohol moieties, that can be linear,
branched, saturated, unsaturated, aromatic or any features with carbon chain lengths up to C18 and
higher [2]. With a diversity of chemical moieties, esters can make up a large space of unique
molecules that have broad applications as flavors, fragrances, cosmetics, pharmaceuticals, green
solvents, and advanced biofuels [2-5].
According to the BCC Research’s recent report, the global market for flavors and
fragrances was valued at US$26 billion in 2015 and is expected to reach US$37 billion by 2021
[6]. Cosmetics takes an even larger share of global market valued at over US$500 billion in 2017,
and its market is expected to reach over US$805 billion by 2023 [7]. The increasing preference for
using natural and sustainable products pushes large fragrance and ingredient firms to find
alternative sources for production of natural ingredient [8]. Since microbes have long been
exploited for production of foods and beverages [9] and biochemicals [10], harnessing microbial
cell factories for production of natural esters from renewable feedstocks is primed to be a
promising sustainable alternative.
In nature, microbes and plants possess diverse metabolic pathways to provide numerous
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Figure 1-1: Overview of biosynthetic pathways of esters. Precursor pathways include α-keto acid
pathway (blue arrows), reversed β-oxidation pathway (yellow arrows), fatty acid biosynthesis
pathway (green arrows), aromatic alcohols synthesis pathway (brown arrows), phenylpropanoid
pathway (red arrows), terpenoids synthesis pathway (purple arrows), polyketide biosynthesis
pathway (pink arrows). Abbreviations: G3P, glyceraldehyde-3-phosphate; PEP,
phosphoenolpyruvate; PYR, pyruvate; E4P, erythrose-4-phosphate; PPP, pentose phosphate; MEP,
methylerythritol phosphate; MVA, mevalonate; DMAPP, dimethylallyl diphosphate; IPP,
isopentenyl diphosphate; GPP, geranyl pyrophosphate, FPP, farnesyl diphosphate; GGPP,
geranylgeranyl pyrophosphate, CM, chorismate, SA, salicylate, ANT, anthranilate; PP, prephenate,
Tyr, tyrosine; Phe, phenylalanine; CN, cinnamate; p-CMA, p-coumarate; Ac-CoA, acetyl-CoA;
AA-CoA, acetoacetyl-CoA; Ma-CoA, malonyl-CoA; ACP, acyl carrier protein; BAHD, BAHD
acyltransferase.
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precursor metabolites for ester biosynthesis (Figure 1-1). For instance, to make linear (carbon)
chain esters, linear short-to-long fatty acyl-CoAs and alcohols can be derived from the fatty acid
biosynthesis and reversed β-oxidation pathways [11]. For branched chain esters, enzymatic on of
⍺-keto acids by branched-chain keto acid dehydrogenase complex (KDHC) and ⍺-keto acid
pathways can be exploited to generate branched acyl-CoAs [12] and alcohols [13], respectively.
For aromatic esters, aryl-CoAs and alcohols can be synthesized from the shikimate and
phenylpropanoid pathways [14]. For terpene esters, methylerythritol phosphate (MEP) and
mevalonate (MVA) pathways can supply various chain length of terpenols [15]. Like the fatty acid
biosynthesis cycles, the polyketide biosynthesis pathways can also be employed to generate a large
and diverse library of linear, branched, and cyclic CoAs and alcohols [16]. By harnessing these
naturally existing biosynthesis pathways, novel microbial cell factories have been developed to
produce various natural esters (Table 1-1).
Current production of natural products relies on chemical extraction of natural sources such
as plants. This traditional technology faces several challenges. The low content and purity of the
ingredients of interest derived from the natural sources limit large-scale production and quality
control, and hence cause increasing concerns for their environmental impact [17]. Furthermore,
chemical extraction method has an inherent disadvantage in production of volatile compounds due
to products loss resulting in a low recovery rate [18]. Harnessing microbial cell factories for natural
ester production can potentially overcome many challenges present in the traditional approach.
First, ester microbial biosynthesis enables industrial-scale production of pure compounds [19].
Second, the microbial conversion route can save time and cost due to higher production, faster
growth of microbes than plants, and ease of ester recovery from fermentation [5, 20]. Third, ester
microbial production can utilize abundant, renewable and/or sustainable feedstocks from biologi-
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Table 1-1: Summary of microbial production of various esters by BAHD acyltransferases.
Products

Uses

Ref.

Products

Short-to-medium chain esters
[4, 21, 22]

Ethyl valerate

Propyl acetate
Butyl acetate

[4]
[25]

Isobutyl valerate
Amyl valerate

Butyl acetate

[4]

Ethyl hexanoate

Isobutyl acetate

[2, 4, 20, 2527]

Isobutyl hexanoate

2-methyl-1-butyl acetate

[27]

Aromatic esters

Amyl acetate

[23]

Benzyl acetate

Isoamyl acetate

[2, 4, 20, 27]

Benzyl lactate

Hexyl acetate

[23]

2-Phenylethyl acetate

Ethyl propionate

[29]

2-Phenylethyl isobutyrate

Propyl propionate

[23]

Methyl anthranilate

[24]

Ethyl benzoate

Isobutyl propionate
Ethyl lactate

Ref.

Short-to-medium chain esters (Continued)

Ethyl acetate

Fuels,
Solvents,
Flavors,
Fragrances

Uses

[4]

Butyl benzoate

Propyl lactate

[4]

Isoamyl benzoate

Butyl lactate

[4]

Isobutyl lactate

[4]

2-Phenylethyl benzoate
Caffeic acid phenethyl
ester (CAPE)

Isoamyl lactate

[4]

Terpene esters

Ethyl butyrate

[32]

Geranyl acetate

Butyl butyrate
Butyl octanoate
Isobutyl butyrate

[23, 32, 34]
[35]
[24, 32]

Geranyl acetate
Geranylgeranyl acetate
Perillyl acetate

Isobutyl isobutyrate

[2]

Farnesyl acetate

Isoamyl isobutyrate

[2]

Retinyl acetate
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[23]
Fuels,
Solvents,
Flavors,
Fragrances

[24]
[23]
[23]
[24]

Fuels,
Solvents,
Flavors,
Fragrances
Flavors,
Fragrances

[4, 25]
[4]
[2,
[28]
[2]
[30]
[31]

Fuels,
Solvents,
Flavors,
Fragrances

[31]
[31]
[31]

Drug candidates

[3, 31]

Jet fuels, Favors,
Fragrances,
Pharmaceuticals,
Biopesticides,
Precursor
chemicals

[33]

Drugs,
Cosmetics,
Food additives.

[5]
[36]
[37]
[38]
[39]

25]

cal wastes such as carboxylic acids [23, 24] to lignocellulosic biomass [40]. Lastly, the wellestablished pathways for generating acyl-CoAs and alcohols [41] as the precursors for ester
biosynthesis can be leveraged to quickly develop microbial cell factories for ester production.
In contrast to the traditional approach, the high volatility of esters become advantageous in
the microbial conversion route [29]. Esters can be readily secreted outside of cells and easily
removed from the fermentation broth by gas stripping or dual-phase separation [42]. In situ
extraction and fermentation help overcome the product toxicity and hence improve final product
titer, rate, and yield [42]. For instance, while cell growth was inhibited by 3 g/L of isobutyl acetate
[2], gas stripping and dual-phase separation approaches enabled the isobutyl acetate microbial
production to reach final titers of ~36 g/L (42% of theoretical maximum yield) [20] and ~17.2 g/L
(80% of theoretical maximum yield) [2], respectively. Likewise, ineffective production of geraniol
caused by its anti-microbial activity [43] has recently been overcome using the ‘detoxification via
esterification’ strategy [5] where instead of geraniol, its esterified derivative geranyl acetate was
produced with better properties [44] and lower toxicity [45]. The strategy comprises of two
processes including conversion of toxic geraniol into less toxic geranyl acetate by AAT and
simultaneous removal of geranyl acetate from the medium with dual-phase separation. This
strategy enables to achieve high production of geraniol acetate (~4.8 g/L) with high purity without
any additional strain engineering such as expression of efflux pumps, changes in membrane
properties, and activation of stress response genes. Taken together, microbial production of esters
coupled with in situ product removal (ISPR) approach such as gas stripping or dual-phase
separation offers an efficient ester production platform.
Despite of these benefits, the development of microbial cell factories for efficient ester
biosynthesis is currently limited by the availability of enzymes responsible for the condensation
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of precursors into esters. To address this issue, efforts have been made by exploring and
engineering various ester-producing enzymes [35, 42, 46]. The most-studied family of enzymes
for ester synthesis is BAHD acyltransferase family [46]. In plants, the members of this family play
an important role in the formation of a wide range of secondary metabolites [47]. The other wellcharacterized member of this family is alcohol acyltransferase (AAT, EC 2.3.1.84), for instance,
ATF1 of S. cerevisiae [48]. AATs catalyze the transfer of the acyl group from an acyl-CoA (donor)
to an alcohol (acceptor) [25]. Thus, the final products can be diverse, depending on the substrate
specificity of AAT towards acyl-CoAs and alcohols [49]. Although ATF1 has been widely used
in production of various acetate esters [2, 23, 24], it has some drawbacks in microbial production
of esters. For example, ATF1 could not catalyze other acyl-CoAs than acetyl-CoA [48] and
showed the very poor solubility in prokaryotes like E. coli [50]. Further, its high KM values for
alcohol substrates (i.e., ~20.2 mM for isobutanol and ~26.0 mM for isoamyl alcohol) can lead to
the inefficient ester production associated with the cytotoxicity from high-level alcohol production
[20]. Moreover, its precise rational design is limited by the lack of available 3D crystal structure.
Like the combinatorial chemical synthesis [51], recent breakthroughs in metabolic
engineering and synthetic biology have enabled novel design of microbial cell factories by
harnessing their unique and diverse cellular metabolisms to synthesize a large space of molecules
with complex structures and many enzymatic reaction steps [52]. The concept of modular cell
design, inspired by modern engineering disciplines and natural systems, has recently been
proposed to enable rapid and predictable construction of multiple production strains to achieve
superior performance in production of biochemicals such as esters with minimal experimental
effort [52, 53]. Each optimal production strain can be obtained by assembling a modular (chassis)
cell with an exchangeable production module(s) in a plug-and-play fashion. Because a modular
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(chassis) cell contains core metabolic phenotypes shared among production modules, the desirable
phenotype of each production strain is determined by the production module, i.e., auxiliary
regulatory and metabolic pathways engineered to couple with the modular cell to produce a
desirable molecule. Based on the modular cell design principle, the best production strains or
modules can be screened or selected based on the growth coupled to product formation phenotypes
(Figure 1-2) [54].
As the functional groups of esters are important for determining their chemical properties, a
large space of esters can be generated by combining i) acyl-CoA synthesis submodule, ii) alcohol
synthesis submodule, and iii) ester condensation submodule in a systematic way. Recently, the
concept of modular cell design for combinatorial biosynthesis of esters has been demonstrated for
the production of butyrate esters [32]. In this work, by using a combination of the butyl-CoA plus
AAT module and various alcohol production modules, the de novo production platform of butyrate
esters was successfully established for the first time. Furthermore, this study demonstrated the
growth-coupled ester production using modular cell design principles. However, while modular
cell design principles have been successfully validated in some cases, its development is still
limited by the small library of demonstrated production modules. Specifically, the current
limitations in the rapid strain development for efficient production of various esters are i) lack of
a framework for rapid design and construction of various ester production modules, ii)
incompatibility between production modules and a modular (chassis) cell majorly due to the
insoluble expression of heterologous enzymes [50], and iii) the lack of an efficient ester-producing
enzymes pool [23].
Presented in this work is my efforts i) to develop a framework for rapid construction of
production modules to explore a large space of molecules such as a large array of esters, and ii) to
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Figure 1-2: Representative presentation of the modular cell design principle for efficient
combinatorial production of esters. TRY stands for titer, rate, and yield.
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demonstrate the modular cell design principles as a rapid strain development platform for efficient
production of molecules of interest. This dissertation consists of five main chapters. Part I presents
the combinatorial biosynthesis of C4-drived esters as a case study of rapid design and construction
of synthetic metabolic pathways. This chapter describes the establishment of a framework for rapid
design and construction of synthetic metabolic pathways and the demonstration of one-step
fermentative production of C4-dereived esters from glucose. Part II presents the biosynthesis of
lactate esters as a case study of expanding a library of esters that can be produced by microbes
from renewable resources using modular design principles. This chapter describes direct
fermentative production of lactate esters from glucose as well as identification and alleviation of
the most limiting enzymatic step in biosynthesis of lactate esters using genetic parts. Part III
presents rational engineering of an alcohol acyltransferase for production of designer esters as a
case study of computer-guided novel enzyme design. This chapter describes the development a
computer-guided rational protein engineering protocol for altering the substrate specificity of a
chloramphenicol acetyltransferase. Part IV presents the development of a 96-well plate-based
high-throughput ester biosynthesis screening platform as a case study of developing a rapid
enzyme substrate profiling platform. This chapter describes the development of a microplate-based
platform for cell culturing as well as colorimetric quantification of esters. Part V presents the
growth selection of efficient AATs or ester production modules in a modular (chassis) cell. As a
proof-of-concept, this chapter describes the growth selection of an efficient butyl acetate
production module with AAT variants in a modular (chassis) cell. This work offers a blueprint for
rapid development of efficient production strains of a large space of biofuels and biochemicals
from renewable resources with a case study of production of various esters.
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2.1 Abstract
Medium chain esters are considered as fuel additives due to its favorable properties as dropin fuels. Here, we reported rapid development of a microbial platform for one-step fermentative
production of C4-derived esters including butyl acetate, ethyl butyrate, and butyl butyrate from
glucose using a modular Escherichia coli. Specifically, to achieve efficient production of C4derived ester, we applied a series of design and engineering approaches including modular
pathway design, optimization of induction conditions, and a combinatorial solubilization of
pathway enzymes. Finally, the final engineered strains produced 441.4 ± 40.9 mg/L of butyl acetate
(9.2% of maximum theoretical yield), 408.9 ± 44.3 mg/L of ethyl butyrate (8.5% of maximum
theoretical yield), and 449.6 ± 43.0 mg/L of butyl butyrate (10.0% of maximum theoretical yield)
with the selectivity of 91.74%, 85.51%, and 53.52%, respectively. This study provides a
framework for efficient microbial combinatorial biosynthesis of various natural esters from
renewable biomass.

2.2 Introduction
Microbial platforms for production of biochemicals and fuels from renewable biomass have
been considered as a promising alternative to the chemical processes to mitigate climate change
and enhance oil independency [1]. For alternative fuels, while alcohols such as ethanol, butanol or
isobutanol have taken a large portion of this sector, medium chain esters have recently been
attracting attention as drop-in fuels due to its favorable properties such as high energy density [2],
high hydrophobicity [3], and good compatibility with current infrastructures including engines,
transport, and storage density [4, 5]. Specifically, the medium-chain esters (C6-C10) such as ethyl
valerate (C7) [6], butyl butyrate (C8) [5, 7], butyl valerate (C9) [4], and pentyl valerate (C10) [4]
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are good fuel additives for gasolines and butyl butyrate (C8) [5, 7] and ethyl octanoate (C10) [7]
are also considered as an alternative jet fuel.
Compared to acetate esters such as isobutyl acetate [3, 8] and isoamyl acetate [3], the
microbial production of C4-derived esters with high specificities such as ethyl butyrate [9] and
butyl butyrate [10] has been less successful majorly due to i) the low substrate preference of
alcohol acetyltransferases (AATs), the key enzyme in ester biosynthesis [1, 11], towards butylCoA [12] and ii) the low availability of endogenous butyl-CoA [13, 14]. Specifically, although
AATs exhibit their activity towards medium-chain acyl-CoAs like butyl-CoA, due to their
substrate promiscuity [15-17], the low selective production has been the significant challenge in
production of C4-derived esters [9, 10]. Further, the substrate promiscuity of AATs can be more
problematic in intracellular environments where medium-chain acyl-CoAs like butyl-CoA present
at a low abundance as intermediates of 𝛽-oxidation [14, 18, 19]. In other words, because butylCoA can be outcompeted by other acyl-CoAs that are abundant or have a higher affinity to AATs
[20-22], to achieve efficient C4-derived esters, the AATs with a high substrate preference towards
medium-chain acyl-CoAs/alcohols need to be identified and harnessed.
To date, Escherichia coli have been considered as a model bacterial chassis in the
laboratories as well as a workhorse in the industries due to its rapid growth rate, abundant available
genetic engineering tools, cost-effectiveness, high yield of the recombinant proteins, and easy
scale-up process [23]. Further, because E. coli has well-established platforms for production of the
precursor metabolites of esters such as various acyl-CoAs and alcohols [24], by using a
combinatorial synthesis approach, a large array of diverse esters with various industrial
applications such as flavors, fragrances, solvents, lubricants, coatings, and drop-in fuels can be
produced from renewable resources [25] in a renewable and sustainable way.
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However, E. coli also offers some challenges in expression of active enzymes due to lack of
post-translational machinery and the formation of inclusion bodies [26]. Given that the maximum
possible metabolic flux (𝐽max) is determined by the product of the turnover number (kcat) and the
concentration of active enzyme ([E]active) for the weakest pathway enzyme (𝐽max = kcat x [E]active)
[27, 28], all pathway enzymes should be expressed in an active form to obtain the metabolic flux
of the given pathway. Thus, to address this problem, several metabolic engineering strategies
including fine-tuning of the synthetic pathways [29] and combinatorial pathway optimization [3032] have been proposed. However, despite these efforts, because some proteins are inherently
prone to aggregate in E. coli like an AAT [3, 33], we need the strategies to express these enzymes
in an active form prior to the pathway optimization.
In this work, to develop a microbial platform for efficient one-step modular fermentative
biosynthesis pathway of C4-derived esters in the engineered E. coli modular cell from glucose, we
employed the following design and engineering strategies. First, the biosynthesis pathways of C4derived esters were constructed via a combinatorial modular pathway design. Second, the culture
conditions for expression of pathway enzymes including culture temperatures and the
concentration of inducer were optimized. Third, to improve the soluble expression of alcohol
acetyltransferase (AAT), a combinatorial protein solubilization including codon optimization, the
use of fusion tags, co-expression of chaperones, and/or the combination thereof was identified.
Finally, to evaluate the performance of the final strains, we characterized them in anaerobic bottles
with pH-adjustment. This study offers a framework that can be applied to produce a large variety
of natural esters from renewable resources.
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2.3 Methods
2.3.1 Strains and plasmids
Strains and plasmids used in this study are presented in Table 2-1 and Table 2-2. Briefly,
E. coli TOP10 strain was used for molecular cloning. Except for EcJWBA15-17, TCS083 (DE3)
ΔfadE described previously [9] was used for production of C4-derived esters. For EcJWBA15-17,
TCS095 (DE3) [34] was used as a host strain. A set of duet vectors including pACYCDuet-1,
pETDuet-1, and pRSFDuet-1 were used as plasmid backbones for constructing a library of BA,
EB, and BB production modules. The origins of replication and the copy number of pACYCDuet1, pETDuet-1, and pRSFDuet-1 are as follows: P15A, ~10; ColE1, ~40; RSF1030, ~100,
respectively [30]. The codon-optimized S. cerevisiae ATF1 (ATF1Scopt), cultivated strawberry (F.
ananassa) SAAT (SAATFaopt), Candida boidinii fdh (fdhCbopt), and C. acetobutylicum adhE2
(adhE2Caopt) were synthesized by the U.S. Department of Energy (DOE) Joint Genome Institute
(JGI). The enzymes used in this study are presented in Table 2-3 and the list of codon optimized
gene sequences is presented in Table 2-4.
2.3.2 Culture conditions
For molecular cloning and seed cultures, LB (Lysogeny Broth) medium was used. For ester
production, TBD50 medium, TB (Terrific Broth) with 50 g/L glucose was used (without
supplementation with glycerol). For all cultures, 30 µg/mL chloramphenicol (Cm), 50 µg/mL
kanamycin (Kan), and/or 100 µg/mL ampicillin (Amp) was added to the medium where applicable.
For seed cultures, 1% (v/v) of stock cells were grown overnight in 5 mL of LB medium with
appropriate antibiotics. For ester production in conical tubes, seed cultures were prepared as
described in seed cultures. Next, 1% (v/v) of seed cultures inoculated in 500 mL baffled flask con18

Table 2-1: A list of strains used in this study. Key strains are in bold.
Strains

Plasmid 1

Plasmid 2

Plasmid 3

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd ; CmR
pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR
pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pETD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; AmpR
pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; KanR
pACYCD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; CmR

EcJWBA4

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; KanR

-

EcJWBA5

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pACYCD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; CmR

-

EcJWBA6

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pETD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Sc; AmpR

-

EcJWBA7

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::ATF1Scopt; KanR

-

EcJWBA8

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::malE_ATF1Scopt; KanR

-

EcJWBA9

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::nusA_ATF1Scopt; KanR

-

EcJWBA10

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::trx_ATF1Scopt; KanR

-

EcJWBA1
EcJWBA2
EcJWBA3

-

opt

EcJWBA11

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca ::fdhCbPT7lac::trx_ATF1Scopt; KanR

-

EcJWBA12

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::malE_adhE2Caopt::fdhCbPT7lac:: trx_ATF1Scopt; KanR

-

EcJWBA13

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::nusA_adhE2Caopt::fdhCbPT7lac:: trx_ATF1Scopt; KanR

-

EcJWBA14

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::trx_adhE2Caopt::fdhCbPT7lac:: trx_ATF1Scopt; KanR

-

EcJWEB1

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pETD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; AmpR

-

EcJWEB2

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; KanR

-

EcJWEB3

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pACYCD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; CmR

-

EcJWEB4

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pRSFD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; KanR

-

EcJWEB5

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pACYCD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; CmR

-

EcJWEB6

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pETD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; AmpR

-

EcJWEB7

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::pdcZm::adhBZm::fdhCbPT7lac::SAATFa; KanR

pACYC ParaB::groES::groEL;
AmpR

EcJWBB1

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pETD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; AmpR

-

EcJWBB2

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; KanR

-

EcJWBB3

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pACYCD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; CmR

-

EcJWBB4

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; KanR

-

19

Table 2-1: Continued
Strains

Plasmid 1

Plasmid 2

Plasmid 3

EcJWBB5

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pACYCD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; CmR

-

EcJWBB6

pRSFD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; KanR

pETD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; AmpR

-

EcJWBB7

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::adhE2Ca::fdhCbPT7lac::SAATFa; KanR

pACYC ParaB::groES::groEL;
AmpR

EcJWBB8

pACYCD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; CmR

pRSFD PT7lac::Trx_adhE2Caopt::fdhCbPT7lac::SAATFa; KanR

EcJWATF1

pET29 PT7lac::atf1Sc; KanR

-

-

EcJWATF1opt

pET29 PT7lac::atf1Scopt; KanR

-

-

EcJWATF1MBP

pET29 PT7lac::malE_atf1Sc; KanR

-

-

EcJWATF1NusA

pET29 PT7lac::nusA_atf1Sc; KanR

-

-

EcJWATF1Trx

pET29 PT7lac::trx_atf1Sc; KanR

-

-

EcJWATF1Chp1

pET29 PT7lac::atf1Sc; KanR

pACYC ParaB::tig; CmR

-

EcJWATF1Chp2

pET29 PT7lac::atf1Sc; KanR

pACYC ParaB::groES::groEL; CmR

-

EcJWATF1Chp3

pET29 PT7lac::atf1Sc; KanR

pACYC Ppzt-1::groES::groEL::tig;
CmR

-

EcJWATF1Chp4

pET29 PT7lac::atf1Sc; KanR

pACYC ParaB::dnaK::dnaJ::grpE; CmR

-

EcJWATF1Chp5

pET29 PT7lac::atf1Sc; KanR

pACYC ParaB::dnaK::dnaJ::grpE-PpztR
1::groES::groEL; Cm

-

EcJWC4SAAT

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATSc; KanR

-

EcJWC4SAATopt

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATFaopt; KanR

-

EcJWC4SAATMBP

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::malE_SAATFa; KanR

-

EcJWC4SAATNusA

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::nusA_SAATFa; KanR

-

EcJWC4SAATTrx

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::trx_SAATFa; KanR

-

EcJWC4SAATChp1

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATSc; KanR

pACYC ParaB::tig; CmR

EcJWC4SAATChp2

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATSc; KanR

pACYC ParaB::groES::groEL;
CmR

EcJWC4SAATChp3

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATSc; KanR

pACYC PpztR
1::groES::groEL::tig; Cm

EcJWC4SAATChp4

pETD PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd; AmpR

pET29 PT7lac::SAATSc; KanR

pACYC
ParaB::dnaK::dnaJ::grpE; CmR
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taining 50 ml of TBD50 medium with appropriate antibiotics. The cells were aerobically grown in
shaking incubators at 28oC or 37oC, 200 rpm and induced at an O.D.600 of 0.6~0.8 with various
concentrations of IPTG, arabinose (if applicable), and/or 5 ng/ml of tetracycline (if applicable).
After 2 hours of induction, the cultures in the baffled flasks were distributed into 15 mL conical
centrifuge tubes (Cat. #339650, Thermo Scientific, MA, USA) with a working volume of 5 mL.
Then, each tube was overlaid with 1ml hexadecane (20% (v/v)) for in situ ester recovery and
capped to generate anaerobic conditions. Finally, the tubes were grown for another 18 hours on a
75° angled platform in shaking incubators at 28oC or 37oC, 200 rpm. The remained cultures in the
baffled flasks were induced for 2 additional hours and then the cells were harvested for SDS-PAGE
analysis.
For ester production in anaerobic bottles with pH-adjustment, the induced cultures were
prepared as described in ester production in conical tubes. To generate the anaerobic conditions,
the induced cultures were transferred into anaerobic bottles with a working volume of 100 mL.
Then, each anaerobic bottle was overlaid with 20 ml hexadecane 20% (v/v) for in situ ester
recovery and sealed with a rubber stopper inside the anaerobic chamber. The headspace of the
anaerobic bottles was vacuumed and replaced by an anaerobic mix of 90% N2, 5% H2, and 5%
CO2 inside the anaerobic chamber. Finally, the anaerobic bottles were grown for another 90 hours
in shaking incubators at 28°C or 37°C, 200 rpm. The culture medium and hexadecane overlay
samples were taken through the rubber stopper via a syringe and needle by maintaining the ratio
of 5:1. The culture pH was adjusted to around 7 using 10 M NaOH every 24 hours. All experiments
were performed in biological triplicates.
2.3.3 Protein expression and SDS-PAGE analysis
The cells were collected from the culture by centrifugation and resuspended in 1X PBS
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(Phosphate Buffered Saline) buffer (pH 7.4) at the final O.D.600 of 10. Cell pellets were disrupted
using the B-PER complete reagent (Cat. #89822, Thermo Scientific, MA, USA), according to the
manufacturer’s instruction. Total and soluble fractions were separated by centrifugation for 20 min
at 4℃. The resulting samples were mixed with 6X SDS (sodium dodecyl sulfate) sample buffer,
heated at 95℃ for 5 min, and analyzed by SDS-PAGE (SDS-polyacrylamide gel electrophoresis)
using NovexTM 14 Tris-Glycine protein gels (Cat. #XP00145BOX, Thermo Scientific, MA,
USA). Protein bands were visualized with Coomassie Brilliant Blue staining.
2.3.4 Determination of cell concentrations
The optical density was measured at 600 nm using a spectrophotometer (GENESYS 30,
Thermo Scientific, IL, USA). The dry cell mass was determined by multiplying the optical density
of culture broth with a pre-determined conversion factor, 0.48 g/L/O.D.
2.3.5 High performance liquid chromatography (HPLC)
Metabolites and doped alcohols were quantified by using the Shimadzu HPLC system
(Shimadzu Inc., MD, USA) equipped with the Aminex HPX-87H cation exchange column
(BioRad Inc., CA, USA) heated at 50℃. A mobile phase of 10 mN H2SO4 was run at a flow rate
of 0.6 mL/min. Detection was made with the reflective index detector (RID).
2.3.6 Gas chromatography coupled with mass spectroscopy (GC/MS)
All esters were quantified by GC/MS. For GC/MS analysis, the cultures were centrifuged
at 15,000 x g for 2 min and the hexadecane overlays were used for quantification of esters. The
samples were prepared by diluting hexadecane extracts from the cultures with hexadecane
containing internal standard (isoamyl alcohol) in a 1:1 (v/v) ratio. Then, 1 μL of samples were
directly injected into a gas chromatograph (GC) HP 6890 equipped with the mass selective detector
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(MS) HP 5973. For the GC system, helium was used as the carrier gas at a flow rate of 0.5 mL/min
and the analytes were separated on a Phenomenex ZB-5 capillary column (30 m x 0.25 mm x 0.25
μm). The oven temperature was programmed with an initial temperature of 50℃ with a 1℃/min
ramp to 58℃. Next a 25℃/min ramp was deployed to 235℃ and then a 50℃/min ramp was
deployed to 300℃. Finally, a temperature of 300℃ was held for 2 minutes to elute any residual
non-desired analytes. The injection was performed using the splitless mode with an initial injector
temperature of 280℃.
For the MS system, a selected ion monitoring (SIM) mode was deployed to detect analytes.
The SIM parameters for detecting esters were as follows: i) for ethyl acetate, ions 45.00, and 61.00
detected from 4.15 to 5.70 min, ii) for isoamyl alcohol (internal standard), ions 45.00, and 88.00
detected from 5.70 to 7.20 min, iii) for ethyl butyrate, ions 47.00, and 116.00 detected from 7.20
to 7.75 min, iv) for butyl acetate, ions 61.00, and 116.00 detected from 7.75 to 11.25 min, vi) for
butyl butyrate, ions 101.00, and 116.00 detected from 11.25 to 12.50 min.

2.4 Results
2.4.1 Combinatorial modular plasmid assembly for raid construction of biosynthesis
pathways of C4-derived esters
We first designed the biosynthesis pathways of C4-derived esters. Biologically, esters can
be synthesized by condensing an acyl-CoA and an alcohol using an alcohol acyltransferase (AAT)
(Figure 2-1a). Thus, to establish the biosynthesis pathway of C4-derived esters, three major
pathways including i) butyl-CoA synthesis pathway, ii) alcohol synthesis pathway such as ethanol,
butanol, and iii) ester synthesis pathway (AAT) are needed. In our previous studies, the production
modules for butyl-CoA and alcohols (ethanol, butanol) have been constructed [9] and the substrate
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specificity of AATs has been studied [21]. Additionally, it was reported that co-expression of a
NAD+-dependent formate dehydrogenase (Fdh) improve butanol production by increasing
intracellular NADH availability [35, 36]. Thus, using these previously identified genetic parts and
gained knowledge, we modulated the ester synthetic pathways into four submodules; submodule1
(SM1) carrying E. coli atoB (atoBEc), Clostridium acetobutylicum Hbd (hbdCa), C. acetobutylicum
crt (crtCa), and Treponema denticola ter (terTd) for butyl-CoA synthesis, submodule2 (SM2)
consisted of Zymomonas mobilis pdc (pdcZm) and adhB (adhBZm) or C. acetobutylicum adhE2
(adhE2Ca) for alcohol synthesis, submodule3 (SM3) carrying Candida boidinii fdh (fdhCb) for
NADH regeneration, and submodule4 (SM4) carrying Saccharomyces cerevisiae ATF1 (ATF1Sc)
or Fragaria x ananassa (cultivated strawberry) SAAT (SAATFa) for ester synthesis (Figure 2-1b).
Then, by using a combinatorial plasmid assembly approach, the submodules were assembled into
two parts - plasmid #1 carrying the SM1, a common pathway for C4-derived esters biosynthesis,
and plasmid #2 carrying the SM2-SM3-SM4, variable pathways in C4-derived esters using
plasmids with various copy numbers for pathway optimization (Figure 2-1c, Table 2-2). Figure 22a, 2-3a, and 2-4a show how the combination of each submodule can comprise the biosynthesis
pathways of BA, EB, and BB, respectively. Finally, a combination of plasmid #1 and plasmid #2
for each compound were transferred into the modular E. coli strain, TCS083 (DE3) ΔfadE [9],
resulting in six initial strains, EcJWBA1-6; EcJWEB1-6; and EcJWBB1-6 (Table 2-1, Figure 22b, Figure 2-3b, and Figure 2-4b).
2.4.2 Endogenous production of C4-derived esters in initial strains
Following the construction of initial strains, we characterized them in conical tubes to
validate the constructed biosynthesis pathways of C4-derived esters as well as to identify the best
combination of plasmid #1 (SM1) and plasmid #2 (SM2-SM3-SM4). We also confirmed protein
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Figure 2-1: Design one-step modular fermentative pathways of C4-derived esters. (a)
Biosynthesis of esters by an alcohol acyltransferase (AAT). (b) Modular biosynthetic pathways of
C4-derived esters. (c) Schematic representation of modular plasmid assembly.
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expressions by SDS-PAGE analysis (Figure 2-6). The results show that EcJWBA2, EcJWEB2,
and EcJWBB2 carrying the plasmid #1 with low copy number and the plasmid #2 with high copy
number achieved the highest ester production among the characterized six initial strains for each
compound. For BA production, EcJWBA2 produced 34.2 ± 6.6 mg/L of BA with the selectivity
of 74.27% (Figure 2-2c, Table 2-5, Figure 2-7a). For EB production, EcJWEB2 produced 71.0 ±
6.6 mg/L of EB with the selectivity of 91.97% (Figure 2-3c, Table 2-6, Figure 2-8a). For BB
production, EcJWBB2 produced 33.5 ± 2.9 mg/L of BB with the selectivity of 20.75% (Figure 24c, Table 2-7, Figure 2-9a).
After validating the synthetic pathways of C4-derived esters, we next optimized induction
conditions with the identified best ester producers, EcJWBA2, EcJWEB2, and EcJWBB2. To
optimize induction conditions, we tested various induction conditions using a combination of two
different temperatures (28/37℃), and three different concentrations of the inducer (0.01/0.1/1.0
mM IPTG). The results show that the titer of BA, EB, and BB were improved by 1.40, 2.82, and
3.80-fold at the optimized induction conditions, respectively. Specifically, for BA production,
EcJWBA2 produced 48.0 ± 7.1 mg/L of BA with the selectivity of 83.13% when it induced by 0.1
mM of IPTG at 28℃ (Figure 2-2d, Table 2-8, Figure 2-7b). For EB production, EcJWEB2
produced 200.4 ± 9.4 mg/L of EB with the selectivity of 89.57% when it induced by 0.1 mM of
IPTG at 28℃ (Figure 2-3d, Table 2-9, Figure 2-8b). For BB production, EcJWBB2 produced
127.4 ± 32.5 mg/L of BB with the selectivity of 33.96% when it induced by 0.1 mM of IPTG at
37℃ (Figure 2-4c, Table 2-7, Figure 2-9b). Collectively, we found the optimized induction
conditions for production of C4-derived esters and we used these conditions for further studies.
However, because SDS-PAGE analysis results show that weak protein bands of ATF1 and SAAT
compared to the other protein bands (Figure 2-10), we next investigated whether the enhanced sol-
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Figure 2-2: One-step fermentative butyl acetate (BA) production from glucose. (a) Modular de
novo biosynthesis pathway of BA. (b) Schematic of initial six strains carrying BA production
modules with different copy numbers. The plasmid copy numbers are as follows: P15A (green
square), ~10; ColE1 (blue square), ~40; RSF1030 (red square), ~100. (c-f) De novo BA production
from glucose. Endogenous BA production by (c) six initial strains (EcJWBA1~EcJWBA6); (d)
EcJWBA2 in the optimized induction conditions (28℃, 0.1 mM IPTG); (e) EcJWBA10 and
EcJWBA14; (f) EcJWBA14 in anaerobic bottles with pH-adjustment.
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Figure 2-3: One-step fermentative ethyl butyrate (EB) production from glucose. (a) Modular de
novo biosynthesis pathway of EB. (b) Schematic of initial six strains carrying EB production
modules with different copy numbers. The plasmid copy numbers are as follows: P15A (green
square), ~10; ColE1 (blue square), ~40; RSF1030 (red square), ~100. (c-f) De novo EB production
from glucose. Endogenous EB production by (c) six initial strains (EcJWEB1~EcJWEB6); (d)
EcJWEB2 in the optimized induction conditions (28℃, 0.1 mM IPTG); (e) EcJWEB7; (f)
EcJWEB7 in anaerobic bottles with pH-adjustment.
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Figure 2-4: One-step fermentative butyl butyrate (BB) production from glucose. (a) Modular de
novo biosynthesis pathway of BB. (b) Schematic of initial six strains carrying BB production
modules with different copy numbers. The plasmid copy numbers are as follows: P15A (green
square), ~10; ColE1 (blue square), ~40; RSF1030 (red square), ~100. (c-f) De novo BB production
from glucose. Endogenous BB production by (c) six initial strains (EcJWBB1~EcJWBB6); (d)
EcJWBB2 in the optimized induction conditions (37℃, 0.1 mM IPTG); (e) EcJWBB8; (f)
EcJWBB8 in anaerobic bottles with pH-adjustment.
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uble expression of AATs could improve ester production.
2.4.3 Evaluation of various AATs solubilization strategies for improved ester synthesis in
alcohol doping experiments
To examine the effect of AAT solubilization on ester production, we first chose three wellstudied strategies including i) codon optimization [37, 38]; ii) the use of fusion partners such as
maltose binding protein (MBP) [39], N-utilization substrate A (NusA) [40], or thioredoxin 1 (TrxA)
[41]; and iii) co-expression of molecular chaperones (DnaK/DnaJ/GrpE, GroES/GroEL, or Trigger
factor (Tf)) [42]. Then, we started to construct plasmids carrying wildtype AATs, codon optimized
AATs, fusion partner tagged AATs. Specifically, for BA production, the plasmids carrying
wildtype ATF1Sc, codon optimized ATF1Sc (ATF1Scopt), and N’-terminus MBP-, NusA-, or TrxAtagged ATF1Sc (malE_ATF1Sc, nusA_ATF1Sc, or trxA_ATF1Sc) were constructed and introduced
into TCS083 (DE3) ΔfadE [9], resulting EcJWATF1, EcJWATF1opt, EcJWATF1MBP,
EcJWATF1NusA, EcJWATF1TrxA, respectively (Table 2-1).
For EB and BB production, the plasmids carrying wildtype SAAT (SAATFa), codon
optimize SAATFa (SAATFaopt), and N’-terminus MBP-, NusA-, or TrxA-tagged SAATFa
(malE_SAATFa; nusA_SAATFa; or trxA_SAATFa, respectively) were constructed and introduced into
TCS083 (DE3) ΔfadE [9] with the pACYCDuet-1 carrying the SM1 (Butyl-CoA pathway),
resulting EcJWSAAT, EcJWSAATopt, EcJWSAATMBP, EcJWSAATNusA, EcJWSAATTrxA,
respectively (Table 2-1). To co-express chaperones with AATs, the chaperone plasmid set
consisted of five different plasmids carrying various chaperones (Cat. #3340, TaKaRa Bio Inc.)
were introduced into EcJWATF1 and EcJWSAAT, resulting EcJWATF1Chp1~EcJWATF1Chp5 and
EcJWSAATChp1~EcJWSAATChp5, respectively (Table 2-1). Finally, we characterized them in
conical tubes with 2 g/L of alcohol doping including ethanol and butanol to evaluate the conversion
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of an alcohol (ethanol/butanol) into an ester (ethyl acetate/butyl acetate) by ATF1Sc (Figure 2-11a)
or EB/BB by SAATFa (Figure 2-12a), respectively. The protein expressions were confirmed by
SDS-PAGE analysis (Figure 2-13). The cultures were induced by 0.1 mM of IPTG, 0.5 mg/ml of
L-arabinose (if applicable) and/or 5 ng/ml of tetracycline (if applicable).
The results show that, indeed, the strategies for enhancing soluble expression of AATs
improved the conversion of an alcohol into an ester. However, we observed that the different
strategies are required for different AATs. For example, while codon optimization and the use of
a fusion partner including MBP, NusA, or TrxA improved the EA/BA conversion with ATF1, coexpression of chaperones including GroES/EL, GroES/EL/Tf, or DnaK/DnaJ/GrpE/GroES/EL
improved the EB/BB conversion with SAAT. Specifically, for the EA conversion, EcJWATF1opt,
EcJWATF1MBP, EcJWATF1NusA, EcJWATF1TrxA achieved 2.30%, 1.01%, 1.31%, and 1.32% of
EA conversion, resulting 20.53, 9.04, 11.66, and 11.78-fold improvement compared with the
EcJWATF1 (0.11%), respectively (Figure 2-11b, Table 2-11).
For the BA conversion, EcJWATF1opt, EcJWATF1MBP, EcJWATF1NusA, EcJWATF1TrxA
achieved 85.90%, 74.55%, 79.53%, and 86.61% of BA conversion, resulting 7.14, 6.20, 6.61, and
7.20-fold improvement as compared to EcJWATF1 (12.03%), respectively (Figure 2-11c, Table
2-11). For EB production, EcJWSAATChp2, EcJWSAATChp3, and EcJWSAATChp5 achieved 2.60%,
1.50%, and 1.97% of EB conversion, resulting 8.45, 4.67, and 6.40-fold improvement as compared
to EcJWSAAT (0.31%), respectively (Figure 2-12b, Table 2-12). For BB conversion,
EcJWSAATChp2, EcJWSAATChp3, and EcJWSAATChp5 achieved 36.82%, 19.14%, and 11.86% of
BB conversion, resulting 9.04, 4.70, and 2.91-fold improvement as compared to EcJWSAAT
(4.07%), respectively (Figure 2-12c, Table 2-12).
After confirming the improved ester conversion via AAT solubilization strategies in the al-
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cohol doping experiments, we next evaluated the reproducibility of this result in the endogenous
ester production from glucose. Moreover, for BA production, because both strategies, including
codon optimization and tagging a fusion partner, improved ester production with ATF1, we also
investigated whether the synergistic effect exists when these two strategies are combined.
2.4.4 Combinatorial solubilization of ATF1Sc improved BA production
To evaluate the reproducible AAT solubilization results in the endogenous production from
glucose, for the BA production, we first constructed the four pRSFDuet-1 carrying SM2(adhE2Ca)SM3(fdhopt)-SM4(ATF1Scopt, malE_ATF1Scopt, nusA_ATF1Scopt, or trxA_ATF1Scopt), respectively
(Table 2-2). Then, we introduced them into TCS083 (DE3) ΔfadE [9] with the pACYCDuet-1
carrying the SM1 (Butyl-CoA pathway), resulting EcJWBA7~EcJWBA10, respectively (Table 21). For the EB/BB production, we additionally introduced the plasmid carrying groES and groEL
into EcJWEB2 and EcJWBB2, resulting EcJWEB7 and EcJWBB7, respectively (Table 2-1).
Finally, we characterized them in conical tubes and evaluated the AAT solubilization strategies
for improved ester production in the endogenous production from glucose. For the expression of
chaperones in EB/BB production, we also tested the three different concentrations of inducer (Larabinose).
Unfortunately, the characterization results show that while BA and EB production were
improved by 1.08~1.86-fold and 1.32~1.82-fold, respectively, BB production was reduced by
0.20~0.40-fold compared with the initial strains. Specifically, for BA production,
EcJWBA7~EcJWBA10 produced 51.7 ± 7.1 mg/L, 79.3 ± 9.8 mg/L, 76.1 ± 6.2 mg/L, and 89.5 ±
14.8 mg/L of BA, resulting 1.08, 1.65, 1.59, and 1.86-fold improved BA production compared
with the EcJWBA2 (48.0 ± 7.1 mg/L), respectively (Figure 2-7c, Table 2-13). Notably, because
EcJWBA8~10 expressing ATF1Scopt with N’-terminus fusion partner such as MBP, NusA, and
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TrxA achieved the higher BA production than that of EcJWBA7 expressing ATF1Scopt alone, we
could confirm that there is a synergistic effect between codon optimization and the use of a fusion
partner in BA production with ATF1Scopt.
For EB production, EcJWEB7 produced 263.9 ± 51.8 mg/L, 337.6 ± 46.1 mg/L, 365.7 ±
69.2 mg/L, and 346.2 ± 59.8 mg/L of EB, resulting 1.32, 1.68, 1.82, and 1.73-fold improved EB
production compared with the EcJWEB2 (200.4 ± 9.4 mg/L) when the cultures were induced by 0
mg/ml, 0.1 mg/ml, 0.5 mg/ml, and 5.0 mg/ml of L-arabinose, respectively (Figure 2-8c, Table 214). For BB production, EcJWBB7 produced 25.6 ± 10.7 mg/L, 30.0 ± 4.8 mg/L, 51.4 ± 3.4 mg/L,
and 42.1 ± 4.1 mg/L of BB, achieving 0.20, 0.24, 0.40, and 0.33-fold decreased BB production
compared with the EcJWBB2 (127.4 ± 32.5 mg/L) when the cultures were induced by 0 mg/ml,
0.1 mg/ml, 0.5 mg/ml, and 5.0 mg/ml of L-arabinose, respectively (Figure 2-9c, Table 2-15).
2.4.5 Combinatorial solubilization of AdhE2Ca improved BA/BB production
Next, because we observed the low residual butanol in BA/BB production throughout the
experiment and the low butanol production, one of the precursors of butyl esters, can limit BA/BB
production, we next tested whether the approach used for ATF1Sc could also be applied for
solubilizing AdhE2Ca for improved BA/BB production. AdhE2 Ca is known for its critical role in
butanol production and its insolubility can significantly reduce in vivo activities compared with
the in vitro activities [35]. For BA production, we first constructed four pRSFDuet-1 carrying
SM2(adhE2Caopt,

malE_adhE2Caopt,

nusA_adhE2Caopt,

or

trxA_adhE2Caopt)-SM3(fdhopt)-

SM4(trxA_ATF1Scopt), respectively (Table 2-2). Then, we introduced them into TCS083 (DE3)
ΔfadE [9] with the pACYCDuet-1 carrying the SM1 (Butyl-CoA pathway), resulting
EcJWBA11~EcJWBA14, respectively (Table 2-1). Finally, we characterized them in conical tubes
and evaluated whether the AdhE2Ca solubilization strategies improved BA production. The protein
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expressions were confirmed by SDS-PAGE analysis (Figure 2-14).
Remarkably, the results show that EcJWBA14 achieved 2.27-fold improved BA
production (203.0 ± 5.7 mg/L) as compared to EcJWBA10 (89.5 ± 14.8 mg/L), indicating that
solubilization of pathway enzymes using a fusion partner can be a simple, but useful extendable
pathway optimization strategy in metabolic engineering. Specifically, EcJWBA11~EcJWBA14
produced 80.3 ± 9.0 mg/L, 54.2 ± 4.9 mg/L, 82.8 ± 15.5 mg/L, and 203.0 ± 5.7 mg/L of BA,
respectively (Figure 2-7d, Table 2-16). To strengthen this result, we also evaluated whether the
use of TrxA fusion partner with AdhE2Caopt could improve BB production. We first constructed
the pRSFDuet-1 carrying SM2(trxA_adhE2Caopt)-SM3(fdhopt)-SM4(SAATFa) (Table 2-3) and
introduced it into TCS083 (DE3) ΔfadE [9] with the pACYCDuet-1 carrying the SM1 (Butyl-CoA
pathway), resulting EcJWBB8 (Table 2-1). Finally, we characterized EcJWBB8 in conical tubes.
Indeed, the results shows that EcJWBB8 achieved 1.31-fold improved BB production
(167.3 ± 18.2 mg/L) as compared to EcJWBB2 (127.4 ± 32.5 mg/L), confirming the potential of
combinatorial solubilization as a pathway optimization strategy in metabolic engineering (Figure
2-9d, Table 2-16). Furthermore, notably, EcJWBB8 achieved ~1.49-fold improved BB selectivity
(50.63%) as compared to EcBB2 (33.96%), resulting ~1.65-fold improved butanol/ethanol ratio
(g/g of butanol to ethanol) (from 0.04 to 0.07) and ~0.63-fold reduced EB production (from 246.2
± 72.6 mg/L to 156.3 ± 22.4 mg/L) (Table 2-10 and 2-16). This result suggests that there was a
substrate competition between ethanol and butanol in the enzymatic reaction of ATF1Sc and hence
it requires two potential strategies for improved production of designer esters by AATs including
i) engineering alcohol substrate preference of AATs and ii) selective alcohol production.
Although BA and BB production were improved to some extent via combinatorial
solubilization of AdhE2Ca, residual butanol titers were still low, at the levels of 0.18 ± 0.00 g/L for
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EcJWBB8 and for 0.20 ± 0.01 g/L (EcJWBA14) (Table 2-10 and 2-16). Given that the abundant
alcohol production is important for ester synthesis due to the high KM value of AATs [3, 30],
butanol production should be improved for further improvement in butyl esters production.
Because anaerobic conditions can improve alcohol production [35, 43], we next characterized the
final strains, EcJWBA14, EcJWEB7, and EcJWBB8, in anaerobic bottles with pH-adjustment to
evaluate their performance in production of C4-dereived esters. The culture pH was adjusted to
around 7 with 10 M NaOH every 24 hours to maintain the optimum growth pH of E. coli [44].
2.4.6 Production of C4-derived esters in anaerobic bottles with pH-adjustment
The characterization results of the final strains, including EcJWBA14, EcJWEB7, and
EcJWBB8, achieved 12.89-, 5.76-, and 13.42-fold improvements in titers, 4.79-, 3.71-, and 4.64fold improvements in yields, and 6.45, 1.44, and 3.36-fold improvement in productivities as
compared to the initial strains, EcJWBA2, EcJWEB2, and EcJWBB2, respectively. Specifically,
EcJWBA14 produced 441.4 ± 40.9 mg/L of BA (9.2% of maximum theoretical yield) with 91.74%
of selectivity (Fig. 2-2f, Figure 2-15, and Table 2-17), EcJWEB7 produced 408.9 ± 44.3 mg/L of
EB (8.5% of maximum theoretical yield) 85.5% of selectivity (Fig. 2-3f, Figure 2-16, and Table
2-17), and EcJWBB8 produced 449.6 ± 43.0 mg/L of BB (10.0% of maximum theoretical yield)
53.52% of selectivity (Fig. 2-4f, Figure 2-17, and Table 2-17). As compared to the best direct
fermentative production of C4-derived esters in literature, EcJWBA14 achieved 52.73, 79.27, and
135.76-fold improved TRY (titer, productivity, and yield) in BA production, EcJWEB7 achieved
3.05, 3.05, and 11.02-fold improved TRY in EB production, and EcJWBB8 achieved 8.98, 6.74,
and 23.31-fold improved TRY in BB production (Table 2-18).

35

2.5 Discussion
With the recent shale oil revolution, the cost of raw materials for fuels and chemicals with
low carbon numbers such as short-chain linear alcohols are expected to decrease [45]. Thus, to
ensure economic feasibility of microbial production of biochemicals from renewable resources,
we should focus on production of chemicals with high carbon numbers and/or more complex
structures. Esterification reaction, condensing an alcohol and an acyl-CoA into esters, can be used
for increasing the carbon numbers as well as the degree of complexity of raw materials. For
example, to valorize short-chain linear alcohols such as ethanol (C2), butanol (C4), the alcohols
can be condensed with butyl-CoA or benzyl-CoA resulting in ethyl butyrate (C6), butyl butyrate
(C8) or ethyl benzoate (C9), butyl benzoate (C11), respectively. Furthermore, this reaction can be
used for synthesis of a large array of diverse esters with various industrial applications such as
flavors, fragrances, solvents, lubricants, coatings, and drop-in fuels [25].
While the biosynthesis pathway of esters is simple and enzymes consisting of the pathway
have been well elucidated, their production is still too low for industrial production. Seeking to
develop a platform for rapid design, construction, and validation of various ester synthetic
pathways, E. coli was chosen as a chassis cell because of its various benefits in biochemical
production. However, for the efficient ester production in E. coli, the pool (soluble) expression
issue of AATs should be addressed [3, 33]. To address this problem, we applied a combinatorial
protein solubilization including codon optimization, the use of fusion tags, co-expression of
chaperones, and/or the combination thereof and achieved improved C4-derived ester production.
To date, while a combinatorial protein solubilization has not been commonly considered as a
metabolic engineering strategy, this study suggests it can provide a useful tool for improved
microbial production of biochemicals(fuels) with (eukaryotic) aggregate-prone enzymes in the ba36

cterial chassis cells like E. coli.
More importantly, our findings can be valuable for efficient strain development with
laboratory automation. To date, while the recent advances in laboratory automation have
significantly accelerated the Design-Build-Test-Learn (DBTL) cycle [46, 47], still not many
successful commercialization cases have been reported. This indicates that there must be other
critical factors we overlooked in strain development than the mechanical assembly of genetic parts
including promoters, RBS, biosynthesis pathways or introducing the assembled genetic parts into
chassis cells. The recent study used machine learning approach for production of dodecanol in E.
coli emphasized the critical need of tools for accurate prediction of protein expression [47],
suggesting the importance of enzyme expression in synthetic pathways design.
Taken together, to facilitate the development of efficient production strains, we need tools
for predicting soluble expression of pathway enzymes as well as solubilizing aggregate-prone
enzymes. Interestingly, for predicting soluble expression of pathway enzymes, Protein-Sol: a web
tool for predicting protein solubility from sequence [48] identified the low soluble enzymes such
as AATs and AdhE2Ca which targeted for solubilization in this study (Figure 2-18). To date, to
solubilize these enzymes, several approaches have been proposed including codon optimization
[37, 38], the use of fusion partners [39-41], co-expression of chaperones [42], and protein
solubility engineering [27, 28, 49, 50]. However, considering the simplicity and compatibility with
the automated plasmid assembly platform, the use of a combinatorial library of fusion partners can
be a cost-effective solution coupled with the laboratory automation. Indeed, a recent study has
demonstrated the potential of this approach in construction of efficient synthetic pathways with
aggregate-prone enzymes using a combinatorial library of different fusion partners in a systematic
way [51].

37

The presented modular design has a lot of benefits in strain development. First, it enables
rapid construction of combinatorial synthetic pathways. For example, Figure 2-1b well represents
how the modular pathway design facilitates the construction of C4-esters producing strains in a
plug-and-play fashion. Second, it allows quick evaluation of various engineering strategy. For
example, the summary of C4-derived ester production in engineered strains shows how the various
engineering strategy can be evaluated with the combinatorial modular synthetic pathways to
improve biochemical production (Figure 2-19). Lastly, it also allows rapid calculation of
theoretical yield of multiple products derived from the same intermediate. For example, the
stoichiometric balance for synthesis of C4-derived esters (Figure 2-5, Figure 2-20).
In this study, we reported the development of a microbial platform for efficient production
of C4-derived esters from renewable resources by one-step fermentation. Based on rational
knowledge of the C4-derived ester pathways, we modularized a set of 11 genes into four parts,
Submodule (SM) 1~4, to facilitate construction and validation of each aspect of the design for
synthesis of three different target products with minimal experimental effort. Finally, our efforts
led to the highest ester production for all targeted compounds including BA, EB, and BB ever
reported in an engineered E. coli. Furthermore, the modular microbial ester synthesis platform
presented is expected to accelerate strain development for biosynthesis of diverse natural esters
with various industrial applications. This study also highlights a combinatorial protein
solubilization as a metabolic engineering strategy as well as the importance of synthetic pathwaychassis compatibility in microbial production of biochemicals(fuels) by demonstrating the
improved biochemical (ester) production via solubilizing pathway enzymes. Therefore, a
combination of modular pathway design, a model-driven prediction of protein solubility, and
laboratory automation with solubilizing aggregate-prone enzymes would help accelerate the strain
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Figure 2-5: Stoichiometric balance for synthesis of C4-derived esters. (a) Reactions in modular
biosynthetic pathways of C4-derived esters from glucose. (b) Net reactions for biosynthesis of
butyl acetate, ethyl butyrate, or butyl butyrate from glucose. *Ester yield on glucose.
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development.
Overall, this work offers a blueprint of efficient strain development for production of various
biochemicals with increased carbon numbers and the degree of structural complexity.

40

2.6 References
1.
2.
3.
4.
5.
6.

7.
8.
9.
10.
11.
12.

13.
14.
15.

16.
17.

18.

19.

Chubukov, V., et al., Synthetic and systems biology for microbial production of commodity
chemicals. Npj Systems Biology and Applications, 2016. 2.
Layton, D.S. and C.T. Trinh, Microbial synthesis of a branched-chain ester platform from
organic waste carboxylates. Metab Eng Commun, 2016. 3: p. 245-251.
Tai, Y.S., M.Y. Xiong, and K.C. Zhang, Engineered biosynthesis of medium-chain esters
in Escherichia coli. Metabolic Engineering, 2015. 27: p. 20-28.
Contino, F., et al., Combustion and emissions characteristics of valeric biofuels in a
compression ignition engine. Journal of Energy Engineering, 2013. 140(3): p. A4014013.
Jenkins, R.W., et al., Potential renewable oxygenated biofuels for the aviation and road
transport sectors. Fuel, 2013. 103: p. 593-599.
Contino, F., et al., Engine performances and emissions of second-generation biofuels in
spark ignition engines: The case of methyl and ethyl valerates. SAE Technical Paper, 201324, 2013. 98.
Chuck, C.J. and J. Donnelly, The compatibility of potential bioderived fuels with Jet A-1
aviation kerosene. Applied energy, 2014. 118: p. 83-91.
Tashiro, Y., S.H. Desai, and S. Atsumi, Two-dimensional isobutyl acetate production
pathways to improve carbon yield. Nat Commun, 2015. 6: p. 7488.
Layton, D.S. and C.T. Trinh, Engineering modular ester fermentative pathways in
Escherichia coli. Metabolic Engineering, 2014. 26: p. 77-88.
Noh, H.J., et al., Metabolic engineering of Clostridium acetobutylicum for the production
of butyl butyrate. Appl Microbiol Biotechnol, 2018. 102(19): p. 8319-8327.
Kruis, A.J., et al., Microbial production of short and medium chain esters: Enzymes,
pathways, and applications. Biotechnology Advances, 2019. 37(7).
Layton, D.S., Trinh, C.T., Expanding the Modular Ester Fermentative Pathways for
Combinatorial Biosynthesis of Esters from Volatile Organic Acids. Biotechnol Bioeng,
2016. 113(8): p. 1764-76.
Xin, F.X., W.M. Zhang, and M. Jiang, Bioprocessing Butanol into More Valuable Butyl
Butyrate. Trends in Biotechnology, 2019. 37(9): p. 923-926.
Chacon, M.G., E.G. Kendrick, and D.J. Leak, Engineering Escherichia coli for the
production of butyl octanoate from endogenous octanoyl-CoA. Peerj, 2019. 7.
Morales-Quintana, L., et al., Structural characterization and substrate specificity of
VpAAT1 protein related to ester biosynthesis in mountain papaya fruit. Journal of
Molecular Graphics & Modelling, 2011. 29(5): p. 635-642.
Beekwilder, J., et al., Functional characterization of enzymes forming volatile esters from
strawberry and banana. Plant Physiology, 2004. 135(4): p. 1865-1878.
Cumplido-Laso, G., et al., The fruit ripening-related gene FaAAT2 encodes an acyl
transferase involved in strawberry aroma biogenesis. Journal of Experimental Botany,
2012. 63(11): p. 4275-4290.
Torella, J.P., et al., Tailored fatty acid synthesis via dynamic control of fatty acid
elongation. Proceedings of the National Academy of Sciences of the United States of
America, 2013. 110(28): p. 11290-11295.
Lennen, R.M. and B.F. Pfleger, Engineering Escherichia coli to synthesize free fatty acids.
Trends in Biotechnology, 2012. 30(12): p. 659-667.

41

20.
21.

22.

23.
24.
25.
26.

27.
28.
29.
30.
31.
32.
33.
34.
35.
36.

37.
38.

39.

Souleyre, E.J.F., et al., An alcohol acyl transferase from apple (cv. Royal Gala), MpAAT1,
produces esters involved in apple fruit flavor. Febs Journal, 2005. 272(12): p. 3132-3144.
Layton, D.S. and C.T. Trinh, Expanding the modular ester fermentative pathways for
combinatorial biosynthesis of esters from volatile organic acids. Biotechnol Bioeng, 2016.
113(8): p. 1764-76.
Verstrepen, K.J., et al., Expression levels of the yeast alcohol acetyltransferase genes ATF1,
Lg-ATF1, and ATF2 control the formation of a broad range of volatile esters. Appl Environ
Microbiol, 2003. 69(9): p. 5228-37.
Singhvi, P., et al., Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins.
Trends Biotechnol, 2020. 38(5): p. 474-486.
Kallscheuer, N., et al., Reversal of beta-oxidative pathways for the microbial production
of chemicals and polymer building blocks. Metabolic Engineering, 2017. 42: p. 33-42.
Lee, J.W. and C.T. Trinh, Towards renewable flavors, fragrances, and beyond. Curr Opin
Biotechnol, 2020. 61: p. 168-180.
Sahdev, S., S.K. Khattar, and K.S. Saini, Production of active eukaryotic proteins through
bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell
Biochem, 2008. 307(1-2): p. 249-64.
Wrenbeck, E.E., et al., An Automated Data-Driven Pipeline for Improving Heterologous
Enzyme Expression. ACS Synth Biol, 2019. 8(3): p. 474-481.
Mosavi, L.K. and Z.Y. Peng, Structure-based substitutions for increased solubility of a
designed protein. Protein Eng, 2003. 16(10): p. 739-45.
Farasat, I., et al., Efficient search, mapping, and optimization of multi-protein genetic
systems in diverse bacteria. Molecular Systems Biology, 2014. 10(6).
Lee, J.W. and C.T. Trinh, Microbial biosynthesis of lactate esters. Biotechnology for
Biofuels, 2019. 12(1).
Jeschek, M., D. Gerngross, and S. Panke, Rationally reduced libraries for combinatorial
pathway optimization minimizing experimental effort. Nature Communications, 2016. 7.
Naseri, G., et al., COMPASS for rapid combinatorial optimization of biochemical pathways
based on artificial transcription factors. Nat Commun, 2019. 10(1): p. 2615.
Zhu, J., et al., Microbial host selection affects intracellular localization and activity of
alcohol-O-acetyltransferase. Microb Cell Fact, 2015. 14: p. 35.
Wilbanks, B., et al., A Prototype for Modular Cell Engineering. ACS Synth Biol, 2018.
7(1): p. 187-199.
Shen, C.R., et al., Driving forces enable high-titer anaerobic 1-butanol synthesis in
Escherichia coli. Appl Environ Microbiol, 2011. 77(9): p. 2905-15.
Lim, J.H., et al., Model-driven rebalancing of the intracellular redox state for optimization
of a heterologous n-butanol pathway in Escherichia coli. Metabolic Engineering, 2013. 20:
p. 49-55.
Rosano, G.L. and E.A. Ceccarelli, Rare codon content affects the solubility of recombinant
proteins in a codon bias-adjusted Escherichia coli strain. Microb Cell Fact, 2009. 8: p. 41.
Gorochowski, T.E., et al., Trade-offs between tRNA abundance and mRNA secondary
structure support smoothing of translation elongation rate. Nucleic Acids Research, 2015.
43(6): p. 3022-3032.
Waugh, D.S., The remarkable solubility-enhancing power of Escherichia coli maltosebinding protein. Postepy Biochem, 2016. 62(3): p. 377-382.

42

40.
41.

42.

43.

44.
45.
46.
47.

48.
49.
50.

51.

Raran-Kurussi, S. and D.S. Waugh, Unrelated solubility-enhancing fusion partners MBP
and NusA utilize a similar mode of action. Biotechnol Bioeng, 2014. 111(12): p. 2407-11.
Lavallie, E.R., et al., A Thioredoxin Gene Fusion Expression System That Circumvents
Inclusion Body Formation in the Escherichia-Coli Cytoplasm. Nature Biotechnology, 1993.
11: p. 187-193.
Thomson, N.M., et al., Efficient Production of Active Polyhydroxyalkanoate Synthase in
Escherichia coli by Coexpression of Molecular Chaperones. Applied and Environmental
Microbiology, 2013. 79(6): p. 1948-1955.
Bond-Watts, B.B., R.J. Bellerose, and M.C.Y. Chang, Enzyme mechanism as a kinetic
control element for designing synthetic biofuel pathways. Nature Chemical Biology, 2011.
7(4): p. 222-227.
Philip, P., et al., Parallel substrate supply and pH stabilization for optimal screening of Ecoli with the membrane-based fed-batch shake flask. Microbial Cell Factories, 2018. 17.
Noda, S. and A. Kondo, Recent Advances in Microbial Production of Aromatic Chemicals
and Derivatives. Trends Biotechnol, 2017. 35(8): p. 785-796.
Carbonell, P., et al., An automated Design-Build-Test-Learn pipeline for enhanced
microbial production of fine chemicals. Commun Biol, 2018. 1: p. 66.
Opgenorth, P., et al., Lessons from Two Design-Build-Test-Learn Cycles of Dodecanol
Production in Escherichia coli Aided by Machine Learning. ACS Synth Biol, 2019. 8(6):
p. 1337-1351.
Hebditch, M., et al., Protein-Sol: a web tool for predicting protein solubility from sequence.
Bioinformatics, 2017. 33(19): p. 3098-3100.
Xie, X., et al., Rational improvement of simvastatin synthase solubility in Escherichia coli
leads to higher whole-cell biocatalytic activity. Biotechnol Bioeng, 2009. 102(1): p. 20-8.
Carballo-Amador, M.A., et al., Surface patches on recombinant erythropoietin predict
protein solubility: engineering proteins to minimise aggregation. BMC Biotechnol, 2019.
19(1): p. 26.
Eichmann, J., et al., Selection of High Producers From Combinatorial Libraries for the
Production of Recombinant Proteins in Escherichia coli and Vibrio natriegens. Front
Bioeng Biotechnol, 2019. 7: p. 254.

43

2.7 Appendix
Table 2-2: A list of plasmids used in this study. Abbreviations: MCS, multiple cloning site.
Plasmid
Module 1: Butyl-CoA synthesis
pACYCDuet-1
PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd

pETDuet-1
PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd

pRSFDuet-1
PT7lac::atoBEc::hbdCa::crtCaPT7lac::terTd

Primers (5’➝3’)

Cloning strategies

CrCoA_F:
CAGCAGCCATCACCATCATCACCACAGCCAGGATCCGATG
AAAAATTGTGTCATCGTCAG
CrCoA_R:
CTATCTATTTTTGAAGCCTTCAATTT
MCS1_MCS2 linker_F:
GCTTTCATAGAGAAAAGAAAAATTGAAGGCTTCAAAAATA
GATAGGAATTCGAGCTCGGC
MCS1_MCS2 linker_R:
ATTGTTCCTAACCATTGGTTTTACAATCATCATATGTATATC
TCCTTCTTATACTTAACT
terTd_F:
AGTTAAGTATAAGAAGGAGATATACATATGATGATTGTAA
AACCAATGGTTAGG
terTd_R:
TCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTTA
AATCCTGTCGAACCTTTCT
BB_Duet_F:
CGGATCCTGGCTGTGG
BB_Duet_R:
CTCGAGTCTGGTAAAGAAACC

Biosynthesis pathway of
Butyl-CoA in pDL2 [1] was
subcloned into the plasmids
with various copy numbers by
Gibson Assembly method [2].
Specifically, atoBEc- hbdCacrtCa and TerTd were subcloned
into the MCS1and MCS2 of
the duet vectors, respectively.

Module 2/3/4 for BA: Butanol+NADH+ATF1

pACYCDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::ATF1Sc

pETDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::ATF1Sc

pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::ATF1Sc

pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::ATF1Scopt

adhE2Ca_F:
GCCATCACCATCATCACCACAGCCAGGATCCGATGAAAGT
TACAAATCAAAAAGAACTAA
adhE2Ca_R:
TATATCTCCTTTTAAAATGATTTTATATAGATATCCTTAAGT
TCAC
fdhCbopt_F:
AGGATATCTATATAAAATCATTTTAAAAGGAGATATAATG
AAAATTGTGCTGGTTTTGTA
fdhCbopt_R:
TTGTCGACCTGCAGGCGCGCCGAGCTCGAATTCTTATTTTT
TATCGTGTTTACCATACGC
MCS1_MCS2 linker_BA_F:
TAAGAATTCGAGCTCGGC
MCS1_MCS2 linker_BA_R:
GATTTCATTCATCATATGTATATCTCCTTCTTATACTTAACT
ATF1Sc_F:
ATATTAGTTAAGTATAAGAAGGAGATATACATATGATGAA
TGAAATCGATGAGAAAAATC
ATF1Sc_R:
CGTTCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAG
CTAAGGGCCTAAAAGGAGA
BB_Duet_F:
CGGATCCTGGCTGTGG
BB_Duet_R:
CTCGAGTCTGGTAAAGAAACC
ATF1Scopt_F:
ATGAACGAAATCGACGAAAAAAATCAG
ATF1Scopt_R:
CGGACCCAGTAACAAAGCTTTATA
BB_BA_ATF1Scopt_F:
GAGCTTTGTAGCATATATAAAGCTTTGTTACTGGGTCCGCT
CGAGTCTGGTAAAGAAAC
BB_BA_ATF1Scopt_R:
GCGCCTGATTTTTTTCGTCGATTTCGTTCATCATATGTATAT
CTCCTTCTTATACTTAAC
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Five PCR fragments including
i) adhE2Ca from gDNA of C.
acetobutylicum, ii) fdhCbopt
from pET29 PT7lac::fdhCbopt,
iii) MCS1_MCS2 linker from
pACYCDuet-1, iv) ATF1Sc
from , and v) plasmid
backbone with various copy
numbers were assembled by
Gibson Assembly method [2].
Specifically, adhE2Ca-fdhCb
and ATF1Sc were subcloned
into the MCS1and MCS2 of
the duet vectors, respectively.

ATF1Sc in pRSFDuet-1
PT7::adhE2Ca::fdhCboptPT7::ATF1Sc was replaced with
ATF1Scopt from pET29
PT7::ATF1Scopt by Gibson
Assembly method [2].

Table 2-2: Continued
Plasmid

pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::malE_ATF1Scopt

pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::nusA_ATF1Scopt

pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::trxA_ATF1Scopt

pRSFDuet-1
PT7lac::adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt

pRSFDuet-1
PT7lac::malE_adhE2Caopt::fdhCboptopt
T7lac::trxA_ATF1Sc

pRSFDuet-1
PT7lac::nusA_adhE2Caopt::fdhCboptopt
T7lac::trxA_ATF1Sc

pRSFDuet-1
PT7lac::trxA_adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt

Primers (5’➝3’)

Cloning strategies

malE_ATF1Scopt_F:
ATATTAGTTAAGTATAAGAAGGAGATATACATATGAT
GAAAATCGAAGAAGGTAAACTGG
malE_ATF1Scopt_R:
CCTGCTGAACTGGCGCCTGATTTTTTTCGTCGATTTCG
TTCTTGGTGATACGAGTCTGC
BB_BA_ FP_ATF1Scopt_F:
AACGAAATCGACGAAAAAAATCAG
BB_BA_FP_ATF1Scopt_R:
CATATGTATATCTCCTTCTTATACTTAACTAATATACT
nusA_ATF1Scopt_F:
ATATTAGTTAAGTATAAGAAGGAGATATACATATGAT
GAACAAAGAAATTTTGGCTGTAG
nusA_ATF1Scopt_R:
CACTCCTGCTGAACTGGCGCCTGATTTTTTTCGTCGAT
TTCGTTCGCTTCGTCACCGAAC
BB_BA_ FP_ATF1Scopt_F:
AACGAAATCGACGAAAAAAATCAG
BB_BA_FP_ATF1Scopt_R:
CATATGTATATCTCCTTCTTATACTTAACTAATATACT
trxA_ATF1Scopt_F:
TATTAGTTAAGTATAAGAAGGAGATATACATATGATG
AGCGATAAAATTATTCACCTGAC
trxA_ATF1Scopt_R:
CTGCTGAACTGGCGCCTGATTTTTTTCGTCGATTTCGT
TCGCCAGGTTAGCGTC
BB_BA_ FP_ATF1Scopt_F:
AACGAAATCGACGAAAAAAATCAG
BB_BA_FP_ATF1Scopt_R:
CATATGTATATCTCCTTCTTATACTTAACTAATATACT
adhE2Caopt_F:
ATGAAAGTGACCAATCAAAAAGAGC
adhE2Caopt_R:
TTAGAAACTCTTTATGTAAATGTCTTTGAGTTCG
BB_BA_adhE2Caopt_F:
CAAAGACATTTACATAAAGAGTTTCTAAAAGGAGATA
TAATGAAAATTGTGCTGGTTTTG
BB_BA_adhE2Caopt_R:
GTTCAGTTTCTGTTTCAGCTCTTTTTGATTGGTCACTTT
CATCGGATCCTGGCTGTGG
malE_adhE2Caopt_F:
GCAGCCATCACCATCATCACCACAGCCAGGATCCGAT
GAAAATCGAAGAAGGTAAACTGG
malE_adhE2Caopt_R:
CGTTCAGTTTCTGTTTCAGCTCTTTTTGATTGGTCACTT
TCTTGGTGATACGAGTCTGC
BB_BA_FP_adhE2Caopt_F:
CGGATCCTGGCTGTGG
BB_BA_FP_adhE2Caopt_R:
AAAGTGACCAATCAAAAAGAGCTG
nusA_adhE2Caopt_F:
GCAGCCATCACCATCATCACCACAGCCAGGATCCGAT
GAACAAAGAAATTTTGGCTGTAG
nusA_adhE2Caopt_R:
CGTTCAGTTTCTGTTTCAGCTCTTTTTGATTGGTCACTT
TCGCTTCGTCACCGAAC
BB_BA_FP_adhE2Caopt_F:
CGGATCCTGGCTGTGG
BB_BA_FP_adhE2Caopt_R:
AAAGTGACCAATCAAAAAGAGCTG
trxA_adhE2Caopt_F:
CAGCCATCACCATCATCACCACAGCCAGGATCCGATG
AGCGATAAAATTATTCACCTGAC
trxA_adhE2Caopt_R:
CGTTCAGTTTCTGTTTCAGCTCTTTTTGATTGGTCACTT
TCGCCAGGTTAGCGTC
BB_BA_FP_adhE2Caopt_F:
CGGATCCTGGCTGTGG
BB_BA_FP_adhE2Caopt_R:
AAAGTGACCAATCAAAAAGAGCTG
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The start codon of ATF1Scopt in
pRSFDuet-1
PT7::adhE2Ca::fdhCboptPT7::ATF1Scopt was replaced with
the malE from gDNA of E. coli
MG1655 by Gibson Assembly
method [2].
The start codon of ATF1Scopt in
pRSFDuet-1
PT7::adhE2Ca::fdhCboptPT7::ATF1Scopt was replaced with
the nusA from gDNA of E. coli
MG1655 by Gibson Assembly
method [2].
The start codon of ATF1Scopt in
pRSFDuet-1
PT7::adhE2Ca::fdhCboptPT7::ATF1Scopt was replaced with
the trxA from gDNA of E. coli
MG1655 by Gibson Assembly
method [2].
adhE2Ca in pRSFDuet-1
PT7::adhE2Ca::fdhCboptPT7::trxA_ATF1Sc was replaced
with adhE2Caopt from pET29
PT7:: adhE2Caopt by Gibson
Assembly method [2].
The start codon of adhE2Caopt in
pRSFDuet-1
PT7lac::adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt was
replaced with the malE from
gDNA of E. coli MG1655 by
Gibson Assembly method [2].
The start codon of adhE2Caopt in
pRSFDuet-1
PT7lac::adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt was
replaced with the nusA from
gDNA of E. coli MG1655 by
Gibson Assembly method [2].
The start codon of adhE2Caopt in
pRSFDuet-1
PT7lac::adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt was
replaced with the trxA from
gDNA of E. coli MG1655 by
Gibson Assembly method [2].

Table 2-2: Continued
Plasmid

Primers (5’➝3’)

Cloning strategies

Module 2/3/4 for EB: Ethanol+NADH+SAAT

pACYCDuet-1
PT7lac::pdcZm::adhBZm::fdhCboptPT7lac::SAATFa

pETDuet-1
PT7lac::pdcZm::adhBZm::fdhCboptPT7lac::SAATFa

pRSFDuet-1
PT7lac::pdcZm::adhBZm::fdhCboptPT7lac::SAATFa

EtOH_F:
GGCAGCAGCCATCACCATCATCACCACAGCCAGGATC
CGATGAGTTATACTGTCGGTACC
EtOH_R:
CGCATCATACAAAACCAGCACAATTTTCATTATATCTC
CTTTTAGAAAGCGCTCAGGAAG
fdhCbopt_F:
ATGAAAATTGTGCTGGTTTTGTAATGAAAATTGTGCTG
GTTTTGTA
fdhCbopt_R:
TTGTCGACCTGCAGGCGCGCCGAGCTCGAATTCTTATT
TTTTATCGTGTTTACCATACGC
MCS1_MCS2 linker_F:
AAAATAAGAATTCGAGCTCGGC
MCS1_MCS2 linker_R:
GGAATTTATACTGACCTCAATTTTCTCCATCATATGTA
TATCTCCTTCTTATACTTAACT
SAATFa_F:
AGTTAAGTATAAGAAGGAGATATACATATGATGGAGA
AAATTGAGGTCAGTATA
SAATFa_R:
AAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTT
AAATTAAGGTCTTTGGAGATGC
BB_Duet_F:
CGGATCCTGGCTGTGG
BB_Duet_R:
CTCGAGTCTGGTAAAGAAACC

Five PCR fragments including i)
pdcZm-adhBZm from pCT24 [1],
ii) fdhCbopt from pET29
PT7lac::fdhCbopt, iii)
MCS1_MCS2 linker from
pACYCDuet-1, iv) SAATFa
from pDL1 [1], and v) plasmid
backbone with various copy
numbers were assembled by
Gibson Assembly method [2].
Specifically, pdcZm-adhBZmfdhCb and SAATFa were
subcloned into the MCS1and
MCS2 of the duet vectors,
respectively.

Module 2/3/4 for BB: Butanol+NADH+SAAT
pACYCDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::SAATFa
pETDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::SAATFa
pRSFDuet-1
PT7lac::adhE2Ca::fdhCboptPT7lac::SAATFa

pRSFDuet-1
PT7lac::trxA_adhE2Caopt::fdhCboptPT7lac::SAATFa

adhE2Ca_F:
GCCATCACCATCATCACCACAGCCAGGATCCGATGAA
AGTTACAAATCAAAAAGAACTAA
adhE2Ca_R:
TATATCTCCTTTTAAAATGATTTTATATAGATATCCTTA
AGTTCAC
BB_Duet_F:
CGGATCCTGGCTGTGG
BB_BB_R:
AGGATATCTATATAAAATCATTTTAAAAGGAGATATA
ATGAAAATTGTGCTGGTTTTGTA

pdcZm-adhBZm in EB production
modules were replaced with
adhE2Ca from gDNA of C.
acetobutylicum by Gibson
Assembly method [2].

SAATFa_F:
AGTTAAGTATAAGAAGGAGATATACATATGATGGAGA
AAATTGAGGTCAGTATA
SAATFa_R:
AAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTT
AAATTAAGGTCTTTGGAGATGC
BB_trxA_adhE2Caopt_F:
ATGTATATCTCCTTCTTATACTTAACTAATATACTAAG
ATGG
BB_Duet_R:
CTCGAGTCTGGTAAAGAAACC

trxA_ATF1Scopt in pRSFDuet-1
PT7lac::trxA_adhE2Caopt::fdhCboptPT7lac::trxA_ATF1Scopt was
replaced with the SAATFa from
pET29 PT7lac::SAATFa by
Gibson Assembly method [2].

-

Chapter 5

Wildtype AATs

pET29 PT7lac::ATF1Sc
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Table 2-2: Continued
Plasmid

Primers (5’➝3’)

Cloning strategies

pET29 PT7lac::SAATFa

SAATFa_F:
TAGAAATAATTTTGTTTAACTTTAAGAAGGAGATAT
AGATATGGAGAAAATTGAGGTCAG
SAATFa_R:
GTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTGGT
GGATAATTAAGGTCTTTGGAGATGC
BB_pET29_F:
ATCCACCACCACCACC
BB_pET29_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTATT
TCTAG

SAATFa in pDL001 [3] was
subcloned into pET29 by Gibson
Assembly method [2].

univ_F:
CCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAG
A
univ_R:
CGGATCTCAGTGGTGGTGGT

The plasmids were constructed
by JGI. The synthesized genes
were amplified and cloned into
pET29 plasmid using the EcoRV
restriction site. The genes were
codon optimized to E. coli.

Codon optimized genes from JGI
pET29 PT7lac::ATF1Scopt
pET29 PT7lac::SAATFaopt
pET29 PT7lac::fdhCbopt
pET29 PT7lac::adhE2Caopt
AATs with fusion partners

pET29 PT7lac::malE_ATF1Sc

pET29 PT7lac::nusA_ATF1Sc

pET29 PT7lac::trxA_ATF1Sc

malE_ATF1Sc_F:
TTTGTTTAACTTTAAGAAGGAGATATAGATATGAAA
ATCGAAGAAGGTAAACTGGTAATC
malE_ATF1Sc_R:
CTTGTTGCACGGGGGCCTGATTTTTCTCATCGATTT
CATTCTTGGTGATACGAGTCTGCG
BB_pET29 ATF1Sc_F:
AATGAAATCGATGAGAAAAATCAGGC
BB_pET29 ATF1Sc_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTATT
TCTAG
nusA_ATF1Sc_F:
ATTTTGTTTAACTTTAAGAAGGAGATATAGATATGA
ACAAAGAAATTTTGGCTGTAGTTG
nusA_ATF1Sc_R:
ATTCTTGTTGCACGGGGGCCTGATTTTTCTCATCGA
TTTCATTCGCTTCGTCACCGAACC
BB_pET29 ATF1Sc_F:
AATGAAATCGATGAGAAAAATCAGGC
BB_pET29 ATF1Sc_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTATT
TCTAG
trxA_ATF1Sc_F:
ATTTTGTTTAACTTTAAGAAGGAGATATAGATATGA
GCGATAAAATTATTCACCTGACTG
trxA_ATF1Sc_R:
CATTCTTGTTGCACGGGGGCCTGATTTTTCTCATCG
ATTTCATTCGCCAGGTTAGCGTCG
BB_pET29 ATF1Sc_F:
AATGAAATCGATGAGAAAAATCAGGC
BB_pET29 ATF1Sc_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTATT
TCTAG
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The start codon of ATF1Sc in
pET29 PT7::ATF1Sc was
replaced with malE from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

The start codon of ATF1Sc in
pET29 PT7::ATF1Sc was
replaced with nusA from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

The start codon of ATF1Sc in
pET29 PT7::ATF1Sc was
replaced with trxA from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

Table 2-2: Continued
Plasmid

pET29 PT7lac::malE_SAATFa

pET29 PT7lac::nusA_SAATFa

pET29 PT7lac::trxA_SAATFa

Primers (5’➝3’)

Cloning strategies

malE_ATF1Sc_F:
TTTGTTTAACTTTAAGAAGGAGATATAGATATGAA
AATCGAAGAAGGTAAACTGGTAATC
malE_ATF1Sc_R:
TGATGGTGTGTTTGGAATTTATACTGACCTCAATT
TTCTCCTTGGTGATACGAGTCTGCG
BB_pET29 SAATFa_F:
GAGAAAATTGAGGTCAGTATAAATTCCAAAC
BB_pET29 SAATFa_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTAT
TTCTAG
nusA_ATF1Sc_F:
ATTTTGTTTAACTTTAAGAAGGAGATATAGATATG
AACAAAGAAATTTTGGCTGTAGTTG
nusA_ATF1Sc_R:
GTTTGATGGTGTGTTTGGAATTTATACTGACCTCA
ATTTTCTCCGCTTCGTCACCGAACC
BB_pET29 SAATFa_F:
GAGAAAATTGAGGTCAGTATAAATTCCAAAC
BB_pET29 SAATFa_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTAT
TTCTAG
trxA_ATF1Sc_F:
ATTTTGTTTAACTTTAAGAAGGAGATATAGATATG
AGCGATAAAATTATTCACCTGACTG
trxA_ATF1Sc_R:
GGTTTGATGGTGTGTTTGGAATTTATACTGACCTC
AATTTTCTCCGCCAGGTTAGCGTCG
BB_pET29 SAATFa_F:
GAGAAAATTGAGGTCAGTATAAATTCCAAAC
BB_pET29 SAATFa_R:
ATCTATATCTCCTTCTTAAAGTTAAACAAAATTAT
TTCTAG

Co-expression of chaperones
pACYC ParaB:tig
pACYC ParaB::groES::groEL
pACYC Ppzt-1::groES::groEL::tig

-

pACYC ParaB::dnaK::dnaJ::grpE

-

pACYC ParaB::dnaK::dnaJ::grpEPpzt-1::groES::groEL

-

pACYC ParaB::groES::groEL
(AmpR)

AmpR_F:
ATTAGTTAAGTATAAGAAGGAGATATACATATGA
TGAACGAAATCGACGAAAAAAATCAG
AmpR_R:
TTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGCG
GACCCAGTAACAAAGCTTTATATAT
BB_groES/EL_F:
CTCGAGTCTGGTAAAGAAACC
BB_groES/EL_R:
CATATGTATATCTCCTTCTTATACTTAACTAATATA
CT

The start codon of SAATFa in
pET29 PT7::SAATFa was
replaced with malE from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

The start codon of SAATFa in
pET29 PT7::SAATFa was
replaced with nusA from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

The start codon of SAATFa in
pET29 PT7::SAATFa was
replaced with trxA from gDNA
of E. coli MG1655 by Gibson
Assembly method [2].

The chaperone plasmid kit was
purchased from TaKaRa Bio
Inc. (Cat. #3340).

-

48

The chloramphenicol resistance
marker of pACYC ParaB::groES::
groEL was replaced with the
ampicillin resistance marker
from pETDuet-1 by Gibson
Assembly method [2].

Table 2-3: A list of enzymes used in this study.
#Module

Gene

Enzyme
Acetyl-CoA
acetyltransferase
3-hydroxybutyryl-CoA
dehydrogenase
Short-chain-enoyl-CoA
hydratase
Trans-2-enoyl-CoA
reductase
Aldehyde-alcohol
dehydrogenase
Codon optimized adhE2Ca
for expression in E. coli

AtoBEc

1

Butyl-CoA
synthesis

HbdCa
CrtCa
TerTd
AdhE2Ca
AdhE2Caopt

2

3

Alcohol
synthesis

NADH
synthesis

TrxA_AdhE2Ca

opt

4

C. acetobutylicum
T. denticola
C. acetobutylicum
-

tagged with TrxA

-

Improving soluble expression
of adhE2Ca
Synthesis of acetaldehyde from
pyruvate
Synthesis of ethanol from
acetaldehyde

P76461
P52041
P52046
Q73Q47
Q9ANR5
-

Z. mobilis

AdhBZm

Alcohol dehydrogenase

Z. mobilis

FdhCbopt

Formate dehydrogenase

C. boidinii

Synthesis of NADH from
NAD+

O13437

ATF1Sc

Alcohol O-acetyltransferase

S. cerevisiae

Synthesis of an acetate ester
from an alcohol and acetylCoA.

P40353

ATF1Scopt

Codon optimized ATF1Sc for
expression in E. coli
ATF1Sc tagged with MBP
without the N-terminus
signal sequence

-

ATF1Sc tagged with NusA

-

TrxA_ATF1Sc

ATF1Sc tagged with TrxA

-

ATF1Sc

opt

tagged with TrxA

P0DJA2

Improving soluble expression
of ATF1Sc

-

-

Synthesis of a butyrate ester
from an alcohol and butyl-CoA.

SAATFa

Alcohol O-acetyltransferase

SAATFaopt
MBP_SAATFa

Codon optimized SAATFa
for expression in E. coli
SAATFa tagged with MBP

NusA_SAATFa

SAATFa tagged with NusA

-

TrxA_SAATFa

SAATFa tagged with TrxA
Maltose binding protein
without the N-terminus
signal sequence
(KIKTGARILALSALTTM
MFSASALA)

-

-

E. coli

P0AEX9

NusA

N-Utilization substrate A

E. coli

P0AFF6

TrxA

Thioredoxin 1

E. coli

P0AA25

Tf

Trigger factor

E. coli

DnaK

Chaperone protein

E. coli

Fusion
tags

F. ananassa

P06672

-

-

NusA_ATF1Sc

MBP

Chaperones

C. acetobutylicum

Synthesis of acetoacetyl-CoA
from two acetyl-CoA
Synthesis of 3-hydroxybutyrylCoA from acetoacetyl-CoA
Synthesis of crotonyl-CoA from
3-hydroxybutyryl-CoA
Synthesis of butyryl-CoA from
crotonyl-CoA
Synthesis of butanol from
butyryl-CoA

Pyruvate decarboxylase

TrxA_ATF1Scopt

etc.

adhE2Ca

opt

E. coli

#Accession
(UniProt)

Assigned function

PdcZm

MBP_ATF1Sc

Ester
synthesis

Organism

-

Improving soluble expression
of SAATFa

-

Improving the solubility of
heterologous proteins[4]

DnaJ

Chaperone protein

E. coli

GrpE

Protein GrpE

E. coli

GroES

10 kDa chaperonin

E. coli

GroEL

60 kDa chaperonin

E. coli
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Q9FVF1

Protein folding. Acts as a
mechanical foldase by
interacting directly with the
newly synthesized proteins[5]

P0A850

P0A6Y8
Unfolding, disaggregation,
stabilization of extended
chains[6].

P08622
P09372

Protein folding, prevention of
aggregation[6].

P0A6F9
P0A6F5

Table 2-4: A list of codon optimized gene sequences.
Gene

ATF1opt

SAATopt

adhE2Caopt

fdhCbopt

Sequences
ATGAACGAAATCGACGAAAAAAATCAGGCGCCAGTTCAGCAGGAGTGTCTGAAAGAAATGATTCAAAATGGTCATGCGCGTAGA
ATGGGTTCAGTGGAGGATTTGTACGTTGCGCTGAATCGCCAAAACCTTTACCGTAACTTTTGCACGTATGGTGAGCTGTCAGATT
ACTGCACTCGTGATCAGTTGACGCTGGCGCTCCGTGAAATCTGCTTAAAAAACCCGACTCTTCTGCATATTGTGTTACCGACGCG
CTGGCCGAACCACGAAAACTATTATAGAAGCAGTGAATATTACAGCCGTCCTCACCCTGTGCACGACTACATATCGGTCTTACAG
GAATTAAAGCTGTCGGGCGTGGTGTTGAATGAACAACCTGAATACTCAGCGGTTATGAAACAGATTCTGGAAGAATTCAAAAATA
GCAAGGGCAGCTATACGGCTAAGATCTTTAAACTTACCACCACCCTGACAATCCCATACTTCGGCCCCACAGGCCCATCTTGGCG
CTTGATTTGTTTGCCCGAAGAGCACACTGAAAAATGGAAGAAATTCATATTTGTGAGCAATCATTGCATGTCAGATGGCCGCTCC
TCCATTCATTTCTTCCACGATCTGCGTGACGAACTTAACAATATTAAAACTCCGCCGAAGAAGCTAGATTACATCTTCAAATACGA
AGAAGACTACCAGCTGCTGCGTAAACTGCCGGAGCCGATCGAAAAAGTGATTGATTTTCGTCCGCCGTATCTTTTTATTCCTAAA
TCCCTCTTATCGGGATTTATATACAATCACCTTCGATTTTCATCAAAAGGGGTATGTATGCGCATGGATGATGTGGAAAAGACGG
ACGACGTCGTTACCGAAATCATTAATATTAGCCCGACTGAATTTCAAGCGATAAAAGCAAACATCAAATCGAACATCCAGGGCAA
ATGTACCATTACTCCCTTTCTCCATGTTTGTTGGTTCGTGTCTCTGCATAAATGGGGCAAGTTCTTTAAACCTCTGAACTTTGAAT
GGCTGACTGATATTTTCATCCCTGCGGACTGCCGCTCTCAGTTGCCTGATGACGATGAAATGCGCCAGATGTACCGGTATGGTGC
GAATGTGGGCTTCATTGACTTCACTCCGTGGATCAGCGAATTTGACATGAATGATAACAAAGAAAATTTTTGGCCACTGATTGAG
CACTATCATGAGGTGATCAGTGAGGCGCTTCGTAACAAAAAACATCTGCATGGTTTGGGTTTCAACATTCAGGGTTTCGTACAAA
AGTACGTGAACATAGATAAAGTCATGTGTGACCGGGCTATTGGTAAACGTCGTGGCGGTACTCTACTCAGCAATGTTGGTCTGTT
CAATCAACTTGAAGAACCTGACGCCAAATATTCTATTTGCGACTTAGCTTTTGGCCAATTCCAGGGCAGCTGGCACCAGGCTTTT
AGTCTCGGTGTGTGCTCTACGAATGTTAAAGGTATGAATATCGTCGTCGCGTCGACAAAAAACGTCGTAGGTTCACAGGAGTCCC
TGGAAGAGCTTTGTAGCATATATAAAGCTTTGTTACTGGGTCCG
ATGGAAAAAATCGAAGTCTCAATTAACTCCAAGCATACCATCAAACCCTCTACCTCTAGTACCCCGCTACAACCCTATAAACTGA
CCTTACTGGATCAGCTGACGCCACCAGCCTATGTCCCGATCGTGTTTTTTTACCCGATCACCGATCACGATTTTAATCTGCCGCA
GACGCTGGCGGACTTACGTCAAGCTCTGTCGGAGACTCTCACGCTGTATTATCCCCTGAGCGGACGTGTTAAAAACAATTTGTAT
ATTGATGACTTTGAGGAAGGCGTGCCGTACTTAGAAGCGCGTGTAAATTGCGATATGACCGATTTTCTGCGTCTGCGCAAAATTG
AGTGCCTGAACGAATTTGTACCGATTAAACCTTTCAGTATGGAAGCAATTAGCGATGAACGTTACCCGTTGCTGGGCGTCCAGGT
TAATGTTTTTGATTCGGGCATCGCGATCGGAGTGTCAGTCAGTCATAAATTGATAGATGGTGGCACGGCAGATTGTTTCCTTAAA
TCTTGGGGCGCCGTGTTTCGTGGCTGCCGTGAAAATATTATCCACCCGAGTCTGAGTGAGGCTGCGCTGTTGTTCCCCCCACGC
GATGACCTGCCAGAAAAATACGTTGACCAAATGGAGGCCCTGTGGTTTGCGGGGAAAAAAGTCGCCACCCGACGCTTTGTTTTC
GGTGTGAAAGCGATTAGCAGCATTCAAGACGAAGCAAAATCTGAGAGCGTCCCAAAACCGTCTCGCGTTCATGCCGTGACAGGC
TTCTTATGGAAGCACCTGATAGCTGCGTCCCGCGCATTGACAAGTGGGACTACATCGACCCGTCTGTCAATTGCCGCGCAAGCA
GTAAACCTGCGTACTCGCATGAACATGGAAACCGTTTTAGATAACGCTACGGGTAACCTGTTCTGGTGGGCCCAGGCGATCCTA
GAACTGTCGCATACCACCCCGGAGATTTCTGACCTTAAACTGTGTGATCTGGTTAACTTGCTGAACGGATCCGTCAAGCAGTGCA
ATGGCGACTATTTCGAGACCTTTAAAGGTAAAGAAGGCTATGGCCGGATGTGTGAATACTTGGATTTCCAGCGAACAATGTCGTC
CATGGAACCGGCTCCGGACATTTATCTGTTTTCATCCTGGACTAACTTTTTTAACCCGTTGGATTTCGGCTGGGGCCGCACCTCC
TGGATTGGAGTTGCAGGTAAAATTGAGAGTGCGTCCTGCAAATTTATAATCCTCGTGCCCACACAGTGCGGTTCGGGTATCGAG
GCCTGGGTCAACTTGGAGGAAGAAAAAATGGCCATGCTCGAACAGGATCCGCATTTTCTAGCGCTGGCGTCACCTAAAACCCTG
ATC
ATGAAAGTGACCAATCAAAAAGAGCTGAAACAGAAACTGAACGAACTTCGTGAAGCGCAAAAAAAATTCGCAACCTACACGCAG
GAGCAGGTGGATAAAATTTTCAAGCAGTGTGCGATTGCGGCGGCGAAAGAGCGGATTAACCTGGCGAAGCTGGCGGTGGAAGA
AACCGGGATTGGGCTGGTGGAGGACAAAATCATCAAGAACCATTTTGCCGCGGAATACATTTATAACAAGTACAAAAACGAAAA
GACGTGTGGTATTATTGATCACGATGACTCCCTGGGCATCACGAAGGTGGCAGAACCGATCGGTATCGTCGCTGCGATCGTTCC
GACGACCAATCCCACGTCAACGGCGATCTTTAAAAGTTTGATTAGCCTGAAAACTCGTAACGCCATCTTCTTTTCCCCCCACCCC
CGTGCGAAAAAGAGCACCATCGCGGCCGCGAAACTTATCTTGGATGCTGCCGTGAAGGCGGGGGCCCCGAAGAACATCATTGGC
TGGATCGACGAGCCGTCAATTGAGCTCAGCCAAGACCTGATGAGCGAAGCGGATATTATTCTGGCGACAGGCGGTCCGAGCATG
GTTAAAGCGGCCTACTCGTCTGGCAAACCAGCCATTGGTGTTGGAGCCGGCAACACTCCGGCAATTATTGATGAGAGCGCCGAT
ATCGATATGGCGGTTAGTAGCATCATCCTGTCTAAAACCTACGACAATGGTGTGATCTGCGCGAGCGAACAAAGTATTCTCGTCA
TGAACTCTATCTATGAAAAGGTGAAAGAAGAGTTTGTGAAGCGTGGTAGCTATATCCTGAACCAGAACGAAATTGCCAAAATCAA
AGAAACAATGTTTAAGAATGGAGCTATCAATGCCGATATCGTTGGTAAAAGTGCCTATATTATCGCGAAAATGGCTGGCATCGAA
GTCCCGCAAACTACCAAAATTTTAATTGGTGAGGTTCAGAGCGTGGAAAAATCGGAGTTGTTTTCCCACGAAAAACTGTCGCCGG
TATTAGCAATGTATAAAGTAAAAGATTTTGACGAAGCCCTGAAAAAGGCCCAGCGCTTAATTGAATTAGGCGGCTCTGGTCATAC
CTCATCGCTGTACATCGATAGCCAGAACAATAAAGATAAAGTTAAAGAATTTGGCCTGGCCATGAAGACAAGTCGCACGTTTATC
AATATGCCTTCAAGCCAGGGCGCCTCGGGTGATCTTTATAATTTTGCAATCGCGCCGAGCTTCACTCTGGGTTGTGGGACGTGGG
GTGGCAATAGCGTCTCACAGAATGTCGAACCGAAGCATTTACTGAACATCAAATCAGTCGCGGAACGCCGTGAAAACATGCTGT
GGTTCAAAGTGCCGCAAAAAATCTATTTCAAGTATGGTTGCCTGCGATTCGCACTGAAGGAACTGAAAGATATGAACAAAAAACG
TGCGTTTATTGTTACCGATAAGGACCTGTTTAAACTGGGCTATGTGAACAAAATTACTAAAGTTCTGGATGAAATTGATATTAAAT
ACTCGATCTTCACCGATATTAAAAGTGACCCTACGATCGATAGCGTGAAAAAAGGCGCGAAAGAAATGCTTAACTTTGAACCGGA
TACCATTATCAGTATTGGGGGTGGTTCTCCGATGGATGCGGCCAAAGTTATGCATCTGTTGTATGAGTATCCGGAAGCCGAGATT
GAGAACCTGGCTATCAATTTTATGGACATCCGAAAGCGGATCTGCAACTTCCCAAAGTTAGGTACGAAAGCCATTAGCGTAGCCA
TTCCTACCACCGCGGGTACCGGTAGTGAGGCCACGCCGTTCGCGGTGATTACCAATGATGAGACCGGTATGAAATACCCGTTGA
CCAGCTATGAATTAACACCAAACATGGCAATTATCGATACGGAACTGATGCTGAACATGCCTCGTAAACTTACAGCGGCGACTGG
GATTGATGCCCTGGTTCACGCGATTGAAGCATACGTGAGTGTGATGGCAACCGATTATACCGATGAGCTGGCCCTGCGCGCTAT
CAAAATGATCTTCAAATATCTGCCGCGTGCCTACAAAAACGGCACCAATGATATCGAAGCTCGAGAAAAAATGGCGCATGCCTCA
AACATCGCAGGGATGGCATTCGCGAACGCGTTTCTGGGCGTGTGCCACTCTATGGCACACAAACTGGGTGCGATGCACCATGTG
CCACACGGCATTGCATGTGCTGTGTTAATTGAAGAAGTTATTAAATATAATGCGACCGACTGCCCAACCAAACAAACCGCGTTTC
CGCAATACAAAAGCCCGAATGCTAAGCGTAAATACGCTGAAATTGCGGAATATCTGAATCTGAAAGGCACCTCTGATACCGAGAA
AGTGACCGCCCTGATTGAAGCTATCTCTAAGTTAAAAATTGATCTGAGCATCCCGCAGAACATCTCGGCAGCTGGGATCAATAAA
AAAGATTTTTACAATACCTTGGATAAAATGTCTGAACTCGCGTTCGACGATCAATGCACAACCGCCAACCCACGCTATCCGCTGA
TCTCCGAACTCAAAGACATTTACATAAAGAGTTTC
ATGAAAATTGTGCTGGTTTTGTATGATGCGGGAAAGCATGCGGCGGACGAAGAAAAGCTTTATGGGTGTACCGAAAACAAACTG
GGCATTGCTAACTGGCTGAAAGACCAGGGTCATGAACTCATTACCACGAGCGATAAAGAAGGCGAAACCTCCGAATTAGACAAG
CATATTCCGGATGCGGACATTATTATCACCACTCCGTTTCACCCGGCATACATTACCAAAGAACGTTTAGATAAAGCTAAAAACC
TGAAACTGGTCGTCGTCGCCGGTGTCGGCAGTGATCACATTGATTTAGATTATATTAACCAGACGGGCAAAAAAATCTCCGTGTT
AGAGGTAACAGGTAGCAACGTCGTCTCAGTGGCGGAACACGTGGTAATGACCATGCTAGTTTTGGTCCGTAACTTTGTTCCGGC
ACATGAACAAATTATCAATCATGACTGGGAGGTCGCGGCTATCGCGAAAGATGCCTACGATATTGAGGGCAAAACCATTGCGAC
TATTGGTGCGGGGCGCATCGGTTATCGTGTACTTGAACGCCTTCTTCCGTTTAACCCGAAGGAGCTGTTGTACTACGACTACCAG
GCGTTACCAAAAGAGGCTGAAGAAAAAGTGGGCGCGCGCCGTGTTGAGAATATTGAGGAACTCGTTGCACAGGCAGATATTGTT
ACCGTGAATGCGCCGCTGCACGCGGGAACCAAAGGTTTGATCAACAAAGAACTACTGAGTAAATTTAAAAAAGGCGCCTGGCTC
GTGAATACAGCTCGTGGTGCGATTTGCGTAGCTGAAGATGTGGCCGCAGCACTGGAGAGCGGTCAGCTGCGCGGCTATGGGGG
CGACGTGTGGTTCCCCCAACCGGCACCTAAAGATCATCCCTGGCGTGATATGCGTAACAAATACGGCGCAGGCAATGCTATGAC
CCCGCATTACTCCGGCACAACCTTGGACGCACAAACTCGCTACGCGGAAGGTACTAAGAACATTCTGGAGTCGTTTTTTACGGGC
AAGTTTGATTACCGACCGCAGGATATAATTCTTCTGAACGGTGAATACGTGACCAAGGCGTATGGTAAACACGATAAAAAA
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Table 2-5: Summary of validation of biosynthesis pathway of BA. Key strain is in bold;
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.d.:
not detected.
Strains

EcJWBA1

EcJWBA2

EcJWBA3

EcJWBA4

EcJWBA5

EcJWBA6

O.D.600

2.13 ± 0.28

2.06 ± 0.05

2.34 ± 0.21

1.94 ± 0.02

1.20 ± 0.08

2.50 ± 0.13

Consumed glucose, g/L (mM)

5.41 ± 0.43
(30.05 ± 2.37)

4.20 ± 0.25
(23.31 ± 1.39)

6.03 ± 0.13
(33.49 ± 0.72)

5.26 ± 0.10
(29.20 ± 0.56)

2.57 ± 0.16
(14.28 ± 0.91)

6.63 ± 0.05
(36.83 ± 0.30)

Lactate, g/L (mM)

0.30 ± 0.07
(3.37 ± 0.75)

0.18 ± 0.02
(2.00 ± 0.20)

0.26 ± 0.06
(2.84 ± 0.62)

0.18 ± 0.04
(2.03 ± 0.40)

0.18 ± 0.01
(2.01 ± 0.08)

0.23 ± 0.06
(2.51 ± 0.63)

Formate, g/L (mM)

0.51 ± 0.02
(11.10 ± 0.52)

0.38 ± 0.01
(8.23 ± 0.20)

0.50 ± 0.02
(10.77 ± 0.33)

0.54 ± 0.02
(11.77 ± 0.36)

0.49 ± 0.01
(10.61 ± 0.12)

0.66 ± 0.04
(14.42 ± 0.94)

Acetate, g/L (mM)

0.62 ± 0.02
(10.37 ± 0.39)

0.65 ± 0.00
(10.87 ± 0.02)

0.54 ± 0.00
(9.02 ± 0.06)

0.52 ± 0.00
(8.68 ± 0.03)

0.40 ± 0.00
(6.74 ± 0.02)

0.59 ± 0.02
(9.90 ± 0.32)

Ethanol, g/L (mM)

2.46 ± 0.12
(53.45 ± 2.70)

2.41 ± 0.03
(52.38 ± 0.69)

3.00 ± 0.08
(65.17 ± 1.82)

2.54 ± 0.08
(55.21 ± 1.63)

2.38 ± 0.03
(51.65 ± 0.68)

2.46 ± 0.02
(53.34 ± 0.54)

Butanol, g/L (mM)

0.04 ± 0.01
(0.58 ± 0.12)

0.06 ± 0.00
(0.84 ± 0.01)

0.03 ± 0.00
(0.45 ± 0.01)

0.03 ± 0.00
(0.42 ± 0.01)

0.11 ± 0.01
(1.43 ± 0.13)

0.05 ± 0.01
(0.67 ± 0.08)

EA

5.7 ± 1.3
(0.06 ± 0.01)

11.9 ± 1.9
(0.13 ± 0.02)

3.7 ± 0.5
(0.04 ± 0.01)

0.8 ± 0.1
(0.01 ± 0.00)

0.2 ± 0.0
(0.00 ± 0.00)

1.3 ± 0.5
(0.01 ± 0.01)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

12.9 ± 5.9
(0.11 ± 0.05)

34.2 ± 6.6
(0.29 ± 0.06)

3.8 ± 0.8
(0.03 ± 0.01)

2.1 ± 0.3
(0.02 ± 0.00)

0.7 ± 0.12
(0.01 ± 0.00)

10.5 ± 4.6
(0.09 ± 0.04)

BB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Ester total

18.6 ± 7.2
(0.18 ± 0.06)

46.1 ± 8.5
(0.43 ± 0.08)

7.5 ± 1.3
(0.07 ± 0.01)

2.9 ± 0.4
(0.03 ± 0.00)

0.9 ± 0.2
(0.01 ± 0.00)

11.8 ± 5.0
(0.11 ± 0.04)

EA

0.23 ± 0.02
(2.59 ± 0.27)

0.50 ± 0.07
(5.62 ± 0.82)

0.14 ± 0.03
(1.57 ± 0.33)

0.04 ± 0.00
(0.40 ± 0.04)

0.01 ± 0.00
(0.16 ± 0.01)

0.05 ± 0.02
(0.51 ± 0.18)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

0.51 ± 0.16
(4.37 ± 1.36)

1.43 ± 0.26
(12.31 ± 2.21)

0.14 ± 0.04
(1.22 ± 0.37)

0.09 ± 0.01
(0.78 ± 0.12)

0.05 ± 0.01
(0.42 ± 0.08)

0.36 ± 0.15
(3.12 ± 1.33)

BB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Ester total

0.74 ± 0.18
(6.95 ± 1.60)

1.93 ± 0.33
(17.93 ± 3.04)

0.28 ± 0.07
(2.79 ± 0.69)

0.13 ± 0.02
(1.18 ± 0.16)

0.06 ± 0.01
(0.58 ± 0.08)

0.41 ± 0.17
(3.63 ± 1.50)

EA

1.04 ± 0.16
(2.13 ± 0.32)

2.84 ± 0.60
(5.81 ± 1.23)

0.62 ± 0.09
(1.26 ± 0.18)

0.15 ± 0.02
(0.31 ± 0.04)

0.08 ± 0.01
(0.16 ± 0.03)

0.20 ± 0.07
(0.40 ± 0.14)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

2.33 ± 0.86
(3.62 ± 1.33)

8.22 ± 2.02
(12.75 ± 3.13)

0.63 ± 0.15
(0.98 ± 0.24)

0.39 ± 0.07
(0.60 ± 0.11)

0.27 ± 0.08
(0.42 ± 0.13)

1.59 ± 0.70
(2.46 ± 1.08)

BB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Ester total

3.38 ± 1.01
(5.75 ± 1.63)

11.06 ± 2.62
(18.56 ± 4.36)

1.25 ± 0.24
(2.24 ± 0.41)

0.54 ± 0.09
(0.92 ± 0.15)

0.35 ± 0.10
(0.58 ± 0.15)

1.78 ± 0.77
(2.86 ± 1.23)

Ester titers,
mg/L (mM)

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester yields,
mg/g glucose
(mM/M)
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Table 2-6: Summary of validation of biosynthesis pathway of EB. Key strain is in bold;
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.d.:
not detected.
Strains

EcJWEB1

EcJWEB2

EcJWEB3

EcJWEB4

EcJWEB5

EcJWEB6

O.D.600

2.12 ± 0.03

3.39 ± 0.26

3.86 ± 0.24

3.02 ± 0.08

0.93 ± 0.02

2.79 ± 0.06

Consumed glucose, g/L (mM)

7.53 ± 0.13
(41.79 ± 0.72)

7.21 ± 0.39
(40.02 ± 2.19)

19.61 ± 0.20
(108.86 ±
1.10)

13.40 ± 0.22
(74.40 ± 1.24)

2.77 ± 0.37
(15.37 ± 2.05)

9.30 ± 0.39
(51.62 ± 2.16)

Lactate, g/L (mM)

0.02 ± 0.03
(0.22 ± 0.34)

n.d.

0.19 ± 0.01
(2.10 ± 0.16)

0.18 ± 0.00
(1.95 ± 0.05)

n.d.

0.06 ± 0.00
(0.62 ± 0.01)

Formate, g/L (mM)

0.44 ± 0.01
(9.63 ± 0.16)

0.17 ± 0.01
(3.79 ± 0.12)

0.61 ± 0.03
(13.32 ± 0.57)

0.69 ± 0.02
(14.96 ± 0.39)

0.18 ± 0.02
(3.93 ± 0.46)

0.56 ± 0.01
(12.23 ± 0.32)

Acetate, g/L (mM)

0.48 ± 0.01
(7.94 ± 0.12)

0.37 ± 0.00
(6.10 ± 0.04)

0.56 ± 0.01
(9.25 ± 0.09)

0.53 ± 0.00
(8.80 ± 0.07)

0.36 ± 0.00
(6.03 ± 0.06)

0.49 ± 0.01
(8.16 ± 0.11)

Ethanol, g/L (mM)

4.92 ± 0.11
(106.72 ±
2.32)

5.16 ± 0.14
(111.92 ±
2.96)

10.89 ± 0.10
(236.41 ±
2.13)

7.25 ± 0.04
(157.34 ±
0.90)

2.84 ± 0.04
(61.66 ± 0.89)

5.29 ± 0.15
(114.85 ±
3.27)

Butanol, g/L (mM)

n.d.

n.d.

0.02 ± 0.00
(0.25 ± 0.02)

n.d.

0.03 ± 0.00
(0.40 ± 0.02)

n.d.

EA

0.5 ± 0.2
(0.01 ± 0.00)

4.9 ± 0.5
(0.06 ± 0.01)

7.4 ± 1.7
(0.08 ± 0.02)

2.5 ± 0.4
(0.03 ± 0.00)

0.1 ± 0.1
(0.00 ± 0.00)

1.8 ± 0.3
(0.02 ± 0.00)

EB

17.1 ± 3.4
(0.15 ± 0.03)

71.0 ± 6.6
(0.61 ± 0.06)

21.7 ± 2.9
(0.19 ± 0.03)

8.4 ± 1.0
(0.07 ± 0.01)

1.4 ± 0.2
(0.01 ± 0.00)

15.8 ± 1.3
(0.14 ± 0.01)

BA

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BB

n.d.

1.3 ± 0.7
(0.01 ± 0.00)

n.d.

n.d.

n.d.

n.d.

Ester total

17.6 ± 3.2
(0.15 ± 0.03)

77.2 ± 7.7
(0.68 ± 0.07)

29.1 ± 4.7
(0.27 ± 0.04)

10.9 ± 1.3
(0.10 ± 0.01)

1.5 ± 0.1
(0.01 ± 0.00)

17.6 ± 1.6
(0.16 ± 0.01)

EA

0.02 ± 0.01
(0.22 ± 0.10)

0.12 ± 0.02
(1.42 ± 0.17)

0.17 ± 0.05
(1.88 ± 0.57)

0.07 ± 0.01
(0.82 ± 0.14)

0.01 ± 0.01
(0.07 ± 0.07)

0.05 ± 0.01
(0.61 ± 0.11)

EB

0.69 ± 0.13
(5.98 ± 1.10)

1.81 ± 0.23
(15.60 ± 1.95)

0.49 ± 0.10
(4.20 ± 0.85)

0.24 ± 0.02
(2.05 ± 0.20)

0.13 ± 0.01
(1.09 ± 0.12)

0.49 ± 0.05
(4.20 ± 0.43)

BA

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BB

n.d.

0.03 ± 0.02
(0.23 ± 0.12)

n.d.

n.d.

n.d.

n.d.

Ester total

0.71 ± 0.12
(6.19 ± 1.00)

1.97 ± 0.26
(17.25 ± 2.24)

0.65 ± 0.15
(6.08 ± 1.41)

0.31 ± 0.03
(2.87 ± 0.31)

0.13 ± 0.01
(1.16 ± 0.05)

0.54 ± 0.06
(4.81 ± 0.53)

EA

0.06 ± 0.03
(0.13 ± 0.06)

0.68 ± 0.03
(1.39 ± 0.06)

0.38 ± 0.09
(0.77 ± 0.19)

0.19 ± 0.04
(0.39 ± 0.07)

0.02 ± 0.02
(0.05 ± 0.04)

0.19 ± 0.04
(0.39 ± 0.07)

EB

2.27 ± 0.43
(3.53 ± 0.66)

9.84 ± 0.42
(15.26 ± 0.65)

1.11 ± 0.16
(1.72 ± 0.25)

0.62 ± 0.07
(0.97 ± 0.12)

0.51 ± 0.14
(0.79 ± 0.21)

1.71 ± 0.21
(2.65 ± 0.33)

BA

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BB

n.d.

0.18 ± 0.08
(0.22 ± 0.10)

n.d.

n.d.

n.d.

n.d.

Ester total

2.34 ± 0.40
(3.65 ± 0.60)

10.70 ± 0.53
(16.87 ± 0.81)

1.48 ± 0.25
(2.49 ± 0.44)

0.81 ± 0.10
(1.35 ± 0.18)

0.53 ± 0.11
(0.84 ± 0.17)

1.90 ± 0.24
(3.03 ± 0.40)

Ester titers,
mg/L (mM)

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester yields,
mg/g glucose
(mM/M)
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Table 2-7: Summary of validation of biosynthesis pathway of BB. Key strain is in bold;
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.d.:
not detected.
Strains

EcJWBB1

EcJWBB2

EcJWBB3

EcJWBB4

EcJWBB5

EcJWBB6

O.D.600

2.31 ± 0.10

1.96 ± 0.02

2.61 ± 0.08

2.31 ± 0.06

1.24 ± 0.05

2.01 ± 0.07

Consumed glucose, g/L
(mM)

6.98 ± 0.17
(38.72 ± 0.96)

3.90 ± 0.26
(21.63 ± 1.43)

10.46 ± 0.15
(58.04 ± 0.86)

8.90 ± 1.05
(49.42 ± 5.82)

1.75 ± 0.04
(9.71 ± 0.20)

5.15 ± 0.21
(28.60 ± 1.18)

Lactate, g/L (mM)

0.21 ± 0.01
(2.32 ± 0.14)

0.09 ± 0.01
(1.05 ± 0.06)

0.17 ± 0.01
(1.87 ± 0.15)

0.16 ± 0.02
(1.76 ± 0.17)

0.10 ± 0.01
(1.15 ± 0.13)

0.17 ± 0.01
(1.87 ± 0.11)

Formate, g/L (mM)

0.49 ± 0.01
(10.56 ± 0.14)

0.36 ± 0.01
(7.82 ± 0.17)

0.56 ± 0.02
(12.25 ± 0.50)

0.63 ± 0.02
(13.70 ± 0.40)

0.40 ± 0.05
(8.67 ± 1.19)

0.61 ± 0.01
(13.27 ± 0.15)

Acetate, g/L (mM)

0.54 ± 0.00
(8.93 ± 0.03)

0.46 ± 0.00
(7.71 ± 0.05)

0.53 ± 0.01
(8.87 ± 0.10)

0.52 ± 0.02
(8.59 ± 0.32)

0.40 ± 0.01
(6.64 ± 0.09)

0.49 ± 0.00
(8.15 ± 0.04)

Ethanol, g/L (mM)

3.04 ± 0.07
(65.93 ± 1.53)

2.66 ± 0.09
(57.82 ± 1.88)

3.68 ± 0.08
(79.96 ± 1.74)

2.91 ± 0.16
(63.23 ± 3.44)

2.47 ± 0.30
(53.58 ± 6.42)

2.50 ± 0.03
(54.21 ± 0.71)

Butanol, g/L (mM)

0.11 ± 0.01
(1.54 ± 0.15)

0.13 ± 0.00
(1.71 ± 0.06)

0.02 ± 0.00
(0.24 ± 0.00)

0.04 ± 0.03
(0.54 ± 0.43)

0.09 ± 0.02
(1.27 ± 0.29)

0.13 ± 0.01
(1.76 ± 0.12)

EA

0.7 ± 0.1
(0.01 ± 0.00)

1.5 ± 0.3
(0.02 ± 0.00)

4.6 ± 0.5
(0.05 ± 0.01)

1.1 ± 0.2
(0.01 ± 0.00)

n.d.

0.4 ± 0.6
(0.00 ± 0.01)

EB

43.6 ± 6.1
(0.38 ± 0.05)

126.2 ± 11.5
(1.09 ± 0.10)

5.3 ± 0.1
(0.05 ± 0.00)

1.6 ± 0.2
(0.01 ± 0.00)

0.4 ± 0.7
(0.00 ± 0.01)

4.6 ± 3.1
(0.04 ± 0.03)

BA

0.3 ± 0.1
(0.00 ± 0.00)

0.3 ± 0.0
(0.00 ± 0.00)

0.2 ± 0.1
(0.00 ± 0.00)

0.2 ± 0.1
(0.00 ± 0.00)

n.d.

0.0 ± 0.1
(0.00 ± 0.00)

BB

16.0 ± 3.8
(0.11 ± 0.03)

33.5 ± 2.9
(0.23 ± 0.02)

n.d.

1.0 ± 0.4
(0.01 ± 0.00)

n.d.

11.5 ± 1.0
(0.08 ± 0.01)

Ester total

60.5 ± 9.9
(0.50 ± 0.08)

161.4 ± 14.4
(1.34 ± 0.12)

10.0 ± 0.6
(0.10 ± 0.01)

4.0 ± 0.4
(0.04 ± 0.00)

0.4 ± 0.7
(0.00 ± 0.01)

16.5 ± 1.7
(0.12 ± 0.01)

EA

0.03 ± 0.00
(0.29 ± 0.03)

0.07 ± 0.01
(0.75 ± 0.14)

0.15 ± 0.02
(1.71 ± 0.24)

0.04 ± 0.01
(0.48 ± 0.09)

n.d.

0.02 ± 0.03
(0.19 ± 0.32)

EB

1.62 ± 0.20
(13.95 ± 1.71)

5.54 ± 0.48
(47.66 ± 4.16)

0.17 ± 0.01
(1.50 ± 0.07)

0.06 ± 0.01
(0.52 ± 0.05)

0.03 ± 0.05
(0.24 ± 0.42)

0.20 ± 0.13
(1.68 ± 1.10)

BA

0.01 ± 0.00
(0.08 ± 0.03)

0.01 ± 0.00
(0.11 ± 0.01)

0.01 ± 0.00
(0.05 ± 0.02)

0.01 ± 0.00
(0.07 ± 0.03)

n.d.

0.00 ± 0.00
(0.02 ± 0.03)

BB

0.59 ± 0.12
(4.11 ± 0.86)

1.47 ± 0.13
(10.19 ± 0.89)

n.d.

0.04 ± 0.01
(0.26 ± 0.09)

n.d.

0.49 ± 0.05
(3.42 ± 0.37)

Ester total

2.25 ± 0.32
(18.43 ± 2.57)

7.08 ± 0.61
(58.71 ± 5.10)

0.33 ± 0.03
(3.26 ± 0.32)

0.15 ± 0.01
(1.33 ± 0.07)

0.03 ± 0.05
(0.24 ± 0.42)

0.71 ± 0.05
(5.30 ± 0.44)

EA

0.10 ± 0.01
(0.20 ± 0.01)

0.39 ± 0.10
(0.80 ± 0.21)

0.44 ± 0.05
(0.89 ± 0.10)

0.13 ± 0.02
(0.26 ± 0.03)

n.d.

0.07 ± 0.12
(0.14 ± 0.25)

EB

6.24 ± 0.75
(9.68 ± 1.16)

32.61 ± 5.19
(50.57 ± 8.06)

0.51 ± 0.01
(0.78 ± 0.02)

0.19 ± 0.04
(0.29 ± 0.06)

0.23 ± 0.40
(0.36 ± 0.62)

0.90 ± 0.61
(1.40 ± 0.95)

BA

0.04 ± 0.01
(0.06 ± 0.02)

0.07 ± 0.01
(0.11 ± 0.02)

0.02 ± 0.01
(0.03 ± 0.01)

0.02 ± 0.01
(0.04 ± 0.01)

n.d.

0.01 ± 0.02
(0.01 ± 0.02)

BB

2.29 ± 0.50
(2.86 ± 0.63)

8.65 ± 1.32
(10.81 ± 1.65)

n.d.

0.12 ± 0.06
(0.15 ± 0.07)

n.d.

2.23 ± 0.22
(2.79 ± 0.28)

Ester total

8.66 ± 1.26
(12.80 ± 1.80)

41.72 ± 6.59
(62.29 ± 9.88)

0.96 ± 0.07
(1.71 ± 0.13)

0.46 ± 0.10
(0.74 ± 0.14)

0.23 ± 0.40
(0.36 ± 0.62)

3.21 ± 0.44
(4.34 ± 0.64)

Ester titers,
mg/L (mM)

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester yields,
mg/g glucose
(mM/M)
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Table 2-8: Summary of optimization of biosynthetic pathway of BA. The best culture condition
is in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl
butyrate; n.d.: not detected.
Strain

EcJWBA2
28’C

Temperature

37’C

IPTG concentration, mM

0.01

0.1

1.0

0.01

0.1

1.0

O.D.600

6.55 ± 0.12

3.80 ± 0.02

1.62 ± 0.08

8.95 ± 0.23

2.50 ± 0.07

1.78 ± 0.06

Consumed glucose, g/L (mM)

7.77 ± 0.16
(43.14 ± 0.90)

4.39 ± 0.19
(24.35 ± 1.03)

12.17 ± 0.40
(67.53 ± 2.23)

3.82 ± 0.36
(21.21 ± 2.00)

3.54 ± 0.51
(19.63 ± 2.84)

Lactate, g/L (mM)

0.26 ± 0.01
(2.88 ± 0.15)

0.27 ± 0.06
(2.95 ± 0.64)

2.02 ± 0.02
(11.23 ±
0.11)
0.01 ± 0.02
(0.15 ± 0.18)

0.84 ± 0.02
(9.38 ± 0.17)

0.11 ± 0.00
(1.22 ± 0.02)

0.08 ± 0.01
(0.91 ± 0.10)

Formate, g/L (mM)

2.32 ± 0.06
(50.34 ± 1.27)

0.86 ± 0.35
(18.68 ± 7.50)

0.23 ± 0.02
(4.95 ± 0.37)

2.35 ± 0.07
(51.15 ± 1.42)

0.51 ± 0.01
(11.17 ± 0.17)

0.61 ± 0.02
(13.18 ± 0.49)

Acetate, g/L (mM)

0.94 ± 0.02
(15.62 ± 0.26)

0.76 ± 0.01
(12.68 ± 0.09)

0.87 ± 0.01
(14.42 ± 0.16)

0.55 ± 0.00
(9.15 ± 0.04)

0.43 ± 0.01
(7.09 ± 0.17)

Ethanol, g/L (mM)

3.56 ± 0.11
(77.24 ± 2.28)

2.30 ± 0.23
(49.97 ± 5.07)

3.06 ± 0.08
(66.42 ± 1.65)

2.39 ± 0.04
(51.82 ± 0.79)

2.69 ± 0.17
(58.31 ± 3.71)

0.17 ± 0.03
(2.33 ± 0.43)
10.1 ± 2.4
(0.11 ± 0.03)

0.09 ± 0.04
(1.19 ± 0.58)
8.6 ± 2.6
(0.10 ± 0.03)

0.41 ± 0.00
(6.80 ± 0.07)
1.69 ± 0.02
(36.62 ±
0.44)
0.06 ± 0.01
(0.86 ± 0.07)
2.4 ± 0.9
(0.03 ± 0.01)

0.07 ± 0.00
(0.88 ± 0.05)
13.4 ± 5.1
(0.15 ± 0.06)

0.10 ± 0.01
(1.32 ± 0.07)
5.3 ± 1.1
(0.06 ± 0.01)

0.11 ± 0.00
(1.45 ± 0.06)
2.1 ± 0.8
(0.02 ± 0.01)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

35.9 ± 5.5
(0.31 ± 0.05)

48.0 ± 7.1
(0.41 ± 0.06)

8.0 ± 3.8
(0.07 ± 0.03)

19.5 ± 7.3
(0.17 ± 0.06)

15.0 ± 1.8
(0.13 ± 0.02)

8.9 ± 1.5
(0.08 ± 0.01)

Butanol, g/L (mM)
EA

Ester titers,
mg/L (μM)

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

46.0 ± 5.6
(0.42 ± 0.05)
0.13 ± 0.03
(1.51 ± 0.33)

56.6 ± 9.7
(0.51 ± 0.09)
0.19 ± 0.06
(2.21 ± 0.69)

10.3 ± 4.7
(0.10 ± 0.04)
0.13 ± 0.05
(1.43 ± 0.58)

32.8 ± 12.4
(0.32 ± 0.12)
0.13 ± 0.05
(1.47 ± 0.59)

20.3 ± 2.4
(0.19 ± 0.02)
0.18 ± 0.03
(2.06 ± 0.39)

11.0 ± 2.2
(0.10 ± 0.02)
0.10 ± 0.03
(1.15 ± 0.37)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

0.47 ± 0.07
(4.06 ± 0.61)

1.09 ± 0.17
(9.35 ± 1.46)

0.43 ± 0.21
(3.68 ± 1.80)

0.19 ± 0.07
(1.62 ± 0.64)

0.52 ± 0.05
(4.44 ± 0.41)

0.43 ± 0.06
(3.70 ± 0.54)

BB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

0.60 ± 0.07
(5.57 ± 0.59)
1.31 ± 0.33
(2.67 ± 0.67)

1.28 ± 0.23
(11.57 ± 2.14)
1.94 ± 0.48
(3.97 ± 0.98)

0.55 ± 0.26
(5.11 ± 2.37)
1.12 ± 0.61
(2.29 ± 1.26)

0.32 ± 0.13
(3.09 ± 1.23)
1.09 ± 0.39
(2.24 ± 0.80)

0.70 ± 0.06
(6.50 ± 0.63)
1.37 ± 0.18
(2.81 ± 0.37)

0.53 ± 0.09
(4.85 ± 0.85)
0.59 ± 0.12
(1.20 ± 0.25)

EB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

BA

4.61 ± 0.62
(7.16 ± 0.97)

10.88 ± 0.98
(16.88 ± 1.51)

4.02 ± 2.62
(6.23 ± 4.07)

1.59 ± 0.57
(2.47 ± 0.88)

3.95 ± 0.64
(6.13 ± 0.99)

2.52 ± 0.27
(3.91 ± 0.42)

BB

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Ester total

5.92 ± 0.65
(9.83 ± 1.08)

9.01 ± 0.55
(14.72 ± 0.92)

5.13 ± 3.24
(8.52 ± 5.32)

2.70 ± 0.95
(4.73 ± 1.66)

5.33 ± 0.68
(8.94 ± 1.08)

3.10 ± 0.29
(5.10 ± 0.47)

BB
Ester total
EA

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester total
EA

Ester yields,
mg/g glucose
(mM/M)
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Table 2-9: Summary of optimization of biosynthetic pathway of EB. The best culture condition is
in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate;
n.d.: not detected.
Strain

EcJWEB2
28’C

Temperature

37’C

IPTG concentration, mM

0.01

0.1

1.0

0.01

0.1

1.0

O.D.600

5.90 ± 0.21

3.88 ± 0.10

2.07 ± 0.14

17.37 ± 0.74

3.03 ± 0.03

3.50 ± 0.51

Consumed glucose, g/L (mM)

18.69 ± 0.26
(103.73 ± 1.46)

9.84 ± 0.24
(54.63 ± 1.35)

3.32 ± 0.46
(18.44 ± 2.54)

40.80 ± 2.00
(226.47 ± 11.10)

8.14 ± 0.23
(45.19 ± 1.26)

7.71 ± 1.38
(42.82 ± 7.64)

Lactate, g/L (mM)

0.02 ± 0.00
(0.17 ± 0.00)

n.d.

0.03 ± 0.00
(0.29 ± 0.00)

1.37 ± 0.08
(15.17 ± 0.86)

0.03 ± 0.00
(0.39 ± 0.02)

n.d.

Formate, g/L (mM)

0.11 ± 0.01
(2.44 ± 0.16)

0.12 ± 0.00
(2.60 ± 0.11)

0.04 ± 0.00
(0.80 ± 0.06)

0.42 ± 0.15
(9.23 ± 3.28)

0.38 ± 0.01
(8.33 ± 0.25)

0.31 ± 0.10
(6.77 ± 2.09)

Acetate, g/L (mM)

0.37 ± 0.00
(6.16 ± 0.03)

0.27 ± 0.00
(4.48 ± 0.03)

0.25 ± 0.00
(4.09 ± 0.04)

0.63 ± 0.00
(10.44 ± 0.07)

0.28 ± 0.00
(4.66 ± 0.00)

0.26 ± 0.02
(4.40 ± 0.26)

Ethanol, g/L (mM)

9.52 ± 0.21
(206.66 ± 4.61)

5.64 ± 0.09
(122.33 ± 1.88)

2.35 ± 0.19
(50.91 ± 4.10)

18.55 ± 0.30
(402.67 ± 6.44)

5.14 ± 0.08
(111.56 ± 1.67)

5.18 ± 0.39
(112.35 ± 8.41)

Butanol, g/L (mM)

0.05 ± 0.02
(0.69 ± 0.22)

n.d.

n.d.

0.23 ± 0.00
(3.11 ± 0.02)

n.d.

n.d.

EA

14.5 ± 4.6
(0.17 ± 0.05)

18.2 ± 1.6
(0.21 ± 0.02)

2.3 ± 1.1
(0.03 ± 0.01)

8.3 ± 1.0
(0.09 ± 0.01)

4.5 ± 0.3
(0.05 ± 0.00)

5.8 ± 1.6
(0.07 ± 0.02)

EB

123.4 ± 37.2
(1.06 ± 0.32)

200.4 ± 9.4
(1.73 ± 0.08)

23.9 ± 20.0
(0.21 ± 0.17)

131.5 ± 12.5
(1.13 ± 0.11)

113.4 ± 34.1
(0.98 ± 0.29)

48.3 ± 19.6
(0.42 ± 0.17)

BA

0.1 ± 0.2
(0.00 ± 0.00)

n.d.

n.d.

0.5 ± 0.1
(0.00 ± 0.00)

n.d.

n.d.

BB

6.7 ± 1.7
(0.05 ± 0.01)

5.1 ± 0.3
(0.04 ± 0.00)

n.d.

14.3 ± 2.5
(0.10 ± 0.02)

1.7 ± 1.5
(0.01 ± 0.01)

0.9 ± 1.3
(0.01 ± 0.01)

Ester total

144.8 ± 42.7
(1.27 ± 0.38)

223.7 ± 10.7
(1.97 ± 0.10)

26.2 ± 21.1
(0.23 ± 0.18)

154.5 ± 15.9
(1.33 ± 0.14)

119.6 ± 32.7
(1.04 ± 0.28)

55.0 ± 19.3
(0.49 ± 0.16)

EA

0.21 ± 0.08
(2.43 ± 0.85)

0.40 ± 0.02
(4.58 ± 0.25)

0.10 ± 0.05
(1.10 ± 0.57)

0.04 ± 0.00
(0.46 ± 0.03)

0.13 ± 0.01
(1.45 ± 0.08)

0.09 ± 0.09
(1.07 ± 1.06)

EB

1.81 ± 0.59
(15.58 ± 5.06)

4.44 ± 0.06
(38.19 ± 0.48)

1.01 ± 0.86
(8.68 ± 7.42)

0.64 ± 0.03
(5.51 ± 0.28)

3.23 ± 1.00
(27.80 ± 8.63)

0.75 ± 0.67
(6.43 ± 5.80)

BA

0.00 ± 0.00
(0.01 ± 0.02)

n.d.

n.d.

0.00 ± 0.00
(0.02 ± 0.00)

n.d.

n.d.

BB

0.10 ± 0.03
(0.68 ± 0.18)

0.11 ± 0.01
(0.78 ± 0.08)

n.d.

0.07 ± 0.01
(0.48 ± 0.06)

0.05 ± 0.04
(0.33 ± 0.29)

0.01 ± 0.02
(0.09 ± 0.16)

Ester total

2.12 ± 0.68
(18.70 ± 6.00)

4.95 ± 0.07
(43.55 ± 0.65)

1.11 ± 0.91
(9.78 ± 7.98)

0.75 ± 0.04
(6.47 ± 0.38)

3.40 ± 0.96
(29.57 ± 8.31)

0.86 ± 0.76
(7.60 ± 6.69)

EA

0.78 ± 0.24
(1.59 ± 0.49)

1.87 ± 0.13
(3.83 ± 0.27)

0.69 ± 0.32
(1.41 ± 0.65)

0.14 ± 0.12
(0.28 ± 0.24)

0.55 ± 0.05
(1.13 ± 0.10)

0.69 ± 0.07
(1.41 ± 0.15)

EB

6.61 ± 2.00
(10.25 ± 3.10)

20.61 ± 0.59
(31.96 ± 0.91)

7.11 ± 5.72
(11.03 ± 8.87)

2.17 ± 1.88
(3.37 ± 2.92)

13.88 ± 3.92
(21.52 ± 6.08)

6.16 ± 3.45
(9.55 ± 5.35)

BA

0.00 ± 0.01
(0.01 ± 0.01)

n.d.

n.d.

0.01 ± 0.01
(0.01 ± 0.01)

n.d.

n.d.

BB

0.36 ± 0.09
(0.45 ± 0.11)

0.53 ± 0.04
(0.66 ± 0.06)

n.d.

0.24 ± 0.21
(0.29 ± 0.26)

0.21 ± 0.18
(0.26 ± 0.23)

0.13 ± 0.18
(0.16 ± 0.23)

Ester total

7.75 ± 2.29
(12.30 ± 3.63)

23.01 ± 0.67
(36.45 ± 1.12)

7.80 ± 6.04
(12.44 ± 9.52)

2.55 ± 2.21
(3.96 ± 3.43)

14.63 ± 3.72
(22.91 ± 5.79)

6.98 ± 3.57
(11.13 ± 5.44)

Ester titers,
mg/L (μM)

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester yields,
mg/g glucose
(mM/M)
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Table 2-10: Summary of optimization of biosynthetic pathway of BB. The best culture condition
is in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl
butyrate; n.d.: not detected.
Strain

EcJWBB2
28’C

Temperature

37’C

IPTG concentration, mM

0.01

0.1

1.0

0.01

0.1

1.0

O.D.600

6.65 ± 0.23

4.37 ± 0.22

2.20 ± 0.18

8.47 ± 0.24

3.29 ± 0.11

1.78 ± 0.05

Consumed glucose, g/L (mM)

9.02 ± 0.19
(50.05 ± 1.03)

6.89 ± 0.14
(38.23 ± 0.76)

3.75 ± 0.07
(20.80 ± 0.37)

13.07 ± 0.16
(72.56 ± 0.90)

4.89 ± 0.31
(27.14 ± 1.72)

3.99 ± 0.21
(22.15 ± 1.18)

Lactate, g/L (mM)

0.31 ± 0.05
(3.46 ± 0.61)

0.44 ± 0.03
(4.86 ± 0.32)

0.10 ± 0.02
(1.14 ± 0.18)

1.01 ± 0.02
(11.25 ± 0.20)

0.14 ± 0.00
(1.52 ± 0.02)

0.05 ± 0.00
(0.52 ± 0.02)

Formate, g/L (mM)

2.33 ± 0.12
(50.66 ± 2.60)

1.66 ± 0.03
(36.17 ± 0.71)

0.55 ± 0.06
(11.94 ± 1.32)

2.54 ± 0.03
(55.28 ± 0.70)

1.16 ± 0.01
(25.11 ± 0.16)

0.72 ± 0.01
(15.71 ± 0.13)

Acetate, g/L (mM)

0.53 ± 0.01
(8.79 ± 0.11)

0.41 ± 0.00
(6.75 ± 0.04)

0.31 ± 0.00
(5.21 ± 0.01)

0.62 ± 0.01
(10.35 ± 0.08)

0.50 ± 0.00
(8.40 ± 0.07)

0.34 ± 0.00
(5.66 ± 0.02)

Ethanol, g/L (mM)

3.83 ± 0.21
(83.05 ± 4.53)

3.65 ± 0.11
(79.19 ± 2.48)

2.63 ± 0.07
(57.00 ± 1.56)

3.18 ± 0.01
(69.12 ± 0.17)

3.48 ± 0.03
(75.63 ± 0.65)

3.07 ± 0.05
(66.64 ± 1.11)

Butanol, g/L (mM)

0.36 ± 0.04
(4.92 ± 0.53)

0.14 ± 0.05
(1.89 ± 0.62)

0.09 ± 0.04
(1.24 ± 0.52)

0.22 ± 0.00
(2.97 ± 0.04)

0.15 ± 0.00
(1.99 ± 0.04)

0.14 ± 0.00
(1.89 ± 0.02)

EA

2.7 ± 1.1
(0.03 ± 0.01)

2.4 ± 0.0
(0.03 ± 0.00)

1.1 ± 1.0
(0.01 ± 0.01)

1.8 ± 0.5
(0.02 ± 0.01)

1.3 ± 0.6
(0.01 ± 0.01)

0.59 ± 0.18
(0.01 ± 0.00)

EB

77.9 ± 24.3
(0.67 ± 0.21)

229.8 ± 72.7
(1.98 ± 0.63)

175.6 ± 12.8
(1.51 ± 0.11)

43.7 ± 4.6
(0.38 ± 0.04)

246.2 ± 72.6
(2.12 ± 0.63)

121.1 ± 4.4
(1.04 ± 0.04)

BA

0.8 ± 0.2
(0.01 ± 0.00)

0.5 ± 0.1
(0.00 ± 0.00)

n.d.

0.4 ± 0.6
(0.00 ± 0.00)

0.2 ± 0.3
(0.00 ± 0.00)

n.d.

BB

36.2 ± 12.7
(0.25 ± 0.09)

89.1 ± 28.7
(0.62 ± 0.20)

47.0 ± 10.0
(0.33 ± 0.07)

21.4 ± 2.5
(0.15 ± 0.02)

127.4 ± 32.5
(0.88 ± 0.23)

57.9 ± 1.6
(0.40 ± 0.01)

Ester total

117.6 ± 38.3
(0.96 ± 0.31)

321.8 ± 101.6
(2.63 ± 0.83)

223.7 ± 16.9
(1.85 ± 0.13)

67.2 ± 6.0
(0.55 ± 0.05)

375.1 ± 105.5
(3.02 ± 0.86)

179.6 ± 4.9
(1.45 ± 0.04)

EA

0.03 ± 0.01
(0.39 ± 0.17)

0.05 ± 0.00
(0.52 ± 0.01)

0.04 ± 0.04
(0.50 ± 0.45)

0.02 ± 0.01
(0.21 ± 0.06)

0.03 ± 0.02
(0.39 ± 0.17)

0.03 ± 0.01
(0.32 ± 0.10)

EB

1.01 ± 0.31
(8.66 ± 2.69)

4.40 ± 1.44
(37.92 ± 12.40)

6.92 ± 0.89
(59.55 ± 7.68)

0.45 ± 0.05
(3.88 ± 0.41)

6.44 ± 1.92
(55.42 ± 16.55)

5.85 ± 0.34
(50.34 ± 2.96)

BA

0.01 ± 0.00
(0.09 ± 0.03)

0.01 ± 0.00
(0.09 ± 0.02)

n.d.

0.00 ± 0.01
(0.04 ± 0.05)

0.00 ± 0.01
(0.04 ± 0.06)

n.d.

BB

0.47 ± 0.17
(3.25 ± 1.15)

1.71 ± 0.57
(11.84 ± 3.94)

1.83 ± 0.25
(12.68 ± 1.72)

0.22 ± 0.03
(1.53 ± 0.18)

3.33 ± 0.85
(23.08 ± 5.89)

2.80 ± 0.15
(19.38 ± 1.02)

Ester total

1.52 ± 0.50
(12.40 ± 4.02)

6.17 ± 2.01
(50.37 ± 16.37)

8.79 ± 0.88
(72.73 ± 7.68)

0.69 ± 0.06
(5.65 ± 0.48)

9.80 ± 2.78
(78.93 ± 22.58)

8.67 ± 0.46
(70.04 ± 3.82)

EA

0.30 ± 0.13
(0.61 ± 0.26)

0.35 ± 0.00
(0.71 ± 0.00)

0.29 ± 0.26
(0.59 ± 0.52)

0.14 ± 0.04
(0.28 ± 0.08)

0.27 ± 0.13
(0.55 ± 0.27)

0.15 ± 0.04
(0.30 ± 0.08)

EB

8.68 ± 2.84
(13.45 ± 4.41)

32.97 ± 9.94
(51.13 ± 15.42)

46.86 ± 2.91
(72.68 ± 4.51)

3.34 ± 0.29
(5.18 ± 0.46)

50.96 ± 17.85
(79.03 ± 27.69)

30.39 ± 1.31
(47.13 ± 2.03)

BA

0.09 ± 0.03
(0.14 ± 0.04)

0.08 ± 0.02
(0.12 ± 0.03)

n.d.

0.03 ± 0.04
(0.05 ± 0.07)

0.03 ± 0.06
(0.05 ± 0.09)

n.d.

BB

4.04 ± 1.48
(5.05 ± 1.85)

12.78 ± 3.92
(15.96 ± 4.90)

12.51 ± 2.46
(15.63 ± 3.08)

1.64 ± 0.16
(2.05 ± 0.20)

26.31 ± 8.04
(32.87 ± 10.04)

14.55 ± 1.15
(18.18 ± 1.43)

Ester total

13.11 ± 4.47
(19.25 ± 6.55)

46.17 ± 13.88
(67.93 ± 20.34)

59.66 ± 3.51
(88.90 ± 5.05)

5.15 ± 0.37
(7.55 ± 0.51)

77.57 ± 26.00
(112.50 ± 37.96)

45.09 ± 2.38
(65.61 ± 3.37)

Ester titers,
mg/L (μM)

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester yields,
mg/g glucose
(mM/M)
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Table 2-11: Summary of solubility engineering of ATF1Sc. Key strategies are in bold;
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.a.:
not applicable.
Target
products

EA
(Ethanol
doping)

BA
(Butanol
doping)

a

Expressed
enzymes/pathways

Ester titer (mg/L (mM))

Conversion
yield (%)

EA

BA

Total

ATF1Sc

10.4 ± 0.9
(0.12 ± 0.01)

n.a.

10.4 ± 0.9
(0.12 ± 0.01)

0.11a

ATF1Scopt

188.1 ± 25.0
(2.13 ± 0.28)

n.a.

188.1 ± 25.0
(2.13 ± 0.28)

2.30a

MAP_ATF1Sc

84.5 ± 11.5
(0.96 ± 0.13)

n.a.

84.5 ± 11.5
(0.96 ± 0.13)

1.01a

NusA_ATF1Sc

104.4 ± 3.0
(1.19 ± 0.03)

n.a.

104.4 ± 3.0
(1.19 ± 0.03)

1.31a

TrxA_ATF1Sc

110.6 ± 8.1
(1.25 ± 0.09)

n.a.

110.6 ± 8.1
(1.25 ± 0.09)

1.32a

ATF1Sc+Tf

14.6 ± 0.8
(0.17 ± 0.01)

n.a.

14.6 ± 0.8
(0.17 ± 0.01)

0.15a

ATF1Sc+GroES/GroEL

17.6 ± 5.3
(0.20 ± 0.06)

n.a.

17.6 ± 5.3
(0.20 ± 0.06)

0.17a

ATF1Sc+GroES/GroEL/Tf

18.9 ± 4.1
(0.21 ± 0.05)

n.a.

18.9 ± 4.1
(0.21 ± 0.05)

0.19a

ATF1Sc+DnaK/DnaJ/GrpE

12.5 ± 2.4
(0.14 ± 0.03)

n.a.

12.5 ± 2.4
(0.14 ± 0.03)

0.12a

ATF1Sc+DnaK/DnaJ/GrpE+
/GroES/GroEL

12.4 ± 1.9
(0.14 ± 0.02)

n.a.

12.4 ± 1.9
(0.14 ± 0.02)

0.13a

ATF1Sc

3.2 ± 1.4
(0.04 ± 0.02)

370.7 ± 42.7
(3.19 ± 0.37)

373.9 ± 44.0
(3.23 ± 0.38)

12.03b

ATF1Scopt

44.7 ± 12.3
(0.51 ± 0.14)

2,256.1 ± 222.8
(19.42 ± 1.92)

2,300.8 ± 228.3
(19.93 ± 1.98)

85.90b

MBP_ATF1Sc

25.7 ± 8.3
(0.29 ± 0.09)

2,062.3 ± 165.3
(17.75 ± 1.42)

2,088.0 ± 173.5
(18.05 ± 1.52)

74.55b

NusA_ATF1Sc

31.5 ± 8.2
(0.36 ± 0.09)

2,081.2 ± 97.5
(17.92 ± 0.84)

2,112.6 ± 95.6
(18.27 ± 0.82)

79.53b

TrxA_ATF1Sc

33.1 ± 12.5
(0.38 ± 0.14)

2,095.3 ± 192.0
(18.04 ± 1.65)

2,128.3 ± 187.9
(18.41 ± 1.61)

86.61b

ATF1Sc+Tf

7.1 ± 1.2
(0.08 ± 0.01)

480.4 ± 73.8
(4.14 ± 0.64)

487.5 ± 74.8
(4.22 ± 0.65)

15.19b

ATF1Sc+GroES/GroEL

8.0 ± 0.7
(0.09 ± 0.01)

635.1 ± 165.3
(5.47 ± 1.42)

643.0 ± 164.6
(5.56 ± 1.42)

19.65b

ATF1Sc+GroES/GroEL/Tf

6.3 ± 0.6
(0.07 ± 0.01)

380.3 ± 67.0
(3.27 ± 0.58)

386.6 ± 66.4
(3.35 ± 0.57)

10.99b

ATF1Sc+DnaK/DnaJ/GrpE

4.5 ± 1.1
(0.05 ± 0.01)

500.2 ± 178.3
(4.31 ± 1.53)

504.7 ± 177.3
(4.36 ± 1.52)

14.21b

ATF1Sc+DnaK/DnaJ/GrpE+
/GroES/GroEL

4.1 ± 1.5
(0.05 ± 0.02)

484.1 ± 17.1
(4.17 ± 0.15)

488.2 ± 18.6
(4.21 ± 0.16)

13.48b

(EA produced) / (EA produced + Ethanol remained)*100, (mole/mole).
(BA produced) / (BA produced + Butanol remained)*100, (mole/mole).

b
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Table 2-12: Summary of solubility engineering of SAATFa. Key strategy is in bold. Abbreviations:
EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate.
Target
products

EB
(Ethanol
doping)

BB
(Butanol
doping)

a

Expressed
enzymes/pathways

Ester titer (mg/L (mM))

Conversion
yield (%)

EA

EB

BA

BB

Total

BCoA+SAATFa

1.8 ± 0.2
(0.02 ± 0.00)

46.5 ± 5.3
(0.40 ± 0.05)

0.3 ± 0.1
(0.00 ± 0.00)

11.4 ± 1.9
(0.08 ± 0.01)

59.9 ± 7.3
(0.50 ± 0.06)

0.32a

BCoA+SAATFaopt

1.0 ± 0.7
(0.01 ± 0.01)

55.2 ± 16.3
(0.47 ± 0.14)

0.2 ± 0.0
(0.00 ± 0.00)

14.0 ± 5.4
(0.10 ± 0.04)

70.3 ± 21.1
(0.58 ± 0.17)

0.34a

BCoA+MBP_SAATFa

1.4 ± 0.1
(0.02 ± 0.00)

24.0 ± 2.0
(0.21 ± 0.01)

0.1 ± 0.0
(0.00 ± 0.00)

6.5 ± 1.0
(0.05 ± 0.01)

32.0 ± 2.6
(0.27 ± 0.02)

0.16a

BCoA+NusA_SAATFa

1.5 ± 0.1
(0.02 ± 0.00)

13.0 ± 1.0
(0.11 ± 0.01)

0.2 ± 0.1
(0.00 ± 0.00)

3.0 ± 0.5
(0.02 ± 0.00)

17.7 ± 1.5
(0.15 ± 0.01)

0.09a

BCoA+TrxA_SAATFa

1.8 ± 0.3
(0.02 ± 0.00)

30.8 ± 2.9
(0.27 ± 0.02)

0.2 ± 0.0
(0.00 ± 0.00)

5.8 ± 0.8
(0.04 ± 0.01)

38.6 ± 3.9
(0.33 ± 0.03)

0.21a

BCoA+SAATFa+Tf

4.1 ± 0.8
(0.05 ± 0.01)

25.2 ± 4.7
(0.22 ± 0.04)

0.3 ± 0.1
(0.00 ± 0.00)

3.0 ± 0.0
(0.02 ± 0.00)

32.6 ± 5.4
(0.29 ± 0.05)

0.17a

BCoA+SAATFa+
GroES/GroEL

6.3 ± 1.3
(0.07 ± 0.01)

464.2 ± 8.9
(4.00 ± 0.08)

0.4 ± 0.0
(0.00 ± 0.00)

66.7 ± 1.6
(0.46 ± 0.01)

537.6 ± 7.4
(4.53 ± 0.07)

2.64a

BCoA+SAATFa+
GroES/GroEL/Tf

9.0 ± 1.2
(0.10 ± 0.01)

250.2 ± 35.8
(2.15 ± 0.31)

0.7 ± 0.1
(0.01 ± 0.00)

39.1 ± 5.6
(0.27 ± 0.04)

299.0 ± 42.6
(2.53 ± 0.36)

1.57a

BCoA+SAATFa+
DnaK/DnaJ/GrpE

2.7 ± 0.9
(0.03 ± 0.01)

10.3 ± 1.1
(0.09 ± 0.01)

0.3 ± 0.0
(0.00 ± 0.00)

1.5 ± 0.2
(0.01 ± 0.00)

14.8 ± 2.1
(0.13 ± 0.02)

0.10a

BCoA+SAATFa+
DnaK/DnaJ/GrpE+
/GroES/GroEL

4.8 ± 1.2
(0.05 ± 0.01)

330.5 ± 44.4
(2.85 ± 0.38)

0.3 ± 0.0
(0.00 ± 0.00)

44.8 ± 6.1
(0.31 ± 0.04)

380.4 ± 48.6
(3.21 ± 0.41)

2.01a

BCoA+SAATFa

0.2 ± 0.0
(0.00 ± 0.00)

10.5 ± 0.9
(0.09 ± 0.01)

17.9 ± 1.3
(0.15 ± 0.01)

207.8 ± 5.1
(1.44 ± 0.04)

236.5 ± 5.4
(1.69 ± 0.04)

4.49b

BCoA+SAATFaopt

0.0 ± 0.1
(0.00 ± 0.00)

7.2 ± 2.7
(0.06 ± 0.02)

21.1 ± 9.3
(0.18 ± 0.08)

344.2 ± 171.6
(2.39 ± 1.19)

372.5 ± 183.6
(2.63 ± 1.29)

6.97b

BCoA+MBP_SAATFa

0.2 ± 0.0
(0.00 ± 0.00)

6.4 ± 0.4
(0.06 ± 0.00)

16.5 ± 0.7
(0.14 ± 0.01)

147.1 ± 14.6
(1.02 ± 0.10)

170.2 ± 14.9
(1.22 ± 0.10)

3.39b

BCoA+NusA_SAATFa

0.1 ± 0.0
(0.00 ± 0.00)

2.9 ± 0.2
(0.02 ± 0.00)

14.2 ± 0.2
(0.12 ± 0.00)

81.5 ± 7.2
(0.57 ± 0.05)

98.7 ± 7.0
(0.71 ± 0.05)

1.97b

BCoA+TrxA_SAATFa

0.2 ± 0.1
(0.00 ± 0.00)

10.8 ± 4.4
(0.09 ± 0.04)

20.2 ± 4.5
(0.17 ± 0.04)

189.2 ± 64.4
(1.31 ± 0.45)

220.4 ± 73.0
(1.58 ± 0.52)

4.65b

BCoA+SAATFa+Tf

0.9 ± 0.4
(0.01 ± 0.00)

11.0 ± 0.9
(0.09 ± 0.01)

59.1 ± 14.8
(0.51 ± 0.13)

152.0 ± 28.8
(1.05 ± 0.20)

223.0 ± 44.3
(1.67 ± 0.33)

4.40b

BCoA+SAATFa+
GroES/GroEL

10.5 ± 3.1
(0.12 ± 0.04)

195.7 ± 15.4
(1.69 ± 0.13)

244.0 ± 101.4
(2.10 ± 0.87)

1,710.1 ±
256.6
(11.86 ± 1.78)

BCoA+SAATFa+
GroES/GroEL/Tf

3.1 ± 0.3
(0.04 ± 0.00)

81.3 ± 6.2
(0.70 ± 0.05)

120.3 ± 16.9
(1.04 ± 0.15)

822.1 ± 109.0
(5.70 ± 0.76)

2,160.4 ±
349.7
(15.76 ± 2.59)
1,026.9 ±
131.0
(7.47 ± 0.95)

BCoA+SAATFa+
DnaK/DnaJ/GrpE

0.6 ± 0.1
(0.01 ± 0.00)

3.5 ± 0.4
(0.03 ± 0.00)

39.5 ± 2.4
(0.34 ± 0.02)

48.3 ± 5.3
(0.34 ± 0.04)

91.9 ± 7.6
(0.71 ± 0.06)

2.04b

BCoA+SAATFa+
DnaK/DnaJ/GrpE+
/GroES/GroEL

1.6 ± 0.1
(0.02 ± 0.00)

52.0 ± 8.0
(0.45 ± 0.07)

56.6 ± 7.5
(0.49 ± 0.06)

565.0 ± 50.4
(3.92 ± 0.35)

675.1 ± 52.7
(4.87 ± 0.37)

13.14b

(Ethyl ester produced) / (Ethyl ester produced + Ethanol remained)*100, (mole/mole).
(Butyl ester produced) / (Butyl ester produced + Butanol remained)*100, (mole/mole).

b
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40.68b
21.85b

Table 2-13: Summary of BA production with strategies for improving solubility of ATF1Sc. Key
strain is in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl
butyrate; n.d.: not detected.
Target product

BA

Strains

EcJWBA7

EcJWBA8

EcJWBA9

EcJWBA10

Strategies for improving
solubility of ATF1Sc

Codon optimization

Codon opt.
+MBP-tag
(N’-terminus)

Codon opt.
+NusA-tag
(N’-terminus)

Codon opt.
+TrxA-tag
(N’-terminus)

O.D.600

5.35 ± 0.18

5.57 ± 0.05

4.45 ± 0.11

5.87 ± 0.23

5.68 ± 0.14
(31.51 ± 0.76)
0.14 ± 0.01
(1.56 ± 0.06)
1.60 ± 0.05
(34.72 ± 0.99)
1.09 ± 0.02
(18.11 ± 0.28)
2.17 ± 0.06
(47.08 ± 1.32)
0.06 ± 0.00
(0.82 ± 0.02)
18.7 ± 1.8
(0.21 ± 0.02)

6.54 ± 0.12
(36.29 ± 0.67)
0.21 ± 0.03
(2.28 ± 0.36)
1.78 ± 0.09
(38.75 ± 1.86)
0.79 ± 0.00
(13.21 ± 0.04)
3.09 ± 0.06
(67.12 ± 1.37)
0.17 ± 0.01
(2.27 ± 0.11)
11.6 ± 2.0
(0.13 ± 0.02)

5.31 ± 0.18
(29.50 ± 1.01)
0.06 ± 0.00
(0.62 ± 0.03)
1.81 ± 0.04
(39.38 ± 0.88)
0.66 ± 0.01
(11.00 ± 0.10)
3.23 ± 0.06
(70.22 ± 1.40)
0.24 ± 0.01
(3.24 ± 0.20)
6.4 ± 0.6
(0.07 ± 0.01)

5.36 ± 0.06
(29.75 ± 0.35)
0.14 ± 0.05
(1.51 ± 0.51)
1.51 ± 0.56
(32.89 ± 12.25)
0.88 ± 0.13
(14.62 ± 2.21)
2.49 ± 0.26
(54.07 ± 5.54)
0.11 ± 0.02
(1.48 ± 0.20)
16.7 ± 1.8
(0.19 ± 0.02)

EB

n.d.

n.d.

n.d.

n.d.

BA

51.7 ± 7.1
(0.44 ± 0.06)

79.3 ± 9.8
(0.68 ± 0.08)

76.1 ± 6.2
(0.66 ± 0.05)

89.5 ± 14.8
(0.77 ± 0.13)

BB

n.d.

n.d.

n.d.

n.d.

70.4 ± 8.8
(0.66 ± 0.08)
0.30 ± 0.04
(0.00 ± 0.00)

90.9 ± 10.8
(0.81 ± 0.10)
0.18 ± 0.03
(0.00 ± 0.00)

82.5 ± 6.3
(0.73 ± 0.05)
0.12 ± 0.01
(0.00 ± 0.00)

106.1 ± 16.0
(0.96 ± 0.14)
0.24 ± 0.02
(0.00 ± 0.00)

EB

n.d.

n.d.

n.d.

n.d.

BA

0.83 ± 0.13
(0.01 ± 0.00)

1.22 ± 0.14
(0.01 ± 0.00)

1.47 ± 0.09
(0.01 ± 0.00)

1.31 ± 0.18
(0.01 ± 0.00)

Consumed glucose, g/L (mM)
Lactate, g/L (mM)
Formate, g/L (mM)
Acetate, g/L (mM)
Ethanol, g/L (mM)
Butanol, g/L (mM)
EA

Ester titers,
mg/L (mM)

Ester total
EA
Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

n.d.

n.d.

n.d.

n.d.

1.13 ± 0.17
(0.01 ± 0.00)
3.29 ± 0.34
(6.74 ± 0.69)

1.40 ± 0.16
(0.01 ± 0.00)
1.77 ± 0.27
(3.62 ± 0.55)

1.59 ± 0.09
(0.01 ± 0.00)
1.20 ± 0.12
(2.46 ± 0.24)

1.55 ± 0.18
(0.01 ± 0.00)
3.11 ± 0.31
(6.35 ± 0.63)

EB

n.d.

n.d.

n.d.

n.d.

BA

9.11 ± 1.25
(14.12 ± 1.94)

12.12 ± 1.44
(18.80 ± 2.23)

14.31 ± 0.71
(22.19 ± 1.10)

16.68 ± 2.75
(25.88 ± 4.26)

BB

n.d.

n.d.

n.d.

n.d.

Ester total

12.40 ± 1.57
(20.86 ± 2.59)

13.89 ± 1.55
(22.42 ± 2.46)

15.51 ± 0.66
(24.65 ± 1.01)

19.79 ± 2.95
(32.23 ± 4.68)

BB
Ester total
EA

Ester yields,
mg/g glucose
(mM/M)
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Table 2-14: Summary of production of EB with strategy for improving solubility of SAATFa. The
best culture condition is in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl
acetate; BB, butyl butyrate; n.d.: not detected.
Target product

EB

Strains

EcJWEB7

Strategy for improving
solubility of SAATFa
Arabinose conc. for inducing
expression of GroES/EL
O.D.600
Consumed glucose, g/L (mM)
Lactate, g/L (mM)
Formate, g/L (mM)
Acetate, g/L (mM)
Ethanol, g/L (mM)
Butanol, g/L (mM)
EA
EB
Ester titers,
mg/L (mM)

BA
BB
Ester total
EA

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

EB
BA
BB
Ester total
EA
EB

Ester yields,
mg/g glucose
(mM/M)

BA
BB
Ester total

Co-expression of GroES/EL
0 mg/ml

1 mg/ml

5 mg/ml

50 mg/ml

3.85 ± 0.13

3.86 ± 0.34

3.47 ± 0.23

3.69 ± 0.10

9.83 ± 0.10
(54.57 ± 0.54)
0.08 ± 0.00
(0.87 ± 0.01)
0.26 ± 0.01
(5.74 ± 0.16)
0.24 ± 0.00
(4.03 ± 0.01)
5.17 ± 0.03
(112.22 ± 0.60)
0.03 ± 0.00
(0.47 ± 0.04)
15.4 ± 1.1
(0.18 ± 0.01)
263.9 ± 51.8
(2.27 ± 0.45)

9.78 ± 0.08
(54.28 ± 0.45)
0.08 ± 0.00
(0.88 ± 0.01)
0.25 ± 0.01
(5.42 ± 0.15)
0.24 ± 0.00
(4.04 ± 0.01)
5.12 ± 0.05
(111.15 ± 0.99)
0.03 ± 0.00
(0.40 ± 0.06)
29.8 ± 6.4
(0.34 ± 0.07)
337.6 ± 46.1
(2.91 ± 0.40)

9.49 ± 0.19
(52.68 ± 1.07)
0.08 ± 0.00
(0.87 ± 0.01)
0.25 ± 0.01
(5.41 ± 0.23)
0.24 ± 0.00
(4.01 ± 0.01)
5.04 ± 0.09
(109.31 ± 2.05)
0.03 ± 0.00
(0.34 ± 0.01)
19.6 ± 11.2
(0.22 ± 0.13)
365.7 ± 69.2
(3.15 ± 0.60)

7.71 ± 0.16
(42.81 ± 0.91)
0.09 ± 0.00
(0.97 ± 0.02)
0.24 ± 0.00
(5.24 ± 0.05)
0.25 ± 0.00
(4.14 ± 0.04)
5.45 ± 0.07
(118.26 ± 1.52)
0.03 ± 0.01
(0.43 ± 0.07)
41.0 ± 4.5
(0.47 ± 0.05)
346.2 ± 59.8
(2.98 ± 0.51)

n.d.

n.d.

n.d.

n.d.

6.4 ± 1.9
(0.04 ± 0.01)
285.7 ± 53.8
(2.49 ± 0.46)
0.34 ± 0.01
(3.83 ± 0.11)
5.73 ± 1.52
(49.30 ± 13.11)

7.5 ± 1.3
(0.05 ± 0.01)
374.9 ± 51.1
(3.30 ± 0.45)
0.66 ± 0.18
(6.15 ± 2.02)
6.70 ± 0.49
(57.64 ± 4.25)

8.4 ± 2.4
(0.06 ± 0.02)
393.6 ± 72.7
(3.43 ± 0.63)
0.48 ± 0.26
(5.45 ± 2.90)
8.79 ± 1.63
(75.70 ± 14.01)

7.6 ± 1.2
(0.05 ± 0.01)
394.7 ± 62.0
(3.50 ± 0.54)
0.96 ± 0.14
(9.46 ± 1.63)
8.80 ± 1.40
(75.74 ± 12.07)

n.d.

n.d.

n.d.

n.d.

0.13 ± 0.05
(0.91 ± 0.33)
6.19 ± 1.56
(54.04 ± 13.33)
1.57 ± 0.12
(3.21 ± 0.25)
26.81 ± 5.05
(41.58 ± 7.83)

0.16 ± 0.01
(1.08 ± 0.07)
7.39 ± 0.59
(64.86 ± 5.48)
3.05 ± 0.63
(6.23 ± 1.29)
34.53 ± 4.72
(53.55 ± 7.32)

0.20 ± 0.06
(1.41 ± 0.44)
9.48 ± 1.54
(82.56 ± 12.81)
2.06 ± 1.15
(4.20 ± 2.35)
38.46 ± 6.72
(59.64 ± 10.42)

0.20 ± 0.02
(1.37 ± 0.13)
9.83 ± 1.44
(86.56 ± 12.44)
5.32 ± 0.68
(10.88 ± 1.39)
44.87 ± 7.47
(69.58 ± 11.59)

n.d.

n.d.

n.d.

n.d.

0.65 ± 0.18
(0.81 ± 0.23)
29.03 ± 5.24
(45.60 ± 8.08)

0.76 ± 0.13
(0.95 ± 0.17)
38.34 ± 5.20
(60.73 ± 8.22)

0.88 ± 0.25
(1.10 ± 0.31)
41.39 ± 6.95
(64.94 ± 10.78)

0.98 ± 0.15
(1.22 ± 0.18)
51.17 ± 7.78
(81.69 ± 12.14)
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Table 2-15: Summary of production of BB with strategies for improving solubility of SAATFa.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.d.:
not detected.
Target product

BB

Strains

EcJWBB7

Strategy for improving
solubility of SAATFa
Arabinose conc. for inducing
expression of GroES/EL
O.D.600
Consumed glucose, g/L (mM)
Lactate, g/L (mM)
Formate, g/L (mM)
Acetate, g/L (mM)
Ethanol, g/L (mM)
Butanol, g/L (mM)
EA
EB
Ester titers,
mg/L (mM)

BA
BB
Ester total
EA
EB

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

BA
BB
Ester total
EA
EB

Ester yields,
mg/g glucose
(mM/M)

BA
BB
Ester total

Co-expression of GroES/EL
0 mg/ml

1 mg/ml

5 mg/ml

50 mg/ml

2.97 ± 0.47

2.09 ± 0.08

2.27 ± 0.10

3.14 ± 0.16

3.72 ± 2.80
(20.67 ± 15.52)
0.19 ± 0.02
(2.08 ± 0.23)
1.03 ± 0.35
(22.47 ± 7.54)
0.48 ± 0.03
(8.05 ± 0.55)
2.71 ± 0.23
(58.92 ± 4.99)
0.02 ± 0.01
(0.31 ± 0.13)
6.0 ± 1.6
(0.07 ± 0.02)
155.8 ± 7.7
(1.34 ± 0.07)
0.3 ± 0.1
(0.00 ± 0.00)
25.6 ± 10.7
(0.18 ± 0.07)
187.7 ± 16.2
(1.59 ± 0.12)
0.18 ± 0.06
(2.02 ± 0.66)
4.57 ± 0.50
(39.32 ± 4.32)
0.01 ± 0.00
(0.07 ± 0.02)
0.74 ± 0.29
(5.13 ± 2.01)
5.49 ± 0.62
(46.54 ± 5.15)
1.20 ± 0.21
(2.46 ± 0.42)
28.85 ± 4.50
(44.74 ± 6.98)
0.04 ± 0.02
(0.07 ± 0.03)
4.22 ± 2.70
(5.28 ± 3.37)
34.32 ± 7.01
(52.54 ± 9.96)

1.58 ± 0.98
(8.77 ± 5.43)
0.12 ± 0.00
(1.29 ± 0.05)
0.76 ± 0.02
(16.49 ± 0.36)
0.41 ± 0.01
(6.75 ± 0.17)
1.99 ± 0.02
(43.14 ± 0.54)
0.06 ± 0.04
(0.75 ± 0.48)
6.1 ± 1.0
(0.07 ± 0.01)
147.3 ± 15.1
(1.27 ± 0.13)
0.6 ± 0.1
(0.01 ± 0.00)
30.0 ± 4.8
(0.21 ± 0.03)
184.0 ± 20.3
(1.55 ± 0.17)
0.25 ± 0.05
(2.84 ± 0.54)
6.07 ± 0.82
(52.28 ± 7.06)
0.03 ± 0.00
(0.22 ± 0.03)
1.24 ± 0.24
(8.58 ± 1.63)
7.59 ± 1.08
(63.92 ± 9.00)
2.59 ± 0.26
(5.29 ± 0.54)
67.66 ± 2.00
(104.94 ± 3.10)
0.29 ± 0.00
(0.45 ± 0.01)
13.54 ± 1.48
(16.91 ± 1.85)
84.08 ± 3.22
(127.59 ± 4.42)

0.95 ± 0.87
(5.26 ± 4.83)
0.08 ± 0.00
(0.85 ± 0.02)
0.81 ± 0.01
(17.58 ± 0.26)
0.44 ± 0.01
(7.40 ± 0.15)
2.11 ± 0.08
(45.70 ± 1.67)
0.07 ± 0.01
(0.90 ± 0.12)
8.2 ± 1.6
(0.09 ± 0.02)
240.4 ± 14.4
(2.07 ± 0.12)
1.9 ± 0.1
(0.02 ± 0.00)
51.4 ± 3.4
(0.36 ± 0.02)
302.0 ± 18.7
(2.54 ± 0.16)
0.31 ± 0.05
(3.53 ± 0.61)
9.12 ± 0.21
(78.52 ± 1.82)
0.07 ± 0.00
(0.61 ± 0.03)
1.95 ± 0.05
(13.53 ± 0.35)
11.45 ± 0.25
(96.19 ± 2.04)
5.41 ± 0.87
(11.06 ± 1.77)
161.52 ± 16.97
(250.51 ± 26.32)
1.25 ± 0.17
(1.94 ± 0.27)
34.44 ± 3.39
(43.02 ± 4.24)
202.62 ± 19.67
(306.54 ± 29.06)

1.10 ± 0.61
(6.08 ± 3.36)
0.14 ± 0.00
(1.60 ± 0.03)
0.93 ± 0.03
(20.30 ± 0.59)
0.49 ± 0.01
(8.18 ± 0.24)
2.85 ± 0.09
(61.81 ± 1.90)
0.04 ± 0.04
(0.53 ± 0.52)
6.9 ± 2.6
(0.08 ± 0.03)
224.2 ± 14.0
(1.93 ± 0.12)
1.5 ± 0.1
(0.01 ± 0.00)
42.1 ± 4.1
(0.29 ± 0.03)
274.7 ± 15.8
(2.31 ± 0.13)
0.19 ± 0.08
(2.17 ± 0.89)
6.17 ± 0.63
(53.10 ± 5.45)
0.04 ± 0.00
(0.35 ± 0.01)
1.16 ± 0.13
(8.02 ± 0.90)
7.56 ± 0.74
(63.64 ± 6.20)
6.49 ± 3.77
(13.26 ± 7.70)
166.53 ± 62.14
(258.27 ± 96.38)
1.13 ± 0.27
(1.76 ± 0.41)
30.14 ± 9.03
(37.66 ± 11.29)
204.29 ± 75.21
(310.95 ± 115.78)
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Table 2-16: Summary of BA and BB production with strategies for improving solubility of
AdhE2Ca. Key strain is in bold; Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl
acetate; BB, butyl butyrate; n.d.: not detected.
Target product

BA

BB

Strains

EcJWBA11

EcJWBA12

EcJWBA13

EcJWBA14

EcJWBB8

Strategies for improving
solubility of AdhE2ca

Codon
optimization

Codon opt.
+MBP-tag
(N’-terminus)

Codon opt.
+NusA-tag
(N’-terminus)

Codon opt.
+TrxA-tag
(N’-terminus)

Codon opt.
+TrxA-tag
(N’-terminus)

O.D.600

4.19 ± 0.14

3.70 ± 0.19

3.85 ± 0.20

4.28 ± 0.19

4.97 ± 0.26

8.23 ± 0.71
(45.67 ± 3.95)
0.04 ± 0.00
(0.42 ± 0.02)
0.60 ± 0.12
(12.98 ± 2.63)
0.69 ± 0.05
(11.43 ± 0.75)
1.15 ± 0.03
(24.90 ± 0.71)
0.10 ± 0.00
(1.30 ± 0.05)
12.4 ± 1.5
(0.14 ± 0.02)

2.13 ± 1.55
(11.82 ± 8.62)
0.06 ± 0.01
(0.65 ± 0.09)
0.67 ± 0.07
(14.62 ± 1.63)
0.75 ± 0.01
(12.57 ± 0.16)
1.60 ± 0.09
(34.83 ± 1.86)
0.14 ± 0.00
(1.93 ± 0.06)
9.2 ± 0.5
(0.10 ± 0.01)

2.21 ± 0.04
(12.25 ± 0.19)
0.03 ± 0.00
(0.37 ± 0.03)
0.63 ± 0.03
(13.78 ± 0.62)
0.80 ± 0.01
(13.24 ± 0.24)
1.33 ± 0.02
(28.81 ± 0.37)
0.16 ± 0.01
(2.11 ± 0.15)
9.7 ± 4.1
(0.11 ± 0.05)

2.34 ± 0.06
(13.00 ± 0.35)
0.05 ± 0.00
(0.51 ± 0.04)
0.69 ± 0.02
(15.08 ± 0.34)
0.78 ± 0.01
(12.99 ± 0.13)
1.40 ± 0.02
(30.33 ± 0.42)
0.20 ± 0.01
(2.76 ± 0.13)
2.0 ± 0.4
(0.02 ± 0.00)

EB

n.d.

n.d.

n.d.

n.d.

BA

80.3 ± 9.0
(0.69 ± 0.08)

54.2 ± 4.9
(0.47 ± 0.04)

82.8 ± 15.5
(0.71 ± 0.13)

203.0 ± 5.7
(1.75 ± 0.05)

BB

n.d.

n.d.

n.d.

n.d.

92.8 ± 10.5
(0.83 ± 0.09)
0.26 ± 0.04
(0.00 ± 0.00)

63.3 ± 4.8
(0.57 ± 0.04)
0.21 ± 0.02
(0.00 ± 0.00)

92.5 ± 19.6
(0.82 ± 0.18)
0.22 ± 0.09
(0.00 ± 0.00)

205.0 ± 6.1
(1.77 ± 0.05)
0.04 ± 0.01
(0.00 ± 0.00)

EB

n.d.

n.d.

n.d.

n.d.

BA

1.65 ± 0.24
(0.01 ± 0.00)

1.26 ± 0.07
(0.01 ± 0.00)

1.90 ± 0.30
(0.02 ± 0.00)

4.18 ± 0.11
(0.04 ± 0.00)

BB

n.d.

n.d.

n.d.

n.d.

1.91 ± 0.28
(0.02 ± 0.00)
1.53 ± 0.32
(3.13 ± 0.66)

1.47 ± 0.08
(0.01 ± 0.00)
8.85 ± 9.69
(18.09 ± 19.82)

2.12 ± 0.38
(0.02 ± 0.00)
4.33 ± 1.77
(8.85 ± 3.62)

4.22 ± 0.12
(0.04 ± 0.00)
0.88 ± 0.20
(1.79 ± 0.41)

EB

n.d.

n.d.

n.d.

n.d.

BA

9.88 ± 2.04
(15.32 ± 3.16)

56.91 ± 67.39
(88.27 ± 104.51)

37.22 ± 6.42
(57.72 ± 9.96)

86.79 ± 5.78
(134.61 ± 8.96)

BB

n.d.

n.d.

n.d.

n.d.

Ester total

11.41 ± 2.36
(18.45 ± 3.82)

65.76 ± 77.08
(106.36 ± 124.32)

41.54 ± 8.19
(66.57 ± 13.58)

87.67 ± 5.98
(136.40 ± 9.38)

4.00 ± 2.37
(22.20 ± 13.13)
0.10 ± 0.01
(1.15 ± 0.07)
0.92 ± 0.09
(19.89 ± 1.96)
0.47 ± 0.03
(7.77 ± 0.54)
2.53 ± 0.05
(54.84 ± 1.02)
0.18 ± 0.00
(2.40 ± 0.02)
2.7 ± 1.0
(0.03 ± 0.01)
156.3 ± 22.4
(1.35 ± 0.19)
4.1 ± 0.5
(0.04 ± 0.00)
167.3 ± 18.2
(1.16 ± 0.13)
330.5 ± 16.3
(2.57 ± 0.14)
0.05 ± 0.02
(0.54 ± 0.21)
2.72 ± 0.49
(23.40 ± 4.24)
0.07 ± 0.01
(0.62 ± 0.08)
2.90 ± 0.35
(20.10 ± 2.42)
5.74 ± 0.57
(44.65 ± 4.70)
0.64 ± 0.34
(1.32 ± 0.70)
42.54 ± 21.00
(65.97 ± 32.56)
1.17 ± 0.68
(1.81 ± 1.05)
53.29 ± 30.08
(66.57 ± 37.58)
97.64 ± 52.10
(135.68 ± 71.90)

Consumed glucose, g/L (mM)
Lactate, g/L (mM)
Formate, g/L (mM)
Acetate, g/L (mM)
Ethanol, g/L (mM)
Butanol, g/L (mM)
EA

Ester titers,
mg/L (mM)

Ester total
EA

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

Ester total
EA

Ester yields,
mg/g glucose
(mM/M)
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Table 2-17: Summary of production of C4-derived esters in anaerobic bottles with pH-adjustment.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate; n.d.:
not detected.
Strains

EcJWBA14

EcJWEB7

EcJWBB8

O.D.600

3.76 ± 0.20

4.36 ± 0.26

4.22 ± 0.20

11.85 ± 0.91
(65.80 ± 5.04)
0.06 ± 0.00
(0.68 ± 0.02)
2.14 ± 0.06
(46.55 ± 1.20)
1.03 ± 0.01
(17.17 ± 0.23)
2.05 ± 0.02
(44.56 ± 0.51)
0.16 ± 0.01
(2.11 ± 0.17)
39.8 ± 7.6
(0.45 ± 0.09)

41.40 ± 1.50
(229.78 ± 8.32)
1.05 ± 0.17
(11.71 ± 1.85)
3.58 ± 0.57
(77.81 ± 12.33)
0.40 ± 0.02
(6.65 ± 0.38)
9.88 ± 0.28
(214.41 ± 5.98)
0.20 ± 0.02
(2.76 ± 0.33)
1.2 ± 0.5
(0.01 ± 0.01)
381.9 ± 24.7
(3.29 ± 0.21)
7.4 ± 1.2
(0.06 ± 0.01)
449.6 ± 43.0
(3.12 ± 0.30)
839.9 ± 68.4
6.48 ± 0.52)
0.01 ± 0.00
(0.00 ± 0.00)
2.02 ± 0.13
(0.02 ± 0.00)
0.04 ± 0.01
(0.00 ± 0.00)
2.38 ± 0.23
(0.02 ± 0.00)
4.45 ± 0.36
(0.03 ± 0.00)
0.10 ± 0.04
(0.21 ± 0.08)
34.06 ± 2.20
(52.82 ± 3.41)
0.66 ± 0.11
(1.02 ± 0.17)
40.10 ± 3.84
(50.09 ± 4.79)
74.91 ± 6.10
(104.14 ± 8.29)
96

EB

n.d.

BA

39.37 ± 3.64
(61.06 ± 5.65)

BB

n.d.

Ester total

42.91 ± 4.32
(68.31 ± 7.03)

29.71 ± 0.23
(164.90 ± 1.27)
0.17 ± 0.01
(1.93 ± 0.15)
0.18 ± 0.01
(3.89 ± 0.18)
0.22 ± 0.00
(3.61 ± 0.04)
12.52 ± 0.10
(271.74 ± 2.25)
0.03 ± 0.00
(0.46 ± 0.03)
58.3 ± 9.3
(0.66 ± 0.11)
408.9 ± 44.3
(3.52 ± 0.38)
0.9 ± 0.1
(0.01 ± 0.00)
10.1 ± 1.0
(0.07 ± 0.01)
478.2 ± 54.8
(4.26 ± 0.50)
0.31 ± 0.05
(0.00 ± 0.00)
2.17 ± 0.23
(0.02 ± 0.00)
0.00 ± 0.00
(0.00 ± 0.00)
0.05 ± 0.01
(0.00 ± 0.00)
2.53 ± 0.29
(0.02 ± 0.00)
5.20 ± 0.83
(10.63 ± 1.70)
36.47 ± 3.95
(56.57 ± 6.13)
0.08 ± 0.01
(0.13 ± 0.02)
0.90 ± 0.09
(1.12 ± 0.11)
42.65 ± 4.88
(68.45 ± 7.96)

48

96

Consumed glucose, g/L (mM)
Lactate, g/L (mM)
Formate, g/L (mM)
Acetate, g/L (mM)
Ethanol, g/L (mM)
Butanol, g/L (mM)
EA

Ester titers,
mg/L (mM)

EB

n.d.

BA

441.4 ± 40.9
(3.80 ± 0.35)

BB

n.d.

Ester total
EA

Specific ester
productivity,
mg/gDCW/h
(μM/gDCW/h)

EB

n.d.

BA

5.04 ± 0.47
(0.04 ± 0.00)

BB

n.d.

Ester total
EA

Ester yields,
mg/g glucose
(mM/M)

Culture time (h)

481.1 ± 48.4
(4.25 ± 0.44)
0.45 ± 0.09
(0.01 ± 0.00)

5.49 ± 0.55
(0.05 ± 0.00)
3.55 ± 0.68
(7.25 ± 1.38)
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Table 2-18: Summary of direct fermentative production of C4-derived esters from sugar.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; BB, butyl butyrate.

Products

Strains

Strategies

Titers
(mg/L)

Volumetric
productivity
(mg/L/h)

Yields
(mg ester/
g glucose)

Ester
Selectivity
(%)

*Maximum
theoretical
yield (%)

Ref.

E. coli

SAATFa

0.5

0.005

0.01

0.28

0.002

[1]

C. acetobutylicum

SAATFa opt

8.4

0.116

0.29

14.17

0.07

[7]

E. coli

ATF1Sc

34.2

1.426

8.22

74.27

1.91

E. coli

ATF1Sc

48.0

1.999

10.88

83.13

2.53

E. coli

TrxA_ATF1Scopt

89.5

3.727

16.68

84.30

3.88

203.0

8.457

86.79

99.00

20.18

441.4

9.195

39.37

91.74

9.16

134.0

1.396

3.31

78.22

0.77

[1]
[7]

BA

E. coli

E. coli

EB

E. coli

SAATFa

C. acetobutylicum

SAATFa opt

0.6

0.008

0.02

1.03

0.005

E. coli

SAATFa

71.0

2.960

9.84

91.97

2.29

E. coli

SAATFa

200.4

8.350

20.61

89.57

4.79

365.7

15.236

38.46

92.90

8.94

408.9

4.260

36.47

85.51

8.48

E. coli

E. coli

BB

TrxA_ATF1Scopt
+TrxA_adhE2opt
TrxA_ATF1Scopt
+TrxA_adhE2opt
+Anaerobic culture
with pH adjustment

SAATFa
+GroES/EL
SAATFa
+GroES/EL
+Anaerobic culture
with pH adjustment

This
study

This
study

E. coli

SAATFa

36.8

0.384

0.91

21.50

0.23

[1]

C. acetobutylicum

SAATFa opt

50.1

0.695

1.72

84.79

0.43

[7]

E. coli

SAATFa

33.5

1.395

8.65

20.75

2.16

E. coli

SAATFa

127.4

5.308

26.31

33.96

6.58

167.3

6.971

53.29

50.63

13.32

449.6

4.683

40.10

53.52

10.03

E. coli

E. coli

SAATFa
+TrxA_adhE2opt
SAATFa
+TrxA_adhE2opt
+Anaerobic culture
with pH adjustment

*Actual molar yield / theoretical molar yield from glucose *100.
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This
study

Figure 2-6: SDS-PAGE analysis for confirming expression of heterologous enzymes in EcJWBA2,
EcJWEB2, and EcJWBB2. (a) EcJWBA1-6. (b) EcJWEB1-6. (c) EcJWBB1-6. Red arrows
indicate the expected size of overexpressed enzymes. Abbreviations: L, protein ladder; T, total
fractions; S, Soluble fractions. (Induction conditions: 37℃, 0.5 mM IPTG)
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Figure 2-7: Summary of BA production optimization. (a) Pathway validation. (b) Optimization
of induction conditions. (c) Improving solubility of ATF1Sc. (d) Improving solubility of adhE2Ca.
(e-h) Ester selectivity.
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Figure 2-8: Summary of EB production optimization. (a) Pathway validation. (b) Optimization of
induction conditions. (c) Improving solubility of SAATFa. (d-f) Ester selectivity.
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Figure 2-9: Summary of BB production optimization. (a) Pathway validation. (b) Optimization of
induction conditions. (c) Improving solubility of SAATFa. (d) Improving solubility of AdhE2Ca.
(e-h) Ester selectivity.
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Figure 2-10: SDS-PAGE analysis for confirming expression of heterologous enzymes in
EcJWBA2, EcJWEB2, and EcJWBB2 with various induction conditions. (a) EcJWBA2. (b)
EcJWEB2. (c) EcJWBB2. Red arrows indicate the expected size of overexpressed enzymes.
Yellow stars indicate the conditions result in the highest esters production among the evaluated
conditions. Abbreviations: L, protein ladder; T, total fractions; S, Soluble fractions. (Induction
conditions: 28/37℃, 0.01/0.1/1.0 mM IPTG)
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Figure 2-11: Summary of solubility engineering of ATF1Sc. (a) Schematic representation of the
conversion of an alcohol (ethanol/butanol) into an ester (ethyl acetate (EA)/butyl acetate (BA)) by
ATF1Sc in E. coli. Evaluation of various soluble protein expression strategies in the conversion of
(b) ethanol into EA, and (c) butanol into BA. Grey box indicates a negative control.
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Figure 2-12: Summary of solubility engineering of SAATFa. (a) Schematic representation of the
conversion of an alcohol (ethanol/butanol) into an ester (ethyl butyrate (EB)/butyl butyrate (BB))
by SAATFa in E. coli. Evaluation of various soluble protein expression strategies in the conversion
(b) ethanol into EB and (c) butanol into BB. Grey box indicates a negative control.
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Figure 2-13: SDS-PAGE analysis for confirming expression of heterologous enzymes in (a)
EcJWBA2 and EcJWBA7-10, (b) EcJWEB7, and (c) EcJWBB7 with various induction conditions.
Red arrows indicate the expected size of overexpressed enzymes. Abbreviations: L, protein ladder;
T, total fractions; S, Soluble fractions. (Induction conditions: EcJWBA7-10 and EcJWEB7: 28℃,
0.1 mM IPTG; EcJWBB7: 37℃, 0.1 mM IPTG).
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Figure 2-14: SDS-PAGE analysis for confirming expression of heterologous enzymes in
EcJWBA10-14. Red arrows indicate the expected size of overexpressed enzymes. Abbreviations:
L, protein ladder; T, total fractions; S, Soluble fractions. (Induction conditions: 28℃, 0.1 mM
IPTG).

73

Figure 2-15: BA production by EcJWBA14 in anaerobic bottles with pH-adjustment to pH ~7
every 24 h. (a) Fermentation profile of cell growth (O.D.600), glucose consumption, and alcohol
production. Consumed glucose (in red squares); O.D.600 values (in blue circles); Ethanol (in green
triangles); Butanol, (in purple diamonds). (b) Ester production. (c) Ester selectivity at 48 h.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; and BB, butyl butyrate.
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Figure 2-16: EB production by EcJWEB7 in anaerobic bottles with pH-adjustment to pH ~7 every
24 h. (a) Fermentation profile of cell growth (O.D.600), glucose consumption, and alcohol
production. Consumed glucose (in red squares); O.D.600 values (in blue circles); Ethanol (in green
triangles); Butanol, (in purple diamonds). (b) Ester production. (c) Ester selectivity at 96 h.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; and BB, butyl butyrate.
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Figure 2-17: BB production by EcJWBB8 in anaerobic bottles with pH-adjustment to pH ~7 every
24 h. (a) Fermentation profile of cell growth (O.D.600), glucose consumption, and alcohol
production. Consumed glucose (in red squares); O.D.600 values (in blue circles); Ethanol (in green
triangles); Butanol, (in purple diamonds). (b) Ester production. (c) Ester selectivity at 96 h.
Abbreviations: EA, ethyl acetate; EB, ethyl butyrate; BA, butyl acetate; and BB, butyl butyrate.
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Figure 2-18: Predicted solubility of enzymes used in this study. The solubility of enzymes were
predicted with Protein-Sol [8] (https://protein-sol.manchester.ac.uk) from the amino acid
sequences. The AVER value (0.45) indicates the population average for the experimental dataset[9]
(in grey). Thus, while the solubility values greater than 0.45 is predicted to have a higher solubility
than the average soluble E. coli protein (in orange), the values lower than 0.45 is predicted to be
less soluble (in blue).

77

Figure 2-19: Summary of C4-derived esters production in engineered strains. (a-b) BA production;
(a) BA titer, (b) BA selectivity. (c-d) EB production; (c) EB titer, (d) EB selectivity; (e-f) BB
production (e) BB titer, (f) BB selectivity. Abbreviations: EA, ethyl acetate; EB, ethyl butyrate;
BA, butyl acetate; and BB, butyl butyrate.
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Figure 2-20: Summary of stoichiometric balance for synthesis of C4-derived esters.
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3 Microbial Production of Lactate Esters
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3.1 Abstract
Green organic solvents such as lactate esters have broad industrial applications and favorable
environmental profiles. Thus, manufacturing and use of these biodegradable solvents from
renewable feedstocks help benefit the environment. However, to date, the direct microbial
biosynthesis of lactate esters from fermentable sugars has not yet been demonstrated.
In this work, we present a microbial conversion platform for direct biosynthesis of lactate
esters from fermentable sugars. First, we designed a pyruvate-to-lactate ester module, consisting
of a lactate dehydrogenase (ldhA) to convert pyruvate to lactate, a propionate CoA-transferase (pct)
to convert lactate to lactyl-CoA, and an alcohol acyltransferase (AAT) to condense lactyl-CoA and
alcohol(s) to make lactate ester(s). By generating a library of five pyruvate-to-lactate ester modules
with divergent AATs, we screened for the best module(s) capable of producing a wide range of
linear, branched, and aromatic lactate esters with an external alcohol supply. By co-introducing a
pyruvate-to-lactate ester module and an alcohol (i.e., ethanol, isobutanol) module into a modular
Escherichia coli (chassis) cell, we demonstrated for the first time the microbial biosynthesis of
ethyl and isobutyl lactate esters directly from glucose. In an attempt to enhance ethyl lactate
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production as a proof-of-study, we re-modularized the pathway into 1) the upstream module to
generate the ethanol and lactate precursors and 2) the downstream module to generate lactyl-CoA
and condense it with ethanol to produce the target ethyl lactate. By manipulating the metabolic
fluxes of the upstream and downstream modules through plasmid copy numbers, promoters,
ribosome binding sites, and environmental perturbation, we were able to probe and alleviate the
metabolic bottlenecks by improving ethyl lactate production by 4.96-fold. We found that AAT is
the most rate limiting step in biosynthesis of lactate esters likely due to its low activity and
specificity towards the non-natural substrate lactyl-CoA and alcohols.
Here, we have successfully established the biosynthesis pathway of lactate esters from
fermentable sugars and demonstrated for the first time the direct fermentative production of lactate
esters from glucose using an E. coli modular cell. This study defines a cornerstone for the microbial
production of lactate esters as green solvents from renewable resources with novel industrial
applications.

3.2 Introduction
Solvents are widely used as primary components of cleaning agents, adhesives, and coatings
and in assisting mass and heat transfer, separation and purification of chemical processes [1].
However, these solvents are volatile organic compounds (VOCs) that contribute to ozone depletion
and photochemical smog via free radical air oxidation and hence cause many public health
problems such as eye irritation, headache, allergic skin reaction, and cancer [1, 2]. Thus, recent
interest in use of alternative green solvents is increasing due to environmental regulation and
compelling demand for the eco-friendly solvents derived from renewable sources [3, 4].
Lactate esters are platform chemicals that have a broad range of industrial applications in
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flavor, fragrance, and pharmaceutical industries [5]. These esters are generally considered as green
solvents because of their favorable toxicological and environmental profiles. For instance, ethyl
lactate is 100% biodegradable, non-carcinogenic, non-corrosive, low volatile, and unhazardous to
human health and the environment [6]. Due to the unique beneficial properties of ethyl lactate, it
has been approved as a Significant New Alternatives Policy (SNAP) solvent by the U.S.
Environmental Protection Agency (EPA) and as food additives by the U.S. Food and Drug
Administration (FDA) [6]. Recent technical and economic analysis conducted by the National
Renewable Energy Laboratory (NREL) considers ethyl lactate to be one of the top twelve
bioproducts [7].
In industrial chemical processes, lactate esters are currently produced by esterification of
lactic acid with alcohols using homogenous catalysts (e.g., sulfuric acid, hydrogen chloride, and/or
phosphoric acid) under high temperature reaction conditions [8]. However, use of strong acids as
catalysts cause corrosive problems and often require more costly equipment for process operation
and safety. Furthermore, the esterification reactions are thermodynamically unfavorable (G = +5
kcal/mol) in aqueous solutions and often encounter significant challenge due to selfpolymerization of lactate [9]. Alternatively, microbial catalysts can be harnessed to produce these
esters from renewable and sustainable feedstocks in a thermodynamically favorable reaction (G
= -7.5 kcal/mol) in an aqueous phase environment at room temperature and atmospheric pressure
[10-16]. This reaction uses an alcohol acyltransferase (AAT) to generate an ester by condensing
an alcohol and an acyl-CoA. AAT can catalyze a broad substrate range including i) linear or
branched short-to-long chain fatty alcohols [10, 11, 17], ii) aromatic alcohols [18], and iii)
terpenols [19-22] as well as various fatty acyl-CoAs [11, 13]. To date, while microbial biosynthesis
of the precursor metabolites for lactate esters have been well established such as lactate [13, 16,
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23-27], lactyl-CoA [28-30], ethanol [31, 32], propanol [33], isopropanol [34], butanol [35],
isobutanol [36], amyl alcohol [37], isoamyl alcohol [38], benzyl alcohol [39], 2-phenylethanol [40,
41], and terpenols [19-22], the direct microbial biosynthesis of lactate esters from fermentable
sugars has not yet been demonstrated.
In this work, we aimed to demonstrate the feasibility of microbial production of lactate
esters as green organic solvents from renewable resources. To enable the direct microbial
biosynthesis of lactate esters from fermentable sugars, we first screened for an efficient AAT
suitable for lactate ester production using a library of five pyruvate-to-lactate ester modules with
divergent AATs. We next demonstrated direct fermentative biosynthesis of ethyl and isobutyl
lactate esters from glucose by co-introducing a pyruvate-to-lactate ester module and an alcohol
module (i.e., ethanol and isobutanol) into an engineered Escherichia coli modular cell. As a proofof-study to improve ethyl lactate production, we employed a combination of metabolic engineering
and synthetic biology approaches to dissect the pathway to probe and alleviate the potential
metabolic bottlenecks.

3.3 Materials and Methods
3.3.1 Strain construction
The list of strains used in this study are presented in Table 3-1. For molecular cloning, E.
coli TOP10 strain was used. To generate the lactate ester production strains, the modules, including
i) the pyruvate-to-lactate ester modules (pJW002-006), ii) the upstream and/or downstream
modules (pJW007-pJW028), and iii) the alcohol modules (pCT24 or pCT13), were transformed
into the engineered modular E. coli chassis cell, EcDL002 [10] via electroporation [42].
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Table 3-1: A list of strains used in this study.
Strains

Genotypes

E. coli TOP10

F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu)
7697 galU galK rpsL (StrR) endA1 nupG
F− λ−

E. coli MG1655
Clostridium
propionicum
EcDL002
EcJW101
EcJW102
EcJW103
EcJW104
EcJW105
EcJW201
EcJW202
EcJW106
EcJW203
EcJW204
EcJW205
EcJW107
EcJW206
EcJW207
EcJW208
EcJW108
EcJW209
EcJW210
EcJW211
EcJW212
EcJW213
EcJW214
EcJW215
EcJW216
EcJW217
EcJW218
EcJW219
EcJW220
EcJW221
EcJW109
EcJW110
EcJW111
EcJW112
EcJW113
EcJW114
EcJW115
EcJW116
EcJW117

Sources
Invitrogen
ATCC 47076

Wildtype

ATCC 25522

TCS083 (λDE3) ΔfadE
EcDL002/pJW002; ampR
EcDL002/pJW003; ampR
EcDL002/pJW004; ampR
EcDL002/pJW005; ampR
EcDL002/pJW006; ampR
EcDL002/pJW005 pCT24; ampR kanR
EcDL002/pJW005 pCT13; ampR kanR
EcDL002/pJW013; cmR
EcDL002/pJW007 pJW011; cmR ampR
EcDL002/pJW007 pJW012; cmR kanR
EcDL002/pJW008 pJW010; cmR ampR
EcDL002/pJW014; ampR
EcDL002/pJW008 pJW012; ampR kanR
EcDL002/pJW009 pJW010; cmR kanR
EcDL002/pJW009 pJW011; ampR kanR
EcDL002/pJW015; kanR
EcDL002/pJW019 pJW012; cmR kanR
EcDL002/pJW020 pJW012; cmR kanR
EcDL002/pJW021 pJW012; cmR kanR
EcDL002/pJW022 pJW012; cmR kanR
EcDL002/pJW007 pJW027; cmR kanR
EcDL002/pJW007 pJW028; cmR kanR
EcDL002/pJW007 pJW029; cmR kanR
EcDL002/pJW007 pJW030; cmR kanR
EcDL002/pJW007 pJW031; cmR kanR
EcDL002/pJW007 pJW032; cmR kanR
EcDL002/pJW007 pJW033; cmR kanR
EcDL002/pJW007 pJW034; cmR kanR
EcDL002/pJW007 pJW035; cmR kanR
EcDL002/pJW027; kanR
EcDL002/pJW028; kanR
EcDL002/pJW029; kanR
EcDL002/pJW030; kanR
EcDL002/pJW031; kanR
EcDL002/pJW032; kanR
EcDL002/pJW033; kanR
EcDL002/pJW034; kanR
EcDL002/pJW035; kanR

[10]
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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Table 3-2: A list of plasmids used in this study.
Plasmids
pACYCDuet-1
pETDuet-1
pRSFDuet-1
pETite*
pCT24
pCT13
pDL004
pDL005
pDL001
pDL006
pCT16
pJW001
pJW002
pJW003
pJW004
pJW005
pJW006
pJW007
pJW008
pJW009
pJW010
pJW011
pJW012
pJW013
pJW014
pJW015
pJW016
pJW017
pJW018
pJW019
pJW020
pJW021
pJW022
pJW023
pJW024
pJW025
pJW026
pJW027
pJW028
pJW029
pJW030
pJW031
pJW032
pJW033
pJW034
pJW035

Genotypes

Sources

Two sets of MCS, T7 promoter, P15A ori; cmR
Two sets of MCS, T7 promoter, ColE1 ori; ampR
Two sets of MCS, T7 promoter, RSF1030 ori; kanR
T7 promoter, pBR322 ori; kanR
pETite* PT7::pdc::adhB::TT7; kanR

Novagen
Novagen
Novagen
[10]
[10]
[43]
[13]
[13]
[13]
[13]
[44]
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

pCOLA PT7::alsS::ilvC::ilvD−PT7::kivd::adhE::TT7; kanR
pETite* ATF1; kanR
pETite* ATF2; kanR
pETite* SAAT; kanR
pETite* VAAT; kanR
pETite* atfA; kanR
pETite* PT7::ldhA::pct::TT7; ampR
pJW001 PT7::ldhA::pct-PT7::ATF1::TT7; ampR
pJW001 PT7::ldhA::pct-PT7::ATF2::TT7; ampR
pJW001 PT7::ldhA::pct-PT7::SAAT::TT7; ampR
pJW001 PT7::ldhA::pct-PT7::VAAT::TT7; ampR
pJW001 PT7::ldhA::pct-PT7::atfA::TT7; ampR
pACYCDuet-1 PT7::ldhA::pdc::adhB::TT7; cmR
pETDuet-1 PT7::ldhA::pdc::adhB::TT7; ampR
pRSFDuet-1 PT7::ldhA::pdc::adhB::TT7; kanR
pACYCDuet-1 PT7::pct::VAAT::TT7; cmR
pETDuet-1 PT7::pct::VAAT::TT7; ampR
pRSFDuet-1 PT7::pct::VAAT::TT7; kanR
pACYCDuet-1 PT7::ldhA::pdc::adhB-PT7::pct::VAAT::TT7; cmR
pETDuet-1 PT7::ldhA::pdc::adhB-PT7::pct::VAAT::TT7; ampR
pRSFDuet-1 PT7::ldhA::pdc::adhB-PT7::pct::VAAT::TT7; kanR
pACYCDuet-1 PT7::ldhA::TT7-PT7::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY1::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY3::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY1::synRBSpdc#1::pdc::adhB::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY1::synRBSpdc#2::pdc::adhB::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY3::synRBSpdc#3::pdc::adhB::TT7; cmR
pACYCDuet-1 PT7::ldhA::TT7-PAY3::synRBSpdc#4::pdc::adhB::TT7; cmR
pRSFDuet-1 PT7::pct::TT7-PT7::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#1::pct::TT7-PT7::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#2::pct::TT7-PT7::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#3::pct::TT7-PT7::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#1::pct::TT7-PT7::synRBSVAAT#1::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#1::pct::TT7-PT7::synRBSVAAT#2::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#1::pct::TT7-PT7::synRBSVAAT#3::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#2::pct::TT7-PT7::synRBSVAAT#1::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#2::pct::TT7-PT7::synRBSVAAT#2::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#2::pct::TT7-PT7::synRBSVAAT#3::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#3::pct::TT7-PT7::synRBSVAAT#1::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#3::pct::TT7-PT7::synRBSVAAT#2::VAAT::TT7; kanR
pRSFDuet-1 PT7::synRBSpct#3::pct::TT7-PT7::synRBSVAAT#3::VAAT::TT7; kanR
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Table 3-3: A list of primers used in this study.
Primers
Sequences (5’➝3’)
Pyruvate-to-lactyl-CoA module
DL_0001 CATCATCACCACCATCACTAA
DL_0002 ATGTATATCTCCTTCTTATAGTTAAAC
DL_0032 TAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAAACTCGCCGTTTATAG
DL_0033 GGGAACCTTTCTCATTATATCTCCTTTTAAACCAGTTCGTTCGGGC
DL_0034 ACGAACTGGTTTAAAAGGAGATATAATGAGAAAGGTTCCCATTAT
DL_0035 GCCGCTCTATTAGTGATGGTGGTGATGATGTCAGGACTTCATTTCCTTCAG
Pyruvate-to-lactate ester module
DL_0013 GAGCCTCAGACTCCAGCGTA
DL_0014 ATATCAAGCTTGAATTCGTTACCCGG
DL_0015 GGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATTAATACGACTCACTATAGGG
DL_0016 GTCCAGTTACGCTGGAGTCTGAGGCTC
Upstream module
JW_0001 GGGCAGCAGCCATCACCATCATCACCACAGCCAGGATCCATGAAACTCGCCGTTTATAGC
JW_0002 CTAAATAGGTACCGACAGTATAACTCATTATATCTCCTTTTAAACCAGTTCGTTCGGGC
JW_0003 CGAAACCTGCCCGAACGAACTGGTTTAAAAGGAGATATAATGAGTTATACTGTCGGTACC
JW_0004 CGCAAGCTTGTCGACCTGCAGGCGCGCCGAGCTCGAATTCTTAGAAAGCGCTCAGGAAG
JW_0005 GGATCCTGGCTGTGGTGATGA
JW_0006 GAATTCGAGCTCGGCGCG
Downstream module
JW_0007 GTATATTAGTTAAGTATAAGAAGGAGATATACATATGATGAGAAAGGTTCCCATTATTAC
JW_0008

GAAATTATACTGACCTCAATTTTCTCCATTATATCTCCTTTCAGGACTTCATTTCCTTC

JW_0009

AATGGGTCTGAAGGAAATGAAGTCCTGAAAGGAGATATAATGGAGAAAATTGAGGTCAG

JW_0010

CAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTCAATATCTTGAAATTAGCGTCT

JW_0011

CATATGTATATCTCCTTCTTATACTTAACT

JW_0012 CTCGAGTCTGGTAAAGAAAC
Synthetic operons for upstream module
JW_0013 GGGAATTGTGAGCGGATAACAATTCCCCAAGGAGATATAATGAAACTCGCCGTTTATAGC
JW_0014 TTATGCTAGTTATTGCTCAGCGGTGGCGGCCGCTCTATTATTAAACCAGTTCGTTCGG
JW_0015 TCTGGAAAAAGGCGAAACCTGCCCGAACGAACTGGTTTAATAATAGAGCGGCCGC
JW_0016 GATTATGCGGCCGTGTACAATACGATTACTTTCTGTTCGATTTCTACCGAAGAAAGGC
JW_0017 CATTATATCTCCTTGGGGAATTGTTATCCGC
JW_0018 TCGAACAGAAAGTAATCGTATTG
JW_0019 AAATTTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGCATGAGTTATACTGTCGGTACC
JW_0020 GCGTTCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTTAGAAAGCGCTCAGGAA
JW_0021 AAATCTGACAGCTAGCTCAGTCCTAGGTATAATGCTAGCATGAGTTATACTGTCGGTACC
JW_0022 CATGCTAGCACTGTACCTAGGACTGAGCTAGCCGTCAAATTTCGATTATGCGGCC
JW_0023 CATGCTAGCATTATACCTAGGACTGAGCTAGCTGTCAGATTTCGATTATGCGGCC
JW_0024 TACAGTGCTAGCAGCTTAGCGACAACCCTAGGCGCTCGCATGAGTTATACTGTCGGTACC
JW_0025 GTATAATGCTAGCTTAGCAGTACCAGGACGTACCGGAGTATGAGTTATACTGTCGGTACC
JW_0026 TAGGTACAGTGCTAGCACTAGGCCTAGCGATTCCGCTAAATGAGTTATACTGTCGGTACC
JW_0027 TATAATGCTAGCAGTTTACCTAGGGCAATAGCGTACCGAATGAGTTATACTGTCGGTACC
JW_0028 CATGCGAGCGCCTAGGGTTGTCGCTAAGCTGCTAGCACTGTACCTAGG
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Table 3-3: Continued
Primers
Sequences (5’➝3’)
JW_0029 CATTTAGCGGAATCGCTAGGCCTAGTGCTAGCACTGTACCTAGG
JW_0030 CATACTCCGGTACGTCCTGGTACTGCTAAGCTAGCATTATACCTAGG
JW_0031 CATTCGGTACGCTATTGCCCTAGGTAAACTGCTAGCATTATACCTAGG
Synthetic operons for downstream module
JW_0032 TTATGCTAGTTATTGCTCAGCGGTGGCGGCCGCTCTATTATCAGGACTTCATTTCCTTCA
JW_0033 TGCAGAAGGCTTAATGGGTCTGAAGGAAATGAAGTCCTGATAATAGAGCGGCCGC
JW_0034 GATTATGCGGCCGTGTACAATACGATTACTTTCTGTTCGATTTCTACCGAAGAAAGGC
JW_0035 GATATAGCTCGAACGCGGAAAGAGATGAGAAAGGTTCCCATTATTAC
JW_0036 TCAGGACTTCATTTCCTTCA
JW_0037 GCAACCTATTTTAATCCAAGGAAGATCTAATGAGAAAGGTTCCCATTATTAC
JW_0038 GCAATAACAACTAGGAGAGACGACATGAGAAAGGTTCCCATTATTAC
JW_0039 TAATGGGAACCTTTCTCATCTCTTTCCGCGTTCGAGCTATATCGGGGAATTGTTATCCGC
JW_0040 TGCAGAAGGCTTAATGG
JW_0041 GGAACCTTTCTCATTAGATCTTCCTTGGATTAAAATAGGTTGCGGGGAATTGTTATCCGC
JW_0042 TAATGGGAACCTTTCTCATGTCGTCTCTCCTAGTTGTTATTGCGGGGAATTGTTATCCGC
JW_0043 TAACCAAAACACTAACGCAAGATGGAGAAAATTGAGGTCAGT
JW_0044 AGGGCACGAGGAGGAACCAGTAGAATGGAGAAAATTGAGGTCAGT
JW_0045 GCAACCAACACAACGAGGAGGCATTTAATGGAGAAAATTGAGGTCAGT
JW_0046 TACTGACCTCAATTTTCTCCATCTTGCGTTAGTGTTTTGGTTAGGGGAATTGTTATCCGC
JW_0047 CTCAATTTTCTCCATTCTACTGGTTCCTCCTCGTGCCCTGGGGAATTGTTATCCGC
JW_0048 CTCAATTTTCTCCATTAAATGCCTCCTCGTTGTGTTGGTTGCGGGGAATTGTTATCCGC
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3.3.2 Plasmid construction
The list of plasmids and primers used in this study are presented in Table 3-2 and Table 33, respectively. Pathway construction includes pyruvate-to-lactate ester modules and a library of
upstream and downstream modules with various plasmid copy numbers, promoters, and ribosome
binding sites (RBSs).
3.3.2.1 Construction of pyruvate-to-lactate ester modules
A library of pyruvate-to-lactate ester modules with five divergent AATs were constructed
to screen for an efficient AAT for production of lactate esters via two rounds of cloning. First, the
pyruvate-to-lactyl-CoA module (pJW001) was constructed by assembling three DNA fragments:
i) the ldhA gene, encoding D-lactate dehydrogenase, amplified from E. coli MG1655 genomic
DNA using the primer pair DL_0032/DL_0033, ii) the pct gene, encoding propionate CoAtransferase, amplified from Clostridium propionicum genomic DNA using the primer pair
DL_0034/DL_0035, and iii) the backbone amplified from pETite* using the primer pair
DL_0001/DL_0002 [45]. Then, the pyruvate-to-lactate ester modules (pJW002-006) were
constructed by assembling three DNA fragments: i) the pyruvate-to-lactyl-CoA module amplified
from pJW001 using the primer pair DL_0032/DL_0014, ii) the ATF1 gene amplified from pDL004
for pJW002, the ATF2 gene amplified from pDL005 for pJW003, the SAAT gene amplified from
pDL001 for pJW004, the VAAT gene amplified from pDL006 for pJW005, or the atfA gene
amplified from pCT16 for pJW006, using the primer pair DL_0015/DL_0016, and iii) the
backbone amplified from pETite* using the primer pair DL_0013/ DL_0002. The genes ATF1 and
ATF2 are originated from Saccharomyces cerevisiae [46], whereas the genes SAAT, VAAT and
atfA are derived from Fragaria ananassa [47], F. vesca [48], and Acinetobacter sp. ADP1 [49],
respectively.
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3.3.2.2 Construction of a library of upstream and downstream modules with
various plasmid copy numbers
A library of upstream and downstream modules were constructed to improve ethyl lactate
biosynthesis through a combinatorial pathway optimization strategy using three different plasmids:
i) pACYCDuet-1 (P15A origin of replication), ii) pETDuet-1 (ColE1 origin), and iii) pRSFDuet1 (RSF1030 origin), having the plasmid copy numbers of 10, 40, and 100, respectively [50].
The upstream modules (pJW007-009) were constructed by assembling three DNA
fragments: i) the ldhA gene amplified from pJW001 using the primer pair JW_0001/JW_0002, ii)
the ethanol module containing pdc and adhB genes amplified from pCT24 using the primer pair
JW_0003/JW_0004, and iii) the backbone amplified from pACYCDuet-1 for pJW007, from
pETDuet-1 for pJW008, or from pRSFDuet-1 for pJW009 using the primer pair
JW_0005/JW_0006.
The downstream modules (pJW010-012) were constructed by assembling three DNA
fragments: i) the pct gene amplified from pJW001 using the primer pair JW_0007/JW_0008, ii)
the VAAT gene amplified from pJW005 using the primer pair JW_0009/JW_0010, and iii) the
backbone amplified from pACYCDuet-1 for pJW010, pETDuet-1 for pJW011, or pRSFDuet-1 for
pJW012 using the primer pair JW_0011/JW_0012.
The combined upstream and downstream modules (pJW013-015) were constructed by
assembling two DNA fragments: i) the upstream module amplified from pJW007 using the primer
pair JW_0001/JW_0004 and ii) the backbone containing the downstream module amplified from
pJW010 for pJW013, pJW011 for pJW014, or pJW012 for pJW015 using the primer pair
JW_0005/JW_0006.
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3.3.2.3 Construction of a library of upstream and downstream modules with
various promoters and RBSs
For tighter regulation of biosynthetic pathway of ethyl lactate, we constructed the upstream
and downstream modules with tunable promoters and RBSs. The upstream modules (pJW019-022)
were constructed via three rounds of cloning. First, the T7 terminator (TT7) was added between the
multiple cloning site 1 (MCS1) and MCS2 of the pACYCDuet-1 backbone to create the first
intermediate plasmid, pJW016, by assembling three DNA fragments: i) the ldhA gene amplified
from pJW001 using the primer pair JW_0013/JW_0014, ii) the linker containing TT7 terminator
amplified from pETite* using the primer pair JW_0015/JW_0016, and iii) the backbone amplified
from pACYCDuet-1 using the primer pair JW_0017/JW_0018. Next, the original T7 promoter
(PT7) in MCS2 of pJW016 was replaced with the PAY1 (BBa_J23100) promoter and PAY3
(BBaJ23108) promoter to generate two second intermediate plasmids, pJW017 and pJW018,
respectively, by assembling two DNA fragments: i) the ethanol module amplified from pCT24
under the PAY1 promoter for pJW017 or PAY3 promoter for pJW018 using the primer pair
JW_0019/JW_0020 or JW_0021/JW_0020, respectively, and ii) the backbone amplified from
pJW016 using the primer pair JW_0022/JW_0012 or JW_0023/JW_0012, respectively. Lastly, the
final four synthetic operons (pJW019-022) were constructed by assembling two DNA fragments:
i) the ethanol module amplified from pCT24 with the synthetic RBS sequences with predicted
translation initiation rates of 0.33au for pJW019 and pJW021 and 0.03au for pJW020 and pJW022
using the primer pairs JW_0024/JW_0020, JW_0025/JW_0020, JW_0026/JW_0020, and
JW_0027/JW_0020, respectively, and ii) the backbone amplified from pJW017 for pJW019,
pJW017 for pJW020, pJW018 for pJW021, and pJW018 for pJW022 using the primer pairs
JW_0028/JW_0012,

JW_0029/JW_0012,

JW_0030/JW_0012,
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and

JW_0031/JW_0012,

respectively. The PAY1 and PAY3 promoter sequences were obtained from the iGEM Anderson
promoter library (http://parts.igem.org/Promoters/Catalog/Anderson) and the strength of
promoters were assigned as PAY3 = 0.5 x PAY1. The RBS Calculator v2.0 [51, 52] was used to
generate four synthetic RBS sequences with predicted translation initiation rates of 0.33 and 0.03
between the PAY1 (or PAY3) promoter and pdc start codon (Figure 3-8).
The downstream modules (pJW027-035) were constructed via three rounds of cloning.
First, the TT7 terminator was added between MCS1 and MCS2 of the pRSFDuet-1 backbone to
generate the first intermediate plasmid, pJW023, by assembling three DNA fragments: i) the pct
gene amplified from pJW001 using the primer pair JW_0013/JW_0032, ii) the linker containing
TT7 terminator from pETite* using the primer pair JW_0033/JW_0034, and iii) the backbone from
pRSFDuet-1 using the primer pair JW_0017/JW_0018. Then, the original RBS in MCS1 of
pJW023 was replaced with synthetic RBSs of various strengths to generate the second intermediate
plasmids, pJW024-026, by assembling two DNA fragments: i) the pct gene amplified from
pJW001 with the synthetic RBS sequences with predicted translation initiation rates at 90, 9000,
or 90000au for pJW024, pJW025 or pJW026 using the primer pair JW_0035/JW_0036,
JW_0037/JW_0036, or JW_0038/JW_0036, respectively, and ii) the backbone amplified from
pJW023 using the primer pair JW_0039/JW_0040 for pJW024, JW_0041/JW_0040 for pJW025,
or JW_0042/JW_0040 for pJW026, respectively. Lastly, the final nine downstream modules
(pJW027-035) were constructed by assembling a combination of two DNA fragments: i) the VAAT
gene amplified from pDL006 with the synthetic RBS sequences predicted with translation
initiation rates of 90, 9000, or 90000au for pJW027/pJW030/pJW033, pJW028/pJW031/pJW034,
or pJW029/pJW032/pJW035 using the primer pair JW_0043/JW_0010, JW_0044/JW_0010, or
JW_0045/JW_0010, respectively, and ii) the backbone amplified from pJW024, pJW025, or
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pJW026 for pJW027-029, pJW030-032, or pJW033-035 using the primer pair JW_0046/JW_0012,
JW_0047/JW_0012 or JW_0048/JW_0012, respectively. The RBS Calculator v2.0 [51, 52] was
used to generate six synthetic RBS sequences with predicted translation initiation rates of 90, 9000,
and 90000au between the PT7 promoter and pct (or VAAT) start codon (Figure 3-8).
3.3.3 Culture media and conditions
3.3.3.1 Culture media
For molecular cloning, seed cultures, and protein expression analysis, the Luria-Bertani
(LB) medium, comprising of 10 g/L peptone, 5 g/L yeast extract, and 5 g/L NaCl, was used. For
high-cell density cultures, pre-cultures of bioreactor batch fermentations, and growth inhibition
analysis of lactate esters, the M9 hybrid medium [10] with 20 g/L glucose was used. For bioreactor
batch fermentations, the M9 hybrid medium with 50 g/L glucose and 100 µL of antifoam
(Antifoam 204, Sigma-Aldrich, MO, USA) was used. 30 µg/mL chloramphenicol (cm), 50 µg/mL
kanamycin (kan), and/or 50 µg/mL ampicillin (amp) was added to the media for selection where
applicable.
3.3.3.2 High-cell density cultures
For seed cultures, 2% (v/v) of stock cells were grown overnight in 5 mL of LB with
appropriate antibiotics. For pre-cultures, 1% (v/v) of seed cultures were transferred into 100 mL
of LB medium in 500 mL baffled flasks. For main cultures, pre-cultures were aerobically grown
overnight (at 37°C, 200 rpm), centrifuged (4700 rpm, 10 min), and resuspended to yield an optical
density measured at 600nm (OD600nm) of 3 in M9 hybrid medium containing appropriate
concentration of isopropyl-beta-D-thiogalatopyranoside (IPTG) and antibiotics. The resuspended
cultures were distributed into 15 mL polypropylene centrifuge tubes (Thermo Scientific, IL, USA)
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with a working volume of 5 mL and grown for 24 hour (h) on a 75° angled platform in a New
Brunswick Excella E25 at 37°C, 200 rpm. The tubes were capped to generate anaerobic condition.
All high-cell density culture studies were performed in biological triplicates.
3.3.3.3 pH-Controlled bioreactor batch fermentations
pH-Controlled bioreactor batch fermentations were conducted with a Biostat B+ (Sartorius
Stedim, NY, USA) dual 1.5 L fermentation system at a working volume of 1 L M9 hybrid medium.
The seed and pre-cultures were prepared as described in high-cell density cultures in LB and M9
hybrid media, respectively. For main cultures, 10% (v/v) of pre-cultures were inoculated into
fermentation cultures. During the fermentation, to achieve high cell density, dual-phase
fermentation approach [25, 53], aerobic cell growth phase followed by anaerobic production phase,
was applied. For the first aerobic phase, the temperature, agitation, and air flow rate were
maintained at 37°C, 1000 rpm, and 1 volume/volume/min (vvm) for 4 h, respectively. Then, the
oxygen in the medium was purged by sparing nitrogen gas at 2 vvm for 2 h to generate anaerobic
condition. For the subsequent anaerobic phase, 0.5 mM of IPTG was added to induce the protein
expression, and the culture temperature and nitrogen flow rate were maintained at 30°C and 0.2
vvm, respectively. During the fermentation, the pH was maintained at 7.0 with 5 M KOH and 40%
H3PO4. Bioreactor batch fermentation studies were performed in biological duplicates.
3.3.3.4 Growth inhibition analysis of lactate esters
Seed cultures of EcDL002 were prepared as described in high-cell density cultures. 4 %
(v/v) of seed cultures were inoculated into 100 µL of the M9 hybrid media, containing various
concentrations (0.5~40 g/L) of lactate esters including ethyl-, propyl-, butyl-, isobutyl-, isoamyl-,
or benzyl lactate, in a 96-well microplate. Then, the microplate was sealed with a plastic adhesive

95

sealing film, SealPlate® (EXCEL Scientific, Inc., CA, USA) to prevent evaporation of lactate
esters and incubated at 37oC with continuous shaking using a BioTek Synergy HT microplate
reader (BioTek Instruments, Inc., VT, USA). OD600nm was measured at 20 min intervals. Growth
inhibition studies of lactate esters were performed twice in biological triplicates (n = 6).
3.3.4 Protein expression and SDS-PAGE analysis
Seed cultures were prepared as described in high-cell density cultures. 1% (v/v) of seed
cultures subsequently inoculated in 500 mL baffled flasks containing 100 ml of LB medium. Cells
were aerobically grown at 37oC and 200 rpm and induced at an OD600nm of 0.6~0.8 with 0.5 mM
of IPTG. After 4 h of induction, cells were collected by centrifugation and resuspended in 100 mM
of sodium phosphate buffer (pH 7.0) at the final OD600nm of 10. Cell pellets were disrupted using
a probe-type sonicator (Model 120, Fisher Scientific, NH, USA) on ice-water mixture. The
resulting crude extracts were mixed with 6x sodium dodecyl sulfate (SDS) sample buffer, heated
at 100oC for 5 min, and then analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE,
14 polyacrylamide gel). Protein bands were visualized with Coomassie Brilliant Blue staining.
3.3.5 Analytical methods
3.3.5.1 Determination of cell concentrations
The optical density was measured at 600 nm using a spectrophotometer (GENESYS 30,
Thermo Scientific, IL, USA). The dry cell mass was obtained by multiplication of the optical
density of culture broth with a pre-determined conversion factor, 0.48 g/L/OD.
3.3.5.2 High performance liquid chromatography (HPLC)
Glucose, lactate, acetate, ethanol, isobutanol, isoamyl alcohol, and benzyl alcohol were
quantified by using the Shimadzu HPLC system (Shimadzu Inc., MD, USA) equipped with the
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Aminex HPX-87H cation exchange column (BioRad Inc., CA, USA) heated at 50°C. A mobile
phase of 10 mN H2SO4 was used at a flow rate of 0.6 mL/min. Detection was made with the
reflective index detector (RID) and UV detector (UVD) at 220 nm.
3.3.5.3 Gas chromatography coupled with mass spectroscopy (GC/MS)
All esters were quantified by GC/MS. For GC/MS analysis, analytes in the supernatants
were extracted with dichloromethane (DCM), containing pentanol as an internal standard, in a 1:1
(v/v) ratio for 1 h at 37°C, 200 rpm in 15 mL polypropylene centrifuge tubes. After extraction,
supernatant-DCM mixtures were centrifuged and 5 μL of DCM extracts were injected into a gas
chromatograph (GC) HP 6890 equipped with the mass selective detector (MS) HP 5973. For the
GC system, helium was used as the carrier gas at a flow rate of 0.5 mL/min and the analytes were
separated on a Phenomenex ZB-5 capillary column (30 m x 0.25 mm x 0.25 μm). The oven
temperature was programmed with an initial temperature of 50°C with a 1°C/min ramp up to 58°C.
Next a 25°C/min ramp was deployed to 235°C and then finally held a temperature of 300°C for 2
minutes to elute any residual non-desired analytes. The injection was performed using a splitless
mode with an initial injector temperature of 280°C. For the MS system, a selected ion monitoring
(SIM) mode was deployed to detect analytes.
The SIM parameters for detecting lactate esters were as follows: i) for pentanol, ions 53.00,
60.00, and 69.00 detected from 5.00 to 7.70 min, ii) for ethyl lactate, ions 46.00, 47.00, and 75.00
detected from 7.70 to 10.10 min, iii) for propyl lactate, ions 59.00, 88.00, and 89.00 detected from
10.10 to 11.00 min, iv) for isobutyl lactate, ions 56.00, 57.00, and 59.00 detected from 11.00 to
11.60 min, v) for butyl lactate, ions 75.00, 91.00, and 101.00 detected from 11.60 to 12.30 min, vi)
for isoamyl lactate, ions 46.00, 73.00, 75.00 from 12.30 to 14.50 min, and vii) for benzyl lactate,
ions 45.00, 91.00, and 180.00 from 14.50 to 15.08 min. The SIM parameters for detecting acetate
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esters were as follows: i) for ethyl acetate, ions 45.00, 61.00, and 70.00 detected from 4.22 to 5.35
min, ii) for propyl acetate, ions 57.00, 59.00, and 73.00 detected from 5.35 to 6.40 min, iii) for
pentanol, ions 53.00, 60.00, and 69.00 detected from 6.40 to 6.60 min, iv) for isobutyl acetate, ions
56.00, 61.00, and 73.00 detected from 6.60 to 7.70 min, v) for butyl acetate, ions 57.00, 71.00, and
87.00 detected from 7.70 to 9.45 min, vi) for isoamyl acetate, ions 58.00, 70.00, and 88.00 detected
from 9.45 to 13.10 min, and vii) for benzyl acetate, ions 63.00, 107.00, and 150.00 from 13.10 to
15.82 min.
3.3.6 Statistics
Statistical analysis was performed with SigmaPlot v.14 using the two-tailed unpaired
Student’s t-test.

3.4 Results and Discussion
3.4.1 In vivo screening of efficient AATs critical for lactate ester biosynthesis
The substrate specificity of AATs is critical to produce target esters [13]. For example,
ATF1 exhibits substrate preference for biosynthesis of acyl (C4-C6) acetates while SAAT and
VAAT prefer biosynthesis of ethyl (C2-C6) acylates. Even though both SAAT and VAAT are
derived from the same strawberry genus, they also show very distinct substrate preferences;
specifically, SAAT prefers longer (C4-C6) acyl-CoAs whereas VAAT prefers shorter (C2-C4)
acyl-CoAs. To date, none of AATs have been tested for lactate ester biosynthesis. Thus, to enable
lactate ester biosynthesis, we began with identification of the best AAT candidate. We designed,
constructed, and characterized a library of five pyruvate-to-lactate ester modules (pJW002-006)
carrying five divergent AATs including ATF1, ATF2, SAAT, VAAT, and AtfA, respectively.
AtfA was used as a negative control because it prefers long-chain acyl-CoAs (C14-C18) and
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alcohols (C14-C18) [54]. For characterization, 2 g/L of ethanol, propanol, butanol, isobutanol,
isoamyl alcohol, and benzyl alcohol were added to culture media with 0.5 mM of IPTG for
pathway induction to evaluate biosynthesis of six different lactate esters including ethyl lactate,
propyl lactate, butyl lactate, isobutyl lactate, isoamyl lactate, and benzyl lactate, respectively, in
high-cell density cultures (Figure 3-1A). The results show that most of the strains could produce
different types of lactate esters with external supply of alcohols (Figure 3-1B and C). EcJW104
achieved the highest titer of lactate esters in all cases, producing 1.6 ± 0.0 mg/L of ethyl lactate,
5.5 ± 0.3 mg/L of propyl lactate, 11.8 ± 0.4 mg/L of butyl lactate, 9.9 ± 0.1 mg/L of isobutyl lactate,
24.7 ± 0.6 mg/L of isoamyl lactate, and 51.6 ± 2.1 mg/L of benzyl lactate in ethanol, propanol,
butanol, isobutanol, isoamyl alcohol, and benzyl alcohol doping, respectively. The lactate ester
biosynthesis of EcJW104 exhibited different alcohol substrate preference in the following order:
benzyl alcohol > isoamyl alcohol > butanol > isobutanol > propanol > ethanol (Figure 3-1B, Table
3-5).
Due to the presence of endogenous acetyl-CoA, we also produced acetate esters in addition
to lactate esters (Figure 3-1). Among the strains, EcJW101 achieved the highest titers of acetate
esters in all cases, producing 115.5 ± 4.8 mg/L of ethyl acetate, 801.6 ± 33.5 mg/L of propyl acetate,
1,017.9 ± 20.2 mg/L of butyl acetate, 1,210.4 ± 24.8 mg/L of isobutyl acetate, 692.7 ± 7.7 mg/L
of isoamyl acetate, and 1,178.0 ± 45.7 mg/L of benzyl acetate in ethanol, propanol, butanol,
isobutanol, isoamyl alcohol, and benzyl alcohol doping, respectively. EcJW101 showed different
alcohol substrate preference for the acetate ester biosynthesis in the following order: isobutanol >
benzyl alcohol > butanol > propanol > isoamyl alcohol > ethanol (Table 3-5).
Taken altogether, VAAT and ATF1 are the most suitable AATs for biosynthesis of lactate
esters and acetate esters, respectively. Among the library of 12 esters (Figure 3-1C), seven of these
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esters, including ethyl lactate, propyl lactate, butyl lactate, isobutyl lactate, isoamyl lactate, benzyl
lactate, and benzyl acetate, were demonstrated for in vivo production in microbes for the first time.
EcJW104 that harbors the pyruvate-to-lactate module with VAAT could produce 6 out of 6 target
lactate esters including ethyl, propyl, butyl, isobutyl, isoamyl, and benzyl lactate. Since EcJW104
achieved the highest titer of lactate esters in all cases, it was selected for establishing the
biosynthesis pathway of lactate esters from glucose.
3.4.2 Establishing the lactate ester biosynthesis pathways
We next demonstrated direct fermentative production of lactate esters from glucose using
the best VAAT candidate. We focused on the biosynthesis of ethyl and isobutyl lactate esters. We
designed the biosynthesis pathways for ethyl and isobutyl lactate by combining the pyruvate-tolactate ester module (pJW005) with the ethanol (pCT24) and isobutanol (pCT13) modules,
respectively. By co-transforming pJW005/pCT24 and pJW005/pCT13 into the modular cell
EcDL002, we generated the production strains, EcJW201 and EcJW202, for evaluating direct
conversion of glucose to ethyl and isobutyl lactate esters. We characterized EcJW201 and
EcJW202 together with the parent strain, EcDL002, as a negative control in high-cell density
cultures. The results show EcJW201 and EcJW202 produced ethyl (Figure 3-2A) and isobutyl
(Figure 3-2B) lactate from glucose, respectively, while the negative control strain EcDL002 could
not.
Consistently, the expressions of metabolic enzymes of the ethyl and isobutyl lactate
pathways were confirmed in EcJW201 and EcJW202, respectively, by SDS-PAGE analysis
(Figure 3-6). During 24 h fermentation, EcJW201 produced 2.2 ± 0.3 mg/L of ethyl lactate with a
specific productivity of 0.04 ± 0.00 mg/gDCW/h while EcJW202 produced 0.3 ± 0.0 mg/L of
isobutyl lactate with a specific productivity of 0.01 ± 0.00 mg/gDCW/h. In addition to ethyl or
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Figure 3-1: In vivo characterization of various alcohol acyltransferases for biosynthesis of lactate
esters. (A) Biosynthesis pathways of lactate and acetate esters with external supply of alcohols.
(B) Ester production of EcJW101, EcJW102, EcJW103, EcJW104, and EcJW105 harboring ATF1,
ATF2, SAAT, VAAT, and atfA, respectively in high cell density cultures with various alcohol
doping. Each error bar represents 1 standard deviation (s.d., n=3). Symbols: n.s., not significant,
*p-value < 0.073, and **p-value < 0.013 (Student’s test). (C) The library of esters produced. Green
check marks indicate the esters produced in this study while red star marks indicate the esters
produced for first time in engineered strains.
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isobutyl lactate biosynthesis, EcJW201 also produced 92.3 ± 9.2 mg/L of ethyl acetate while
EcJW202 generated 1.4 ± 0.7 mg/L of ethyl acetate and 0.3 ± 0.1 mg/L of isobutyl acetate (Table
3-6A). Taken altogether, the direct microbial synthesis of lactate esters from fermentable sugar
was successfully demonstrated. Since the lactate ester production was low, the next logical step
was to identify and alleviate the key pathway bottlenecks for enhanced lactate ester biosynthesis.
As proof-of-principle, we focused on optimization of the ethyl lactate production as presented in
the subsequent sections.
3.4.3 Identifying and alleviating key bottlenecks of the ethyl lactate biosynthesis pathway
3.4.3.1 Evaluating the biosynthesis of ethyl lactate in pH-controlled fermentation as
a basis to identify potential pathway bottlenecks
To identify the key bottlenecks of the ethyl lactate biosynthesis pathway, we characterized
EcJW201 in pH-controlled bioreactors. The results show that EcJW201 produced 9.2 ± 0.1 mg/L
of ethyl lactate with a specific productivity of 0.15 ± 0.02 mg/gDCW/h and a yield of 0.19 ± 0.00
mg/g glucose (Figure 3-2C, Table 3-6B) in 18 h. Under pH-controlled fermentation, EcJW201
achieved 4.09-fold (from 2.2 ± 0.3 to 9.2 ± 0.1 mg/L), 3.75-fold (from 0.04 ± 0.00 to 0.15 ± 0.02
mg/gDCW/h), and 19-fold (from 0.01 ± 0.00 to 0.19 ± 0.00 mg/g glucose) improvement in titer,
specific productivity, and yield, respectively, as compared to the strain performance in the high
cell density culture. It is interesting to observe that ethyl acetate was first produced then consumed
after 10 h, which is likely due to the endogenous esterase of E. coli as observed in a recent study
[55]. Different from ethyl acetate, we did not observe ethyl lactate degradation during fermentation,
especially after glucose was depleted. Even though the strain performance in pH-controlled
bioreactors was enhanced by increased supply of precursor metabolites (19.35 ± 0.29 g/L of lactate
and 10.31 ± 0.41 g/L of ethanol, Table 3-6B) from higher concentration of carbon source, the titer
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of ethyl lactate did not increase during the fermentation. This result suggests that (i) rate-limiting
conversion of lactate into lactyl-CoA by Pct and/or condensation of lactyl-CoA with an ethanol by
VAAT and/or (ii) toxicity of ethyl lactate on E. coli health might have limited lactate ester
biosynthesis. Therefore, to enhance ethyl lactate production, it is important to elucidate and
alleviate these identified potential bottlenecks.
3.4.3.2 Ethyl lactate exhibited minimal toxicity on cell growth among lactate esters
To determine whether lactate esters inhibited cell growth and hence contributed to low
lactate ester production, we cultured the parent strain, EcDL002, in a microplate reader with or
without supply of various concentrations of lactate esters including ethyl, propyl, butyl, isobutyl,
isoamyl, or benzyl lactate. The results show that ethyl lactate was the least toxic among the six
lactate esters characterized where the growth rate (0.47 ± 0.04 1/h) and cell titer (OD = 0.42 ± 0.03)
decreased by 6% and 10%, respectively, upon cell exposure to 5 g/L ethyl lactate. On the other
hand, isoamyl lactate was the most toxic among the lactate esters, where cell exposure to only 0.5
g/L ester resulted in 18% and 15% reduction in the growth rate (0.41 ± 0.02 1/h) and OD (0.40 ±
0.03), respectively (Figure 3-7A). This result was consistent with literature, illustrating that
increasing toxicity of esters is highly correlated with increasing chain length of alcohol moieties
that can severely disrupt cell membrane [56]. The toxicity of lactate esters can be ranked in the
following order: isoamyl lactate > benzyl lactate > butyl lactate > isobutyl lactate > propyl lactate
> ethyl lactate. There existed a positive correlation between the logP values of lactate esters and
their degrees of toxicity (Figure 3-7B).
It should be note that since E. coli can effectively secrete short-chain esters [10], external
exposure of cells to lactate esters in our experiment design is sufficient to probe the potential
toxicity caused by endogenous production of these esters. Taken altogether, ethyl lactate is the
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least toxic and was not likely the main reason for the low production of ethyl lactate observed. It
was likely the downstream pathway, responsible for conversion of lactate into lactyl-CoA by Pct
and/or condensation of lactyl-CoA with ethanol by VAAT, might have been contributed to the
inefficient ethyl lactate biosynthesis.
3.4.3.3 Downstream pathway of the lactate ester biosynthesis is the key bottleneck
To identify and alleviate the ethyl lactate biosynthesis pathway, we re-modularized it with
two new parts: i) the upstream module carrying ldhA, pdc, and adhB for production of lactate and
ethanol from sugar and ii) the downstream module carrying pct and VAAT for converting lactate
into lactyl-CoA and condensing lactyl-CoA and ethanol (Figure 3-3A). We controlled metabolic
fluxes of these modules by manipulating their plasmid copy numbers and levels of promoter
induction with IPTG. By introducing the plasmids pJW007-015 into EcDL002, we generated the
strains EcJW106-108 and EcJW203-208, respectively (Figure 3-3B). To evaluate the performance
of these constructed strains for ethyl lactate production, we characterized them in high cell density
cultures induced with various concentrations of IPTG (0.01, 0.1, and 1.0 mM).
The results show that EcJW204, carrying the upstream module with a low copy number
plasmid (P15A origin) and the downstream module with a high copy number plasmid (RSF1030
origin) induced by 0.01 mM of IPTG, achieved the highest titer of ethyl lactate. As compared to
EcJW201, EcJW204 achieved 4.96-fold (an increase from 2.2 to 11.1 ± 0.6 mg/L), 5.50-fold (from
0.04 ± 0.00 to 0.22 ± 0.02 mg/gDCW/h), and 54.0-fold (from 0.01 ± 0.00 to 0.54 ± 0.04 mg/g
glucose) improvement in titer, specific productivity, and yield of ethyl lactate, respectively (Figure
3-3B, Table 3-8). Upon IPTG induction at 24 h, we observed the reduced cell growth of the host
strains with use of high concentration of IPTG (Figure 3-3C, Table 3-7), suggesting that they
suffered from metabolic burden due to overexpression of multiple enzymes [57] and also explain104

Figure 3-2: Design, construction, and validation of the lactate ester biosynthesis pathways in E.
coli. (A) Engineered biosynthesis pathway of ethyl lactate from glucose and its production in high
cell density culture of EcJW201. (B) Engineered biosynthesis pathway of isobutyl lactate from
glucose and its production in high cell density culture of EcJW202. In Figure 2A and 2B, all the
strains were induced at 0 h with 0.5 mM IPTG. Each error bar represents 1 s.d. (n=3). (C)
Production of ethyl lactate from glucose in pH-controlled batch fermentation of EcJW201. The
strain was induced at 6 h with 0.5 mM IPTG. Each error bar represents 1 s.d. (n=2).
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Figure 3-3: Combinatorial modular pathway optimization of enhanced ethyl lactate biosynthesis
by varying plasmid copy number. (A) Re-modularization of the ethyl lactate biosynthesis pathway.
Pyruvate-to-lactate ester and ethanol modules were re-modulated into upstream and downstream
modules using plasmids with different copy numbers. (B) Ethyl lactate production, (C) OD600, (D)
consumed glucose, (E) acetate, (F) lactate, (G) ethanol, and (H) ethyl acetate of EcJW106-108
and EcJW203-208 in high cell density cultures induced with various concentrations of IPTG.
Green rectangle: low copy number plasmid (10); P15A: origin of pACYCDuet-1; Blue rectangle:
medium copy number plasmid (40); ColE1: origin of pETDuet-1; Red rectangle: high copy number
plasmid (100); RSF1030: origin of pRSFDuet-1; PT7: T7 promoter; TT7: T7 terminator. All the
strains were induced at 0 h with 0.01, 0.1, or 1.0 mM IPTG, respectively. Each error bar represents
1 s.d. (n=3). Red arrows indicate the selected strain with an optimum concentration of IPTG for
the further studies.
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ing why the use of low concentration of IPTG can help yield better production of ethyl lactate.
Although EcJW204 showed better performance in ethyl lactate production than EcJW201, the
accumulation of lactate and ethanol was still observed (Figure 3-3F and G, Table 3-9), indicating
the pathway bottleneck remained. In particular, the downstream module flux was outcompeted by
the upstream module flux and hence failed to turn over the precursor metabolites quickly enough.
This result helps explain why a combination of the upstream module (for producing lactate
and ethanol from sugar) with a low copy number plasmid and the downstream module (for
converting lactate into lactyl-CoA and condensing lactyl-CoA and ethanol) with a high copy
number plasmid outperformed eight other combinations. Notably, the best ethyl lactate producer
EcJW204 achieved the highest lactate and lowest ethanol production among the nine characterized
strains (Figure 3-3F and G, Table 3-7), suggesting re-distribution of the carbon flux from ethanol
to lactate likely helped improve ethyl lactate production. Thus, we hypothesized that redistribution
of the carbon source from ethanol to lactate would help to improve ethyl lactate production. To
test this hypothesis, we first examined whether i) downregulation of the ethanol flux of the
upstream module enabled redistribution of the carbon flow from ethanol to lactate and ii) this
redistribution could improve ethyl lactate production before proceeding to investigate the potential
bottleneck of downstream module.
3.4.3.4 High ethanol synthesis of the upstream module was critical for ethyl lactate
biosynthesis due to low specificity and activity of AAT.
To downregulate the ethanol flux of the upstream module, we first reconfigured pJW007,
the upstream module of the best performer EcJW204, with a library of two weaker promoters and
four weaker synthetic RBSs (Figure 3-4A, Figure 3-8A), resulting in four new upstream modules
(pJW019-022). By introducing each newly constructed upstream module into EcDL002 together
107

Figure 3-4: Probing and alleviating the potential metabolic bottlenecks of the upstream or
downstream modules of EcJW204 by varying the strength of promoters and/or ribosome binding
sites. (A) Design of synthetic operons for the upstream and downstream modules. For the upstream
module, the T7 promoter in MCS2 and the RBS between T7 promoter in MCS2 and the start codon
of pdc were replaced with the combination of PAY1 or PAY3 promoter and 0.3 or 0.03au RBS. For
the downstream module, the RBS between T7 promoter in MCS1 and the start codon of pct gene
and the RBS between T7 promoter in MCS2 and the start codon of VAAT gene were replaced with
the combination of 90, 9000, or 90000au RBS and 90, 9000, or 90000au RBS, respectively.
Production of ethyl lactate in high cell density cultures of (B) EcJW209-212 and (C) EcJW213221. Green rectangle: low copy number plasmid (10); P15A: origin of pACYCDuet-1; Red
rectangle: high copy number plasmid (100); RSF1030: origin of pRSFDuet-1; PT7: T7 promoter;
TT7: T7 terminator. All the strains were induced at 0 h with 0.01 mM IPTG. Each error bar
represents 1 s.d. (n=3).
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with the downstream module pJW012 used in EcJW204, we next generated the strains EcJW209212 and characterized them in high cell density cultures induced with 0.01 mM IPTG. The results
show that while the carbon flux was successfully redistributed from ethanol to lactate, resulting in
5.97~6.92-fold decrease in ethanol production (from 8.30 ± 0.17 to 1.39 ± 0.10 ~ 1.20 ± 0.01 g/L)
and 1.67~2.59-fold increase in lactate production (from 1.06 ± 0.09 to 1.77 ± 0.37 g/L~2.75 ± 0.09
g/L) (Table 3-9A), the ethyl lactate production was reduced by 7.99~11.81-fold in ethyl lactate
production (from 11.1 ± 0.6 to 1.4 ± 0.4 ~ 0.9 ± 0.2 mg/L) in all four characterized strains as
compared to that of EcJW204 (Figure 3-4B, Table 3-9B). This result suggests that a high level of
ethanol is critical for VAAT to produce ethyl lactate.
To support this conclusion, we evaluated the effect of external ethanol supply on
production of ethyl esters in high cell density cultures of EcJW209-212 induced with 0.01 mM
IPTG. Indeed, with external ethanol supply, we observed enhanced production of both ethyl lactate
and ethyl acetate in EcJW209-212. Specifically, with addition of 2 g/L of ethanol, the ethyl lactate
and ethyl acetate production increased by 2.27 ~ 3.33-fold (from 1.4 ± 0.4 to 3.2 ± 0.2 mg/L ~
from 1.0 ± 0.2 to 3.2 ± 0.3 mg/L) and 1.27~2.07-fold (from 36.5 ± 3.9 to 46.2 ± 1.3 mg/L ~ from
22.0 ± 0.8 to 45.4 ± 1.2 mg/L), respectively (Table 3-9). Further addition of ethanol up to 10 g/L
improved the ethyl lactate and ethyl acetate production by 3.78~5.26-fold (from 1.4 ± 0.4 to 5.3 ±
0.3 mg/L ~ from 0.9 ± 0.2 mg/L to 4.5 ± 0.4 mg/L) and 4.09~6.92-fold (from 36.5 ± 3.9 to 149.0
± 3.8 mg/L ~ from 22.0 ± 0.8 mg/L to 151.9 ± 2.3 mg/L), respectively (Table 3-9).
Interestingly, while the total titer of ethyl esters increased with the increasing addition of
ethanol (Figure 3-5A), the proportion of ethyl lactate in the total ester slightly increased in the
range of 3.2~7.0% (Figure 3-5B), suggesting that VAAT prefers acetyl-CoA over lactyl-CoA with
ethanol as a co-substrate. Notably, we observed a strong linear correlation between ethyl esters
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production and the amount of added ethanol (i.e., for ethyl lactate, R2 = 0.85~0.94; for ethyl acetate,
R2 = 0.99~1.00) (Supplementary Figure S4A). The results revealed that abundant availability of
ethanol is essential to achieve high production of ethyl esters, indicating the main reason for the
improved ethyl lactate production in EcJW204 was most likely due to the upregulation of
downstream module with a high copy number plasmid.
3.4.3.1 AAT was the most rate limiting step of the downstream module
To determine whether Pct for conversion of lactate to lactyl-CoA or VAAT for
condensation of lactyl-CoA and an alcohol was the most rate limiting step of the downstream
module, we constructed nine downstream modules (pJW027-035) using a combination of synthetic
RBSs for expression of Pct (synRBSpct#1-3) and VAAT (synRBSVAAT#1-3) with pJW012 from the
best performer EcJW204, respectively (Figure 3-4A, Figure 3-8B). We introduced each newly
constructed downstream module into EcDL002 together with the original upstream module
(pJW007) used in EcJW204 to generate EcJW213-221. Then, we characterized the constructed
strains in high cell density cultures induced with 0.01 mM IPTG.
The results show that the strains harboring the stronger RBSs for VAAT expression
achieved the higher titers of ethyl lactate and ethyl acetate regardless of the RBS strengths for Pct
expression (Figure 3-4C, Table 3-10). There is a strong linear correlation between ethyl ester
production and the strength of RBS for VAAT expression (Figure 3-9B). To further validate these
results without the influence of the upstream module, we additionally constructed the strains
EcJW109-117 by introducing nine individual downstream modules (pJW027-035) into EcDL002
and then characterized these strains in high cell density cultures with addition of 2 g/L of lactate,
2 g/L of ethanol, and 0.01 mM of IPTG. We could observe the same strong linear correlation
between ethyl ester production and high VAAT expression without the upstream module (Figure
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Figure 3-5: (A) Total esters and (B) composition of total esters produced in high cell density
cultures of EcJW209-212 with or without addition of ethanol. (C) Ethyl lactate production of
EcJW109-117 with addition of 2 g/L of lactate and ethanol. Red rectangle: high copy number
plasmid (100); RSF1030: origin of pRSFDuet-1; PT7: T7 promoter; TT7: T7 terminator. All the
strains were induced at 0 h with 0.01 mM IPTG. Each error bar represents 1 s.d. (n=3).
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3-5C, Table 3-11). Taken altogether, these results suggest that VAAT not Pct was the most rate
limiting step of the downstream module of the ethyl lactate biosynthesis pathway. Specifically, a
combination of low affinity towards lactyl-CoA and ethanol of VAAT contributed to low ethyl
lactate biosynthesis. Further studies on discovery of novel AATs, exhibiting high activity towards
lactyl-CoA and alcohols but not acetyl-CoA, together with rational protein engineering of these
enzymes would be warranted for improving lactate ester production. In principle, the lactate ester
platform can be controlled to produce enantiomers with broad industrial applications. Since the
endogenous E. coli D-lactate dehydrogenase (LdhA) was overexpressed in the ldhA-deficient
modular cell of our study, it is anticipated that D-(-)-lactate and the associated D-(-)-lactate esters
were mainly produced.
To date, production of optically pure D-(-)-[23] and L-(+)-form [26] of lactate from glucose
in E. coli [25] has been well established. In addition, pct from C. propionicum [28] and
Megasphaera elsdenii [29, 30] have been used for converting D-(-)-lactate into D-(-)-lactyl-CoA
in polylactic acid (PLA) production in E. coli and their catalytic activity towards L-(+)-lactate has
also been demonstrated [58, 59]. Thus, by combining stereospecific Ldh and Pct enzymes together
with AATs, it is highly feasible to extend our lactate ester platform for microbial production of
stereospecific lactate esters from renewable resources.

3.5 Conclusions
In this study, we have successfully developed a microbial lactate ester production platform
and demonstrated for the first time the microbial biosynthesis of lactate esters directly from
fermentable sugars in an E. coli modular cell. This study defines a cornerstone for the microbial
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production of lactate esters as green solvents from renewable resources with novel industrial
applications.
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3.7 Appendix
Table 3-4: Summary of high cell density cultures of EcJW101, EcJW102, EcJW103, EcJW104, and EcJW105 with addition of glucose
and various alcohols after 24 h. The subscripts i and f are referred to the initial (0 h) and final (24 h) time of the culture, respective.
Abbreviations: n.a.: not applicable.
Doped alcohols

None

Ethanol

Propanol

Butanol

Isobutanol

Isoamyl alcohol

Benzyl alcohol

Strains
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105

ODi
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00
2.96 ± 0.00
2.91 ± 0.00
2.93 ± 0.00
2.84 ± 0.00
3.01 ± 0.00

ODf
4.82 ± 0.15
4.77 ± 0.05
4.16 ± 0.09
4.05 ± 0.03
4.94 ± 0.05
4.70 ± 0.11
4.64 ± 0.14
4.07 ± 0.03
4.04 ± 0.04
4.87 ± 0.01
4.65 ± 0.04
4.74 ± 0.66
4.07 ± 0.03
4.12 ± 0.02
4.71 ± 0.01
3.92 ± 0.04
4.73 ± 0.10
4.14 ± 0.03
4.04 ± 0.03
4.80 ± 0.01
4.09 ± 0.09
4.74 ± 0.12
4.17 ± 0.08
4.11 ± 0.06
4.79 ± 0.19
2.79 ± 0.12
4.36 ± 0.07
4.22 ± 0.10
3.96 ± 0.04
4.48 ± 0.13
2.85 ± 0.03
4.21 ± 0.08
4.12 ± 0.02
4.06 ± 0.06
4.62 ± 0.12

Glucosei, g/L
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00
23.65 ± 0.00

Glucosef, g/L
17.66 ± 0.12
17.35 ± 0.03
17.44 ± 0.04
17.56 ± 0.03
17.84 ± 0.02
17.97 ± 0.05
17.61 ± 0.02
17.76 ± 0.02
17.61 ± 0.20
18.02 ± 0.06
17.85 ± 0.25
17.49 ± 0.15
17.70 ± 0.02
17.43 ± 0.20
17.95 ± 0.05
18.23 ± 0.03
17.42 ± 0.07
17.72 ± 0.01
17.58 ± 0.17
18.29 ± 0.03
18.06 ± 0.04
17.42 ± 0.01
17.67 ± 0.01
17.45 ± 0.17
17.98 ± 0.01
20.24 ± 0.28
17.73 ± 0.28
17.95 ± 0.06
17.99 ± 0.01
17.90 ± 0.33
20.58 ± 0.56
17.66 ± 0.11
17.71 ± 0.22
17.79 ± 0.23
18.05 ± 0.02
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Lactate, g/L
0.25 ± 0.01
5.75 ± 0.31
5.62 ± 0.45
5.49 ± 0.38
4.81 ± 0.14
0.39 ± 0.01
5.93 ± 0.01
5.81 ± 0.01
5.34 ± 0.71
5.40 ± 0.02
0.24 ± 0.01
4.66 ± 0.85
5.75 ± 0.02
5.42 ± 0.20
4.86 ± 0.04
0.31 ± 0.00
5.24 ± 0.91
5.68 ± 0.00
5.32 ± 0.46
4.48 ± 0.01
0.32 ± 0.01
5.65 ± 0.27
5.63 ± 0.01
5.45 ± 0.19
4.68 ± 0.01
0.16 ± 0.03
4.85 ± 0.08
5.17 ± 0.09
5.11 ± 0.03
4.75 ± 0.27
0.14 ± 0.02
4.45 ± 1.08
4.38 ± 0.17
4.46 ± 0.82
4.61 ± 0.45

Acetate, g/L
1.13 ± 1.34
0.52 ± 0.11
0.74 ± 0.30
0.49 ± 0.10
0.66 ± 0.25
0.78 ± 0.01
1.00 ± 0.00
0.97 ± 0.00
0.98 ± 0.04
1.02 ± 0.02
0.31 ± 0.00
0.65 ± 0.08
0.86 ± 0.01
0.53 ± 0.01
0.50 ± 0.02
0.54 ± 0.00
0.69 ± 0.14
0.90 ± 0.22
1.02 ± 0.04
0.62 ± 0.02
0.59 ± 0.01
0.66 ± 0.02
1.04 ± 0.01
1.03 ± 0.01
0.65 ± 0.01
0.56 ± 0.03
0.60 ± 0.05
1.16 ± 0.01
1.12 ± 0.00
1.03 ± 0.27
0.59 ± 0.05
0.61 ± 0.11
1.88 ± 0.60
1.75 ± 0.56
0.62 ± 0.12

Added alcoholi, g/L
n.a.
n.a.
n.a.
n.a.
n.a.
2.74 ± 0.00
2.46 ± 0.00
2.32 ± 0.00
2.31 ± 0.00
2.39 ± 0.00
2.13 ± 0.00
2.13 ± 0.00
2.32 ± 0.00
2.09 ± 0.00
2.15 ± 0.00
1.87 ± 0.00
1.97 ± 0.00
2.00 ± 0.00
2.20 ± 0.00
2.00 ± 0.00
1.98 ± 0.00
1.88 ± 0.00
2.05 ± 0.00
2.04 ± 0.00
1.98 ± 0.00
1.44 ± 0.00
1.59 ± 0.00
1.78 ± 0.00
1.95 ± 0.00
1.92 ± 0.00
2.60 ± 0.00
2.56 ± 0.00
2.66 ± 0.00
2.62 ± 0.00
2.65 ± 0.00

Added alcoholf, g/L
n.a.
n.a.
n.a.
n.a.
n.a.
2.74 ± 0.07
2.18 ± 0.00
2.18 ± 0.00
2.12 ± 0.01
2.14 ± 0.00
2.02 ± 0.01
1.99 ± 0.01
2.22 ± 0.00
1.96 ± 0.00
1.99 ± 0.00
1.12 ± 0.02
1.84 ± 0.02
1.88 ± 0.01
2.04 ± 0.01
1.88 ± 0.00
1.44 ± 0.01
1.83 ± 0.01
2.01 ± 0.01
1.99 ± 0.00
1.93 ± 0.01
0.57 ± 0.06
1.49 ± 0.01
1.73 ± 0.00
1.89 ± 0.00
1.88 ± 0.01
2.02 ± 0.31
2.36 ± 0.09
2.62 ± 0.00
2.58 ± 0.00
2.62 ± 0.00

Table 3-5: Summary of titer, specific productivity, and yield of esters in high cell density cultures of EcJW101, EcJW102, EcJW103,
EcJW104, and EcJW105 with addition of glucose and various alcohols after 24 h. The acyl acetate, and acyl lactate columns correspond
to the acyl alcohols added. For example, with the exogenous addition of ethanol, the acyl acetate and acyl lactate columns represent
ethyl acetate, and ethyl lactate, respectively. Abbreviations: n.a.: not applicable, n.d.: not detected.
Doped
alcohols

None

Ethanol

Propanol

Butanol

Isobutanol

Isoamyl
alcohol

Benzyl
alcohol

Strains
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105
EcJWL101
EcJWL102
EcJWL103
EcJWL104
EcJWL105

Acyl acetate
11.4 ± 0.4
n.d.
n.d.
n.d.
n.d.
115.5 ± 4.8
0.7 ± 0.0
5.8 ± 0.2
5.4 ± 0.2
n.d.
801.6 ± 33.5
18.8 ± 0.8
19.9 ± 0.8
18.8 ± 0.9
n.d.
1017.9 ± 20.2
60.6 ± 6.1
16.2 ± 0.7
16.6 ± 0.6
n.d.
1210.4 ± 24.8
102.4 ± 0.9
19.4 ± 0.3
19.1 ± 0.7
n.d.
692.7 ± 7.7
170.9 ± 10.2
21.4 ± 1.2
21.0 ± 0.8
0.6 ± 0.0
1178.0 ± 45.7
734.3 ± 120.3
108.2 ± 5.4
108.5 ± 4.5
n.d.

Ester titer (mg/L)
Acyl lactate
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
1.4 ± 0.1
1.6 ± 0.0
n.d.
n.d.
n.d.
4.9 ± 0.3
5.5 ± 0.3
n.d.
n.d.
n.d.
10.4 ± 0.3
11.8 ± 0.4
0.9 ± 0.1
n.d.
n.d.
9.4 ± 0.2
9.9 ± 0.1
n.d.
n.d.
0.9 ± 0.1
23.8 ± 0.9
24.7 ± 0.6
0.4 ± 0.1
n.d.
7.5 ± 1.8
49.0 ± 2.4
51.6 ± 2.1
5.2 ± 0.4

Total
11.4 ± 0.4
n.d.
n.d.
n.d.
n.d.
115.5 ± 4.8
0.7 ± 0.0
7.2 ± 0.3
6.9 ± 0.3
n.d.
801.6 ± 33.5
18.8 ± 0.8
24.8 ± 1.1
24.3 ± 1.1
n.d.
1017.9 ± 20.2
60.6 ± 6.1
26.6 ± 1.0
28.3 ± 1.0
0.9 ± 0.1
1210.4 ± 24.8
102.4 ± 0.9
28.8 ± 0.4
29.1 ± 0.8
n.d.
692.7 ± 7.7
171.8 ± 10.3
45.3 ± 2.2
45.8 ± 1.3
1.0 ± 0.1
1178.0 ± 45.7
741.7 ± 122.0
157.3 ± 7.7
160.1 ± 6.6
5.2 ± 0.4

Specific ester productivity (mg/gDCW/h)
Acyl acetate
Acyl lactate
Total
0.25 ± 0.01
n.a.
0.25 ± 0.01
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
2.60 ± 0.14
n.a.
2.60 ± 0.14
0.02 ± 0.00
n.a.
0.02 ± 0.00
0.14 ± 0.01
0.03 ± 0.00
0.18 ± 0.01
0.13 ± 0.01
0.04 ± 0.00
0.17 ± 0.01
n.a.
n.a.
n.a.
18.13 ± 0.73
n.a.
18.13 ± 0.73
0.43 ± 0.05
n.a.
0.43 ± 0.05
0.49 ± 0.02
0.12 ± 0.01
0.61 ± 0.02
0.47 ± 0.02
0.14 ± 0.01
0.60 ± 0.02
n.a.
n.a.
n.a.
25.45 ± 0.38
n.a.
25.45 ± 0.38
1.37 ± 0.15
n.a.
1.37 ± 0.15
0.39 ± 0.02
0.25 ± 0.01
0.65 ± 0.02
0.41 ± 0.01
0.29 ± 0.01
0.71 ± 0.01
n.a.
0.02 ± 0.00
0.02 ± 0.00
29.54 ± 0.71
n.a.
29.54 ± 0.71
2.30 ± 0.05
n.a.
2.30 ± 0.05
0.47 ± 0.01
0.23 ± 0.01
0.70 ± 0.02
0.48 ± 0.02
0.25 ± 0.00
0.72 ± 0.03
n.a.
n.a.
n.a.
20.72 ± 0.31
n.a.
20.72 ± 0.31
4.04 ± 0.21
0.02 ± 0.00
4.07 ± 0.21
0.52 ± 0.03
0.57 ± 0.02
1.09 ± 0.05
0.53 ± 0.03
0.62 ± 0.01
1.15 ± 0.03
0.01 ± 0.00
0.01 ± 0.00
0.02 ± 0.00
34.86 ± 1.30
n.a.
34.86 ± 1.30
17.76 ± 3.13
0.18 ± 0.04
17.94 ± 3.11
2.64 ± 0.13
1.20 ± 0.06
3.84 ± 0.11
4.06 ± 2.44
1.91 ± 1.10
5.98 ± 3.54
n.a.
0.12 ± 0.01
0.12 ± 0.01
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Ester yield (mg/g glucose)
Acyl acetate
Acyl lactate
Total
1.89 ± 0.05
n.a.
1.89 ± 0.05
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
n.a.
20.33 ± 0.99
n.a.
20.33 ± 0.99
0.12 ± 0.00
n.a.
0.12 ± 0.00
0.99 ± 0.04
0.24 ± 0.01
1.23 ± 0.04
0.89 ± 0.05
0.26 ± 0.01
1.15 ± 0.05
n.a.
n.a.
n.a.
138.22 ± 4.09
n.a.
138.22 ± 4.09
3.05 ± 0.20
n.a.
3.05 ± 0.20
3.35 ± 0.14
0.82 ± 0.06
4.18 ± 0.19
3.03 ± 0.19
0.88 ± 0.01
3.91 ± 0.18
n.a.
n.a.
n.a.
187.85 ± 2.75
n.a.
187.85 ± 2.75
9.73 ± 1.03
n.a.
9.73 ± 1.03
2.73 ± 0.12
1.75 ± 0.05
4.48 ± 0.16
2.73 ± 0.16
1.94 ± 0.02
4.67 ± 0.15
n.a.
0.17 ± 0.02
0.17 ± 0.02
216.69 ± 2.92
n.a.
216.69 ± 2.92
16.44 ± 0.18
n.a.
16.44 ± 0.18
3.25 ± 0.04
1.57 ± 0.03
4.82 ± 0.06
3.09 ± 0.20
1.60 ± 0.05
4.69 ± 0.25
n.a.
n.a.
n.a.
204.48 ± 18.70 n.a.
204.48 ± 18.70
28.94 ± 2.52
0.15 ± 0.02
29.10 ± 2.54
3.76 ± 0.21
4.18 ± 0.20
7.94 ± 0.39
3.72 ± 0.13
4.37 ± 0.11
8.09 ± 0.09
0.10 ± 0.01
0.07 ± 0.02
0.17 ± 0.03
393.18 ± 78.03 n.a.
393.18 ± 78.03
122.79 ± 20.81 1.25 ± 0.31
124.04 ± 20.72
18.25 ± 1.49
8.26 ± 0.51
26.51 ± 1.71
18.53 ± 1.25
8.82 ± 0.68
27.35 ± 1.80
n.a.
0.93 ± 0.07
0.93 ± 0.07

Table 3-6: (A) Summary of high cell density cultures of EcDL002, EcJW201, and EcJW202 after
24 h. (B) Summary of bioreactor batch fermentation of EcJW201 after 18 h. The subscripts i and
f are referred to the initial (0 h) and final (24 h) time of the culture, respectively. Abbreviations:
n.a.: not applicable, n.d.: not detected.
A
ODi
ODf
pHi
pHf
Glucosei (g/L)
Glucosef (g/L)
Lactate (g/L)
Acetate (g/L)
Ethanol (g/L)
Isobutanol (g/L)
Ester titer
(mg/L)

Specific ester
productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Ethyl acetate
Ethyl lactate
Isobutyl acetate
Isobutyl lactate
Ester total
Ethyl acetate
Ethyl lactate
Isobutyl acetate
Isobutyl lactate
Ester total
Ethyl acetate
Ethyl lactate
Isobutyl acetate
Isobutyl lactate
Ester total

EcDL002
3.10 ± 0.00
5.92 ± 0.19
7.00 ± 0.00
4.96 ± 0.03
22.6 ± 0.00
18.16 ± 0.02
0.38 ± 0.00
0.47 ± 0.01
0.95 ± 0.01
n.d.
1.2 ± 0.9
n.d.
n.d.
n.d.
1.2 ± 0.9
0.02 ± 0.02
n.a.
n.a.
n.a.
0.02 ± 0.02
0.27 ± 0.21
n.a.
n.a.
n.a.
0.27 ± 0.21

B
OD
Consumed glucose (g/L)
Lactate (g/L)
Acetate (g/L)
Ethanol (g/L)
Ester titer
(mg/L)
Specific ester
productivity
(mg/gDCW/h)
Ester yield
(mg/g glucose)

Ethyl acetate
Ethyl lactate
Ester total
Ethyl acetate
Ethyl lactate
Ester total
Ethyl acetate
Ethyl lactate

6.92 ± 0.74
48.11 ± 0.82
19.35 ± 0.29
2.32 ± 0.01
10.31 ± 0.41
12.4 ± 5.2
9.4 ± 0.1
21.5 ± 5.3
0.21 ± 0.11
0.15 ± 0.02
0.28 ± 0.01
0.26 ± 0.10
0.19 ± 0.00

Ester total

0.35 ± 0.03
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Strains
EcJW201
3.01 ± 0.00
7.20 ± 0.08
7.00 ± 0.00
6.10 ± 0.03
22.6 ± 0.00
0.00 ± 0.00
0.39 ± 0.03
0.50 ± 0.01
10.33 ± 0.02
n.d.
92.3 ± 9.2
2.2 ± 0.3
n.a.
n.a.
94.5 ± 8.9
1.55 ± 0.16
0.04 ± 0.00
n.a.
n.a.
1.59 ± 0.16
4.08 ± 0.41
0.10 ± 0.01
n.a.
n.a.
4.18 ± 0.40

EcJW202
2.97 ± 0.00
5.07 ± 0.05
7.00 ± 0.00
4.99 ± 0.03
22.6 ± 0.00
14.89 ± 0.09
5.36 ± 0.01
0.26 ± 0.00
0.22 ± 0.00
0.26 ± 0.01
1.4 ± 0.7
n.a.
0.3 ± 0.1
0.3 ± 0.0
2.0 ± 0.8
0.03 ± 0.02
n.a.
0.01 ± 0.00
0.01 ± 0.00
0.04 ± 0.02
0.18 ± 0.09
n.a.
0.04 ± 0.01
0.03 ± 0.00
0.25 ± 0.10

Table 3-7: Summary of high cell density cultures of EcJW106-108 and EcJW203-208 with different concentrations of IPTG (0.01, 0.1,
or 1.0 mM) after 24 h. The subscripts i and f are referred to the initial (0 h) and final (24 h) time of the culture, respectively. Abbreviations:
n.a.: not applicable.
IPTG 0.01 mM
ODi

3.02 ± 0.00

IPTG 0.1 mM
EcJW106
3.02 ± 0.00

3.02 ± 0.00

2.86 ± 0.00

IPTG 0.1 mM
EcJW203
2.86 ± 0.00

2.86 ± 0.00

3.12 ± 0.00

IPTG 0.1 mM
EcJW204
3.12 ± 0.00

ODf

7.07 ± 0.18

7.21 ± 0.39

6.91 ± 0.38

6.42 ± 0.24

4.86 ± 0.30

5.02 ± 0.37

5.64 ± 0.29

4.79 ± 0.12

4.58 ± 0.21

pHi

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

pHf

6.02 ± 0.05

6.14 ± 0.01

6.16 ± 0.03

5.74 ± 0.11

6.01 ± 0.02

6.13 ± 0.10

5.25 ± 0.03

5.85 ± 0.01

5.93 ± 0.08

Glucosei (g/L)

20.74 ± 0.00

20.74 ± 0.01

20.74 ± 0.02

20.74 ± 0.03

20.74 ± 0.04

20.74 ± 0.05

20.74 ± 0.06

20.74 ± 0.07

20.74 ± 0.08

Glucosef (g/L)

0.07 ± 0.00

0.07 ± 0.00

0.06 ± 0.00

0.07 ± 0.00

0.06 ± 0.00

0.05 ± 0.00

0.34 ± 0.47

1.72 ± 0.68

1.54 ± 1.29

Lactate (g/L)

0.01 ± 0.01

0.02 ± 0.02

0.00 ± 0.00

0.41 ± 0.15

0.16 ± 0.02

0.12 ± 0.10

1.06 ± 0.09

0.49 ± 0.03

0.49 ± 0.13

Acetate (g/L)
Ethanol (g/L)

0.72 ± 0.09
9.38 ± 0.10

0.54 ± 0.05
9.72 ± 0.08
EcJW205

0.65 ± 0.01
9.47 ± 0.10

0.99 ± 0.02
9.02 ± 0.06

0.64 ± 0.02
9.24 ± 0.03
EcJW107

0.68 ± 0.05
9.08 ± 0.22

1.34 ± 0.02
8.30 ± 0.17

0.91 ± 0.00
8.07 ± 0.22
EcJW206

1.01 ± 0.06
8.05 ± 0.35

ODi
ODf

3.18 ± 0.00
7.14 ± 0.08

3.18 ± 0.00
4.94 ± 0.13

3.18 ± 0.00
5.67 ± 1.58

2.94 ± 0.00
6.68 ± 0.11

2.94 ± 0.00
4.70 ± 0.19

2.94 ± 0.00
4.39 ± 0.11

2.84 ± 0.00
6.69 ± 0.32

2.84 ± 0.00
4.86 ± 0.49

2.84 ± 0.00
3.74 ± 0.24

pHi

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

pHf

6.03 ± 0.04

6.06 ± 0.01

6.18 ± 0.09

6.03 ± 0.04

6.08 ± 0.01

6.04 ± 0.01

6.01 ± 0.01

6.19 ± 0.01

6.20 ± 0.07

Glucosei (g/L)

20.74 ± 0.00

20.74 ± 0.01

20.74 ± 0.02

20.74 ± 0.03

20.74 ± 0.04

20.74 ± 0.05

20.74 ± 0.06

20.74 ± 0.07

20.74 ± 0.08

Glucosef (g/L)

0.07 ± 0.01

0.05 ± 0.00

0.05 ± 0.00

0.07 ± 0.00

0.38 ± 0.40

1.84 ± 0.51

0.07 ± 0.00

1.66 ± 0.50

3.73 ± 0.19

Lactate (g/L)

0.01 ± 0.02

0.05 ± 0.02

0.07 ± 0.06

0.00 ± 0.00

0.28 ± 0.01

0.35 ± 0.04

0.07 ± 0.06

0.16 ± 0.01

0.26 ± 0.01

Acetate (g/L)
Ethanol (g/L)

0.54 ± 0.07
9.26 ± 0.17

0.44 ± 0.02
9.39 ± 0.10
EcJW207

0.46 ± 0.04
9.29 ± 0.23

0.64 ± 0.02
8.74 ± 0.04

0.47 ± 0.00
8.27 ± 0.16
EcJW208

0.52 ± 0.00
7.88 ± 0.16

0.52 ± 0.06
8.96 ± 0.09

0.39 ± 0.05
8.36 ± 0.23
EcJW108

0.48 ± 0.01
7.55 ± 0.13

ODi

3.19 ± 0.00

3.19 ± 0.00

3.19 ± 0.00

2.88 ± 0.00

2.88 ± 0.00

2.88 ± 0.00

3.14 ± 0.00

3.14 ± 0.00

3.14 ± 0.00

ODf

5.88 ± 0.17

4.82 ± 0.12

4.53 ± 0.05

6.34 ± 0.25

4.78 ± 0.09

4.29 ± 0.18

6.70 ± 0.32

4.70 ± 0.07

4.36 ± 0.20

pHi

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

7.00 ± 0.00

pHf

6.09 ± 0.03

6.10 ± 0.02

6.19 ± 0.06

5.90 ± 0.02

6.03 ± 0.02

6.10 ± 0.06

6.09 ± 0.04

6.23 ± 0.11

6.30 ± 0.11

Glucosei (g/L)

20.74 ± 0.00

20.74 ± 0.01

20.74 ± 0.02

20.74 ± 0.03

20.74 ± 0.04

20.74 ± 0.05

20.74 ± 0.06

20.74 ± 0.07

20.74 ± 0.08

Glucosef (g/L)
Lactate (g/L)

0.07 ± 0.00
0.02 ± 0.03

0.05 ± 0.00
0.07 ± 0.01

0.08 ± 0.05
0.10 ± 0.02

0.07 ± 0.00
0.18 ± 0.12

0.05 ± 0.00
0.22 ± 0.04

0.38 ± 0.32
0.30 ± 0.03

0.07 ± 0.00
0.11 ± 0.09

0.05 ± 0.00
0.07 ± 0.06

0.03 ± 0.02
0.02 ± 0.04

Acetate (g/L)

0.35 ± 0.01
9.49 ± 0.04

0.30 ± 0.01
9.33 ± 0.03

0.32 ± 0.03
9.43 ± 0.03

0.78 ± 0.02
8.46 ± 0.02

0.58 ± 0.03
8.43 ± 0.04

0.59 ± 0.03
8.33 ± 0.11

0.75 ± 0.04
8.71 ± 0.07

0.48 ± 0.05
8.35 ± 0.15

0.42 ± 0.14
6.86 ± 2.31

Ethanol (g/L)

IPTG 1.0 mM

IPTG 0.01 mM
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IPTG 1.0 mM

IPTG 0.01 mM

IPTG 1.0 mM
3.12 ± 0.00

Table 3-8: Summary of titer, specific productivity, and yield of esters in high cell density cultures of EcJW106-108 and EcJW203-208
with different concentrations of IPTG (0.01, 0.1, or 1.0 mM) after 24 h.
Esters
Ester titer
(mg/L)

Specific ester
productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

IPTG 0.01 mM

IPTG 0.1 mM
EcJW106

IPTG 1.0 mM

IPTG 0.01 mM

Specific ester
productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Ester titer
(mg/L)

Specific ester
productivity
(mg/gDCW/h)
Ester yield
(mg/g glucose)

IPTG 1.0 mM

IPTG 0.01 mM

IPTG 0.1 mM
EcJW204

IPTG 1.0 mM

Ethyl acetate

315.9 ± 56.9

243.0 ± 75.7

393.6 ± 44.1

291.4 ± 17.8

300.8 ± 4.6

280.8 ± 50.5

439.8 ± 22.0

380.2 ± 146.8

411.7 ± 76.9

Ethyl lactate

0.2 ± 0.1

0.3 ± 0.1

0.1 ± 0.0

2.7 ± 1.1

1.7 ± 0.1

1.2 ± 0.2

11.1 ± 0.6

6.1 ± 2.7

7.9 ± 1.5

Ester total

316.1 ± 57.0

243.2 ± 75.8

393.7 ± 44.1

294.2 ± 18.9

302.5 ± 4.7

281.9 ± 50.6

450.9 ± 22.6

386.4 ± 149.5

419.6 ± 78.4

Ethyl acetate

5.39 ± 0.97

4.09 ± 1.31

6.84 ± 1.01

5.40 ± 0.31

6.71 ± 0.16

6.14 ± 1.19

8.63 ± 0.27

8.25 ± 3.14

9.19 ± 1.57

Ethyl lactate

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

0.05 ± 0.02

0.04 ± 0.00

0.03 ± 0.00

0.22 ± 0.02

0.13 ± 0.06

0.18 ± 0.03

Ester total

5.39 ± 0.97

4.10 ± 1.30

6.85 ± 1.01

5.45 ± 0.30

6.75 ± 0.16

6.17 ± 1.19

8.85 ± 0.26

8.38 ± 3.19

9.37 ± 1.61

Ethyl acetate

15.28 ± 2.75

11.76 ± 3.66

19.04 ± 2.13

14.10 ± 0.86

14.55 ± 0.22

13.57 ± 2.44

21.56 ± 0.99

19.89 ± 7.43

21.34 ± 2.53

Ethyl lactate

0.01 ± 0.01

0.01 ± 0.00

0.01 ± 0.00

0.13 ± 0.05

0.08 ± 0.01

0.06 ± 0.01

0.54 ± 0.04

0.32 ± 0.13

0.41 ± 0.05

Ester total

15.29 ± 2.75

11.77 ± 3.66

19.04 ± 2.13

14.23 ± 0.84

14.63 ± 0.22

13.63 ± 2.43

22.10 ± 0.97

20.21 ± 7.54

21.75 ± 2.58

EcJW205
Ester titer
(mg/L)

IPTG 0.1 mM
EcJW203

EcJW107

EcJW206

Ethyl acetate

274.0 ± 86.2

201.1 ± 41.0

203.6 ± 61.4

375.2 ± 34.7

168.8 ± 6.0

112.3 ± 6.7

124.2 ± 29.6

149.8 ± 5.6

119.7 ± 8.3

Ethyl lactate

0.4 ± 0.3

0.4 ± 0.1

0.7 ± 0.1

0.4 ± 0.1

0.8 ± 0.1

0.7 ± 0.2

0.2 ± 0.1

0.4 ± 0.1

0.4 ± 0.1

Ester total

274.4 ± 86.5

201.5 ± 41.0

204.3 ± 61.5

375.5 ± 34.7

169.5 ± 6.0

112.9 ± 6.9

124.4 ± 29.7

150.2 ± 5.7

120.2 ± 8.4

Ethyl acetate

4.56 ± 1.42

4.27 ± 0.94

4.07 ± 1.58

6.71 ± 0.63

3.80 ± 0.05

2.63 ± 0.17

2.23 ± 0.45

3.36 ± 0.29

3.13 ± 0.15

Ethyl lactate

0.01 ± 0.00

0.01 ± 0.00

0.01 ± 0.00

0.01 ± 0.00

0.02 ± 0.00

0.02 ± 0.01

0.00 ± 0.00

0.01 ± 0.00

0.01 ± 0.00

Ester total

4.57 ± 1.42

4.28 ± 0.94

4.09 ± 1.58

6.72 ± 0.63

3.82 ± 0.04

2.65 ± 0.18

2.23 ± 0.45

3.37 ± 0.29

3.14 ± 0.15

Ethyl acetate

13.26 ± 4.18

9.72 ± 1.98

9.84 ± 2.97

18.15 ± 1.68

8.29 ± 0.29

5.94 ± 0.29

6.01 ± 1.43

7.85 ± 0.28

7.04 ± 0.45

Ethyl lactate

0.02 ± 0.01

0.02 ± 0.00

0.03 ± 0.00

0.02 ± 0.00

0.04 ± 0.00

0.04 ± 0.01

0.01 ± 0.00

0.02 ± 0.01

0.02 ± 0.01

Ester total

13.28 ± 4.18

9.74 ± 1.98
EcJW207

9.88 ± 2.97

18.17 ± 1.68

8.33 ± 0.29
EcJW208

5.98 ± 0.30

6.02 ± 1.43

7.87 ± 0.28
EcJW108

7.06 ± 0.45

Ethyl acetate

143.0 ± 12.7

60.5 ± 9.4

62.5 ± 10.1

225.5 ± 22.7

243.8 ± 7.3

196.9 ± 9.3

517.6 ± 96.7

640.9 ± 121.5

563.7 ± 64.7

Ethyl lactate

0.4 ± 0.3

0.4 ± 0.2

0.3 ± 0.2

1.2 ± 0.0

1.1 ± 0.3

1.2 ± 0.4

2.3 ± 0.9

3.6 ± 0.8

3.1 ± 0.4

Ester total

143.4 ± 13.0

61.0 ± 9.5

62.8 ± 10.3

226.6 ± 22.7

244.9 ± 7.6

198.1 ± 9.7

519.9 ± 97.6

644.5 ± 122.3

566.8 ± 65.1

Ethyl acetate

2.71 ± 0.22

1.30 ± 0.20

1.39 ± 0.22

4.22 ± 0.53

5.47 ± 0.10

4.73 ± 0.33

9.04 ± 1.56

14.09 ± 2.80

12.96 ± 1.74

Ethyl lactate

0.01 ± 0.01

0.01 ± 0.00

0.01 ± 0.00

0.02 ± 0.00

0.03 ± 0.01

0.03 ± 0.01

0.04 ± 0.02

0.08 ± 0.02

0.07 ± 0.01

Ester total

2.72 ± 0.21

1.31 ± 0.19

1.40 ± 0.23

4.24 ± 0.53

5.50 ± 0.10

4.76 ± 0.33

9.08 ± 1.55

14.17 ± 2.82

13.03 ± 1.74

Ethyl acetate

6.92 ± 0.61

2.92 ± 0.45

3.03 ± 0.49

10.91 ± 1.10

11.78 ± 0.35

9.68 ± 0.57

25.04 ± 4.68

30.97 ± 5.87

27.23 ± 3.15

Ethyl lactate
Ester total

0.02 ± 0.01
6.94 ± 0.60

0.02 ± 0.01
2.95 ± 0.45

0.01 ± 0.01
3.04 ± 0.50

0.06 ± 0.00
10.96 ± 1.10

0.05 ± 0.01
11.84 ± 0.34

0.06 ± 0.02
9.73 ± 0.55

0.11 ± 0.04
25.15 ± 4.65

0.18 ± 0.04
31.15 ± 5.91

0.15 ± 0.02
27.38 ± 3.16
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Table 3-9: Summary of high cell density cultures of EcJW209-212 with or without addition of
ethanol (2 or 10 g/L) after 24 h. (A) OD 600 , glucose, lactate, acetate, and ethanol. (B) Titer, specific
productivity, and yield of esters. The subscripts i and f are referred to the initial (0 h) and final (24
h) time of the culture, respectively.
A
Strains
EcJW209
EcJW209 + Ethanol 2 g/L
EcJW209 + Ethanol 10 g/L
EcJW210
EcJW210 + Ethanol 2 g/L
EcJW210 + Ethanol 10 g/L
EcJW211
EcJW211 + Ethanol 2 g/L
EcJW211 + Ethanol 10 g/L
EcJW212
EcJW212 + Ethanol 2 g/L
EcJW212 + Ethanol 10 g/L

OD i
2.93 ± 0.00
3.06 ± 0.00
2.98 ± 0.00
2.83 ± 0.00
3.01 ± 0.00
2.91 ± 0.00
2.96 ± 0.00
3.10 ± 0.00
2.97 ± 0.00
3.04 ± 0.00
3.01 ± 0.00
3.17 ± 0.00

OD f
5.23 ± 0.11
5.44 ± 0.05
5.64 ± 0.19
5.29 ± 0.07
5.63 ± 0.07
5.11 ± 0.41
5.27 ± 0.02
5.55 ± 0.12
5.63 ± 0.20
5.36 ± 0.18
5.43 ± 0.14
5.32 ± 0.12

Glucosei (g/L)
22.60 ± 0.00
21.64 ± 0.00
21.64 ± 0.04
22.60 ± 0.00
21.64 ± 0.01
21.64 ± 0.05
22.60 ± 0.00
21.64 ± 0.02
21.64 ± 0.06
22.60 ± 0.00
21.64 ± 0.03
21.64 ± 0.07

Glucosef (g/L)
18.84 ± 1.08
15.76 ± 0.02
15.85 ± 0.07
17.73 ± 1.19
15.85 ± 0.05
15.72 ± 0.13
18.07 ± 0.69
15.57 ± 0.48
15.74 ± 0.16
17.70 ± 1.03
15.67 ± 0.03
15.74 ± 0.01

Lactate (g/L)
2.17 ± 0.76
2.03 ± 0.04
1.65 ± 0.02
1.77 ± 0.37
1.85 ± 0.01
1.54 ± 0.03
2.75 ± 0.09
2.16 ± 0.03
1.78 ± 0.04
2.28 ± 0.83
2.53 ± 0.01
2.35 ± 0.03

Acetate (g/L)
1.02 ± 0.17
1.84 ± 0.00
1.79 ± 0.00
1.14 ± 0.10
1.81 ± 0.01
1.80 ± 0.02
1.19 ± 0.09
1.71 ± 0.28
1.82 ± 0.05
1.22 ± 0.14
1.89 ± 0.01
1.84 ± 0.02

Ethanol (g/L)
1.39 ± 0.10
2.34 ± 0.33
10.16 ± 0.35
1.39 ± 0.02
2.64 ± 0.02
10.23 ± 0.41
1.20 ± 0.01
2.57 ± 0.15
10.45 ± 0.03
1.21 ± 0.02
2.59 ± 0.13
10.10 ± 0.32

B
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Esters
Ethyl acetate

26.1 ± 1.1

EcJW209

EcJW209 + Ethanol 2 g/L
43.3 ± 8.5

EcJW209 + Ethanol 10 g/L
152.1 ± 5.2

Ethyl lactate

1.0 ± 0.1

3.3 ± 0.3

5.1 ± 0.3

Ester total

27.0 ± 1.1

46.6 ± 8.7

157.2 ± 5.4

Ethyl acetate

0.55 ± 0.02

0.88 ± 0.17

3.04 ± 0.15

Ethyl lactate

0.02 ± 0.00

0.07 ± 0.01

0.10 ± 0.01

Ester total

0.57 ± 0.02

0.94 ± 0.17

3.14 ± 0.15

Ethyl acetate

7.43 ± 2.64

4.45 ± 0.88

15.76 ± 0.66

Ethyl lactate

0.27 ± 0.05

0.33 ± 0.03

0.52 ± 0.03

Ester total

7.70 ± 2.68

4.79 ± 0.89

16.29 ± 0.68
EcJW210+ Ethanol 10 g/L
149.0 ± 3.8

EcJW210
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Ethyl acetate

36.5 ± 3.9

EcJW210 + Ethanol 2 g/L
46.2 ± 1.3

Ethyl lactate

1.4 ± 0.4

3.2 ± 0.2

5.3 ± 0.3

Ester total

37.9 ± 4.2

49.4 ± 1.4

154.2 ± 4.1

Ethyl acetate

0.77 ± 0.09

0.92 ± 0.03

3.20 ± 0.13

Ethyl lactate

0.03 ± 0.01

0.06 ± 0.00

0.11 ± 0.01

Ester total

0.80 ± 0.10

0.98 ± 0.03

3.31 ± 0.14

Ethyl acetate

7.79 ± 2.08

4.79 ± 0.14

15.23 ± 0.49

Ethyl lactate

0.30 ± 0.14

0.33 ± 0.02

0.54 ± 0.03

Ester total

8.09 ± 2.21

5.12 ± 0.15

15.77 ± 0.52

EcJW211
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

EcJW211 + Ethanol 2 g/L

22.0 ± 0.8

45.4 ± 1.2

151.9 ± 2.3

Ethyl lactate

0.9 ± 0.2

3.0 ± 0.1

4.9 ± 0.4

Ester total

22.9 ± 1.0

48.4 ± 1.3

156.8 ± 2.2

Ethyl acetate

0.46 ± 0.02

0.90 ± 0.03

3.04 ± 0.06

Ethyl lactate

0.02 ± 0.00

0.06 ± 0.00

0.10 ± 0.01

Ester total

0.48 ± 0.02

0.96 ± 0.03

3.14 ± 0.05

Ethyl acetate

4.91 ± 0.69

4.58 ± 0.30

15.57 ± 0.45

Ethyl lactate

0.21 ± 0.07

0.31 ± 0.02

0.51 ± 0.05

Ester total

5.12 ± 0.75

4.89 ± 0.32

16.08 ± 0.46

EcJW212
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

EcJW211 + Ethanol 10 g/L

Ethyl acetate

EcJW212 + Ethanol 2 g/L

EcJW212 + Ethanol 10 g/L

Ethyl acetate

23.8 ± 3.1

42.3 ± 2.5

135.6 ± 5.8

Ethyl lactate

1.2 ± 0.4

3.1 ± 0.2

5.6 ± 0.3

Ester total

25.0 ± 3.5

45.3 ± 2.6

141.2 ± 6.1

Ethyl acetate

0.49 ± 0.07

0.86 ± 0.04

2.75 ± 0.08

Ethyl lactate

0.02 ± 0.01

0.06 ± 0.00

0.11 ± 0.00

Ester total

0.51 ± 0.08

0.92 ± 0.04

2.86 ± 0.08

Ethyl acetate

5.03 ± 1.40

4.30 ± 0.25

13.90 ± 0.59

Ethyl lactate

0.26 ± 0.11

0.31 ± 0.02

0.58 ± 0.03

Ester total

5.29 ± 1.51

4.62 ± 0.26

14.48 ± 0.62
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Table 3-10: Summary of high cell density cultures of EcJW213-221 after 24 h. (A) OD 600 , glucose,
lactate, acetate, and ethanol. (B) Titer, specific productivity, and yield of esters. The subscripts i
and f are referred to the initial (0 h) and final (24 h) time of the culture, respectively.
A
Strains
EcJW213
EcJW214
EcJW215
EcJW216
EcJW217
EcJW218
EcJW219
EcJW220
EcJW221
EcJW213
EcJW214
EcJW215

OD i
3.01 ± 0.00
2.94 ± 0.00
2.90 ± 0.00
2.94 ± 0.00
3.05 ± 0.00
2.92 ± 0.00
3.03 ± 0.00
2.89 ± 0.00
2.95 ± 0.00
3.01 ± 0.00
2.94 ± 0.00
2.90 ± 0.00

OD f
5.45 ± 0.14
5.27 ± 0.06
4.98 ± 0.09
5.25 ± 0.13
5.29 ± 0.20
5.02 ± 0.05
5.23 ± 0.13
4.94 ± 0.08
5.18 ± 0.05
5.45 ± 0.14
5.27 ± 0.06
4.98 ± 0.09

Glucosei (g/L)
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00
22.60 ± 0.00

Glucosef (g/L)
0.00 ± 0.00
2.78 ± 1.44
8.17 ± 0.06
5.29 ± 0.39
9.39 ± 4.03
5.58 ± 0.62
8.81 ± 2.00
10.04 ± 0.23
7.83 ± 0.22
0.00 ± 0.00
2.78 ± 1.44
8.17 ± 0.06

Lactate (g/L)
1.44 ± 0.08
1.43 ± 0.05
1.58 ± 0.01
1.35 ± 0.03
1.41 ± 0.38
1.24 ± 0.06
0.95 ± 0.15
1.00 ± 0.01
1.14 ± 0.02
1.44 ± 0.08
1.43 ± 0.05
1.58 ± 0.01

Acetate (g/L)
0.56 ± 0.03
0.92 ± 0.01
0.80 ± 0.00
0.94 ± 0.01
1.13 ± 0.23
0.91 ± 0.01
1.44 ± 0.11
1.37 ± 0.01
1.28 ± 0.01
0.56 ± 0.03
0.92 ± 0.01
0.80 ± 0.00

Ethanol (g/L)
9.81 ± 0.06
8.65 ± 0.52
6.42 ± 0.02
7.68 ± 0.12
5.60 ± 1.26
7.70 ± 0.23
6.29 ± 0.73
5.93 ± 0.09
6.85 ± 0.07
9.81 ± 0.06
8.65 ± 0.52
6.42 ± 0.02

B
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Esters
Ethyl acetate

28.9 ± 7.7

EcJW213
56.0 ± 7.3

EcJW214
169.2 ± 9.3

Ethyl lactate

0.8 ± 0.2

3.4 ± 0.9

6.1 ± 0.4

Ester total

29.7 ± 7.9

59.4 ± 8.2

175.4 ± 9.7

Ethyl acetate

0.59 ± 0.17

1.17 ± 0.15

3.70 ± 0.21

Ethyl lactate

0.02 ± 0.00

0.07 ± 0.02

0.13 ± 0.01

Ester total

0.61 ± 0.17

1.24 ± 0.16

3.83 ± 0.22

Ethyl acetate

1.28 ± 0.34

2.84 ± 0.48

11.73 ± 0.70

Ethyl lactate

0.04 ± 0.01

0.17 ± 0.05

0.43 ± 0.03

Ester total

1.31 ± 0.35

3.02 ± 0.53
EcJW216

Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

EcJW218

Ethyl acetate

9.5 ± 0.5

26.4 ± 14.3

145.5 ± 17.9

Ethyl lactate

0.4 ± 0.2

1.1 ± 0.5

7.0 ± 1.1

Ester total

9.9 ± 0.5

27.5 ± 14.8

152.5 ± 18.6

Ethyl acetate

0.20 ± 0.01

0.54 ± 0.29

3.15 ± 0.40

Ethyl lactate

0.01 ± 0.00

0.02 ± 0.01

0.15 ± 0.02

Ester total

0.21 ± 0.01

0.57 ± 0.30

3.30 ± 0.42

Ethyl acetate

0.55 ± 0.02

2.20 ± 1.52

8.57 ± 1.26

Ethyl lactate

0.02 ± 0.01

0.09 ± 0.06

0.41 ± 0.08

Ester total

0.57 ± 0.02

2.29 ± 1.58

8.98 ± 1.32
EcJW220

EcJW221

Ethyl acetate

7.5 ± 2.7

15.7 ± 0.6

65.2 ± 3.3

Ethyl lactate

0.5 ± 0.1

0.7 ± 0.1

2.5 ± 0.3

Ester total

8.0 ± 2.8

16.4 ± 0.6

67.7 ± 3.3

Ethyl acetate

0.15 ± 0.05

0.34 ± 0.02

1.38 ± 0.07

Ethyl lactate

0.01 ± 0.00

0.02 ± 0.00

0.05 ± 0.01

Ester total

0.17 ± 0.06

0.36 ± 0.02

1.43 ± 0.07

Ethyl acetate

0.53 ± 0.11

1.25 ± 0.02

4.41 ± 0.20

Ethyl lactate

0.03 ± 0.00

0.06 ± 0.01

0.17 ± 0.02

Ester total

0.57 ± 0.12

1.30 ± 0.02
EcJW213

Ester titer
(mg/L)

12.16 ± 0.73
EcJW217

EcJW219
Ester titer
(mg/L)

EcJW215

4.59 ± 0.21
EcJW214

EcJW215

Ethyl acetate

28.9 ± 7.7

56.0 ± 7.3

169.2 ± 9.3

Ethyl lactate

0.8 ± 0.2

3.4 ± 0.9

6.1 ± 0.4

Ester total

29.7 ± 7.9

59.4 ± 8.2

175.4 ± 9.7

Ethyl acetate

0.59 ± 0.17

1.17 ± 0.15

3.70 ± 0.21

Ethyl lactate

0.02 ± 0.00

0.07 ± 0.02

0.13 ± 0.01

Ester total

0.61 ± 0.17

1.24 ± 0.16

3.83 ± 0.22

Ethyl acetate

1.28 ± 0.34

2.84 ± 0.48

11.73 ± 0.70

Ethyl lactate

0.04 ± 0.01

0.17 ± 0.05

0.43 ± 0.03

Ester total

1.31 ± 0.35

3.02 ± 0.53

12.16 ± 0.73
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Table 3-11: Summary of high cell density cultures of EcJW109-117 after 24 h. (A) OD 600 , glucose,
lactate, acetate, and ethanol. (B) Titer, specific productivity, and yield of esters. The subscripts i
and f are referred to the initial (0 h) and final (24 h) time of the culture, respectively. Abbreviations:
n.a.: not applicable, n.d.: not detected.
A
Strains
EcJW109
EcJW110
EcJW111
EcJW112
EcJW113
EcJW114
EcJW115
EcJW116
EcJW117
EcJW109
EcJW110
EcJW111

OD i
3.12 ± 0.00
2.98 ± 0.00
3.23 ± 0.00
3.11 ± 0.00
2.99 ± 0.00
2.94 ± 0.00
2.87 ± 0.00
2.82 ± 0.00
2.90 ± 0.00
3.12 ± 0.00
2.98 ± 0.00
3.23 ± 0.00

OD f
4.93 ± 0.10
4.99 ± 0.40
5.04 ± 0.37
4.83 ± 0.06
4.78 ± 0.13
5.09 ± 0.46
4.74 ± 0.25
4.57 ± 0.09
4.49 ± 0.17
4.93 ± 0.10
4.99 ± 0.40
5.04 ± 0.37

Glucosei (g/L)
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00
19.24 ± 0.00

Glucosef (g/L)
14.10 ± 0.62
13.56 ± 0.95
13.58 ± 0.89
14.37 ± 0.25
14.46 ± 0.19
13.18 ± 1.34
14.89 ± 0.05
14.99 ± 0.03
14.60 ± 1.11
14.10 ± 0.62
13.56 ± 0.95
13.58 ± 0.89

Lactate (g/L)
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00
2.08 ± 0.00

Acetate (g/L)
1.84 ± 0.31
1.37 ± 1.05
1.43 ± 0.96
2.07 ± 0.01
2.07 ± 0.04
0.82 ± 1.07
1.98 ± 0.02
1.98 ± 0.01
1.78 ± 0.18
1.84 ± 0.31
1.37 ± 1.05
1.43 ± 0.96

B
Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Ester titer
(mg/L)

Specific ester productivity
(mg/gDCW/h)

Ester yield
(mg/g glucose)

Esters
Ethyl acetate

EcJW109
0.2 ± 0.0

EcJW110
5.9 ± 1.9

EcJW111
46.7 ± 8.9

Ethyl lactate

n.d.

0.1 ± 0.1

0.7 ± 0.3

Ester total

0.2 ± 0.0

6.0 ± 2.0

47.4 ± 9.2

Ethyl acetate

0.00 ± 0.00

0.13 ± 0.03

0.97 ± 0.19

Ethyl lactate

n.a.

0.00 ± 0.00

0.01 ± 0.01

Ester total

0.00 ± 0.00

0.13 ± 0.04

0.99 ± 0.20

Ethyl acetate

0.03 ± 0.01

1.07 ± 0.42

8.53 ± 2.89

Ethyl lactate

n.a.

0.01 ± 0.01

0.12 ± 0.08

Ester total

0.03 ± 0.01

1.08 ± 0.43

8.65 ± 2.97

Ethyl acetate

EcJW112
0.2 ± 0.0

EcJW113
7.8 ± 0.5

EcJW114
76.1 ± 21.8

Ethyl lactate

n.d.

0.1 ± 0.0

1.2 ± 0.4

Ester total

0.2 ± 0.0

7.9 ± 0.5

77.2 ± 22.1

Ethyl acetate

0.17 ± 0.01

1.62 ± 0.44

Ethyl lactate

0.00 ± 0.00
n.a.

0.00 ± 0.00

0.03 ± 0.01

Ester total

0.00 ± 0.00

0.17 ± 0.01

1.65 ± 0.44

Ethyl acetate

0.05 ± 0.00

1.64 ± 0.16

12.42 ± 1.02

Ethyl lactate

n.a.

0.01 ± 0.00

0.19 ± 0.02

Ester total

0.05 ± 0.00

1.65 ± 0.16

12.61 ± 1.03

EcJW115

EcJW116

EcJW117

Ethyl acetate

0.2 ± 0.0

4.7 ± 0.2

26.4 ± 1.3

Ethyl lactate

n.d.

0.1 ± 0.1

0.7 ± 0.1

Ester total

0.2 ± 0.0

4.8 ± 0.2

27.1 ± 1.3

Ethyl acetate

0.00 ± 0.00

0.11 ± 0.00

0.62 ± 0.04

Ethyl lactate

n.a.

0.00 ± 0.00

0.02 ± 0.00

Ester total

0.00 ± 0.00

0.11 ± 0.00

0.63 ± 0.04

Ethyl acetate

0.04 ± 0.01

1.10 ± 0.04

5.93 ± 1.47

Ethyl lactate

n.a.

0.03 ± 0.01

0.15 ± 0.03

Ester total

0.04 ± 0.01

1.13 ± 0.05

6.08 ± 1.50
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Ethanol (g/L)
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00
1.91 ± 0.00

Figure 3-6: Expression of the recombinant enzymes in engineered E. coli strains. The positions
corresponding to the overexpressed proteins are indicated by arrowheads. Lane M represents
protein ladder while lanes T, S, and I are referred to total, soluble, and insoluble proteins,
respectively. ①~③, Pyruvate-to-lactate ester module; ④~⑤, Ethanol module; ⑥~⑩,
Isobutanol module. Protein sizes were predicted with their amino acid sequences.
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Figure 3-7: Effect of lactate esters on cell growth. (A) Specific growth rates of EcDL002 with or without
addition of lactate esters. (B) logP values of characterized lactate esters. The values were obtained from
http://www.thegoodscentscompany.com. (C-H) Growth curves of EcDL002 with or without addition of (C)
n-ethyl lactate (NEL), (D) n-propyl lactate (NPL), (E) n-butyl lactate (NBL), (F) i-butyl lactate (IBL), (G)
i-amyl lactate (IAL), and (H) benzyl lactate (BZL).
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Figure 3-8: Design of (A) upstream module and (B) downstream module of the ethyl lactate pathway. The
RBS Calculator v2.0 software was used to generate synthetic RBS sequences. For the upstream, four
synthetic RBS sequences were generated with predicted translation initiation rates at 0.33 and 0.03 between
the PAY1 or PAY3 promoter and pdc start codon. For the downstream, six synthetic RBS sequences were
generated with predicted translation initiation rates at 90, 9000, and 90000 au between the PT7 promoter and
pct or VAAT start codon.
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Figure 3-9: (A) Correlation between ester production and the amount of added ethanol in high cell density
cultures of EcJW209-212. (B) Correlation between ester production and the RBS strength for VAAT
expression in high cell density culture of EcJW213-221.
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4.1 Abstract
Esters are versatile chemicals and potential drop-in biofuels. To develop a sustainable
production platform, microbial ester biosynthesis using alcohol acetyltransferases (AATs) has
been studied for decades. Volatility of esters endows high-temperature fermentation with
advantageous downstream product separation. However, due to the limited thermal stability of
AATs known, the ester biosynthesis has largely relied on use of mesophilic microbes. Therefore,
developing thermostable AATs is important for ester production directly from lignocellulosic
biomass by the thermophilic consolidated bioprocessing (CBP) microbes, e.g., Clostridium
thermocellum.
In this study, we engineered a thermostable chloramphenicol acetyltransferase from
Staphylococcus aureus (CATSa) for enhanced isobutyl acetate production at elevated temperature.
We first analyzed the broad alcohol substrate range of CATSa. Then, we targeted a highly
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conserved region in the binding pocket of CATSa for mutagenesis. The mutagenesis revealed that
F97W significantly increased conversion of isobutanol to isobutyl acetate. Using CATSa F97W,
we demonstrated the engineered C. thermocellum could produce isobutyl acetate directly from
cellulose.
This study highlights that CAT is a potential thermostable AAT that can be harnessed to
develop the thermophilic CBP microbial platform for biosynthesis of designer bioesters directly
from lignocellulosic biomass.

4.2 Introduction
Esters are versatile chemicals which have been used as lubricants, solvents, food additives,
fragrances and potential drop-in fuels [1]. Currently, ester production largely relies on synthesis
from petroleum or extraction from plants, which makes it neither sustainable nor economically
feasible. Therefore, microbial production of esters has been studied for decades [2-7]. Most studies
have employed an alcohol acetyltransferase (E.C. 2.3.1.84, AAT), belonging to a broad
acetyltransferase class, that can synthesize a carboxylic ester by condensing an alcohol and an
acyl-CoA in a thermodynamically favorable aqueous environment [5]. For example, an
Escherichia coli, engineered to use this biosynthetic pathway, could achieve high titer of isobutyl
acetate [6, 7]. With appropriate expression of AATs and availability of alcohol and acyl-CoA
moieties, various types of esters can be produced [2, 4].
Due to high volatility of esters, ester production at elevated temperatures can benefit
downstream product separation and hence reduce the process cost. Interestingly, it has recently
been shown that for the same total carbon chain length, short-chain esters are less toxic to microbial
health than alcohols, which is potentially beneficial for ester fermentation [8]. However, most of
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the AATs known to date are isolated from mesophilic microbes or plants [9-12], and none of them
has been reported to be active at elevated temperatures (> 50 o C). The highest temperature reported
for ester production is 42o C in a thermotolerant yeast [13]. Hence, finding and developing a
thermostable AAT is crucial to produce esters at elevated temperature.
Chloramphenicol acetyltransferase (E.C. 2.3.1.28, CAT) is another acetyltransferase class
that has been found in various microbes [14]. This enzyme acetylates chloramphenicol, a protein
synthesis inhibitor, by transferring the acetyl group from acetyl-CoA. The acetylation of
chloramphenicol detoxifies the antibiotic compound and confers chloramphenicol resistance in
bacteria. Recent studies have implied that CATs likely recognize a broad substrate range for
alcohols and acyl-CoAs [7]. In addition, high thermal stability of some CATs enables them to be
used as selection markers in thermophiles [15-17]. Therefore, CAT can function or be repurposed
as a thermostable AAT suitable for ester biosynthesis at elevated temperature.
In this study, we engineered a CAT from Staphylococcus aureus (CATSa) for isobutyl
acetate production at elevated temperatures. First, we investigated a broad alcohol substrate range
of CATSa. Protein homology modeling along with sequence alignment were performed to identify
the binding pocket of CATSa as a potential target for protein engineering to enhance condensation
of isobutanol and acetyl-CoA. In silico mutagenesis successfully discovered a variant (F97W) of
CATSa that was then experimentally validated for improved catalytic activity towards isobutanol.
As a proof of concept, the engineered CATSa was successfully expressed in Clostridium
thermocellum. We demonstrated the F97W CATSa-overexpressing for consolidated bioprocessing
(CBP) to produce isobutyl acetate directly from cellulose without a need for external supply of
cellulases. To our knowledge, this study presents the first demonstration of CAT engineering to
enable ester production directly from cellulose at elevated temperatures.
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4.3 Materials and Methods
4.3.1

Bacterial strains and plasmids.
Bacterial strains and plasmids used in this study are listed in Table 4-1. Clostridium

thermocellum DSM1313 ∆hpt (M1354) strain was used as a host for the ester production at
elevated

temperatures.

It

should

be

noted

that

the

deletion

of

hypoxanthine

phosphoribosyltransferase gene (hpt, Clo1313_2927) in the wildtype DSM1313 allows genetic
engineering by 8-Azahypoxanthine (8-AZH) counter selection; this deletion does not have any
known adverse effect on cell growth and metabolism [18, 19]. The plasmid pNW33N, containing
CATSa, is thermostable and was used to express various CATs in C. thermocellum. The pET
plasmids were used for molecular cloning and enzyme expression in E. coli.
4.3.2

Chemicals and reagents
All chemicals were purchased from Sigma-Aldrich (MO, USA) and/or Thermo Fisher

Scientific (MA, USA), unless specified elsewhere. For molecular cloning, restriction enzymes and
T4 ligase were obtained from New England Biolabs (MA, USA). Phusion Hot Start II DNA
polymerase was used for polymerase chain reaction (PCR).
4.3.3

Media and cultivation
For molecular cloning and protein expression, E. coli strains were grown in lysogeny broth

(LB) containing appropriate antibiotics unless noted otherwise. For in vivo characterization of
CATSa in E. coli, M9 hybrid medium [5] with 20 g/L glucose was used. For C. thermocellum
culture, MTC minimal medium or CTFuD-NY medium [19] was used as specified in the
experiments. Optical density (OD) was measured by a spectrophotometer at 600 nm wavelength
(Spectronic 200+, Thermo Fisher Scientific, MA, USA).
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Table 4-1: A list of plasmids and strains used in this study.
Name
Plasmids
pNW33N
pETDuet-1
pET_CATSa
pET_CATSa F97W
pHS0024

pHS0024_F97W
Strains

Descriptions

Source

Bacillus-E. coli shuttle vector, Cm R, pBC1 ori for gram
positive strains, pBR322 ori for E. coli, source of CATSa
pBR322 ori, Amp R, lacI, T7lac promoter
CATSa wild type encoding gene between BamHI, SacI
site, pETDuet-1 backbone, 6X His-tag at N-terminus
F97W site directed variant, pET_CATSa backbone
CATSa wild type gene under C. thermocellum PgapDH
promoter, downstream of Clo1313_2927 for the
transcription terminator, tdk operon under cbp promoter
substituting with the native cat selection marker,
pNW33N plasmid backbone
CATSa F97W site-directed mutated from pHS0024

Bacillus Genetic
Stock Center
Novagen

Host for molecular cloning, mcrA, ∆(mrr-hsdRMSmcrBC), Phi80lacZ(del)M15, ∆lacX74, deoR, recA1,
E. coli Top10
araD139, ∆(ara-leu)7697, galU, galK, rpsL(SmR),
endA1, nupG
E. coli BL21 (DE3) E. coli B dcm, ompT, hsdS(rB-mB-), gal
M1354
C. thermocellum DSM1313 ∆hpt
HSCT0101
M1354 harboring pHS0024
HSCT0102
M1354 harboring pHS0024_F97W

The plasmids containing mutagenized genes are presented in Table 4-3.
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This study
This study
This study

This study

Invitrogen
Invitrogen
[18]
This study
This study

4.3.4

Multiple sequence alignment analysis
Multiple sequence alignment (MSA) analysis was performed using MEGA7 [20]. Protein

sequences were aligned by ClustalW [21] and visualized by ESPript 3.0 (http://espript.ibcp.fr) [22].
The key features in protein structures of 3U9F [23], 4CLA [24], and 2XAT [25] were extracted
from CAT_SALTI, CAT3_ECOLIX, and CAT4_PSEAE, respectively.
4.3.5

Molecular modeling and docking simulations
4.3.5.1 Three-dimensional (3D) structures
The 3D structure of CATSa and alcohols of interest were first generated using Swiss-Model

[26] and the ‘Builder’ tools of MOE (Molecular Operating Environment software, version
2019.01), respectively. The 3D structure of the dual substrates-bounded CATSa complex (i.e.,
acetyl-CoA-isobutanol-CATSa) was obtained by extracting an isobutanol from the isobutanolCATSa complex and then adding it to the acetyl-CoA-CATSa complex. All the structures were
prepared by the ‘QuickPrep’ tool of MOE with default parameters and further optimized by energy
minimization with the Amber10: EHT force field.
4.3.5.2 Docking simulation
To perform docking simulations, the potential binding pocket was searched using the ‘Site
Finder’ tool of MOE. The best-scored site, consistent with the reported catalytic sites [27], was
selected for further studies. Docking simulations were performed as previously described [28].
Briefly, acetyl-CoA and each alcohol were docked using the induced fit protocol with the Triangle
Matcher placement method and the London G scoring function. After the docking simulations,
the best-scored binding pose, showing the crucial interaction between the residue and the substrate
at root-mean-square-deviation (RMSD) < 2 Å, was selected. As an example, for the acetyl-CoA
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docking, the binding pose exhibiting the hydrogen bond between the hydroxyl of Ser-148 and the
N71 of the CoA was chosen [29]. For the alcohol docking, the binding pose showing the hydrogen
bond between the N 3 of His-189 and the hydroxyl of alcohol was selected [30].
4.3.5.3 In silico mutagenesis analysis
In silico mutagenesis analysis of the acetyl-CoA-isobutanol-CATSa complex was carried
out as previously described [28]. Specifically, the ‘alanine scan’ and ‘residue scan’ tools of MOE
were used to identify the potential residue candidates for mutagenesis.
3.3.6 Molecular cloning
4.3.5.4 Plasmid construction
Plasmids were constructed by the standard molecular cloning technique of ligase dependent
method and/or Gibson assembly [31] using the primers listed in Table 4-3. The constructed
plasmids were introduced into E. coli TOP10 by heat shock transformation. Colonies isolated on
a selective plate were PCR screened and plasmid purified. The purified plasmids were verified via
Sanger sequencing before being transformed into E. coli BL21 (DE3). Site-directed mutagenesis
was performed using the QuickChange™ site-directed mutagenesis protocol with reduced overlap
length [32] or Gibson assembly method [31]. For the C. thermocellum engineering, the plasmid
pHS005 was constructed first and then modified to pHS0024. pHS0024 has no hpt at the
downstream of the operon while other sequences of the plasmid are identical to pHS005.
4.3.5.5 Transformation
The conventional chemical transformation and electroporation methods were used for
transformation of E. coli [33] and C. thermocellum [19], respectively. For C. thermocellum, the
method, however, was slightly modified as described here. First, C. thermocellum M1354 (Table
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1) was cultured in 50 mL CTFuD-NY medium at 50o C inside an anaerobic chamber (Bactron300,
Sheldon manufacturing Inc., OR, USA). The cell culture with OD in a range of 0.8-1.0 was cooled
down at room temperature for 20 minutes. Beyond this point, all steps were performed outside the
chamber. The cooled cells were harvested at 6,500 x g and 4 o C for 20 minutes. The cell pellets
were washed twice with ice-chilled Milli-Q water and resuspended in 200 L of the transformation
buffer consisting of 250 mM sucrose and 10% (v/v) glycerol. Several 30 L aliquots of the
electrocompetent cells were immediately stored at -80o C for further use. For electroporation, the
electrocompetent cells were thawed on ice and incubated with 500−1,000 ng of methylated
plasmids [34] for 10 minutes. Then, the cells were transferred to an ice-chilled 1-mm gap
electroporation cuvette (BTX Harvard Apparatus, MA, USA) followed by two consecutive
exponential decay pulses with 1.8 kV, 350 Ω, and 25 F. The pulses usually resulted in a 7.0-8.0
ms time constant. The cells were immediately resuspended in pre-warmed fresh CTFuD-NY and
recovered at 50o C under anaerobic condition (90 % N 2 , 5% H 2 , and 5% CO 2 ) inside a rubber
capped Balch tube. After 0-12 hours of recovery, the cells were mixed with molten CTFuD-NY
agar medium supplemented with 15 g/mL thiamphenicol. Finally, the medium-cell mixture was
poured on a petri dish and solidified inside the anaerobic chamber. The plate was incubated at
50o C up to one week until colonies appeared. Transformation efficiency was 2-100 colony forming
units per g plasmid (CFU/g plasmid).
4.3.6

In vivo characterization of CAT Sa and its variants in E. coli
For in vivo characterization of CATSa and its variants in E. coli, high-cell density cultures

were performed as previously described [35] with an addition of 2 g/L of various alcohols. For insitu extraction of esters, each tube was overlaid with 25% (v/v) hexadecane. To confirm the protein
expression of CATSa and its variants, 1% (v/v) of stock cells were grown overnight at 37 o C and
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200 rpm in 15 mL culture tubes containing 5 mL of LB media and antibiotics. Then, 4% (v/v) of
the overnight cultures were transferred into 1 mL of LB media containing antibiotics in a 24-well
microplate. The cultures were grown at 37 o C and 350 rpm using an incubating microplate shaker
(Fisher Scientific, PA, USA) until OD reached to 0.4~0.6 and then induced by 0.1 mM isopropyl
β-D-1-thiogalactopyranoside (IPTG) for 4 hours with a Breathe-Easy Sealing Membrane to
prevent evaporation and cross contamination (cat# 50-550-304, Research Products International
Corp., IL, USA). The protein samples were obtained using the B-PER complete reagent (cat#
89822, Thermo Scientific, MA, USA), according to the manufacturer’s instruction and analyzed
by SDS-PAGE.
4.3.7

Enzyme characterization
4.3.7.1 His-tag purification
For enzyme expression, an overnight culture was inoculated with a 1:50 ratio in fresh LB

medium containing 1 mM IPTG and antibiotics, followed by 18 o C overnight incubation (up to 20
hours) in a shaking incubator at 200 rpm. The induced cells were harvested by centrifugation at
4o C, and 4,700 x g for 10 minutes. The cell pellet was then washed once with Millipore water and
resuspended in the B-PER complete reagent. After 30 min incubation at room temperature, the
mixture was centrifuged at 17,000 x g for 2 minutes. The supernatant was collected and designated
as crude extract. For his-tag purification, the crude extract was incubated with HisPur Ni-NTA
superflow agarose in a batch as the manufacturer recommends. Then, the resin was washed with
at least three volumes of wash buffer, consisting of 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10
mM imidazole, and 0.1 mM EDTA. The resin bound proteins were eluted by 300 L elution buffer
containing 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 300 mM imidazole, and 0.1 mM EDTA. The
eluted sample was then desalted and concentrated via an Amicon filter column with 10 kDa
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molecular weight cutoff. Finally, the protein sample was suspended in 200 L of 20 mM Tris-HCl
buffer (pH 8.0). Protein concentration was measured by the Bradford assay [36] with bovine serum
albumin (BSA) as the reference protein.
4.3.7.2 Thermal shift assay
To measure protein melting temperature (Tm), a thermofluor assay was employed with
SYPRO Orange [37]. About 10 to 250 g of His-tag purified protein was mixed with 5x SYPRO
Orange in a 50 L final volume in a 96-well qPCR plate. The plate was sealed with PCR caps
before running the assay. The StepOne real-time PCR machine (Applied Biosystems, CA, USA)
was used to run the assay with the following parameters: ROX reporter, 1 o C increment per cycle,
one-minute hold at every cycle, and temperature range from 20 o C to 98o C. The data was collected,
exported, and processed to calculate Tm.
4.3.7.3 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) assay
Reaction rate for each CAT was determined by a DTNB assay [38] in a 384-well plate.
Total reaction volume was 50 L with the reaction buffer comprising of 50 mM Tris-HCl (pH 8.0).
Concentrations of acetyl-CoA (CoALA Biosciences, TX, USA) and alcohols were varied as
specified in each experiment. Final enzyme concentrations of 0.05 g/mL and 10 g/mL were
used for the reactions towards chloramphenicol and alcohols, respectively. Reaction kinetics were
collected by measuring absorbance at 412 nm every minute for one hour at 50 o C in a microplate
reader (Synergy HTX microplate reader, BioTek). The reaction rate was calculated using the
extinction coefficient from a standard curve of free coenzyme A (MP Biomedicals, OH, USA)
under the same condition. It should be noted that since the maximum operating temperature
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recommended for the plate reader is 50o C, the high throughput enzyme assay for CAT at elevated
temperature was only performed to determine enzyme kinetics parameters.
4.3.7.4 Calculation of kinetic parameters for reaction rates
The parameters of Michaelis-Menten rate law (eqn. 1) were calculated for each enzyme as
follows. First, linear regression was performed on data collected from a microplate reader to
identify initial reaction rates, 𝑦𝑖, at different initial substrate concentrations, 𝑠𝑖 , where i= (1,2,...,n)
is the number of data points collected. Then, these initial reaction rates and associated initial
substrate concentrations for all replicates were simultaneously fit to the Michaelis-Menten model
(eqn. 1) using robust non-linear regression (eqn. 2) with a soft-L1-loss estimator (eqn. 3) as
implemented in the SciPy numerical computing library v1.2.0 [39, 40].
𝑣𝑖 =

𝑣𝑚𝑎𝑥 𝑠𝑖
𝐾𝑀 +𝑠𝑖

[eqn. 1]

𝑚𝑖𝑛 𝑘𝑚,𝑣𝑚𝑎𝑥 ∑𝑛𝑖=1 𝜌((𝑣𝑖 (𝑠𝑖 , 𝐾𝑀 , 𝑣𝑚𝑎𝑥 ) − 𝑦𝑖 ) 2 )
𝜌(𝑧) = 2(√ 1 + 𝑧) − 1

[eqn. 2]

[eqn. 3]

The least squares problem determines the parameters 𝐾𝑀 and 𝑣𝑚𝑎𝑥 by minimizing the difference
between the model predicted reaction rates 𝑣𝑖 and measured reaction rates 𝑦𝑖 (eqn. 2). A
smoothing function 𝜌(𝑧) is used to make the least square problem resistant to outliers (eqn. 3).
Due to the unbiased resistance to outliers and the avoidance of errors resulting from conventional
linearization methods, robust non-linear regression provides the most precise parameter estimate
for the Michaelis-Menten model [41].
4.3.8

Isobutyl acetate production in C. thermocellum
4.3.8.1 Cellobiose fermentation
Isobutyl acetate production from cellobiose in C. thermocellum strains was performed by
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the two-step bioconversion configuration. Cells were first cultured in MTC minimal medium [19]
containing 5 g/L cellobiose in a rubber capped Balch tube until OD reached 0.8~1.0. The cells
were cooled down at room temperature for 20 minutes and centrifuged at 4,700 x g and 4 o C for 20
minutes. After removing the supernatant, cells were resuspended in the same volume of fresh MTC
minimal media containing 2 g/L isobutanol in an anaerobic chamber. The cell suspension was then
divided into 800 L in a 2.0 mL screw cap microcentrifuge tube with a 200 L hexadecane overlay.
The cells were incubated at 55o C for 24 hours followed by analysis of gas chromatography coupled
with a mass spectrometer (GC/MS) to quantify the amount of isobutyl acetate produced.
4.3.8.2 Cellulose fermentation
For the cellulose fermentation, modified MTC medium (C-MTC medium) was used. 20
g/L of Avicel PH-101 was used as a sole carbon source instead of cellobiose, and 10 g/L of MOPS
was added to increase buffer capacity. Initial pH was adjusted to 7.5 by 5M KOH and autoclaved.
In an anaerobic chamber, 0.8 mL of overnight cell culture was inoculated in 15.2 mL of C-MTC
medium (1:20 inoculation ratio) with 4 mL of overlaid hexadecane. Each tube contained a small
magnetic stirrer bar to homogenize cellulose. The rubber capped Balch tube was incubated in a
water bath connected with a temperature controller set at 55 o C and a magnetic stirring system.
Following pH adjustment with 70 L of 5 M KOH injection, 800 L of cell culture and 200 L of
hexadecane layer were sampled every 12 hours. Culture pH was maintained within a range of 6.47.8 during the fermentation.
Cell growth was monitored by measuring pellet protein. The cell-cellulose pellet from 800
L sampling volumes was washed twice with Milli-Q water and suspended by 200 L lysis buffer
(0.2 M NaOH, 1% SDS) followed by an hour incubation at room temperature. Then, the solution
was neutralized with 50 L 0.8 M HCl and diluted by 550 L water. The mixture was centrifuged
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at 17,000 x g for 3 minutes. Protein concentration from the supernatant was analyzed by the
detergent-compatible Bradford assay (Thermo Scientific, WA, USA). The residual pellet was
boiled in a 98o C oven for an hour before quantifying residual cellulose.
Residual cellulose was quantified by the phenol-sulfuric acid method [42] with some
modifications. The boiled sample was washed twice with Milli-Q water and suspended in 800 L
water to make equivalent volume to the original. The sample was homogenized by pipetting and
vortexing for 10 seconds, and 20 L of the homogenized sample was transferred to a new 2.0 mL
microcentrifuge tube or 96-well plate and dried overnight in a 55o C oven. The dried pellet was
suspended in 200 uL of 95% sulfuric acid and incubated for an hour at room temperature. After
the pellet was dissolved completely, 20 L of 5% phenol was added and mixed with the sulfuric
acid solution. After 30 min incubation at room temperature, 100 L of the sample was transferred
to a new 96-well plate, and the absorbance at 490 nm was measured. The absorbance was converted
to cellulose concentration by the standard curve of Avicel PH-101 treated by the same procedure.
4.3.9

Analytical methods
4.3.9.1 High-performance liquid chromatography (HPLC)
Extracellular metabolites were quantified by using a high-performance liquid

chromatography (HPLC) system (Shimadzu Inc., MD, USA). 800 L of culture samples was
centrifuged at 17,000 x g for 3 minutes, then the supernatants were filtered through 0.2 micron
filters and run with 10 mN H 2 SO4 mobile phase at 0.6 mL/min on an Aminex HPX-87H (Biorad
Inc., CA, USA) column at 50o C. Refractive index detector (RID) and ultra-violet detector (UVD)
at 220 nm were used to monitor concentrations of sugars, organic acids, and alcohols.

143

4.3.9.2 Gas chromatography coupled with mass spectroscopy (GC/MS)
Esters were measured by GC (HP 6890, Agilent, CA, USA) equipped with a MS (HP 5973,
Agilent, CA, USA). For the GC system, the Zebron ZB-5 (Phenomenex, CA, USA) capillary
column (30 m x 0.25 mm x 0.25 m) was used to separate analytes, and helium was used as the
carrier with a flow rate of 0.5 mL/min. The oven temperature program was set as follows: 50 oC
initial temperature, 1o C/min ramp up to 58o C, 25o C/min ramp up to 235o C, 50o C/min ramp up to
300o C, and 2-minutes bake-out at 300o C. 1 L of sampled hexadecane layer was injected into the
column in the splitless mode with an injector temperature of 280 o C.
For the MS system, selected ion mode (SIM) was used to detect and quantify esters with the
following parameters: (i) ethyl acetate, m/z 45.00 and 61.00 from 4.2 to 4.6 minute retention time
(RT), (ii) isopropyl acetate, m/z 45 and 102 from 4.7 to 5.0 minute RT, (iii) propyl acetate, m/z 59
and 73 from 5.2 to 5.8 minute RT, (iv) ethyl isobutyrate, m/z 73 and 116 from 6.1 to 6.6 minute
RT, (v) isobutyl acetate, m/z 61 and 101 from 6.6 to 7.6 minute RT, (vi) butyl acetate, m/z 61 and
116 from 7.7 to 9.2 minute RT, (vii) isobutyl isobutyrate, m/z 89 and 129 from 10.1 to 12.5 minute
RT, (viii) benzyl acetate, m/z 108 and 150 from 13.1 to 13.8 minute RT, and (ix) 2-phenethyl
acetate, m/z 104 and 121 from 13.8 to 15.5 minute RT. Isoamyl alcohol and isoamyl acetate were
used as the internal standard analytes. The esters were identified by RT and quantified by the peak
areas and standard curves. Standard curves were determined by using pure esters diluted into
hexadecane at concentrations of 0.01 g/L, 0.05 g/L, 0.1 g/L, 0.5 g/L, and 1 g/L.

4.4 Results and Discussion
4.4.1

In silico and rapid in vivo characterization of a thermostable chloramphenicol
acetyltransferase(s) for broad alcohol substrate range
To develop a thermophilic microbial ester production platform, a thermostable AAT is re144

quired. Unfortunately, the AATs known to date are isolated from mesophilic yeasts or plants, and
none of them has been reported to be active at a temperature above 50o C. To tackle this problem,
we chose CATs to investigate their potential functions as a thermostable AAT because some
thermostable CATs have been successfully used as a selection marker in thermophiles [17, 43-46]
and others have been shown to perform the acetylation for not only chloramphenicol but various
alcohols like AATs [47-50] [7] (Figure 4-1A, Figure 4-5A). As a proof-of-study, we investigated
CATSa, classified as Type A-9, from the plasmid pNW33N for a broad range of alcohol substrates
as it has been widely used for genetic engineering in C. thermocellum at elevated temperature (≥
50o C) [17, 43, 44].
We first conducted alcohol docking simulations using the homology model. Remarkably,
the model predicted binding affinities of short-to-medium chain length alcohols (e.g., ethanol,
propanol, isopropanol, butanol, and isobutanol) and aromatic alcohols (e.g., benzyl alcohol and
phenethyl alcohol) to the binding pocket. The change in the protein’s Gibbs free energy upon the
substrate binding was ordered as follows: 2-phenethyl alcohol > benzyl alcohol > isobutanol >
butanol > propanol > ethanol > isopropanol (Figure 4-1B). To quickly evaluate the in silico
docking simulation results experimentally, we next performed in vivo characterization of a CATSaoverexpressing E. coli and screened for acetate esters production. Acetyl-CoA was derived from
glycolysis while various alcohols were externally supplied to the media. Remarkably, the results
exhibited the same trends of specificities of CATSa towards alcohols as predicted by the in silico
docking simulation (Figure 4-1B).
The CATSa-overexpressing E. coli produced all the expected acetate esters including ethyl
acetate, propyl acetate, isopropyl acetate, butyl acetate, isobutyl acetate, benzyl acetate, and 2phenethyl acetate at titers of 1.1  0.1, 2.3  0.3, 0.1  0.0, 9.8  1.6, 17.1  6.0, 152.4  29.5, and
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Figure 4-1: Broad substrate specificity of CATSa. (A) Acetylation of chloramphenicol and alcohol
by a chloramphenicol acetyltransferase (CAT) and an alcohol acetyltransferase (AAT),
respectively. (B) Comparison between the predicted binding free energies for various alcohols
bound to the binding pocket of CATSa and the titer of esters produced by the CATSa-overexpressing
E. coli with external supply of alcohols. (C) Structure of the CATSa homology model. The red
arrows indicate the binding pockets (in yellow cloud) formulated by the trimeric structure of
CATSa.
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955.3  69.5 mg/L and specific ester production rates of 0.02  0.00, 0.05  0.01, 0.00  0.00, 0.19
 0.03, 0.34  0.12, 3.02  0.57, and 19.27  1.32 mg/gDCW/h, respectively. We observed that
the specific ester production titers and rates are higher for aromatic alcohols than linear, short chain alcohols likely because the hydrophobic binding pocket of CATSa has been evolved towards
chloramphenicol [30], an aromatic antibiotic (Figure 4-1C). Specifically, the bulky binding pocket
of CATSa likely contributes to more interaction with the aromatic substrates than the short, linearchain alcohols (Figure 4-5B and C).
Overall, thermostable CATs, e.g., CATSa, can have broad range of substrate specificities
towards linear, short-chain, and aromatic alcohols and hence can be harnessed as AATs for novel
ester biosynthesis at elevated temperature.
4.4.2

Discovery of a CAT Sa variant improving conversion of isobutanol and acetyl CoA
into isobutyl acetate
Since the in vivo activity of CATSa is more than 50-fold higher for the aromatic alcohols

than isobutanol, we asked whether its activity could be improved for isobutyl acetate biosynthesis.
Using the in-silico analysis, we started by examining whether any modification of the binding
pocket of CATSa could improve the activity towards isobutanol. According to the homology model,
the binding pocket consists of Tyr-20, Phe-27, Tyr-50, Thr-88, Ile-89, Phe-90, Phe-97, Ser-140,
Leu-141, Ser-142, Ile-143, Ile-144, Pro-145, Trp-146, Phe-152, Leu-154, Ile-166, Ile-167, Thr168, His-189, Asp-193, Gly-194, and Tyr-195, where the His189 and Asp193 are the catalytic sites
(Figure 2A). Since chloramphenicol resistance is likely a strong selective pressure throughout
evolution, we expected all CATs to exhibit a common binding pocket structure. Unsurprisingly,
conserved sequences in the binding pocket were observed by protein sequence alignment of CATSa
with other CATs of Type A (Figure 4-6A). Especially, Pro-85 and Phe-97 were highly conserved
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Figure 4-2: Discovery of CATSa F97W responsible for enhanced activity towards isobutanol. (A)
A binding pocket of CATSa and associated amino acid residues. The catalytic site residues are in
purple. (B) Protein sequence alignment of CATSa with different CATs. (C) Screening of F97 sitesaturated mutagenized variants for enhanced isobutyl acetate production in E. coli. The letters
indicate amino acids substituting F in the wildtype CATSa. (D) Superposed binding pocket
structure of the wildtype and CATSa F97W mutant. The red arrow indicates a CH-π interaction
between the hydrogen of isobutanol and the indole ring of F97W.
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in CATs of not only Type-A but also Type-B (Figure 4-2B and Figure 4-6B).
Based on the binding pocket identified, we performed docking simulation with alanine and
residue scans using the acetyl-CoA-isobutanol-CATSa complex to identify potential candidates for
mutagenesis (Figure 4-7A and B). Remarkably, the top three variant candidates were suggested at
the Phe-97 residue (e.g., F97Y, F97W, and F97V). This residue is involved in the formation of a
tunnel-like binding pocket [30]. Motivated by the analysis, Phe-97 was chosen for site saturated
mutagenesis, and the variants were screened in E. coli for isobutyl acetate production by external
supply of isobutanol.
Among the variants characterized, the F97W variant exhibited the best performance
(Figure 4-2C), with the similar protein expression levels in E. coli (Figure 4-8). As compared to
the wildtype, the F97W variant enhanced the isobutyl acetate production by 4-fold. Subsequent in
silico analysis showed that the mutation created a CH-π interaction between the hydrogen of
isobutanol and the indole ring of F97W (Figure 4-2D). The model also indicated no change in
distance between the isobutanol and active site (His-189) in F97W. Therefore, the CH-π interaction
is likely responsible for the improved activity of F97W variant towards isobutyl acetate
biosynthesis.
4.4.3

In vitro characterization of CAT Sa F97W
Before deploying CATSa F97W for isobutyl acetate biosynthesis in the thermophile CBP

organism C. thermocellum, we checked whether the F97W mutation affected thermal stability of
the enzyme. We overexpressed and purified both the wildtype CATSa and CATSa F97W variant
(Figure 4-3A). The SDS-PAGE analysis confirmed the expression and purification of the enzymes
by bands with the expected monomer size (25.8 kDa). Thermofluor assay revealed that the F97W
variant slightly lowered the wildtype melting point from 72 o C to 68.3o C (Figure 4-3B).
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Figure 4-3: In vitro characterization of the wildtype CATSa and CATSa F97W mutant. (A) SDSPAGE of the purified CATSa and CATSa F97W. The black arrow indicates the expected size of
expressed target proteins, including CATSa and CATSa F97W. Notations: column 1, cru de cell
extract of IPTG induced E. coli BL21(DE3) harboring pET_CATSa; column 2, His-tag purified
CATSa; column 3, crude extract of IPTG induced E. coli BL21(DE3) harboring pET_CATSa F97W;
column 4, His-tag purified CATSa F97W; and M, protein ladder. (B) Melting curve of CATSa and
CATSa F97W. The intensity was normalized by each maximum value. (C) Michaelis-Menten plots
of CATSa and CATSa F97W for various isobutanol concentrations at 50 o C. The co-substrate, acetylCoA, was supplemented at the saturated concentration of 2 mM. The error bars represent standard
deviation of three biological replicates.
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Since CATSa F97W maintained high melting point, it is possible that CATSa F97W still maintains
its functionality at high temperature (≥ 50 o C) but needs to be thoroughly characterized.
Table 4-2 shows the in vitro enzymatic activities of both the wildtype CATSa and CATSa
F97W at 50o C. The turnover number (kcat) of CATSa F97W was two times higher than that of the
wildtype. The increased turnover number of CATSa F97W led to 1.9-fold increase in enzymatic
efficiency (kcat/K M, 4.08 ± 0.62, 1/M/sec) while the mutation did not result in significant change
in K M. The improved enzymatic efficiency of CATSa F97W agrees with the enhanced isobutanol
production observed in the in vivo characterization using the CATSa-overexpressing E. coli (Figure
4-2C).
Based on the rigidity of the binding pocket, we originally presumed that mutagenesis on
the binding pocket would result in activity loss towards chloramphenicol. Surprisingly, CATSa
F97W retained the activity towards chloramphenicol (Table 4-2). The F97W mutation decreased
kcat but also lowered K M, resulting in a compensation effect. Turnover number of CATSa (kcat,
202.97 ± 3.36, 1/sec) was similar to the previously reported value by Kobayashi et al. [16], but KM
(0.28 ± 0.02, mM) was about 1.75-fold higher. The difference might attribute to the experimental
condition and analysis performed. Kobayashi et al. used chloramphenicol in a range of 0.05-0.2
mM for the assay and the Lineweaver-Burk method for analysis, while we used a 0-1.0 mM range
with a nonlinear regression analysis method. Interestingly, affinity towards acetyl-CoA was
independent of the alcohol co-substrates (Table 4-4), suggesting that the alcohol affinity would be
likely the main bottleneck for microbial production of isobutyl acetate.
Taken altogether, the F97W mutation not only resulted in 1.9-fold higher enzymatic
efficiency towards isobutanol but also retained thermal stability of CATSa. Thus, CATSa F97W
variant can serve a starting candidate to demonstrate direct biosynthesis of isobutyl acetate at
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elevated temperatures by C. thermocellum.
4.4.4

Isobutyl acetate production from cellulose at elevated temperature by an engineered
C. thermocellum overexpressing CAT Sa F97W
We next investigated whether C. thermocellum overexpressing CATSa F97W could

produce isobutyl acetate at elevated temperature. This thermophile was chosen because it has a
high cellulolytic activity suitable for CBP, a one-step process configuration for cellulase
production, cellulose hydrolysis, and fermentation for direct conversion of lignocellulosic biomass
to fuels and chemicals [51]. Furthermore, studies have demonstrated that the wildtype C.
thermocellum has native metabolism capable of endogenously producing precursor metabolites for
ester biosynthesis, such as acetyl-CoA, isobutyryl-CoA, as well as ethanol [52] and higher
alcohols (e.g., isobutanol) under high cellulose loading fermentation [53-55] (Figure 4-4A and
Figure 4-9A).
We started by generating two isobutyl acetate-producing strains, HSCT0101 and
HSCT0102, by introducing the plasmids pHS0024 (harboring the wildtype CATSa) and
pHS0024_F97W (harboring the mutant CATSa F97W) into C. thermocellum DSM1313. Colonies
were isolated on antibiotics selective plates at 55 o C. Successful transformation clearly indicated
that CATSa F97W conferred the thiamphenicol resistance and hence maintained CAT activity. This
result agrees with the in vitro enzymatic activity of CATSa F97W (Table 4-2).
We next evaluated whether the C. thermocellum strains could synthesize isobutyl acetate
from cellobiose. Since the endogenous isobutanol production from a typical cellobiose
concentration (5 g/L) is low [55], we supplemented the media with 2 g/L isobutanol. Both
HSCT0101 and HSCT0102 could produce isobutyl acetate at 55 o C as expected. Like the in vivo
characterization in E. coli (Figure 4-2C), HSCT0102 outperformed HSCT0101 with 3.5-fold in152

Figure 4-4: Isobutyl acetate production in the engineered C. thermocellum. (A) A simplified
isobutyl acetate production pathway from cellulose in C. thermocellum. (B) Biosynthesis of
isobutyl acetate of the wildtype and engineered C. thermocellum strains at 55o C from MTC
medium with 5 g/L cellobiose and external supply of 2 g/L isobutanol. Isobutyl acetate was
measured after 24 hours from the hexadecane layer of cell cultures. Initial OD of each cell culture
was in a range of 0.8−1.0. The error bars represent standard deviation of five biological replicates.
Statistical analysis: t-test, “*” p value < 4 × 10−4 , t = -6.475, df = 7. (C) Kinetic profiles of cell
growth and residual cellulose of HSCT0102. HSCT0102 was cultured in C-MTC medium with 20
g/L Avicel PH-101. The error bars represent standard deviation of three biological replicates. (D)
Kinetic profiles of isobutanol and isobutyl acetate production by HSCT0102 in C-MTC medium
with 20 g/L Avicel PH-101. The error bars represent standard deviation of three biological
replicates. Abbreviation: KOR, 2-ketoisovalerate ferredoxin oxidoreductase; ADH, alcohol
dehydrogenase.
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crease in isobutyl acetate production (Figure 4-4B). Interestingly, we also observed the parent C.
thermocellum M1354 produced a trace amount of isobutyl acetate (< 0.1 mg/L) even though this
strain does not harbor a CAT (Figure 4-9). This phenomenon was only observed when hexadecane
overlay was used during fermentation for ester extraction. One possible explanation is the
endogenous activity of esterases in C. thermocellum might have been responsible for low isobutyl
acetate production while the organic phase overlay helps extract the target ester. It should be noted
that the esterase reaction is reversible and more thermodynamically favorable for ester degradation
than biosynthesis.
Finally, we tested whether HSCT0102 could endogenously produce isobutyl acetate
directly from cellulose at elevated temperature (55 o C). After 72 hours, cell mass, containing 550
mg/L of pellet protein, reached 1.04 g/L, and 17 g/L of cellulose were consumed (Figure 4-4C).
About 103 mg/L of isobutanol were produced for the first 48 hours, and further increased up to
110 mg/L for additional 24 hours (Figure 4-4D). Besides isobutanol, C. thermocellum also
produced other fermentative metabolites, including ethanol, formate, acetate, and lactate, as
expected (Figure 4-10A and B). For the target isobutyl acetate production, HSCT0102 did not
produce isobutyl acetate for the first 24 hours but started accumulating the target product for the
next 48 hours. The observed profile of isobutyl acetate production could be attributed to the low
substrate affinity of CATSa F97W (Table 4-2). The final titer of isobutyl acetate reached 1.9 mg/L.
Besides the production of the desirable ester isobutyl acetate, we also observed that HSCT0102
produced other detectable esters such as ethyl acetate, ethyl isobutyrate, and isobutyl isobutyrate
(Figure 4-10A, C, and D). Endogenous biosynthesis of these esters could be explained from the
complex redox and fermentative metabolism of C. thermocellum [54, 56]. C. thermocellum can
endogenously synthesize the precursor metabolites such as acetyl-CoA and ethanol via the ethanol
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Table 4-2: Kinetic parameters of the wildtype CATSa and mutant CATSa F97W. The reactions
were performed at 50o C. The co-substrate, acetyl-CoA, was supplied at the saturated concentration
of 2 mM. Melting temperature (Tm) of CATSa and CATSa F97W are 72.0 ± 0.8, and 68.3 ± 1.2o C,
respectively.

Substrates
KM (mM)
kcat (1/sec)
kcat/K M (1/M/sec)

CATSa
Chloramphenicol
Isobutanol
0.28 ± 0.02
138.66 ± 28.92
202.97 ± 3.36
0.30 ± 0.03
5
7.37 ± 0.48 x 10
2.16 ± 0.45
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CATSa F97W
Chloramphenicol
Isobutanol
0.18 ± 0.01
144.77 ± 23.65
102.63 ± 2.04
0.59 ± 0.05
5
5.77 ± 0.49 x 10
4.08 ± 0.62

biosynthesis pathway and isobutyryl-CoA and isobutanol via the valine biosynthesis (Figure 410A). With the availability of four precursor metabolites, C. thermocellum could produce ethyl
acetate, ethyl isobutyrate, isobutyl acetate, and isobutyl isobutyrate as observed experimentally
(Figure 4-10A, C, and D).
Taken altogether, C. thermocellum overexpressing CATSa successfully produced the target
isobutyl acetate from cellulose at elevated temperature (55 o C). However, the low titer and
conversion rate require optimization to improve isobutyl acetate production in future studies. One
of the key metabolic engineering targets is to enhance enzymatic efficiency of CATSa. In contrast
to S. cerevisiae-derived ATF1 that has high specificity towards isobutanol [6] and can be expressed
in E. coli to achieve a high titer of 17.5 g/L isobutyl acetate and 80% theoretical maximum product
yield [7], CATSa F97W exhibits a relatively low affinity towards isobutanol. The rationale for
utilizing CATSa instead of ATF1 is that CATSa is thermostable, and this study is the first ever to
report its function for ester production at elevated temperatures. Tuning gene expression in C.
thermocellum is another challenge that needs to be addressed for enhanced ester production.
Since CATSa F97W still retains the activity towards chloramphenicol, adaptive evolution
strategies such as chemically induced chromosomal evolution (CIChE) can offer a promising
strategy to improve the gene expression level [57]. Finally, model-guided optimization at system
levels should be implemented for the most effective conversion of cellulose into isobutyl acetate
to achieve high production of isobutyl esters and other class of esters [58-60].

4.5 Conclusions
This study demonstrated that a CAT can function and/or be re-purposed as an AAT for novel
biosynthesis of designer esters at elevated temperatures. Both in silico and in vivo characterization
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discovered a broad alcohol substrate range of the thermostable chloramphenicol acetyltransferase
from Staphylococcus aureus (CATSa). Discovery of the F97W mutation of CATSa by model-guided
protein engineering enhanced isobutyl acetate production. This study presented the first report on
the consolidated bioprocessing of cellulose into ester(s) by the thermophilic CBP organism C.
thermocellum harboring an engineered thermostable CATSa F97W. Overall, this research helps
establish a foundation for engineering non-model organisms for direct conversion of
lignocellulosic biomass into designer bioesters.
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4.7 Appendix
Table 4-3: A list of primers used in this study. The bold and underlined letters indicate restriction
and site-directed mutation sites, respectively.
Primers
Primer sequence (5’ to 3’)
Site-saturation mutagenesis of CATSa F97
CATSa_F BamHI
CTCTGGATCCAATGAACTTTAATAAAATTGATTTAG
CTCTGAGCTCTTATAAAAGCCAGTCATTAGGCCTA
CATSa_R SacI
F97R_F
TGATGGTGTATCTAAAACACGTTCTGGTATTTGGACTC
F97R_R
GTCCAAATACCAGAACGTGTTTTAGATACAC
TGATGGTGTATCTAAAACAAAATCTGGTATTTGGACTC
F97K_F
F97K_R
GTCCAAATACCAGATTTTGTTTTAGATACAC
TGATGGTGTATCTAAAACACTGTCTGGTATTTGGACTC
F97L_F
F97L_R
GTCCAAATACCAGACAGTGTTTTAGATACAC
F97W_F
TGATGGTGTATCTAAAACATGGTCTGGTATTTGGACTC
GTCCAAATACCAGACCATGTTTTAGATACAC
F97W_R
F97I_F
TGATGGTGTATCTAAAACAATTTCTGGTATTTGGACTC
GTCCAAATACCAGAAATTGTTTTAGATACAC
F97I_R
F97G_F
TGATGGTGTATCTAAAACAGGTTCTGGTATTTGGACTC
F97G_R
GTCCAAATACCAGAACCTGTTTTAGATACAC
TGTTTAACTTTAAGAAGGAGATATACCAT
CATSa_F
BB_CATSa_R
TGGATCCTGGCTGTGG
CATTCTTTACAGGAGTCCAAATACCAGAGGCTGTTTTAGATACACCATCAAAAATTGTAT
F97A_R
BB_F97A_F
GCCTCTGGTATTTGGACTCCTGTA
F97N_R
CATTCTTTACAGGAGTCCAAATACCAGAATTTGTTTTAGATACACCATCAAAAATTGTAT
AATTCTGGTATTTGGACTCCTGTA
BB_F97N_F
F97D_R
CATTCTTTACAGGAGTCCAAATACCAGAGTCTGTTTTAGATACACCATCAAAAATTGTAT
GACTCTGGTATTTGGACTCCTGTA
BB_F97D_F
F97C_R
CATTCTTTACAGGAGTCCAAATACCAGAACATGTTTTAGATACACCATCAAAAATTGTAT
BB_F97C_F
TGTTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGATTGTGTTTTAGATACACCATCAAAAATTGTAT
F97Q_R
BB_F97Q_F
CAATCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGACTCTGTTTTAGATACACCATCAAAAATTGTAT
F97E_R
BB_F97E_F
GAGTCTGGTATTTGGACTCCTGTA
F97H_R
CATTCTTTACAGGAGTCCAAATACCAGAGTGTGTTTTAGATACACCATCAAAAATTGTAT
CACTCTGGTATTTGGACTCCTGTA
BB_F97H_F
F97M_R
CATTCTTTACAGGAGTCCAAATACCAGACATTGTTTTAGATACACCATCAAAAATTGTAT
ATGTCTGGTATTTGGACTCCTGTA
BB_F97M_F
F97P_R
CATTCTTTACAGGAGTCCAAATACCAGATGGTGTTTTAGATACACCATCAAAAATTGTAT
BB_F97P_F
CCATCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGAGCTTGTTTTAGATACACCATCAAAAATTGTAT
F97S_R
BB_F97S_F
AGCTCTGGTATTTGGACTCCTGTA
CATTCTTTACAGGAGTCCAAATACCAGACGTTGTTTTAGATACACCATCAAAAATTGTAT
F97T_R
BB_F97T_F
ACGTCTGGTATTTGGACTCCTGTA
F97Y_R
CATTCTTTACAGGAGTCCAAATACCAGAGACTGTTTTAGATACACCATCAAAAATTGTAT
GTCTCTGGTATTTGGACTCCTGTA
BB_F97Y_F
F97V_R
CATTCTTTACAGGAGTCCAAATACCAGAGTATGTTTTAGATACACCATCAAAAATTGTAT
TACTCTGGTATTTGGACTCCTGTA
BB_F97V_F
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Table 4-3: Continued
Primers

Primer sequence (5’ to 3’)

Clostridium thermocellum engineering
pHS005 construction (C. thermocellum markless gene deletion plasmid)
pNW33N backbone F

GAGGGGTTTTTTGC CAATCCCGTTTGTTGAACTAC

pNW33N backbone R

CAGGAAACAGCTATGA CAGGAAACAGCTATGACCATGA

PgapDH F

TCATAGCTGTTTCCTGTAATTACTGTATCTCTCTGGC

PgapDH R

AATTTTATTAAAGTTCATTAATATCGCCTCCTATTGTAA

CATSa F

AGGAGGCGATATTAATGAACTTTAATAAAATTGATTTAGACAATTGG

CATSa R

ATCATGACGTCGACCTCCTTTATTATAAAAGCCAGTCATTAGGCCTATC

hpt F

AAAGGAGGTCGACGTCATGATAAATCAAATTAAAGAAATTTTGG

hpt R

CGGCCGTGTACAATAGCAAAACACTATCTCTCATAC

2927 terminator F

GACAAAGAAGATATGGACTAAAAAATATACAAAGGTTTCTTG

2927 terminator R

GATTATGCGGCCGTGTACAATAGCAAAACACTATCTCTCATACA

MCS2 F

ATTGTACACGGCCGCATAATC

MCS2 R

CAAACGGGATTGGCAAAAAACCCCTCAAGACC

bb tdk F

TTTCCCGTTCTCTCTGATTGTGA

bb tdk R

GCAACTATGGATGAACGAAATAGA

tdk F

ATTTCGTTCATCCATAGTTGCAAAAATCCGCTTAAGTCCGCG

tdk R

CAATCAGAGAGAACGGGAAAGTTTCCGTATAAATTAACCGTATG

pHS0024 construction (pHS005 without hpt gene)
-hpt F

AAAATATACAAAGGTTTCTTGTG TTTTTAATACCGTTATGTTAATATAATG

-hpt R

CACAAGAAACCTTTGTATATTTT TTATAAAAGCCAGTCATTAGGC
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Table 4-4: K M values of CATSa and CATSa F97W towards acetyl-CoA.
CATSa
Co-substrates

Chloramphenicol

KM (mM)

0.08 ± 0.01

CATSa F97W
Isobutanol

0.06 ± 0.01
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Chloramphenicol
0.09 ± 0.01

Isobutanol
0.08 ± 0.02

Figure 4-5: (A) Reaction mechanisms of acetylation of chloramphenicol by CATSa. Briefly, the
acetylation of chloramphenicol involves three steps. First, the 3-hydroxyl group of the
chloramphenicol is deprotonated by the imidazole ring of histidine of the CAT’s active site,
generating the activated oxygen. Then, the nucleophilic attack by the oxyanion at the thioester
carbonyl carbon of acetyl-CoA generates a tetrahedral intermediate. Finally, loss of the free CoA
yields the 3-acetylchloramphenicol. (B) Physical properties of various alcohols used in this study
and the predicted Gbind from the docking simulation. (C) Correlation between the predicted Gbind
and the molecular weights of alcohols. (D) Correlation between the predicted G bind and the LogP
values of alcohols.
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Figure 4-6: Multiple sequence alignment of CATs. (A) Sequence alignment of 22 CATs classified
as Type A. (B) Sequence alignment of 27 CATs including Type A and Type B. The highly
conserved regions are red highlighted.
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8

F152W

0.90
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Y195R
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0.47
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Y195Q

2.13
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Y115K
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1.51

0.35
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2.69

2.43
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2.25
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Y195M

2.14

1.89

0.25

15

F152H

2.21

1.96

0.25

Cut off: 1.0 kcal/mol

Figure 4-7: (A) Alanine scan of 23 identified residues in the binding pocket of the CATSaisobutanol-acetyl-CoA complex. Stability (kcal/mol) represents the relative stability of each
variant with respect to its wild type. Positive Stability values indicate that the structural stability
of the protein-ligands complex is reduced if a specific residue is replaced with alanine, suggesting
the significance of that specific residue in the protein-ligands complex. (B) Representative residue
scan from a selection of six selected residues identified from alanine scan in the binding pocket of
the CATSa-isobutanol-acetyl-CoA or CATSa-chloramphenicol-acetyl-CoA complex. To identify
the significant residues in the isobutanol binding exclusively, the Stability(Cm-iBtOH) was
calculated by subtracting StabilityiBtOH from StabilityCm.
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Figure 4-8: SDS-PAGE analysis of E. coli crude extracts expressing CATSa F97 variants. The
overexpressed CATSa F97 variants are shown in the red box. The alphabets annotate the amino
acid variants. LD; protein ladder.
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Figure 4-9: An overlaid GC/MS chromatogram showing the trace amount of isobutyl acetate
produced by the wildtype C. thermocellum.
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Figure 4-10: Fermentative products from cellulose fermentation of HSCT0102. (A) Simplified
metabolic pathways of C. thermocellum for biosynthesis of native fermentative metabolites and
heterologous esters. It should be noted that C. thermocellum has two unique routes to
endogenously produce isobutanol from 2-ketoisovalerate. The first route, that was experimentally
validated [1], uses the 2-ketoisovalerate ferredoxin oxidoreductase (KOR) and alcohol
dehydrogenase (ADH) converts 2-ketoisovalerate into isobutyryl-CoA and then isobutanol. The
second route, that has not yet been experimentally validated, uses keto-isovalerate decarboxylase
(KIVD) and ADH to covert 2-ketoisovalerate to isobutyraldehyde and then isobutanol.
Heterologous, thermostable KIVD was engineered in C. thermocellum [1]; however, the
endogenous acetolactate synthase (ilvBN), that catalyzes the first step in valine biosynthesis and
might have KIVD activity as observed in E. coli [2, 3], has not yet been experimentally confirmed
in C. thermocellum. (B) Kinetic profile of biosynthesis of other esters besides isobutyl acetate,
including ethyl acetate, ethyl isobutyrate, and isobutyl butyrate. (C) An overlaid GC/MS
chromatogram demonstrating ester biosynthesis. (D) Kinetic profile of other fermentative
metabolites. Abbreviation: IS, internal standard.
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5 Establishment of a High-Throughput
Screening Platform for Rapid Probing
Specificities of Alcohol Acyltransferases
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5.1 Abstract
Alcohol acyltransferases (AATs) enable microbial biosynthesis of a large space of esters by
condensing an alcohol and an acyl-CoA. However, the substrate promiscuity of AATs prevents
selectivity microbial biosynthesis of designer esters. Here, we developed a high-throughput
microbial screening platform that facilitates rapid identification of efficient AATs for designer
ester biosynthesis. First, we established a microplate-based culturing technique with in situ
fermentation and extraction of esters. We next validated its capability in rapid profiling of the
alcohol substrate specificity of 20 variants of CATSa, a chloramphenicol acetyltransferase from
Staphylococcus aureus, for microbial biosynthesis of various acetate esters with various
exogeneous alcohol supply. Then, by coupling the microplate-based culturing technique with an
established colorimetric assay, we developed a high-throughput microbial screening platform for
AATs. Finally, we demonstrated that this platform could identify the CATSa F97W with enhanced
isobutyl acetate (IBA) synthesis as well as reveal three beneficial mutations (P348M, P348A, and
P348S) in ATF1Sc, an AAT from Saccharomyces cerevisiae, for enhanced butyl acetate production
from the engineered variants via computer-guided protein design. In addition to screening of
AAT/CAT by direct ester measurement, the platform can also be used to evaluate the effect of
AAT/CAT variants expression on cell growth in a high-throughput manner. We anticipate the
high-throughput microbial screening platform can be a useful tool to identify novel AATs that
have important roles in nature and industrial biocatalysis for designer bioester production.

5.2 Introduction
Esters are an important class of industrial chemicals with broad applications as flavors,
fragrances, cosmetics, pharmaceuticals, green solvents, and advanced biofuels [1]. Currently,
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esters are mainly produced by chemical synthesis from petroleum-based feedstocks that are neither
renewable nor sustainable [2]. Alternatively, microbial conversion has emerged as an alternative
route for renewable and sustainable production of esters [3-8]. Critical to the microbial
biosynthesis of esters is the requirement of alcohol acyltransferases (AATs, EC 2.3.1.84) that
catalyze a thermodynamically-favorable condensation of an alcohol and acyl-CoA in an aqueous
environment. Because esters are commonly found in nature such as fruits (e.g., apple [9-11],
apricot [12], banana [13], melon [14, 15], papaya [16], and strawberry [13, 17-19]) or yeast
fermentation [8, 20], various eukaryotic AATs have been identified and recently exploited for
microbial biosynthesis of esters using synthetic biology and metabolic engineering approaches [4,
21-23]. Recent discovery and repurposing of prokaryotic chloramphenicol acetyltransferases
(CATs, EC 2.3.1.28) to function as AATs have further expanded the library of ester-producing
enzymes [2, 4]. However, due to the substrate promiscuity of these AAT/CAT enzymes,
controllable microbial synthesis of designer esters with high selectivity remains a significant
challenge [5, 7].
Bioprospecting and protein engineering are promising strategies to find novel AATs with
high specificity and activity toward a desired ester [2, 24]. For instance, AATAc, an AAT from
Actinidia chinensis, was engineered to enhance butyl octanoate production and the AATAc S99G
variant achieved about 4.5-fold improved butyl octanoate production in Escherichia coli [25].
Similarly, CATSa, a CAT from Staphylococcus aureus, was engineered to improve isobutyl acetate
(IBA) production and the CATSa F97W variant achieved ~3.5-fold improved IBA production in a
thermophilic, cellulolytic bacterium Clostridium thermocellum via computer-guided ration protein
engineering [2]. Further, by combining both bioprospecting and model-guided protein engineering
strategies, novel CATs have recently been discovered with improved efficiency, robustness, and
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compatibility [24]. Even though engineering AATs/CATs for higher specificity and activities is a
promising approach, a large space of novel AATs/CATs is still underexplored.
For screening of a large space of AATs/CATs in a high-throughput manner, in vitro assay
methods such as i) the DTNB (5,5′-dithiobis-(2-nitrobenzoic acid)) assay [2, 8, 26] and ii) the αKGDH (α-ketoglutarate dehydrogenase)-coupled assay [27, 28] can be used. These assays are
designed to quantify free CoAs, released from the esterification reaction of AAT/CAT by
measuring either the 412 nm absorbance of yellowish TNB (5-thio-2-nitrobenzoic acid) for the
DTNB assay or the 340 nm absorbance of NADH (nicotinamide adenine dinucleotide) for the αKGDH-coupled assay. However, these in vitro assays require expensive acyl-CoA reagents and
enzyme purification steps.
Alternatively, direct measurement of esters for rapid, high-throughput screening of
AAT/CAT specificities and activities in vivo can be attractive before determining the catalytic
efficiencies in depth for promising enzyme candidates. Here, esters produced by microbes can be
extracted with a solvent (e.g., hexane or hexadecane) and then quantified. While the conventional
gas chromatography coupled with mass spectrometer (GC/MS) has been used for this approach, it
is low-throughput and expensive. For high-throughput screening, the colorimetric assay, based on
the hydroxylamine/iron chemistry, can be used. This assay is designed to quantify esters by
measuring the absorbance of a colored ferric hydroxamate complex generated via two chemical
reactions at 520 nm [29-32].
In this study, we aimed to develop a high-throughput microbial screening platform to
identify novel AATs/CATs for biosynthesis of designer esters in a simple, rapid, and efficient
manner. We started by establishing a microplate-based culturing technique with in situ
fermentation and extraction of esters. Then, by coupling the microplate-based culturing technique
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with a modified colorimetric assay, we developed a high-throughput microbial screening platform
to identify novel AATs. The platform could measure both ester titer and cell growth, which enables
rapid profiling of relative specificities and activities of AATs/CATs as well as evaluation of the
effect of AATs/CATs expression on microbial health. We next validated the developed highthroughput screening platform by probing the alcohol substrate preference of 20 variants of F97
residue in CATSa and identifying ATF1Sc variants for enhanced butyl acetate production from a
library of ATF1Sc, generated by computer-guided protein design,. We envision that the developed
high-throughput microbial ester synthesis screening platform is a useful tool to identify novel
AATs that have important roles in nature and industrial biocatalysis for designer bioester
production.
5.2.1

Strains and plasmids
Strains and plasmids used in this study are listed in Table 5-1. Briefly, for molecular

cloning, E. coli TOP10 was used. For ester production, BL21 (DE3) and EcDL002 [5] were used
as a host strain. The pETDuet-1 plasmids containing 20 F97 variants of CATSa were used to
examine the role of the F97 residue on the alcohol substrate preference in CATSa [2]. The pATF1Sc
was constructed by subcloning ATF1 gene in pDL004 [3] into pET29 by Gibson Assembly method
[33]. The variants of ATF1Sc were generated by site-directed mutagenesis using the QuickChange
method. All the constructed plasmids were introduced into the host strains using chemical
transformation. The primers used in this study are listed in Table 5-2. The alphabets annotate the
amino acid variants. R; arginine, H; histidine, K; lysine, D; aspartic acid, E; glutamic acid, S;
serine, T; threonine, N; asparagine, Q; glutamine, C; cysteine, G; glycine, Y; tyrosine, P; proline,
A; alanine, V; valine, I; isoleucine, L; leucine, M; methionine, F; phenylalanine, W; tryptophan.

175

Table 5-1: A list of plasmids and strains used in this study.
Name
Strains

Description

E. coil TOP10
BL21 (DE3)
EcDL002
Plasmids

Source

F– mcrA
Δ(mrr-hsdRMS-mcrBC)
φ80lacZΔM15
ΔlacX74 recA1 araD139
Δ(ara-leu)7697 galU galK Invitrogen
λ– rpsL(StrR) endA1 nupG
F- ompT hsdSB (rB- m B-) gal dcm (DE3)
Invitrogen
TCS083 ΔfadE (DE3)
[5]

pCATSa
pCATSa F97R
pCATSa F97H
pCATSa F97K
pCATSa F97D
pCATSa F97E
pCATSa F97S

pETDuet-1 carrying CATSa; Amp R
pETDuet-1 carrying CATSa F97R; Amp R
pETDuet-1 carrying CATSa F97H; Amp R
pETDuet-1 carrying CATSa F97K; Amp R
pETDuet-1 carrying CATSa F97D; Amp R
pETDuet-1 carrying CATSa F97E; Amp R
pETDuet-1 carrying CATSa F97S; Amp R

[2]
[2]
[2]
[2]
[2]
[2]
[2]

pCATSa F97T
pCATSa F97N
pCATSa F97Q
pCATSa F97C
pCATSa F97G
pCATSa F97Y
pCATSa F97P
pCATSa F97A

pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa
pETDuet-1 carrying CATSa

F97T; Amp R
F97N; Amp R
F97Q; Amp R
F97C; Amp R
F97G; Amp R
F97Y; Amp R
F97P; Amp R
F97A; Amp R

[2]
[2]
[2]
[2]
[2]
[2]
[2]
[2]

pCATSa F97V
pCATSa F97I
pCATSa F97L
pCATSa F97M
pCATSa F97W
pDL004
pATF1 Sc

pETDuet-1 carrying CATSa F97V; Amp R
pETDuet-1 carrying CATSa F97I; Amp R
pETDuet-1 carrying CATSa F97L; Amp R
pETDuet-1 carrying CATSa F97M; Amp R
pETDuet-1 carrying CATSa F97W; Amp R
pETite carrying ATF1 Sc; Kan R
pET29 carrying ATF1 Sc; Kan R

pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc

P348W
P348R
P348M
P348H
P348K
P348N
P348I
P348S

pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc

P348W; Kan R
P348R; Kan R
P348M; Kan R
P348H; Kan R
P348K; Kan R
P348N; Kan R
P348I; Kan R
P348S; Kan R

This
This
This
This
This
This
This
This

study
study
study
study
study
study
study
study

pATF1 Sc
pATF1 Sc
pATF1 Sc
pATF1 Sc

P348D
P348C
P348A
P348Q

pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc
pET29 carrying ATF1 Sc

P348D; Kan R
P348C; Kan R
P348A; Kan R
P348Q; Kan R

This
This
This
This

study
study
study
study
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[2]
[2]
[2]
[2]
[2]
[3]
This study

5.2.2

Culture media
For molecular cloning, seed cultures, and protein expression analysis, the Luria-Bertani

(LB) medium, comprising of 10 g/L peptone, 5 g/L yeast extract, and 5 g/L NaCl, was used. For
characterization of CATSa F97 and ATF1Sc variants, the M9 hybrid medium [5] with 20 g/L glucose
was used. 50 µg/mL kanamycin (kan), or 50 µg/mL ampicillin (amp) was used where applicable.
5.2.3

Characterization of CAT Sa F97 variants with external supply of isobutanol
For pre-cultures, 1% (v/v) of stock cells were grown overnight in 5 mL of LB at 37 o C and

200 rpm on a 75° angled platform in a New Brunswick Excella E25 (Eppendorf, CT, USA). Next,
5 % (v/v) of pre-cultures were inoculated into 100 µL of the M9 hybrid medium containing 20 g/L
of glucose, 0.1 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG), and 2 g/L of isobutanol in
96-well microplates with or without hexadecane overlays in a 1:1 (v/v) ratio. Then, the microplates
were sealed with a plastic adhesive sealing film, SealPlate® (EXCEL Scientific, Inc., CA, USA)
to avoid cross contaminations and evaporation the culture medium. Finally, the microplates were
incubated at 37o C and 400 rpm for 24 hour (h) in an incubating microplate shaker (Fisher Scientific,
PA, USA).
5.2.4

Characterization of CAT Sa F97 variants with external supply of various alcohols
For pre-cultures, single colonies from LB agar plates were inoculated into 100 µL of LB

in 96-well microplates using sterile pipette tips. Specifically, the picked single colony by a sterile
pipette tip was subsequently mixed with the media in the target well. Then, the pre-cultures were
grown overnight at 37o C and 400 rpm in an incubating microplate shaker. For main cultures, 5 %
(v/v) of pre-cultures were inoculated into 100 µL of the M9 hybrid media containing 20 g/L of
glucose, 0.1 mM of IPTG, and 2 g/L of various alcohols including ethanol, butanol, isobutanol, or
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2-phenylethyl alcohol in 96-well microplates with or without hexadecane overlay in a 1:1 (v/v)
ratio. Then, the microplates were sealed with a plastic adhesive sealing film and incubated at 37oC
and 400 rpm for 24 h in an incubating microplate shaker.
5.2.5

Characterization of ATF1Sc variants with external supply of butanol
The pre-cultures were prepared as described in characterization of CATSa F97 variants with

external supply of various alcohols. For main cultures, 5 % (v/v) of pre-cultures were inoculated
into 120 µL of the M9 hybrid media containing 20 g/L of glucose, 0.1 mM of IPTG, and 2 g/L of
butanol in 96-well microplates with hexadecane overlay in a 1:1 (v/v) ratio. Finally, the
microplates were sealed with a plastic adhesive sealing film and incubated at 37 o C and 400 rpm
for 24 h in an incubating microplate shaker.
5.2.6

Molecular modeling and docking simulations
For the computer-guided rational protein engineering of ATF1 Sc, first, the 3D structures of

ATF1Sc, acetyl-CoA, and butanol were generated as previously described [2]. Then, to perform
docking simulations in MOE (Molecular Operating Environment software), the potential binding
pocket was identified using the ‘Site Finder’ tool of MOE. After identifying the potential binding
pockets, the best hit which includes H191 and D195, the conserved catalytic resides in AATs [34],
was chosen. Next, to obtain the acetyl-CoA-butanol-ATF1 complex, the docking simulations were
performed as previously described [35]. Briefly, acetyl-CoA and butanol were docked to the
binding pocket of ATF1Sc, sequentially. After the docking simulations, the best-scored binding
poses were selected.
5.2.7

In silico mutagenesis analysis
In silico mutagenesis analysis was carried out as previously described [35]. Specifically,
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the ‘residue scan’ tool of MOE was used to identify beneficial mutations with the selected residues.
The △affinity values (kcal/mol) represent the relative binding affinity of the mutant to the wild
type. In short, a more negative value indicates a mutant with better affinity.
5.2.8

Cell growth
The optical density (OD) was measured at 600 nm using a BioTek Synergy HT microplate

reader (BioTek Instruments, Inc., VT, USA). The dry cell weight (DCW) of BL21 strains was
obtained by multiplication of the optical density of culture broth with a pre-determined conversion
factor, 0.385 g/L/OD.
5.2.9

Gas chromatography coupled with mass spectroscopy (GC/MS)
For GC/MS analysis of esters, the microplates were centrifuged at 4,800 x g for 5 min and

the hexadecane overlays were used for quantification of esters. The samples were prepared by
diluting hexadecane extracts from the cultures with hexadecane containing internal standard
(isoamyl alcohol) in a 1:1 (v/v) ratio. Then, 1 μL of samples were d irectly injected into a gas
chromatograph (GC) HP 6890 equipped with the mass selective detector (MS) HP 5973. For the
GC system, helium was used as the carrier gas at a flow rate of 0.5 mL/min and the analytes were
separated on a Phenomenex ZB-5 capillary column (30 m x 0.25 mm x 0.25 μm). The oven
temperature was programmed with an initial temperature of 50℃ with a 1℃/min ramp to 58℃.
Next a 25℃/min ramp was deployed to 235℃ and then a 50℃/min ramp was deployed to 300℃.
Finally held a temperature of 300℃ for 2 minutes to elute any residual non-desired analytes. The
injection was performed using the splitless mode with an initial injector temperature of 280℃.
For the MS system, a selected ion monitoring (SIM) mode was deployed to detect analytes.
The SIM parameters for detecting esters were as follows: i) for ethyl acetate, ions 45.00, and 61.00
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detected from 4.15 to 5.70 min, ii) for isoamyl alcohol (internal standard), ions 45.00, and 88.00
detected from 5.70 to 6.60 min, iii) for isobutyl acetate, ions 61.00, and 101.00 detected from 6.60
to 7.75 min, iv) for butyl acetate, ions 61.00, and 116.00 detected from 7.75 to 13.70 min, and v)
for 2-phenethyl acetate, ions 104.00, and 121.00 detected from 13.70 to 13.95 min.
5.2.10 Colorimetric assay for quantification of esters
For colorimetric assay of esters, the previously reported method [32] was slightly modified
as described here. Specifically, first, hydroxylamine solutions and stock ferric iron(Ⅲ) solutions
were prepared as previously described [32]. Then, hydroxymates were produced by reacting 60
µL of hexadecane overlay from the culture with 20 µL of hydroxylamine stock solution for 10
minute (min). Subsequently, with an addition of 120 µL of the ferric working solution (1/20diluted stock ferric iron(Ⅲ) solutions in ethanol), the reactants were incubated for 5 min, resulting
in ferric hydroxamate. Finally, the absorbance of the produced ferric hydroxamate was measured
at 520 nm (Ab520 ) using a BioTek Synergy HT microplate reader. The chemical reactions were
incubated in an incubating microplate shaker at room temperature. Hexadecane overlays,
hydroxylamine solutions, and stock ferric iron(Ⅲ) solutions were transferred or aliquoted using a
F1-ClipTipTM multichannel pipette (Thermo Fisher Scientific, USA). Esters were quantified using
the standard curve.

5.3 Results and Discussion
5.3.1

Establishing a microplate-based culturing technique with in situ fermentation and
extraction of esters
To develop a high-throughput microbial screening platform (MiSP), we first examined

whether the microplate-based culturing technique could be reliably used to monitor cell growth
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and continuously extract esters for downstream quantification. We characterized the recombinant
BL21 (DE3) strains harboring 20 CATSa F97 variants [2] in 96-well plates for production of
isobutyl acetate (IBA) with or without solvent (hexadecane) overlay for in situ ester extraction
(Figure 5-1A). As a basis for comparison, we also performed the high cell density culturing method
in shake tubes that was previously employed for AAT screening [2].
The characterization results show that IBA production in microplates followed the same
trend of its production observed in high cell density cultures (Figure 5-1B). Strong positive linear
correlations (R 2 ≥ 0.98) in IBA production existed between the microplate-based and high cell
density culturing methods (Figure 5-1C and D). The microplate-based culturing method could
validate that the CATSa F97W variant achieved the highest IBA production among the 20
characterized variants (Table 5-3). While these variants exhibited different activities toward IBA,
their cell cultures exhibited similar growth (Figure 5-5)
While IBA production in microplates was almost the same with or without solvent overlays,
we found several advantages of using solvent overlays for microbial biosynthesis of esters. First,
the solvent overlay enables a more reliable measurement of growth kinetics in microplates by
avoiding medium evaporation that caused water condensation (Figure 5-1E) and hence interfered
with optical density measurement (Figure 5-5). Second, the solvent overlay simplifies the sample
preparation step for quantification of esters and is compatible with a high-throughput workflow,
where esters in the solvent layer can be extracted for downstream measurement by either a GC/MS
method or a colorimetric assay [3-6, 32]. Third, the solvent overlay helps alleviate the product
toxicity during fermentation [36] because esters are known to be inhibitory to microbial health
[37].
Overall, the microplate-based culturing method with solvent overlays is reliable and suit-

181

Figure 5-1: A microplate-based culturing method for microbial biosynthesis of esters. (A)
Workflow of the microplate-based culturing method. (B) Comparison of IBA production after 24
hours among three different culturing methods by the recombinant BL21 (DE3) strains carrying
CATSa F97 variants. (C-D) Comparison of (C) IBA titer and (D) specific productivity
measurements among three different culturing methods. The error bars represent standard
deviation of four biological replicates (n=4). (E) Effect of solvent overlay on growth kinetics
measurement in the microplate-based culturing method.
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able for a rapid, high-throughput in vivo screening platform for microbial ester production.
5.3.2

Revealing the influential role of CATSa F97 residue by profiling the alcohol
preference of a library of F97 variants with the microplate-based culturing method
Our previous study discovered that the CATSa F97W mutant improved its catalytic

efficiency towards isobutanol by ~2-fold [2]. We hypothesized that the F97 residue might have an
important role in determining the alcohol substrate preference. Using the established microplatebased culturing method, we evaluated whether it could be used for rapid profiling of the alcohol
substrate preference of CATSa F97 variants. We characterized the recombinant E. coli strains
carrying 20 CATSa F97 variants with exogenous supplementation of alcohols in the media
including linear, short-chain alcohols (ethanol, butanol), a branched-chain alcohol (isobutanol),
and an aromatic alcohol (2-phenylethyl alcohol) in microplates with hexadecane overlay.
The characterization results showed the mutation in F97 residue changed the ester
production profiles (Figure 5-2A, Table 5-4), suggesting that F97 residue plays an important role
in determining the alcohol substrate preference of CATSa. For IBA production, the F97W variant
achieved the highest 6.39-fold improved IBA production as compared to its wildtype, which was
consistent with the prior in vitro study showing that F97W variant has ~2-fold improved catalytic
efficiency towards isobutanol [2]. Among the four target acetate esters investigated, F97W
achieved the highest IBA production (91.2 mg/L) while F97C achieved the highest BA production
(18.3 mg/L). This result indicates that F97C and F97W variants prefer butanol and isobutanol than
the other characterized alcohols, respectively. Similarly, F97H achieved the highest 2-PEA
production (182.3 mg/L), showing its alcohol substrate preference shift towards 2-phenthyl alcohol
rather than the other alcohols. Remarkably, F97T showed significantly improved selective
production of BA (12.4 mg/L), demonstrating the feasibility of production of designer esters using
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re-programmed CATs. Figure 5-2B shows that the binding pockets of CATs are formed at the
subunit interfaces [38] and the F97 residue located on the opposite subunit of the catalytic residues,
H189 and D193. One possible explanation on how only one residue replacement changes the
substrate preference of CATSa is that the mutation in the F97 residue might dramatically change
the size and/or shape of binding pocket by alternating the interactions among subunits of CATSa.
Taken altogether, the microplate-based culturing method coupled with GC/MS can be employed
for rapid profiling of substrate preferences of AATs. The method successfully revealed the
important role of the F97 residue in determining the alcohol substrate preference of CATSa.
5.3.3

Developing a high-throughput microbial screening platform for ester biosynthesis by
integration of the microplate-based culturing method and a colorimetric assay
High-throughput screening of ester biosynthesis has been limited by the use of GC/MS.

Since the reactions of esters with hydroxylamine generate hydroxamic acids that form purple
complexes with ferric ion, esters can be determined colorimetrically by measuring absorbance at
520 nm (Figure 5-3A) [29-32]. This colorimetric assay has recently been adapted for highthroughput screening of ethyl acetate (EA) production from C5, C6, and C12 carbon sources in
Kluyveromyces marxianus [32] where cell culture samples were first collected followed by ester
extraction with hexane. This protocol is useful but might not be compatible with the microplatebased culturing method in our study because hexane is toxic and hence cannot be used for in situ
fermentation and extraction, unlike hexadecane. Here, we tested whether the colorimetric assay
can be modified and coupled with the microplate-based culturing method to facilitate a highthroughput microbial screening of AATs for ester biosynthesis.
To evaluate whether this colorimetric assay can be modified and coupled with the
microplate-based culturing method, we started to test the compatibility of hexadecane with the
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Figure 5-2: Rapid profiling of the alcohol substrate preference of CATSa F97 variants. (A) Relative
fold change in ester production to wild type. (B) The 3D structure of homology model of CATSa
and the reaction mechanism. F97 residue (in green); catalytic residues H189 and D193 (in cyan);
binding pockets (in grey clouds).
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colorimetric assay by i) quantifying the IBA titer of the hexadecane overlay samples, which have
been quantified by GC/MS in the previous study [2], with the colorimetric assay and ii) comparing
it with GC/MS results. The results showed that while the IBA titer measured by the colorimetric
assay was slightly overestimated compared to that measured by GC/MS (Figure 5-3B), the overall
trend of IBA titer was almost identical with a correlation coefficient of 0.972 (Figure 5-3C). We
also found that the colorimetric method could overestimate the IBA production due to the
inevitable by-product, EA formation, compared to the GC/MS method because the E. coli host
produces ethanol endogenously, EA can be produced by the unspecific activity of AAT (Figure 53D, and Table 5-5).
To avoid this problem, we can use △Ab520 adj. values (Ab520 of host strain w/ AAT and w/
alcohol doping - Ab520 values of host strain w/ AAT and w/o alcohol doping) instead of the △Ab520
values (Ab520 values of host strain w/ AAT – Ab520 values of host strain w/o AAT) for reliable
quantification of target esters. Similarly, we can also use a host strain void of the endogenous
pathways causing the biosynthesis of the unwanted alcohol byproduct (e.g., ethanol).
During our protocol development, we observed another interesting phenomenon that the perturbed
emulsified layer of an immiscible the hexadecane-ethanol mixture interfered with the measured
absorbance and generated irreproducible data. Note that ethanol is originated from the ferric
solution used in the colorimetric assay. This problem did not occur in the previous study [32] likely
because hexane used for ester extraction is miscible in ethanol. To address this problem, we used
a centrifugation step to create the immiscible hexadecane-ethanol mixture with the transparent
organic phase and strong purple aqueous phase (Figure 5-6 A and B). We also have validated the
reliability of this assay using a IBA standard curve and we could observe an almost perfect linear
correlation (R2 =0.999) was established between absorbance at 520 nm and IBA concentration wit-
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Figure 5-3: (A) Biosynthesis of isobutyl acetate by CATSa with isobutanol doping. Dotted lines
represent the endogenous ethanol synthesis pathway. Filled line represents the ester synthesis
pathway by CATSa. (B) Chemical reactions involved in the colorimetric assay. (C) Comparison of
IBA titer measured by the colorimetric assay and GC/MS. (D) Correlation between IBA titer
measured by GC/MS and the colorimetric assay. The error bars represent standard deviation of
three biological replicates (n=3).
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hin 0-200 mg/L (Figure 5-6C). Taken together, the microplate-based culturing method coupled
with a colorimetric assay is suitable for high-throughput microbial screening of AATs/CATs for
ester biosynthesis.
5.3.4

Combining the computer-guided protein engineering and high-throughput microbial
screening platform to rapid identify ATF1 Sc variants for improved BA production
With the established high-throughput microbial screening platform, we applied it to rapidly

identify the engineered ATF1Sc mutants for enhanced BA production. We started by generating a
library of potential ATF1Sc candidates for improved BA production in silico for high-throughput
microbial screening. To do this, we first created a 3-D structure of ATF1Sc using the homology
model of 15-O-acetyltrabsferase (PDB:3FP0) best predicted by SWISS-MODEL [39]. We next
identified the binding pocket of ATF1Sc for docking simulations of the BA co-substrates, including
acetyl-CoA and butanol. Based on the homology model, the binding pocket of ATF1Sc consists of
24 residues including V32, Y36, H191, D195, G196, R197, T316, I347, P348, A349, D350, R352,
N370, V371, I374, F376, Y399, I403, L407, K426, L448, S449, N450, V451, F471, and Q473,
where the H191 and D195 are the catalytic residues (Figure 5-7A). By performing docking
simulations, we generated the acetyl-CoA-butanol-ATF1Sc complex and identified the residues
interacting with butanol including V32, Y36, D195, P348, V371, L447, S449, Q473, Q475, and
S483 (Figure 5-7B). Finally, we performed the residue scan against these 10 residues to select the
top 12 candidates including P348W, P348R, P348M, P348H, P348K, P348N, P348I, P348S,
P348D, P348C, P348A, and P348Q for experimental characterization (Figure 5-7C).
To identify the positive ATF1Sc variants for improved BA production, we next
characterized the top 12 candidates using TCS083 △fadE (DE3) [5] as a host strain with or without
an exogenous addition of butanol in microplates with hexadecane overlay to obtain △Ab520 adj.
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values to avoid the overestimation of the BA titer by endogenous EA production. Then the positive
ATF1Sc variants was screened by quantifying the BA titer using the colorimetric assay (Figure 58A and B). We also confirmed that there is a very strong linear correlation (R 2 =0.999) between
the absorbance and the concentration of BA standards in the range of 0-200 mg/L (Figure 5-8C).
Finally, the colorimetric assay results revealed that the P348M, P348S, or P348A mutation in
ATF1Sc improves BA production by 3.34, 2.90, or 2.88-fold, respectively (Figure 5-4A). To
confirm this result, we compared the BA titers measured by the colorimetric assay with those by
GC/MS. Remarkably, we could observe almost identical BA titers between the two methods (Table
5-6) with a strong linear correlation (R 2 =0.973) (Figure 5-4B). This result demonstrates the
reliability of the developed HTS platform in this study. Interestingly, like the F97 residue in CATSa
(Figure 5-2B), the P348 residue in ATF1Sa is also located on the opposite side of the catalytic
residues including H191 and D195 (Figure 5-4C) and interacts with an alcohol substrate, which
might determine the alcohol substrate preference.
Overall, we rationally engineered ATF1 Sc for improved BA production through a
computer-guided rational protein engineering and rapidly identified the beneficial ATF1Sc variants
using the established high-throughput microbial screening platform.

5.4 Conclusions
We developed a high-throughput microbial screening platform to probe specificities of
AATs/CATs for designer ester biosynthesis. This platform integrated the microplate culturing
method with a modified colorimetric assay previously established, which provides useful
information about AAT expression and activity, microbial health, and ester production. For the
microplate-based culturing protocol, the use of solvent overlays is critical to minimize medium
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Figure 5-4: Screening of the positive ATF1Sc variants for improved BA production (A) BA
production of ATF1Sc variants quantified by the colorimetric assay. (B) Correlation of BA titer
measurement between the colorimetric assay and GC/MS in. (C) The location of P348 residue in
ATF1Sc. A yellow cloud represents a binding pocket of ATF1 Sc. The error bars represent standard
deviation of four biological replicates (n=4).
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evaporation, generate reproducible growth measurement, and eliminate the ester extraction step.
For colorimetric assay, the addition of a centrifugation step is crucial to avoid the interference of
ethanol-hexadecane immiscible layer that causes irreproducible measurement. The highthroughput microbial screening platform not only confirmed CATSa F97W with enhanced isobutyl
acetate synthesis but also identified the three ATF1Sc (P348M, P348A, and P348S) variants
generated by computer-guided rational protein engineering for enhanced butyl acetate production.
Overall, this study presents a high-throughput microbial screening platform for rapid profiling of
the alcohol substrate preference of AATs for production of designer esters. We believe that this
platform is scalable and compatible with automated microplate handling systems to increase its
screening capacity.
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5.6 Appendix
Table 5-2: A list of primers used in this study. The underlined letters indicate site-directed
mutation sites of ATF1Sc. F, R, and BB represent forward, reverse, and backbone, respectively.
Primers

Primer sequence (5’ to 3’)

ATF1Sc_F

ATAATTTTGTTTAACTTTAAGAAGGAGATATAGATA
TGAATGAAATCGATGAGAAAAAT

ATF1Sc_R

TTTGTTAGCAGCCGGATCTCAGTGGTGGTGGTGGTG
GTGGATAGGGCCTAAAAGGAGAG

BB_ATF1Sc_F

ATCCACCACCACCACC

BB_ATF1Sc_R
P348W F
P348W R
P348R_F
P348R_R
P348M_F
P348M_R
P348H_F
P348H_R
P348K_F
P348K_R
P348N_F
P348N_R
P348I_F
P348I_R
P348S_F
P348S_R
P348D_F
P348D_R
P348C_F
P348C_R
P348A_F
P348A_R
P348Q_F
P348Q_R

Description

ATCTATATCTCCTTCTTAAAGTTAAAC AAAATTATT
TCTAG
ATTTTTATCTGGGCAGATTGCCGCTC ACAACTA
GGCAATCTGCCCAGATAAAAATATCC GTAAGCC
ATTTTTATCCGTGCAGATTGCC GCTCAC AACTA
GGCAATCTGCACGGATAAAAATATCCGTAAGCC
ATTTTTATCATGGCAGATTGCCGCTC ACAACTA
GGCAATCTGCCATGATAAAAATATCC GTAAGCC
ATTTTTATCCATGCAGATTGCC GCTCAC AACTA
GGCAATCTGCATGGATAAAAATATCC GTAAGCC
ATTTTTATCAAAGCAGATTGCC GCTCAC AAC TA
GGCAATCTGCTTTGATAAAAATATCC GTAAGCC
ATTTTTATCAATGCAGATTGCCGCTC ACAACTA
GGCAATCTGCATTGATAAAAATATCCGTAAGCC
ATTTTTATCATTGCAGATTGCC GCTCAC AACTA
GGCAATCTGCAATGATAAAAATATCC GTAAGCC
ATTTTTATCACAGCAGATTGCCGCTC ACAACTA
GGCAATCTGCTGTGATAAAAATATCCGTAAGCC
ATTTTTATCGATGCAGATTGCCGCTC ACAACTA
GGCAATCTGCATCGATAAAAATATCC GTAAGCC
ATTTTTATCTGCGCAGATTGCC GCTCAC AACTA
GGCAATCTGCGCAGATAAAAATATCCGTAAGCC
ATTTTTATCGCTGCAGATTGCC GCTCAC AACTA
GGCAATCTGCAGCGATAAAAATATCCGTAAGCC
ATTTTTATCCAGGCAGATTGCCGCTC ACAACTA
GGCAATCTGCCTGGATAAAAATATCC GTAAGCC
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Primers for constructing
the pATF1 Sc by Gibson
assembly

Primers for constructing
the pATF1 Sc variants by
site-directed mutagenesis
using the QuickChange
method

Table 5-3: Summary of isobutyl acetate (IBA) production in BL21 strains carrying CATSa F97
variants in various culture methods. WT, wild type.
IBA titer (mg/L)
F97
variants
R
H
K
D
E
S
T
N
Q
C
G
Y
P
A
V
I
L
M
F (WT)
W

Specific IBA productivity (mg/gDCW/h)
Culture methods

Microplates
w/o overlay

Microplates
w/ overlay

High cell
density
w/ overlay

Microplates
w/o overlay

Microplates
w/ overlay

High cell
density
w/ overlay

6.3 ± 1.0

3.5 ± 1.0

0.6 ± 0.1

0.57 ± 0.00

0.59 ± 0.17

0.01 ± 0.00

13.7 ± 4.4
2.6 ± 1.0

20.4 ± 3.8
4.6 ± 2.2

24.4 ± 5.8
1.3 ± 0.2

1.13 ± 0.01
0.22 ± 0.01

3.75 ± 0.69
0.75 ± 0.36

0.58 ± 0.14
0.03 ± 0.00

0.6 ± 0.2

1.6 ± 0.5

0.4 ± 0.1

0.05 ± 0.01

0.26 ± 0.09

0.01 ± 0.00

0.4 ± 0.3
0.7 ± 0.2

1.0 ± 0.2
1.0 ± 0.3

0.6 ± 0.1
0.9 ± 0.3

0.03 ± 0.00
0.06 ± 0.00

0.16 ± 0.04
0.17 ± 0.05

0.01 ± 0.00
0.02 ± 0.01

0.6 ± 0.2
0.4 ± 0.4

0.9 ± 1.0
1.5 ± 1.2

1.0 ± 0.4
0.8 ± 0.1

0.05 ± 0.02
0.04 ± 0.01

0.16 ± 0.18
0.26 ± 0.21

0.02 ± 0.01
0.02 ± 0.00

0.4± 0.6
28.5 ± 5.2

4.6 ± 1.5
23.0 ± 5.4

0.7 ± 0.1
42.9 ± 12.8

0.04 ± 0.02
2.70 ± 0.00

0.83 ± 0.28
4.02 ± 0.94

0.02 ± 0.00
1.01 ± 0.30

2.6 ± 1.7
17.1 ± 1.2

3.9 ± 3.6
12.7 ± 2.3

0.9 ± 0.2
18.2 ± 2.1

0.25 ± 0.01
1.51 ± 0.01

0.66 ± 0.61
2.15 ± 0.38

0.02 ± 0.00
0.42 ± 0.05

7.9 ± 0.7
4.3 ± 0.5

7.0 ± 0.7
3.9 ± 1.2

7.2 ± 0.7
3.4 ± 1.0

0.72 ± 0.01
0.41 ± 0.01

1.06 ± 0.11
0.60 ± 0.18

0.17 ± 0.02
0.08 ± 0.02

4.6 ± 0.4
1.0 ± 0.5

3.9 ± 0.7
2.2 ± 1.3

4.3 ± 0.3
2.7 ± 0.9

0.41 ± 0.01
0.10 ± 0.01

0.66 ± 0.12
0.38 ± 0.23

0.10 ± 0.01
0.06 ± 0.02

2.7± 0.4
9.2 ± 1.8

3.2 ± 0.5
9.4 ± 2.2

2.3 ± 0.7
8.4 ± 1.1

0.27 ± 0.01
0.78 ± 0.01

0.53 ± 0.09
1.47 ± 0.35

0.05 ± 0.02
0.20 ± 0.03

14.2 ± 3.0

18.9 ± 5.5

32.6 ± 5.5

1.31 ± 0.01

3.46 ± 1.01

0.76 ± 0.13

90.5 ± 41.7

75.7 ± 3.7

159.3 ± 24.1

8.74 ± 0.01

12.72 ± 0.62

3.66 ± 0.55
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Table 5-4: The results of rapid profiling the alcohol substrate preference of 20 F97 variants of
CATSa. WT, wild type; n.d., not detected.
F97 variants
R
H
K
D
E
S
T
N
Q
C
G
Y
P
A
V
I
L
M
F (WT)
W

Ethyl acetate
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
0.4

Ester titer (mg/L)
Butyl acetate
Isobutyl acetate
0.8
6.3
0.8
13.8
0.4
2.7
0.4
0.6
n.d.
0.4
0.3
0.7
12.4
0.6
n.d.
0.4
3.0
0.4
18.3
28.7
2.5
2.6
11.3
17.2
7.5
7.9
6.1
4.3
5.6
4.6
2.2
1.1
1.5
2.7
4.0
9.2
4.3
14.3
16.9
91.2
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2-Phenylethyl acetate
11.8
182.3
19.7
3.8
1.4
3.5
7.2
3.3
12.1
153.9
4.5
109.9
58.7
59.1
127.0
63.3
79.3
139.0
149.4
194.6

Table 5-5: Comparison of ester titer measured by GC/MS and △Ab520 values. △Ab520 = Ab520 host
strain carrying CATSa F97 variants – Ab520 host strain . WT, wild type; n.d., not detected. The used hexadecane
overlay samples were obtained from high cell density cultures [1].
CATSa
F97 variants
R
H
K
D
E
S
T
N
Q
C
G
Y
P
A
V
I
L
M
F (WT)
W

Ethyl acetate
n.d.
0.0 ± 0.0
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
0.1 ± 0.0
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
0.1 ± 0.0
0.2 ± 0.0

GC/MS
Ester titer (mg/L)
Isobutyl acetate
0.6 ± 0.1
24.4 ± 5.8
1.3 ± 0.2
0.4 ± 0.1
0.6 ± 0.1
0.9 ± 0.3
1.0 ± 0.4
0.8 ± 0.1
0.7 ± 0.1
42.9 ± 12.8
0.9 ± 0.2
18.2 ± 2.1
7.2 ± 0.7
3.4 ± 1.0
4.3 ± 0.3
2.7 ± 0.9
2.3 ± 0.7
8.4 ± 1.1
32.6 ± 5.5
159.3 ± 24.1
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Colorimetric assay
Total
0.6 ± 0.1
24.5 ± 5.8
1.3 ± 0.2
0.4 ± 0.1
0.6 ± 0.1
0.9 ± 0.3
1.0 ± 0.4
0.8 ± 0.1
0.7 ± 0.1
43.0 ± 12.9
0.9 ± 0.2
18.2 ± 2.1
7.2 ± 0.7
3.4 ± 1.0
4.3 ± 0.3
2.7 ± 0.9
2.3 ± 0.7
8.4 ± 1.1
32.6 ± 5.5
159.5 ± 24.2

△Ab520
0.03 ± 0.00
0.07 ± 0.00
0.01 ± 0.00
0.00 ± 0.01
0.01 ± 0.01
0.02 ± 0.00
0.02 ± 0.00
0.00 ± 0.01
0.01 ± 0.01
0.06 ± 0.01
0.01 ± 0.00
0.05 ± 0.00
0.02 ± 0.01
0.02 ± 0.01
0.03 ± 0.02
0.04 ± 0.02
0.02 ± 0.01
0.02 ± 0.01
0.09 ± 0.03
0.29 ± 0.02

Table 5-6: Butyl acetate titer measured by the colorimetric assay and GC/MS. △Ab520 adj. =
Ab520 BtOH – Ab520 None. Ab520 BtOH and Ab520 None represent the Ab520 values with or without an
exogenous addition of 2 g/L butanol, respectively. WT, wild type. Positive hits in bold.
Colorimetric assay
ATF1 Sc
variants

GC/MS

Ab 520 BtOH

Ab 520 None

△Ab 520 adj.

Butyl acetate
(mg/L)
using △Ab 520 adj.

Butyl acetate
(mg/L)

WT

0.14 ± 0.01

0.11 ± 0.00

0.03 ± 0.01

20.3 ± 5.3

20.5 ± 1.8

P348W

0.14 ± 0.01

0.11 ± 0.00

0.03 ± 0.01

18.0 ± 9.0

21.3 ± 7.2

P348R

0.12 ± 0.00

0.11 ± 0.00

0.02 ± 0.00

11.3 ± 3.1

12.1 ± 5.4

P348M

0.22 ± 0.00

0.12 ± 0.01

0.10 ± 0.01

68.0 ± 6.9

69.9 ± 8.7

P348H

0.12 ± 0.00

0.12 ± 0.00

0.00 ± 0.01

0.0 ± 3.4

5.3 ± 0.9

P348K

0.12 ± 0.00

0.11 ± 0.01

0.01 ± 0.01

8.0 ± 5.3

4.4 ± 1.0

P348N

0.12 ± 0.00

0.12 ± 0.00

0.00 ± 0.00

0.2 ± 2.0

5.0 ± 1.7

P348I

0.13 ± 0.00

0.11 ± 0.00

0.02 ± 0.00

13.0 ± 1.7

7.9 ± 2.9

P348S

0.20 ± 0.01

0.11 ± 0.00

0.09 ± 0.01

58.5 ± 7.6

62.7 ± 19.6

P348D

0.12 ± 0.00

0.11 ± 0.00

0.01 ± 0.00

9.2 ± 2.4

6.9 ± 1.5

P348C

0.14 ± 0.00

0.11 ± 0.00

0.03 ± 0.00

19.2 ± 1.1

20.5 ± 4.4

P348A

0.20 ± 0.02

0.11 ± 0.00

0.09 ± 0.02

59.0 ± 12.9

52.5 ± 22.7

P348Q

0.13 ± 0.00

0.10 ± 0.00

0.03 ± 0.00

17.7 ± 2.8

20.3 ± 5.0
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Figure 5-5: Growth curves of BL21 (DE3) strains carrying CATSa F97 variants in microplates w/
or w/o hexadecane overlay. Blue square indicates w/o overlay; Orange circle indicates w/ overlay.
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Figure 5-6: (A) Effect of centrifugation on the results of colorimetric assay. (B) The colorimetric
assay of hexadecane overlay samples and a series of isobutyl acetate standards with a different
concentration. (C) The isobutyl acetate standard curve used for quantification of isobutyl acetate
in the colorimetric assay.
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Figure 5-7: (A) The 3D structure of homology model of ATF1 Sc. A binding pocket of ATF1Sc (in
a yellow cloud); binding pocket residues of ATF1 Sc (in blue), (B) The 3D structure of acetyl-CoAbutanol-ATF1Sc complex. A binding pocket (in a yellow cloud); residues interacting with butanol
in the acetyl-CoA-butanol-ATF1Sc complex (in green). (C) Residue scan results of the residues
interacting with butanol in the acetyl-CoA-butanol-ATF1Sc complex. The orange bars represent
the selected top 12 candidates for further studies.
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Figure 5-8: The colorimetric assay of hexadecane overlays from the cultures of strains carrying
ATF1Sc variants (A) without or (B) with an exogenous addition of 2 g/L butanol. (C) The butyl
acetate standard curve used for the quantification of butyl acetate in the colorimetric assay.
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6 Evaluation of Growth Selection of Butyl
Acetate Production Modules with ATF1Sc
Variants in a Modular (Chassis) Cell
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6.1 Abstract
Alcohol acetyltransferases (AATs) are valuable biocatalysts that catalyzing an alcohol and
an acyl-CoA into an ester. To date, while microbial ester synthesis platforms has been well
established using AATs, its production is still inefficient for industrial-scale production. To
achieve efficient ester production, discovery or engineering efficient AATs is essential. However,
although several screening methods for rapid discovery of efficient novel AATs or identifying the
positive hits of engineered AAT variants have been developed, these screening approaches are not
the ideal methods for rapid identification of the best hit from a large library of potential candidates.
Thus, we need more efficient and scalable approaches to identify the best hit from a large library.
In this study, we have evaluated and demonstrated the potential of a modular (chassis) cell
as a growth selection platform of efficient AATs or ester production modules with a case study of
growth selection of a ATF1 variant (ATF1 P348M), engineered for the improved butyl acetate
production, in the modular (chassis) cell. Overall, the presented work can help accelerate the
discovery of efficient novel AATs or identification of the positive hits of engineered AAT variants
from a large library of potential candidates.

6.2 Introduction
Alcohol acetyltransferases (AATs) are valuable biocatalysts that catalyzing an alcohol and
an acyl-CoA into an ester (Figure 6-1A) [1, 2]. These enzymes have been studies for microbial
production of various esters including short-to-medium chain [3-9], aromatic [10, 11] and terpene
esters [12-17] from renewable resources. However, while microbial production of various esters
has been well demonstrated, its production is still inefficient for industrial-scale production. Thus,
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for a broader spectrum of industrial uses of renewable and sustainable esters, the microbial
platforms that can produce a larger library of esters in an efficient and systematic way are required.
To solve this problem, the concept of modular cell design has been proposed [18]. Based
on modular cell design, each optimal production strain can be obtained by assembling a modular
(chassis) cell with an exchangeable production module(s) in a plug-and-play fashion using a
chassis-based modular architecture [19]. Here, a module is defined as an essential and selfcontained functional unit, which has standardized interfaces, that enables composition of products
by combination [19]. Based on the definition above, an exchangeable production module(s)
contains auxiliary regulatory and metabolic pathways, and the modular (chassis) cell interfaces
with an exchangeable production module(s) via enzyme synthesis machinery and precursor
metabolites [19].
Further, because the modular (chassis) cell has been designed to be auxotrophic by
imposing cofactor imbalance and/or insufficient supply of precursor metabolites required for cell
growth [18], the production module(s) can be designed to balance redox, and/or supply
energy/precursor metabolites that required to rescue the growth defect of the modular (chassis)
cell to enable growth-coupled product formation in a plug-and-play fashion [20]. Based on this
design principle, because the modular (chassis) cell contains core metabolic phenotypes shared
among production modules, the desirable phenotype of each production strain is determined by
the production module. Thus, with this approach, the best production strains or modules can be
screened or selected with growth [18]. For example, the modular (chassis) cell with the stronger
production module achieves the faster cell growth, substrate consumption, and product formation
[21]. However, to achieve efficient ester production, although the modular (chassis) cell offers a
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frame for rapid development of efficient ester production strains, it still requires efficient ester
production modules.
To construct efficient ester production modules, because AATs have a critical role in
biosynthesis of esters, discovery or engineering a large library of efficient AATs is essential [22].
To date, for rapid discovery of efficient novel AATs or identifying the positive hits of engineered
AAT variants, several screening methods including i) a thin-layer chromatography (TLC) assay
[23], ii) a hydroxylamine/ferric iron assay [24-27], iii) a 5,5′-dithiobis-(2-nitrobenzoic acid)
(DTNB) assay [28-30], and iv) a coupled-enzyme assay with α-ketoglutarate dehydrogenase (αKGDH) [31, 32] have been developed. However, because with these screening approaches, each
individual candidate must be evaluated for the desired property with multiple steps, they were not
the ideal methods for rapid identification of the best hit from a large library of potential candidates.
Compared with the screening methods, selection methods offer more efficient and scalable
approaches to identify the best hit from a large library by directly eliminating undesired candidates
with a certain selective pressure to the library [33]. Specifically, growth selection platform
provides a facile and universal selection platform by employing growth as an easily measurable
readout which allows for substantially higher throughput (>106 samples per round of selection) as
compared to the 96-well plate-based screening methods [34-36]. Fortunately, because the modular
(chassis) cell offers a selection pressure through growth coupling between a chassis and a
production module, the modular (chassis) cell can be used as a growth selection platform for
identification of superior enzymes or production modules [21]. However, to date, while growth
selection of other enzymes such as pyruvate decarboxylase (PDC) in an ethanol production module
has been demonstrated in the modular (chassis) cell [21], its studies on AATs or ester production
modules has been limited majorly due to a lack of AAT variants.
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In our previous work (Chapter 5), because we could obtain ATF1Sc variants (AAT from
Saccharomyces cerevisiae) such as ATF1Sc P348M that showed improved butyl acetate (BA)
production in E. coli, here, we evaluated the potential of the modular (chassis) cell as a growth
selection platform of efficient AATs or ester production modules using the ATF1Sc variants.
Specifically, to evaluate the potential of the modular (chassis) cell as a growth selection platform
of efficient AATs of ester production modules, we first constructed the modular cells carrying
butyl acetate production modules with ATF1 Sc wildtype or ATF1Sc P348M variant. Then by
comparing the growth of the modular (chassis) cell (TCS095 (DE3)) with its derivatives including
the modular (chassis) cell carrying butyl acetate production modules with ATF1Sc wildtype
(EcJWBA) or ATF1Sc P348M variant (EcJWBA mut), the potential of the modular (chassis) cell as
a growth selection platform of efficient AATs or ester production modules has been evaluated.
Overall, this work can help facilitate rapid discovery of efficient novel AATs or identifying the
positive hits of engineered AAT variants in the modular (chassis) cell.

6.3 Materials and Methods
6.3.1

Strains and plasmids
Strains and plasmids used in this study are listed in Table 6-1. For molecular cloning, E.

coli TOP10 was used. For validation of a butanol production module and growth selection of AAT
variants, TCS095 [21] were used as a host strain. All the constructed plasmids were introduced
into host strains using chemical transformation. The primers used in this study are listed in Table
6-2.
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Table 6-1: A list of plasmids and strains used in this study.
Name
Strains
E. coil TOP10
MG1655 (DE3)

Description

Source

F– mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74
recA1 araD139 Δ(ara-leu)7697 galU galK λ– rpsL(StrR)
endA1 nupG
F– λ– (DE3)

Invitrogen
[37]

TCS095 (DE3)

MG1655 ΔldhA::ΔfrdA::ΔsfcA::ΔmaeB::Δzwf::Δndh::Δpta::
ΔpoxB::ΔadhE (DE3)

[21]

EcDL112

TCS095 (DE3)/ pCT24

[21]

EcJWBtOH

TCS095 (DE3)/ pBtOH

This study

EcJWBA

TCS095 (DE3)/ pBtOH pATF1

This study

EcJWBAmut
EcJWATF1

TCS095 (DE3)/ pBtOH pATF1 P348M
TCS095 (DE3)/ pATF1

This study
This study

EcJWATF1 mut

TCS095 (DE3)/ pATF1 P348M

This study

pCT24

pETite PT7lac::pdc::adhB; Kan R

[38]

pBtOH

pACYCD PT7lac::atoB::hbd::crt-PT7lac::ter::adhE2; CmR

This study
Chapter 5

Plasmids

pATF1
pATF1 P348M

R

pET29 PT7lac::ATF1 Sc; Kan
pET29 PT7lac:: ATF1 Sc P348M; Kan R
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Table 6-2: A list of primers used in this study. F, R, and BB represent forward, reverse, and
backbone, respectively.
Primers

Primer sequence (5’ to 3’)

BB_BtOH_F

GTAGAAAGGTTCGACAGGATTTAAAAAGAGGAGAAAATGAAAGTGACCA
ATCAAAAAGAG
CGCAGCAGCGGTTTCTTTACCAGACTCGAGTTAGAAACTCTTTATGTAAA
TGTCTTTGAG
TAACTCGAGTCTGGTAAAGAAACC

BB_BtOH_R

TTTCTCCTCTTTTTAAATCCTGTCGAACCTTTCTAC

adhE2_F
adhE2_R
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6.3.2

Culture media
For molecular cloning, and seed cultures, LB (Lysogeny Broth) medium was used. For

validation of butanol production module, TBD 50 , TB (Terrific Broth) medium containing 50 g/L
glucose was used (without supplementation with glycerol). For growth selection of ATF1 variants,
M9D10 , M9 medium containing 10 g/L glucose was used. 30 µg/mL chloramphenicol (Cm), and/or
50 µg/mL kanamycin (Kan) was added to the media for selection where applicable.
6.3.3

Validation of a butanol production module
For seed cultures, 1% (v/v) of stock cells were grown overnight in 5 mL of LB medium

with appropriate antibiotics on a 75° angled platform in a New Brunswick Excella E25 at 37 °C
and 200 rpm. Next, 1% (v/v) of seed cultures inoculated in 500 mL baffled flasks containing 50
ml of TBD 50 medium with appropriate antibiotics. The cells were aerobically grown in shaking
incubators at 37o C, 200 rpm and induced at an O.D.600 of 0.6~0.8 with 0.1 mM of IPTG at 28o C.
After 2 hours of induction, 10 ml of the cultures were allocated into 25 mL anaerobic culture tubes
and each tube was overlaid with 1ml hexadecane (20% (v/v)) for in situ ester recovery. Finally,
the anaerobic culture tubes were sealed with a rubber stopper inside the anaerobic chamber and
grown for another 24 hours on a 75° angled platform in shaking incubators at 28o C, 200 rpm. All
anaerobic culture tubes were prepared inside the anaerobic chamber contains a mixture of gases
(90% N2 , 5% H2 , and 5% CO2 ). The experiments were performed with biological triplicates.
6.3.4

Growth selection of an efficient butyl acetate production module with ATF1Sc
variants
For seed cultures, the single colonies from LB agar plates were inoculated into 5 mL of LB

medium with appropriate antibiotics on a 75° angled platform in a New Brunswick Excella E25 at
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37 °C and 200 rpm. Next, 1% (v/v) of seed cultures were transferred into 5 mL of M9D10 medium
with appropriate antibiotics to adapt the cell to a defined environment. Then, the cells were
aerobically grown overnight in shaking incubators at 37o C, 200 rpm. Next, 1% (v/v) of the cultures
were inoculated in 5 mL of M9D10 medium with appropriate antibiotics and the cells were grown
for 4 hours at 37 °C and 200 rpm. Then the cells were induced with 0.1 mM of IPTG at 28o C for
2 hours. Lastly, the induced cells were transferred into 25 mL anaerobic culture tubes containing
10 mL of M9D10 with an initial O.D.600 of ~0.05 and the tubes were sealed with a rubber stopper
inside the anaerobic chamber. Finally, the anaerobic culture tubes were characterized on a 75°
angled platform in a New Brunswick Excella E25 at 28 °C and 200 rpm. All anaerobic culture
tubes were prepared inside the anaerobic chamber contains a mixture of gases (90% N 2 , 5% H2,
and 5% CO2 ). The experiments were performed with biological replicates.
6.3.5

Cell growth
The optical density (OD) was measured at 600 nm using a BioTek Synergy HT microplate

reader (BioTek Instruments, Inc., VT, USA).
6.3.6

Statistics
Statistical analysis was performed with Microsoft Excel using the two-tailed unpaired
Student’s t test.

6.3.7

High performance liquid chromatography (HPLC)
Metabolites were quantified by using the Shimadzu HPLC system (Shimadzu Inc., MD,

USA) equipped with the Aminex HPX-87H cation exchange column (BioRad Inc., CA, USA)
heated at 50℃. A mobile phase of 10 mN H 2 SO 4 was used at a flow rate of 0.6 mL/min. Detection
was made with the reflective index detector (RID).
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6.4 Results and Discussion
6.4.1

Construction and validation of a butanol production module
To evaluate the potential of the modular (chassis) cell for growth selection of ester

production modules, we aimed to compare the growth of modular cells carrying butyl acetate
production modules with different AATs including ATF1 Sc wildtype and its P348M variant which
achieved ~3-fold improved butyl acetate production as compared to its wildtype (Chapter 5).
Accordingly, we began to construct a butanol production module because butyl acetate can be
synthesized by condensing butanol and acetyl-CoA by an ATF1Sc (Figure 6-1B). Note that acetylCoA is endogenously produced by the cell.
To construct a butanol production module, we first amplified the two DNA fragments
including i) butyl-CoA synthesis pathway from pDL2 [38] using a set of primers BB_BtOH_F and
BB_BtOH_ R and ii) adhE2 from genomic DNA of Clostridium acetobutylicum using a set of

primers adhE2_F and adhE2_R. Then, by assembling these two DNA fragments with Gibson
Assembly method [39], a butanol production module, pBtOH, has been constructed. After
constructing the butanol production module, we next introduced it into the modular (chassis) cell,
TCS095 (DE3), resulting in the butanol production strain, EcJWBtOH (Figure 6-1C and Table 61). Finally, to validate the butanol production module, we characterized EcJWBtOH.
The characterization results showed that EcJWBtOH produced 2.03 ± 0.01 g/L of butanol
from 7.35 ± 0.10 g/L of glucose after 24 h of culture, showing that the constructed butanol
production module is functional in the modular (chassis) cell (Figure 6-1D). After validating a
butanol production module, we next constructed butyl acetate production strains by introducing
pATF1 or pATF1 P348M into EcJWBtOH, resulting EcJWBA and EcJWBAmut, respectively
(Figure 6-1C and Table 6-1). Finally, to evaluate the potential of the modular (chassis) cell as a
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Figure 6-1: (A) Esterification reaction by an alcohol acyltransferase (AAT). (B) Biosynthetic
pathway of butyl acetate from glucose. (C) Validation of a butanol production module in
EcJWBtOH. (D) Schematic of strains carrying butyl acetate production modules with ATF1 Sc
wildtype (EcJWBA) or ATF1Sc P348M variant (EcJWBA mut). (E) Growth selection of an efficient
ATF1Sc variant. TCS095 (DE3) in red; EcDL112 in blue; EcJWBA in green; EcJWBA mut in purple.
TCS095 (DE3) was used as a negative control. EcDL112 carrying an ethanol production module
was used as a positive control. (F) Comparison of O.D.600 values between the modular (chassis)
cell (TCS095 (DE3)) and its derivatives after 48 h of cultures in the anaerobic culture tubes. N.C.
and P.C. represent a negative control and a positive control, respectively. *p < 0.002 (Student’s ttest).
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growth selection platform of efficient AATs or ester production modules, EcJWBtOH, EcJWBA,
and EcJWBAmut were characterized together with the modular (chassis) cell without a production
module, TCS095 (DE3), as a negative control [21], and the modular (chassis) cell carrying an
ethanol production module, EcDL112, as a positive control [21].
6.4.2

Growth selection of an efficient butyl acetate production module with ATF1Sc
variants in a modular (chassis) cell
The characterization results showed that while EcJWBtOH and EcJWBA grew almost as

similarly as TCS095 (DE3) (negative control), EcJWBAmut achieved ~2.5-fold improved growth
as compared to its counterpart, EcJWBA (Figure 6-1E and F). Specifically, after 48 h of
characterization, the O.D.600 value of EcJWBAmut was 0.193 ± 0.005 while that of EcJWBA was
0.078 ± 0.004 (Figure 6-1F and Table 6-3). Note that EcDL112 (positive control) achieved the
best growth among the characterized five strains as we expected (Figure 6-1E and F). This result
shows the potential of the modular (chassis) cell as a growth selection platform for discovery of
efficient novel AATs or identification of the positive hits of engineered AAT variants with growth
as an easily measurable readout. It also suggests that the modular (chassis) cell can be used for
growth-coupled ester production for improved ester production via adaptive laboratory evolution.
One possible explanation for this phenotype (growth) difference between EcJWBA and
EcJWBAmut is because ATF1Sc P348M of a butyl acetate production module in EcJWBAmut has
higher activity compared to that of its wildtype in EcJWBA, ATF1Sc P348M in EcJWBAmut
provides the stronger driving force to pull carbon fluxes to butyl acetate by enabling ~2.5-fold
improved growth of the modular (chassis) cell (Figure 6-1F). Note that the only carbon outlet in
butyl acetate production is butanol formation [40] and based on the conventional “push-and-pull”
metabolic engineering strategy [41], the carbon fluxes can be pulled into butyl acetate by ATF1 Sc
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Table 6-3: Summary of growth selection of an efficient butyl acetate production module with
ATF1Sc variants in a modular (chassis) cell. A and B indicate biological replicates.
Time
(h)
0
4
8
12
18
24
36
48

TCS095 (DE3)
A
B
0.069
0.063
0.100
0.093
0.095
0.092
0.095
0.090
0.092
0.093
0.090
0.089
0.087
0.087
0.084
0.085

EcJWBtOH
A
B
0.066
0.060
0.105
0.076
0.107
0.089
0.106
0.093
0.111
0.095
0.111
0.092
0.115
0.093
0.119
0.094

Strains
EcJWBA
A
B
0.062
0.067
0.083
0.083
0.083
0.089
0.087
0.090
0.084
0.090
0.079
0.088
0.077
0.085
0.075
0.081
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EcJWBAmut
A
B
0.064
0.071
0.088
0.107
0.113
0.124
0.124
0.138
0.139
0.149
0.158
0.168
0.178
0.178
0.197
0.188

EcDL112
A
B
0.063
0.063
0.088
0.088
0.120
0.122
0.135
0.145
0.168
0.194
0.245
0.296
0.448
0.525
0.651
0.753

variants (Figure 6-1B). However, while this work shows the potential of the modular (chassis) cell
as a growth selection platform for efficient AATs or ester production modules, further work is
necessary i) to elucidate the underlying principle in growth selection of efficient AATs or ester
production modules and ii) to demonstrate improved ester production via growth-coupling with a
large library.

6.5 Conclusions
As a proof-of-concept, here, we have evaluated the potential of the modular (chassis) cell
as a growth selection platform of efficient AATs or ester production modules with a case study of
growth selection of butyl acetate production modules with ATF1Sc variants (ATF1Sc wildtype and
its P348M) in the modular (chassis) cell. Interestingly, we could observe improved growth in the
modular (chassis) cell carrying a better butyl acetate production module. This result suggests the
potential for growth selection of efficient AATs or ester production modules as well as growthcoupled ester production in the modular (chassis) cell. Overall, this work can help accelerate the
discovery of efficient novel AATs or identification of the positive hits of engineered AAT variants
from a large library of potential candidates by allowing the use of simple phenotype (growth) as
an easy readout. As this platform matures, it is expected to enable rapid development of efficient
production strains for production of various designer esters via growth coupling between the
modular (chassis) cell and an efficient ester production module with selected AATs.
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7 Final Conclusions
Despite significant advances in genome-scale modeling and metabolic engineering, the
current strain development is still limited by the vast biochemical space in nature. The use of
modular (chassis) cells can enable us to develop optimal production strains for various products
with minimal experimental effort. However, for the use of modular (chassis) cells in production of
various biochemicals such as a library of esters, there are three major challenges including i) a vast
biochemical space; ii) a compatibility between a chassis cell and production modules; and iii) low
specificity of pathway enzymes such as alcohol acyltransferases (AATs) towards target
substrate(s). To address these challenges, first, a framework for rapid design, construction, and
validation of synthetic metabolic pathways have been developed with a case study of production
of C4-derived esters. Second, the compatibility between a chassis cell and production modules
have been improved by a combinatorial protein solubilization strategies. Third, an in silico rational
protein design protocol for altering the alcohol substrate specificity of AATs has been developed.
Fourth, a high-throughput screening (HTS) platform has been established to accelerate the
identification of beneficial mutations in AATs for improved production of designer esters. Finally,
the potential of a modular (chassis) cell as a growth selection platform of efficient AATs or ester
production modules has been evaluated using butyl acetate production modules with AAT variants.
Furthermore, to expand a library of esters that can be produced from renewable resources, modular
design principles have been used to establish a lactate ester platform.
Overall, this work contributes to validating the modular cell theory by offering a
framework for rapid design, construction, and validation of synthetic metabolic pathways in a
modular (chassis) cell with a case study of production of various esters.
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8 Recommendations
Although this work tackled the challenges that we can encounter in construction of
production modules with knowledge-based metabolic engineering strategies, this process can be
accelerated by using computational tools. For example, at the design stages, basic information on
each biological part comprised of a production module such as genetic parts (e.g., promoter
strength, ribosome binding site strength, and so on) and enzymes (e.g., kinetics, cost, metabolic
burdens, in vivo solubility, in vivo concentrations, and so on) can be predicted to aid better
decision-making for design of novel and efficient production modules. Then, at the build stages,
based on the information obtained from the predictions, each biological part can be assembled into
a production module. One suggestion, here, is developing and the use of a scoring matrix would
help to incorporate the data from multi-layered model predictions to bridge the gap between the
predictions and experimental implementation. Biosensors can also be used for improving product
formation via dynamic flux control. For example, for the synthesis of an ester, because two
different precursors (an alcohol and an acyl-CoA) are required at a 1:1 ratio, the carbon fluxes
and/or cellular resources should be allocated equally between these two molecules. Thus, to
address this problem, transcription factor-based biosensors can be used to regulate gene expression
of the biosynthesis pathways of an alcohol and an acyl-CoA.
One of the biggest challenges in growth selection of efficient ester production modules
and/or growth-coupled ester production in a modular (chassis) cell is the fastest growing strain is
not necessarily the best ester producer. Specifically, because ester production modules are
composed of three different submodules including i) an alcohol synthesis, ii) an acyl-CoA
synthesis, and iii) an AATase, it is possible that while these submodules are coupled to growth,

223

their combination to an ester pathway is not. Therefore, with growth, we cannot differentiate the
best ester producer from the best precursor producers such as an alcohol, an acyl-CoA, or a
combination thereof. In other words, although we could select the winner with ester production
modules, for example, with ethyl butyrate production modules, growth selection could identify the
best ethyl butyrate producer, but also could select for the best ethanol or butyl-CoA producer. Thus,
to examine the potential of a modular (chassis) cell in growth selection of ester production modules
and/or growth-coupled ester production, we need to use the same alcohol and acyl-CoA production
modules by varying the AATase. However, to date, this study could not be conducted because
variants of AATs were not available.
Here, to obtain variants of AATs, a rational protein engineering protocol and a highthroughput ester synthesis screening platform have been developed. Then, by using a combination
of these two techniques, variants of ATF1Sc for improved butyl acetate production were identified.
Although this work showed the potential of a modular (chassis) cell in growth coupling of ester
production modules using butyl acetate production modules with ATF1 variants, further work is
required i) to elucidate the underlying principle in growth selection of efficient AATs or ester
production modules and ii) to demonstrate growth-coupled ester production with a large library.
The framework presented in this work enables the design and construction of a library of ester
production modules with AAT variants, hence contributing to the validation of modular design
principles with a case study of production of various esters.
As this technology matures, natural esters can be produced using microbes from renewable
resources in a sustainable and systematic way. For example, 2-phenethyl acetate has rose smell.
Thus, if the market demand for natural rose smell increasing beyond what nature can offer,
microbes can be used to produce 2-phenethyl acetate, by simply assembling the submodules
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including i) an alcohol synthesis (e.g., 2-phenylethyl alcohol), ii) an acyl-CoA synthesis (e.g.,
endogenous acetyl-CoA), and iii) an AATase that specialized for condensing these two precursors
(e.g., ATF1Sc).
While this is an example of the systematic modular ester synthesis at the molecular level,
this platform can be easily moved to the cellular level to eliminate multiple cloning and
transformation steps as well as to harness the specialty of each strain by taking advantage of the
benefits of modular design principles. For example, a library of alcohol and ester producing strains
can rapidly constructed by introducing alcohol production modules and ester synthesis modules
into the strains A and B, respectively. Then, by using a “mix-and-match” approach at the cellular
level, a large array of esters can be produced without further strain development while harnessing
the specialty of each strain. For example, alcohol producing strain can utilize carbon source A (e.g.,
glucose), whereas ester producing strain can utilize carbon source B. (e.g., xylose). However, to
establish a robust modular co-culture system, further studies on engineering of stable consortium(a)
are required.
In summary, continued efforts in these areas would enable to establish a rapid, efficient,
and systematic strain development platform for production of a large space of molecules (e.g., a
large array of esters) while providing knowledge on engineering of efficient production modules
as well as modular (chassis) cells.
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